data_1p1e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1p1e _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.085 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 2.6 mm-40 -144.34 176.87 9.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.967 0.413 . . . . 0.0 111.169 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -110.9 134.95 52.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.432 HG23 HG13 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -115.66 146.9 41.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.257 0.551 . . . . 0.0 111.415 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.3 99.26 8.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.087 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.403 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -102.15 102.37 13.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.768 -178.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -85.97 119.32 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.466 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.8 mt -110.63 164.14 13.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.945 0.403 . . . . 0.0 111.221 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 90.4 m -130.31 127.71 40.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.581 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.24 112.27 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.416 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.04 146.02 99.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.24 -7.3 20.87 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.659 2.239 . . . . 0.0 112.902 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -98.81 -67.05 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.061 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.8 p -105.6 -51.33 3.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.46 -75.3 0.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.744 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.451 ' C ' ' H ' ' A' ' 39' ' ' ILE . 95.9 m-85 -138.72 76.25 1.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.955 0.407 . . . . 0.0 110.423 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.28 0.64 1.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.911 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.451 ' H ' ' C ' ' A' ' 37' ' ' PHE . 17.8 tt -95.86 132.89 38.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 116.861 0.331 . . . . 0.0 110.599 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -116.95 145.61 43.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.133 0.492 . . . . 0.0 111.731 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.76 122.71 37.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.01 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 0.0 111.296 -179.345 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 N--CA 1.463 -0.281 0 N-CA-C 113.112 0.389 . . . . 0.0 113.112 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -158.48 161.03 37.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.75 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.2 mt -80.22 138.57 19.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.7 t -164.34 41.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.241 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -176.32 123.19 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 0.0 111.48 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.448 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 3.6 mt -133.73 152.51 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.084 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -100.57 155.62 17.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.07 0.462 . . . . 0.0 111.36 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.15 43.25 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.902 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER 168.18 31.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.676 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -112.97 144.38 30.97 Favored Pre-proline 0 CA--C 1.527 0.088 0 CA-C-O 120.707 0.289 . . . . 0.0 110.782 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -45.1 -32.89 7.3 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.638 2.225 . . . . 0.0 112.661 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.411 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -66.39 -46.03 78.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.788 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.448 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -65.34 -39.13 91.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.632 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.429 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -87.37 -8.49 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.652 -179.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.0 t -53.43 -25.03 14.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 111.033 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.64 27.24 73.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.201 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 71' ' ' VAL . 12.3 p -170.97 34.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.406 . . . . 0.0 111.007 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.4 mt -141.42 147.67 38.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.009 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -168.95 171.69 8.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.725 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.9 mt -70.46 123.63 24.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.088 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.42 -24.6 3.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.607 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.431 ' HB3' ' CG2' ' A' ' 111' ' ' ILE . 69.7 m-20 -57.73 123.62 16.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.762 0.315 . . . . 0.0 110.732 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -94.34 98.42 10.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.433 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.528 ' HA ' HG22 ' A' ' 111' ' ' ILE . 2.6 m -75.89 118.31 21.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.972 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.3 ttp -141.14 27.48 1.94 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -178.86 61.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 0.0 110.932 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.6 mt -92.45 130.82 40.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.216 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 43.93 31.14 0.47 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.316 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.84 -44.44 1.64 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.602 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 mm -71.77 110.78 8.41 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.501 0.191 . . . . 0.0 111.289 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 0 N--CA 1.458 -0.606 0 C-N-CA 122.814 2.343 . . . . 0.0 112.686 -179.839 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.931 0.396 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.9 75.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.679 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -58.01 -36.77 73.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.545 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -43.95 97.52 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.653 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.71 -42.49 93.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.613 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 mt -62.86 -37.13 85.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -77.74 -28.42 50.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.126 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.41 -6.72 49.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.463 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 3.5 m -72.68 -26.24 61.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.74 0.305 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.92 -26.85 64.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.218 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.8 mm -53.9 -49.32 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.494 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 t -104.73 -1.06 26.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 78.97 -4.54 2.1 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.791 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -156.58 152.64 27.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.868 0.366 . . . . 0.0 111.111 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 p -131.13 157.54 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.778 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.56 106.87 12.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.86 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -100.64 120.15 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 111.871 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.96 112.12 22.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.454 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -118.43 164.97 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.361 0.6 . . . . 0.0 112.443 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -123.12 124.87 44.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.833 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 49.9 p90 . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.955 0.407 . . . . 0.0 111.263 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 22.1 pt-20 -175.15 177.08 1.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.969 0.414 . . . . 0.0 111.212 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 15.8 p -89.53 128.19 35.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.109 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 t -107.28 136.0 47.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.277 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.79 99.38 11.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -101.02 103.18 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.718 -178.435 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 10.9 t -83.59 113.95 23.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.406 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.418 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 8.7 mt -110.08 137.64 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.009 0.433 . . . . 0.0 111.251 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 96.7 m -109.91 137.89 47.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.577 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.67 146.62 51.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.214 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.02 139.46 28.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.794 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.0 57.23 5.1 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.61 2.207 . . . . 0.0 112.432 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.4 t -155.42 -68.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 -29.76 6.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.011 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.75 -110.93 3.15 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.406 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 29' ' ' LEU . 52.3 m-85 -114.61 -33.01 5.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.51 31.87 82.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.77 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.96 140.96 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 110.959 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.24 159.18 42.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.039 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.49 121.64 31.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.733 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--O 1.232 0.198 0 CA-C-O 120.627 0.178 . . . . 0.0 112.105 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -152.52 150.29 29.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.069 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.7 mt -74.52 147.93 8.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.402 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -175.4 50.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.153 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -173.79 134.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 0.0 111.437 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -150.69 151.88 12.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.219 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.75 155.36 18.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 0.0 111.582 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.87 41.0 1.02 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.863 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER 171.82 33.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.521 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 m -127.11 143.67 47.82 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.07 -32.81 7.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.729 2.286 . . . . 0.0 112.809 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.99 -51.66 68.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.986 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 10.6 tp10 -69.67 -43.14 73.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.69 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.434 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -67.15 -14.11 62.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.402 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.91 -27.44 52.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.941 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.18 31.58 65.93 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.239 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.4 t -137.29 -58.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 111.206 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.38 166.09 24.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.053 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -164.86 169.23 16.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.707 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 58' ' ' SER . 18.0 mt -67.54 114.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.068 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.67 22.17 4.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.648 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.45 141.52 31.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.679 0.276 . . . . 0.0 110.673 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.84 89.66 4.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.345 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.458 ' CG2' ' CG2' ' A' ' 111' ' ' ILE . 5.4 t -74.82 145.85 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.602 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -170.29 29.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 110' ' ' GLU . . . -176.18 46.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 111.661 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.402 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 16.5 mt -67.8 112.99 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.029 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 44.06 35.69 1.25 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.436 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.59 -49.7 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.386 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.11 120.29 77.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.534 0.207 . . . . 0.0 111.138 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 N--CA 1.461 -0.387 0 C-N-CA 122.719 2.28 . . . . 0.0 112.915 -179.771 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 4.2 mt-10 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.962 0.411 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.41 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . . . -60.32 -38.54 84.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.764 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -61.93 -43.67 98.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -62.56 -38.06 88.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.446 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.434 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 12.2 mt -61.71 -40.7 95.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.248 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.4 mt -78.02 -32.17 50.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.363 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -65.89 -25.86 67.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.916 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.54 15.02 10.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.522 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 m -79.32 -23.22 43.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.81 0.338 . . . . 0.0 110.853 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 p -58.59 -35.25 72.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.807 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.9 mm -53.95 -54.37 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.4 p -86.93 -8.69 57.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.984 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 79.35 -5.02 1.99 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.025 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -156.62 166.8 32.37 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.853 0.358 . . . . 0.0 111.187 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 11.4 p -151.13 148.32 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.902 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.33 107.19 15.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.087 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -101.83 126.16 48.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.776 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -92.5 120.53 33.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.62 178.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -133.79 165.48 31.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.383 -178.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -116.86 126.75 53.49 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.102 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.421 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 34.5 p90 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.15 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.219 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.6 OUTLIER -168.26 154.18 7.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.393 . . . . 0.0 111.572 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 72.5 p -89.85 127.06 35.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.265 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.402 HG21 HG12 ' A' ' 111' ' ' ILE . 7.3 t -114.61 131.07 56.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.925 0.393 . . . . 0.0 111.366 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.18 99.42 11.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.724 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.411 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -107.69 133.64 51.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.081 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.6 t -94.28 117.42 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.405 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.17 126.1 52.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.331 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.0 t -103.11 165.88 10.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.215 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.99 30.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.081 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.25 140.22 79.57 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.769 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.02 -0.69 10.83 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.659 2.239 . . . . 0.0 112.874 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.4 t -108.04 -35.69 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.002 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.9 p -133.91 -66.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.72 -109.1 0.57 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.434 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -118.41 -35.43 3.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 111.097 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.7 26.0 38.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.776 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 tt -111.16 127.18 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.994 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 125.14 51.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 mt -108.84 116.3 31.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.756 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.818 0.257 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 1.7 pt? -178.08 169.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.62 141.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.429 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.9 t -117.34 -31.29 5.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.849 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -165.56 167.43 17.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.194 0.521 . . . . 0.0 111.886 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.445 HD11 HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -144.94 153.18 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.922 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -86.37 155.46 20.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.086 0.469 . . . . 0.0 111.516 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.87 38.34 0.8 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.82 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -179.72 26.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.992 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.5 p -120.62 134.58 24.25 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.626 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.52 -29.21 2.03 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.492 2.128 . . . . 0.0 112.752 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.85 99.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.983 0.42 . . . . 0.0 110.815 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 8.8 tp10 -78.48 -50.22 12.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.152 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -8.36 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.916 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -24.95 11.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.771 0.32 . . . . 0.0 111.0 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.84 30.71 63.22 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.237 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.4 t -145.03 -52.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.926 0.393 . . . . 0.0 111.116 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.69 130.68 39.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.047 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 -170.99 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.798 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.9 mm -92.16 75.61 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.187 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.88 42.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.891 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -85.18 -176.03 5.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.583 0.23 . . . . 0.0 110.534 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.91 79.27 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 111.203 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.448 ' CG1' ' CG1' ' A' ' 81' ' ' ILE . 12.2 t -58.45 147.82 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.054 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 11.9 tpt -134.98 -65.36 0.62 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.07 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -125.37 96.95 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.448 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 9.7 mt -88.48 122.96 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.943 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.6 p30 46.53 31.63 1.4 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.01 -34.23 5.2 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.219 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mm -87.72 110.85 37.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.511 0.196 . . . . 0.0 111.155 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 N--CA 1.458 -0.615 0 C-N-CA 122.669 2.246 . . . . 0.0 112.56 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.804 0.335 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.45 73.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -58.16 -36.36 72.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.582 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.92 -43.95 97.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.724 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 mt -60.5 -43.75 96.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.721 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.3 mt -70.96 -31.24 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -67.55 -32.68 73.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.98 -5.82 50.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.233 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -75.55 -23.18 56.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.751 0.31 . . . . 0.0 111.017 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.6 p -63.7 -30.98 72.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.714 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -65.14 -56.14 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.995 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 105' ' ' SER . 42.7 p -77.61 -11.7 59.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.126 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 104' ' ' THR . 1.8 p 84.19 -18.3 0.42 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.925 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 8.6 ptpt -156.43 160.53 39.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 111.284 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 9.8 p -144.67 155.27 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.713 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.99 121.85 46.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.206 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.07 143.84 44.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.446 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -115.18 104.71 12.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.983 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' THR . 0.2 OUTLIER -116.55 161.31 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -93.59 133.57 36.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.689 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 30.6 p90 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.979 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.429 ' O ' ' CG2' ' A' ' 22' ' ' THR . 5.6 t . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER 179.26 177.28 0.55 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.739 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 19.7 p -86.61 127.58 34.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.29 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.403 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 9.9 t -113.98 140.77 48.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.37 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 99.01 9.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.4 ' CG2' HD12 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -101.64 103.17 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.305 -178.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.45 ' CG2' ' HD2' ' A' ' 106' ' ' LYS . 14.4 p -82.74 115.25 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.929 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.78 147.99 37.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.117 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.2 m -108.11 144.7 35.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.1 108.82 17.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.3 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -68.3 140.6 92.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.99 41.38 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.771 2.314 . . . . 0.0 112.814 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.88 -47.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.799 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -127.39 -43.42 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.977 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.17 -118.57 2.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.52 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' A' ' 101' ' ' SER . 29.9 m-85 -108.07 -25.49 11.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.761 0.315 . . . . 0.0 110.943 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.53 41.88 99.65 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.532 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.428 ' HB ' ' CB ' ' A' ' 66' ' ' ALA . 18.8 tt -150.66 126.63 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.775 0.321 . . . . 0.0 111.098 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' A' ' 59' ' ' TYR . 2.8 pm0 -124.28 156.54 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.037 0.446 . . . . 0.0 111.268 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 2.6 mp -103.67 162.3 13.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.779 0.241 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.39 145.12 36.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.198 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 6.3 mt -59.64 145.27 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.516 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 m -147.45 16.84 1.16 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 4.0 t80 -162.26 149.84 14.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.222 0.534 . . . . 0.0 111.799 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.41 152.36 11.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.788 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -94.45 155.63 16.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 111.825 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -87.86 41.48 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.716 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 169.6 31.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.71 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.9 m -120.83 144.15 38.31 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.795 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.45 -27.25 7.03 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.885 2.39 . . . . 0.0 112.547 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.428 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -66.29 -46.84 75.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.976 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 2.9 tp10 -78.06 -39.73 40.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.6 -19.16 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.78 -30.12 31.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.075 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.1 23.56 52.53 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.816 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.39 -38.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.763 0.316 . . . . 0.0 111.232 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 pp -93.59 148.63 21.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.955 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -125.86 169.09 12.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.686 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.9 mm -67.44 107.07 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.047 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.87 4.39 6.7 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.073 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.91 133.18 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.86 0.33 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -98.28 95.71 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.219 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.517 ' CG2' ' CG2' ' A' ' 111' ' ' ILE . 2.7 t -76.19 129.82 36.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.546 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -150.77 31.87 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.274 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 179.36 81.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 41.7 mt -111.91 126.7 69.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.234 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.8 p30 45.19 31.35 0.76 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.234 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.41 -34.75 5.05 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.312 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.0 mm -82.15 111.68 29.55 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.455 0.169 . . . . 0.0 111.083 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 N--CA 1.46 -0.498 0 C-N-CA 122.682 2.254 . . . . 0.0 112.713 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 35.0 mt-10 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.736 0.303 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.36 -43.02 83.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -56.59 -40.94 76.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.058 0.456 . . . . 0.0 110.054 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -63.03 -38.03 89.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.32 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 41.3 mt -61.02 -39.0 88.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 mt -78.09 -28.59 48.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.053 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -74.91 -35.8 62.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.412 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -78.39 -3.2 42.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.652 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.46 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 67.0 m -69.77 -25.02 63.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.858 0.361 . . . . 0.0 110.733 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.03 -27.22 65.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 21.9 mm -49.92 -47.2 23.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.824 0.345 . . . . 0.0 111.241 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 t -108.75 0.94 20.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.057 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 t 62.81 18.06 10.41 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.256 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 0.5 OUTLIER -156.94 144.14 18.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.865 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.427 HG13 ' CE2' ' A' ' 37' ' ' PHE . 10.4 p -152.36 151.94 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.705 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 p -122.15 104.32 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.007 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -102.41 149.17 24.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.181 0.515 . . . . 0.0 112.183 -178.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.27 124.87 50.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.252 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.517 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -138.18 133.31 43.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 35.2 tt0 -92.7 118.64 31.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 22' ' ' THR . 18.8 p90 . . . . . 0 C--O 1.239 0.546 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.783 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.431 HG21 ' N ' ' A' ' 23' ' ' GLU . 96.5 m . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 120.991 0.424 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -178.31 168.31 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.726 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 12.5 p -87.78 151.68 22.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.71 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.427 HG21 HG12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -132.15 143.49 50.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.032 0.444 . . . . 0.0 111.53 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.28 99.61 9.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.55 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.42 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -105.4 106.89 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.616 -178.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.6 p -90.01 114.98 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.703 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.27 164.42 11.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 0.0 110.961 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 m -121.19 142.54 49.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.608 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.85 114.54 23.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 111.121 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.64 147.83 71.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.96 18.64 1.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.968 2.445 . . . . 0.0 112.853 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.84 -41.28 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.801 0.334 . . . . 0.0 111.078 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 t -136.04 -45.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.074 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.4 -109.98 0.93 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.512 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 101' ' ' SER . 87.1 m-85 -118.7 -31.7 4.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.631 0.253 . . . . 0.0 111.191 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.48 35.78 90.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.648 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tt -135.39 131.33 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.965 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.9 155.78 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.041 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.65 135.9 38.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 -179.814 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo . . . . . 0 N--CA 1.466 -0.133 0 CA-C-O 120.969 0.321 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -115.95 151.2 35.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.124 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.4 HG13 ' CG2' ' A' ' 78' ' ' VAL . 29.2 mt -84.37 154.1 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.92 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 t -177.81 51.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.064 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -175.53 133.86 0.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.971 0.415 . . . . 0.0 111.288 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.419 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -150.58 152.18 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.357 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.99 155.46 17.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.652 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.0 41.63 1.01 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.811 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER 172.19 32.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.589 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -126.73 145.61 54.08 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.73 -31.73 15.28 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.991 2.461 . . . . 0.0 112.591 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.8 -45.25 90.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.419 ' CG ' ' NH2' ' A' ' 68' ' ' ARG . 11.8 tp10 -77.96 -41.9 34.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.775 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.424 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -69.38 -11.77 61.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.402 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.1 t -52.98 -30.67 36.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.821 0.343 . . . . 0.0 111.112 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.09 27.89 68.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.44 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 m -152.54 30.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.347 . . . . 0.0 111.179 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 mt -136.92 162.23 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.75 159.07 43.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.3 mm -75.66 98.05 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.244 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.67 38.52 0.61 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.618 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -82.1 126.84 32.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 110.73 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -84.68 90.04 7.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.073 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.404 ' HA ' HG22 ' A' ' 111' ' ' ILE . 2.1 t -70.66 144.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.42 28.47 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.212 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 172.16 89.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 111.278 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.4 mt -116.54 115.09 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.785 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.9 p30 49.6 26.75 1.87 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.248 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.12 -44.25 1.55 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.698 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.9 mm -74.35 111.65 13.7 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.531 0.205 . . . . 0.0 111.191 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo . . . . . 0 N--CA 1.455 -0.745 0 C-N-CA 122.858 2.372 . . . . 0.0 112.777 -179.854 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.953 0.406 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.89 -35.37 70.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.076 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.4 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 7.2 m-20 -62.78 -39.4 94.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.178 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -62.34 -40.3 95.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.09 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.7 mt -59.34 -47.04 86.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.617 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.4 ' CD2' ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -78.01 -26.71 48.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.873 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -73.93 -30.44 62.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.32 7.24 29.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.441 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.439 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -74.22 -17.53 60.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.726 0.298 . . . . 0.0 111.259 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.1 m -59.14 -30.77 68.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.913 0.387 . . . . 0.0 110.615 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.4 mt -57.04 -66.3 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 t -84.98 -2.75 58.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.159 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.85 19.6 11.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.244 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.37 153.91 29.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 111.423 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.41 HG11 ' CE2' ' A' ' 37' ' ' PHE . 13.8 p -145.73 143.67 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.19 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.16 120.89 39.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.488 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.54 132.86 54.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.552 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -107.26 104.68 14.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.821 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -110.99 163.89 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -114.52 121.3 43.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.784 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.445 ' CZ ' ' HG3' ' A' ' 23' ' ' GLU . 39.2 p90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 111.733 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 1.1 m . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.85 0.357 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -147.85 149.77 32.91 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.317 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -88.76 127.12 35.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.814 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.485 HG21 HG13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -114.79 152.4 32.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.244 0.545 . . . . 0.0 111.401 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.32 99.14 6.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.261 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.403 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.03 129.53 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.554 -178.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.17 113.58 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.464 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.473 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -102.12 124.66 48.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.374 . . . . 0.0 110.935 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 67.8 m -105.85 115.31 30.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.08 140.29 44.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.355 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.03 157.36 34.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.41 -1.33 11.5 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.935 2.423 . . . . 0.0 112.753 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 t -104.03 -67.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.33 . . . . 0.0 111.285 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.5 p -105.05 -71.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.62 -72.37 0.28 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.578 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 29' ' ' LEU . 45.7 m-85 -145.41 -43.88 0.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 111.018 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.4 26.86 70.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.733 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tt -124.55 130.71 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 110.922 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.79 148.08 41.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.13 120.83 35.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.651 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.898 0.291 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -177.89 141.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.768 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.6 mt -64.02 134.83 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 t -159.97 42.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -172.44 135.9 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.081 0.467 . . . . 0.0 111.222 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.424 HG22 HD13 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -151.37 152.52 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.234 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.52 155.24 17.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 111.272 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.67 42.37 0.96 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.138 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.421 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER 168.97 33.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.727 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.57 144.57 44.63 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -43.5 -37.75 8.09 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.798 2.332 . . . . 0.0 112.766 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.44 77.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.991 0.424 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.416 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -75.73 -50.52 15.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.683 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.421 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.36 -8.95 57.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.697 -179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.1 t -56.38 -25.24 49.03 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.806 0.336 . . . . 0.0 110.835 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.08 31.76 81.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.293 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.4 t -143.69 -52.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 0.0 111.067 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt -58.96 150.44 24.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.018 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -144.09 160.59 40.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.5 mm -71.67 89.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.26 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.19 35.17 0.83 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.784 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.93 130.94 40.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.785 0.326 . . . . 0.0 110.75 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -85.32 79.33 9.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.733 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 5.8 t -56.88 158.53 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.75 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.342 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.21 96.0 4.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.377 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.4 mt -86.63 121.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.775 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 44.83 30.51 0.56 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.242 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.96 -37.49 3.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.646 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mm -84.77 111.07 32.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.499 0.19 . . . . 0.0 111.208 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 N--CA 1.459 -0.554 0 C-N-CA 122.742 2.295 . . . . 0.0 112.72 -179.746 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.909 0.385 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.29 -44.74 88.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.176 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -60.26 -39.63 87.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.781 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -62.45 -41.55 98.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.2 mt -62.21 -48.17 81.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.9 mt -59.89 -33.85 72.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -29.61 39.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -6.01 49.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.478 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.2 t -79.25 -27.22 42.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.691 0.282 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.2 m -59.43 -34.96 73.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.1 mm -52.48 -46.78 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.496 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 t -101.48 -4.32 27.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.098 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 78.41 -3.31 2.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.77 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 5.0 ptpt -156.8 165.01 37.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.94 0.4 . . . . 0.0 111.131 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.3 146.54 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.525 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.96 109.56 20.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.299 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.25 143.94 39.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 0.0 111.653 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -106.6 121.43 44.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.93 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.485 HG13 HG21 ' A' ' 25' ' ' THR . 0.2 OUTLIER -119.4 164.48 15.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.15 0.5 . . . . 0.0 111.984 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -122.57 118.65 28.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.301 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 22' ' ' THR . 5.4 p90 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.26 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 6.7 t . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.959 0.409 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -168.94 156.09 7.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.408 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 7.9 p -87.68 129.27 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.813 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.411 HG21 ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -117.37 148.09 42.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.033 0.444 . . . . 0.0 110.995 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.56 98.98 9.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.414 ' CG2' ' CG1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -100.96 100.36 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.104 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.425 ' CG2' ' HD2' ' A' ' 106' ' ' LYS . 12.6 p -85.38 117.94 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.045 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.22 152.9 26.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.8 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.5 m -116.53 150.45 37.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.714 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.401 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -92.58 103.84 16.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.162 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -74.89 154.66 86.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.791 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.21 0.02 9.49 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.762 2.308 . . . . 0.0 112.729 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -66.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.821 0.343 . . . . 0.0 110.981 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -108.96 -43.21 4.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.62 -85.72 0.86 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 101' ' ' SER . 96.4 m-85 -133.27 73.66 1.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.975 0.417 . . . . 0.0 110.098 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.89 10.43 0.56 Allowed Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.135 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.474 ' H ' ' C ' ' A' ' 37' ' ' PHE . 13.1 tt -96.16 130.25 45.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.891 0.377 . . . . 0.0 110.788 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.72 136.8 50.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -127.64 114.79 17.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.029 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.86 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.754 0.231 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mp -149.2 127.45 12.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.014 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 69.7 mt -75.63 141.15 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.616 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.7 t -164.04 49.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.723 0.297 . . . . 0.0 111.683 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -176.15 133.81 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.031 0.443 . . . . 0.0 111.504 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.413 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.33 152.05 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.035 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.92 155.5 18.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 111.357 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.27 43.49 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.842 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.84 32.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.609 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -121.47 144.62 40.63 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.04 -35.2 4.47 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.812 2.341 . . . . 0.0 112.86 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.36 96.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.413 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.9 OUTLIER -71.15 -46.73 60.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.842 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -8.68 57.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.633 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 53.5 t -52.0 -40.9 61.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.894 0.378 . . . . 0.0 111.006 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.57 -27.4 15.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.466 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -117.51 26.12 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.757 0.313 . . . . 0.0 111.303 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 mt -124.82 143.48 50.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -169.12 153.39 5.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.785 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.9 mt -59.34 110.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.53 -15.56 3.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.767 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -59.04 139.32 56.97 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.814 0.34 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.28 96.16 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.08 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 2.8 t -65.33 152.04 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.2 tpt -137.05 -63.28 0.61 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.232 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -125.2 93.9 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.338 . . . . 0.0 111.356 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 mt -82.66 124.08 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 44.35 31.77 0.62 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.154 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.09 -37.57 3.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.3 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mm -85.75 112.66 46.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.57 0.224 . . . . 0.0 111.179 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo . . . . . 0 N--CA 1.459 -0.558 0 C-N-CA 122.632 2.222 . . . . 0.0 112.716 -179.782 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 120.82 0.343 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.67 -45.99 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.678 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.08 -38.04 78.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.241 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -62.68 -46.38 88.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.472 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.63 -31.72 71.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.182 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.06 -31.49 50.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.612 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.24 -30.62 38.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.87 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -10.58 59.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.243 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.505 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 16.6 m -72.43 -19.33 61.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.041 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.5 p -65.91 -37.09 85.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.882 0.373 . . . . 0.0 110.746 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -58.55 -55.77 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.3 p -83.19 -9.48 59.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.992 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.28 17.21 9.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.347 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.425 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 tppt? -156.81 146.18 20.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 0.0 111.021 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.403 ' HB ' ' OG ' ' A' ' 101' ' ' SER . 11.7 p -154.8 149.89 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -122.65 124.84 44.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.059 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.15 148.22 48.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.088 0.47 . . . . 0.0 111.993 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -102.1 129.65 48.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.693 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.414 ' CG1' ' CG2' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -138.39 156.62 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.923 0.392 . . . . 0.0 111.815 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -93.9 126.11 38.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.248 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 24.5 p90 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.672 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 113' ' ' PHE . 57.0 m . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.997 0.427 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HG2' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -178.6 166.9 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.174 179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.2 p -90.31 131.83 35.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.108 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.407 HG21 ' CD1' ' A' ' 111' ' ' ILE . 5.2 t -116.26 133.62 55.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.031 0.443 . . . . 0.0 111.936 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.34 98.98 10.43 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -100.88 119.17 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.723 -178.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.6 p -88.73 113.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.965 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.84 164.77 11.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.567 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.6 m -127.2 146.0 50.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.87 97.49 8.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.148 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.34 142.47 90.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.64 -3.86 14.45 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.61 2.207 . . . . 0.0 112.785 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.73 -61.0 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 t -125.57 -41.22 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.01 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.1 -105.06 0.49 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.462 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CE1' ' CG1' ' A' ' 107' ' ' VAL . 96.6 m-85 -113.85 -28.97 7.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.767 0.318 . . . . 0.0 111.005 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.26 47.28 83.09 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.836 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.87 127.63 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 0.0 111.075 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.58 147.87 46.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.909 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 2.8 pp -131.68 127.0 36.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.408 ' NE2' ' CB ' ' A' ' 58' ' ' SER . 3.7 mt-30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.77 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.783 0.243 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -152.09 145.53 24.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.205 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.405 ' HA ' ' CB ' ' A' ' 41' ' ' LEU . 8.5 mt -77.59 143.49 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.612 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.408 ' CB ' ' NE2' ' A' ' 42' ' ' GLN . 3.7 t -162.79 48.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.281 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -172.9 131.54 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.099 0.476 . . . . 0.0 111.389 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.414 HG22 ' HA ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -149.61 152.31 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.031 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.83 155.45 17.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 111.261 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.63 39.88 0.9 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.752 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 175.55 29.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.773 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.62 136.14 26.94 Favored Pre-proline 0 C--O 1.231 0.127 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -43.52 -29.24 2.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.622 2.214 . . . . 0.0 112.807 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.72 -42.08 99.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.932 0.396 . . . . 0.0 111.01 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HA ' HG22 ' A' ' 60' ' ' ILE . 5.8 tp10 -78.31 -49.61 13.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -8.19 53.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.655 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.76 -28.03 14.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 111.001 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.0 26.36 69.05 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.66 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.5 -47.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 111.117 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.1 mt -58.76 156.56 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.18 156.07 18.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.3 mm -70.21 97.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.44 40.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.712 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.42 153.22 19.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.641 0.258 . . . . 0.0 110.508 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -111.91 82.93 1.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.167 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.422 ' CG1' ' CG1' ' A' ' 81' ' ' ILE . 3.6 t -61.8 143.48 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.67 34.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.642 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 174.26 54.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.849 0.357 . . . . 0.0 111.271 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.422 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 25.5 mt -76.12 118.16 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.1 p30 44.89 30.79 0.59 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.271 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.72 -35.43 5.07 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.38 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 mm -78.68 110.83 15.51 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 121.999 0.119 . . . . 0.0 111.198 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 N--CA 1.458 -0.56 0 C-N-CA 122.563 2.175 . . . . 0.0 112.411 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.948 0.404 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.09 87.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -61.18 -42.3 98.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.791 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -62.73 -34.8 77.92 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.764 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 8.8 mt -68.13 -37.75 81.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.631 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.9 -41.65 59.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -68.16 -31.89 71.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.993 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -5.13 49.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.35 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.407 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 69.7 m -69.62 -13.9 62.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.261 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -58.56 -28.38 65.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.0 mm -54.83 -30.9 23.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.172 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -117.45 -4.5 11.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.223 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m 62.91 21.46 12.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.211 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -156.12 151.21 26.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.0 110.956 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.453 ' CG1' ' CE1' ' A' ' 37' ' ' PHE . 13.2 p -150.08 111.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.88 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.87 107.29 19.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.36 150.5 23.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 111.41 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -123.57 105.17 9.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.195 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.416 ' CD1' ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -111.04 159.71 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.097 0.475 . . . . 0.0 111.925 -178.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -110.18 118.49 36.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.517 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.417 ' CE1' ' HG2' ' A' ' 23' ' ' GLU . 14.6 p90 . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.343 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 mt-10 -148.34 173.79 12.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.084 0.468 . . . . 0.0 111.423 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.8 p -108.42 134.15 51.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.288 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.419 HG21 HG13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -111.96 144.52 41.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.083 0.468 . . . . 0.0 111.691 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.9 pt-20 -104.07 100.17 9.93 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.412 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -99.87 102.85 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.826 -178.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.471 ' CG2' ' HD2' ' A' ' 106' ' ' LYS . 9.2 p -86.2 115.55 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.41 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 7.6 mt -115.58 152.44 33.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.018 0.437 . . . . 0.0 111.339 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.9 m -113.78 137.54 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.616 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.7 107.01 2.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.02 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.35 142.53 86.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.06 55.3 5.59 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.796 2.331 . . . . 0.0 112.482 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 t -153.2 -69.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.013 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -116.8 -24.55 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.18 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.67 -112.63 2.29 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.323 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 101' ' ' SER . 21.5 m-85 -113.03 -23.28 10.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 0.0 111.139 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 58.85 54.23 39.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.863 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 tt -147.88 127.2 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.731 0.3 . . . . 0.0 110.747 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.51 147.06 38.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.066 0.46 . . . . 0.0 111.53 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.25 169.09 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.372 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 120.879 0.371 . . . . 0.0 111.06 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo . . . . . 0 C--O 1.232 0.22 0 CA-C-O 120.891 0.288 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -135.65 160.01 39.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.939 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -85.96 143.9 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.736 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.5 m -165.32 50.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.29 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -176.52 132.76 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.979 0.419 . . . . 0.0 111.42 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -149.15 152.26 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.059 179.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.58 155.45 16.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.164 0.507 . . . . 0.0 111.275 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.67 38.85 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.846 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.0 t0 179.08 28.69 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.772 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.408 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 33.4 m -124.35 139.19 32.37 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.591 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -45.51 -27.95 3.82 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.865 2.377 . . . . 0.0 112.77 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.64 96.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.846 0.355 . . . . 0.0 110.843 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -78.56 -48.43 15.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.05 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -7.23 50.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.893 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.72 -25.89 4.88 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.841 0.353 . . . . 0.0 111.175 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.87 25.27 73.12 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.559 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 14.4 p -158.07 29.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.034 0.445 . . . . 0.0 110.874 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 mt -135.82 151.96 50.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.715 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -151.37 172.2 16.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.3 mm -83.01 73.0 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.77 37.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.66 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.7 123.07 48.35 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.75 105.85 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 111.744 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.436 ' CG1' ' CG2' ' A' ' 111' ' ' ILE . 1.3 m -71.45 138.26 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -148.05 21.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.261 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -174.26 59.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.931 0.396 . . . . 0.0 111.319 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.3 mt -88.65 124.61 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 44.24 31.21 0.53 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.324 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.31 -46.67 1.18 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mm -70.33 112.57 13.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.553 0.216 . . . . 0.0 111.166 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 C--N 1.347 0.477 0 C-N-CA 122.636 2.224 . . . . 0.0 112.819 -179.901 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.862 0.363 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.68 -42.08 82.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.685 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -39.48 77.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.286 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -62.97 -41.49 99.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.341 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.3 mt -58.77 -41.9 87.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.591 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.3 mt -77.87 -30.67 50.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.82 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -38.98 92.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -75.33 -7.15 53.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.4 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.45 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 8.7 m -63.95 -22.19 66.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.972 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.89 -39.44 81.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.787 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.8 mm -49.3 -65.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.472 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.6 t -84.32 -4.81 59.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.039 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.0 21.0 12.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.236 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.471 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 0.4 OUTLIER -156.41 150.14 24.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.247 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.426 HG12 ' CE2' ' A' ' 37' ' ' PHE . 9.4 p -155.33 145.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.617 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.23 108.89 13.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.295 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.48 128.36 50.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.041 0.448 . . . . 0.0 111.836 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.41 107.46 19.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.634 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.436 ' CG2' ' CG1' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -109.36 159.9 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.22 0.533 . . . . 0.0 112.152 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -118.83 121.97 41.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.783 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.405 ' CD1' ' O ' ' A' ' 23' ' ' GLU . 52.0 p90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -178.44 177.97 0.9 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.989 0.423 . . . . 0.0 111.585 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 112' ' ' GLU . 68.1 p -87.23 143.14 27.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.509 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 t -132.72 135.09 45.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.6 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.02 99.25 11.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.51 130.48 53.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.97 122.06 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.092 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -116.09 147.97 40.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.635 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.5 m -130.43 144.13 51.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -82.84 147.53 28.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.098 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -110.61 156.13 41.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -80.15 0.11 10.26 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.938 2.425 . . . . 0.0 112.424 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 t -91.25 -55.22 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.157 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 t -135.31 -46.69 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.27 -111.99 0.6 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.452 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.449 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 67.0 m-85 -109.17 -24.86 10.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.766 0.317 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 64.88 42.94 96.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.934 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -143.41 128.4 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.875 0.369 . . . . 0.0 110.689 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -116.22 150.37 37.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 111.458 -179.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.83 160.89 21.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.474 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 111.111 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.849 0.27 . . . . 0.0 112.592 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -160.54 -178.67 7.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.5 mt -87.18 141.19 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.698 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 m -161.85 49.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.392 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CG ' ' HB2' ' A' ' 40' ' ' GLN . 24.4 t80 -177.36 132.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 111.462 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.408 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -151.88 152.54 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.982 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.83 155.02 17.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 111.401 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.73 42.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.856 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.408 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER 170.4 31.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.821 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.408 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 3.9 m -122.84 145.29 45.08 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.002 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.54 -37.48 11.07 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.073 2.515 . . . . 0.0 112.6 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.51 77.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.408 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 1.2 tm-20 -78.24 -51.97 9.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.856 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.408 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -67.03 -11.27 56.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.827 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -24.65 51.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 110.874 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.31 30.58 73.55 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.174 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 t -145.47 -54.46 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.093 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.9 mt -59.58 145.67 43.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -160.88 167.87 25.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.778 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.7 mm -70.24 67.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.74 38.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.474 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -109.59 107.52 17.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.733 0.301 . . . . 0.0 110.554 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -82.21 93.89 7.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.306 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 111' ' ' ILE . 30.5 m -58.63 123.57 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.703 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.0 ttp -118.37 -16.01 9.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.808 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -167.12 98.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 111.551 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.9 mp -103.12 113.27 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.5 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 45.87 29.94 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.224 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.31 -44.38 1.52 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.767 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mm -80.89 113.74 42.87 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.505 0.193 . . . . 0.0 111.166 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 C--N 1.348 0.504 0 C-N-CA 122.509 2.139 . . . . 0.0 112.866 -179.882 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.816 0.341 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.8 -49.16 77.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -60.12 -34.82 74.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.525 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.61 -41.11 98.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.568 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.6 mt -70.08 -30.56 67.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.462 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.08 -46.44 84.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.927 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -73.64 -29.76 62.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.061 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -75.0 -5.61 44.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.503 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 58.1 m -66.44 -22.06 66.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 0.0 111.196 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -58.66 -27.31 64.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.007 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.5 mm -57.35 -48.98 81.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.477 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -100.79 -14.81 17.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.284 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.57 -3.79 2.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.949 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -156.78 129.62 7.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.858 0.361 . . . . 0.0 111.029 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 101' ' ' SER . 0.0 OUTLIER -120.38 166.82 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.86 106.75 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.794 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.93 138.28 35.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.001 0.429 . . . . 0.0 111.881 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -116.2 104.62 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.821 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.405 ' CG2' ' CG1' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -120.28 149.02 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 49.0 tt0 -103.62 118.79 37.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.871 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.301 -179.363 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.46 0.072 0 CA-C-O 120.725 0.298 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.402 ' O ' ' CD2' ' A' ' 113' ' ' PHE . 1.1 mt-10 -151.68 176.56 11.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 0.0 111.26 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 p -103.71 140.79 37.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.412 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.441 HG22 HG12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -116.89 142.07 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.064 0.459 . . . . 0.0 111.441 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.62 98.93 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.427 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -102.91 131.24 51.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.0 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.3 t -107.62 113.4 43.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.179 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.91 164.29 12.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.335 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.0 m -117.5 132.24 56.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 110.819 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.455 ' CB ' ' CE2' ' A' ' 37' ' ' PHE . . . -79.35 91.64 5.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.163 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.15 140.87 94.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.63 -4.96 16.28 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.476 2.117 . . . . 0.0 112.846 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.7 t -99.69 -54.18 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.066 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -108.3 -47.15 3.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.866 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.45 -91.17 1.17 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.672 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.507 ' C ' ' H ' ' A' ' 39' ' ' ILE . 80.9 m-85 -141.61 77.92 1.61 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.938 0.399 . . . . 0.0 110.223 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.48 18.93 0.4 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.072 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.507 ' H ' ' C ' ' A' ' 37' ' ' PHE . 3.4 tt -96.35 130.02 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.91 0.355 . . . . 0.0 110.611 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.07 145.81 37.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.987 0.422 . . . . 0.0 111.463 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.01 156.98 32.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.479 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.915 -179.914 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo . . . . . 0 C--O 1.231 0.142 0 CA-C-O 120.866 0.277 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -167.91 152.94 6.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.97 0.414 . . . . 0.0 111.109 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 76' ' ' ASP . 47.7 mt -72.9 152.48 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.835 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.18 44.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.537 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -176.58 129.38 0.19 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.209 0.528 . . . . 0.0 111.854 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.467 HD11 HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -142.21 152.14 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.374 179.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 63' ' ' ASP . 5.5 tp10 -109.88 154.93 22.36 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.078 0.466 . . . . 0.0 111.858 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.29 42.04 0.15 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.016 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER 175.11 31.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.192 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -122.21 135.05 25.09 Favored Pre-proline 0 CA--C 1.527 0.075 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 69' ' ' CYS . 3.5 Cg_endo -46.37 -30.54 8.34 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.506 2.137 . . . . 0.0 112.424 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.08 -33.27 71.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.768 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -75.04 -49.93 18.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.844 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.419 ' NH2' ' C ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -79.31 -8.26 58.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.943 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -51.53 -34.78 37.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.772 0.32 . . . . 0.0 111.082 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.26 27.12 70.13 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.591 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 p -136.08 -45.3 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.629 0.252 . . . . 0.0 111.131 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 pp -77.99 163.04 26.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.013 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.59 165.29 29.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.865 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.51 75.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.085 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.8 40.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.776 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.401 ' HB2' HD13 ' A' ' 57' ' ' ILE . 45.8 m-20 -99.95 119.13 37.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 110.56 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -86.13 85.64 7.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.218 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.424 ' HA ' HG22 ' A' ' 111' ' ' ILE . 3.5 t -65.54 138.64 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.118 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.2 ttp -171.14 34.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.128 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -179.88 49.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.13 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.418 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 8.7 mt -73.0 117.68 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.6 p30 45.55 30.48 0.77 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.56 -37.65 3.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.096 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.7 mm -74.28 112.04 15.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.552 0.215 . . . . 0.0 111.137 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 N--CA 1.458 -0.617 0 C-N-CA 122.676 2.251 . . . . 0.0 112.488 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.856 0.36 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.73 -48.33 79.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.431 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 9.8 m-80 -61.86 -34.73 76.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.496 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -35.98 82.02 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.51 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.6 mt -69.74 -48.24 60.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.996 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.431 ' CD2' ' HA ' ' A' ' 95' ' ' ASN . 3.2 pp -70.1 -37.02 75.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.157 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 -69.87 -30.41 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.81 0.338 . . . . 0.0 111.009 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -89.16 4.78 47.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.369 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.446 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 0.4 OUTLIER -83.12 -12.12 57.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.338 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.5 p -57.68 -24.77 58.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.714 0.292 . . . . 0.0 110.887 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.7 mm -56.36 -31.51 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.954 0.406 . . . . 0.0 110.896 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -114.34 -5.93 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.058 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.9 t 69.42 23.81 5.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.399 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 150.38 25.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.952 0.406 . . . . 0.0 111.282 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.446 ' HB ' ' CB ' ' A' ' 101' ' ' SER . 13.9 p -144.14 136.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.28 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.32 113.39 25.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.225 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.97 125.2 53.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.966 0.412 . . . . 0.0 111.369 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -101.32 105.0 16.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.871 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -110.2 164.3 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 121.08 0.467 . . . . 0.0 112.07 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -104.19 120.41 41.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.916 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 23' ' ' GLU . 45.0 p90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.29 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.421 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.586 0.232 . . . . 0.0 111.135 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 22.2 mt-10 -162.29 143.99 10.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.943 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 69.5 p -91.94 127.12 37.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.62 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.432 HG21 HG12 ' A' ' 111' ' ' ILE . 1.6 t -115.72 136.59 52.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 111.204 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.71 99.83 11.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.022 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.436 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -106.61 129.01 60.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -179.266 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 t -94.3 120.62 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.176 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.17 123.91 51.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 28.7 m -105.62 141.64 36.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.717 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.65 136.39 37.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.226 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.49 141.91 23.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.828 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.35 55.87 5.28 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.78 2.32 . . . . 0.0 112.56 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -155.41 -64.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.162 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -114.14 -44.48 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.93 -115.57 2.93 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.406 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 54.0 m-85 -113.96 -28.85 7.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.682 0.277 . . . . 0.0 110.971 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.99 24.64 43.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.691 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.44 140.55 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.967 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.54 164.81 28.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.099 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -117.28 160.07 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.7 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.957 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.713 0.214 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -131.9 153.34 50.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 0.0 110.952 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.1 mt -59.87 145.39 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.684 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 m -165.37 44.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.801 0.334 . . . . 0.0 111.557 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -169.97 133.57 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.174 0.511 . . . . 0.0 111.534 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.424 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -151.88 152.52 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.879 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 1.4 mt-10 -103.55 155.39 18.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.065 0.46 . . . . 0.0 111.426 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.89 39.44 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.8 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.03 29.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.684 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.37 142.15 34.77 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.624 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -43.07 -29.48 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.65 2.233 . . . . 0.0 112.87 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.89 -40.26 97.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 2.4 mm-40 -78.12 -52.92 8.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.728 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.84 -8.63 55.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.743 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -38.37 56.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.811 0.339 . . . . 0.0 110.952 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.97 -18.66 55.55 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.819 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 m -128.09 39.24 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.836 0.35 . . . . 0.0 111.188 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.78 143.84 37.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -169.12 152.91 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.713 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.9 mt -58.36 107.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.22 -25.34 1.41 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.406 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -60.14 122.98 15.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.832 0.348 . . . . 0.0 110.662 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.13 105.74 17.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.214 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.415 ' CG1' ' CG1' ' A' ' 81' ' ' ILE . 14.8 t -70.54 146.12 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -165.17 27.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.462 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 174.07 78.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.969 0.414 . . . . 0.0 111.419 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.415 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 21.0 mt -103.83 118.09 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.846 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 45.1 30.57 0.62 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 108.9 -46.1 1.22 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.581 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.0 mm -70.62 109.96 6.08 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.548 0.214 . . . . 0.0 111.436 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 86.0 Cg_endo . . . . . 0 N--CA 1.456 -0.72 0 C-N-CA 122.861 2.374 . . . . 0.0 112.234 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.869 0.366 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.27 85.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.884 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -60.25 -36.2 77.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.441 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -40.21 96.58 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.394 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.74 -28.31 62.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.515 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.92 -47.0 79.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.801 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.4 mpp_? -76.12 -28.57 57.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.966 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.95 -9.03 57.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.431 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.417 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 51.9 m -72.62 -23.72 60.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.098 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 p -58.95 -34.85 72.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 25.7 mm -53.64 -60.66 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.523 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 105' ' ' SER . 1.4 t -75.27 -8.86 57.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.388 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 104' ' ' THR . 0.9 OUTLIER 84.19 -16.3 0.53 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.009 179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 1.5 ptpt -156.65 158.08 36.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.758 0.313 . . . . 0.0 111.051 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.47 160.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.673 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.02 109.43 15.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.263 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.06 133.18 48.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 111.619 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' THR . 6.2 mt-10 -107.84 104.79 14.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.057 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 24' ' ' THR . 0.2 OUTLIER -109.37 159.47 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.08 0.467 . . . . 0.0 112.25 -178.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.79 119.24 38.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.884 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 23.4 p90 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.964 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 120.633 0.254 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 113' ' ' PHE . 1.8 pt-20 -177.99 176.91 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.1 p -101.81 127.36 48.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.403 HG22 HG13 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -101.49 158.78 15.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.194 0.521 . . . . 0.0 111.28 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.13 99.17 8.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -103.24 105.81 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.774 -178.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.97 116.01 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.437 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.52 141.59 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.916 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 87.4 m -115.46 142.17 47.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.84 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.93 141.61 29.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.147 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.61 138.26 22.53 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.865 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.06 58.68 5.64 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.547 2.165 . . . . 0.0 112.356 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 t -154.19 -68.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.055 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 p -110.63 -28.99 8.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -118.15 4.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.381 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 40.8 m-85 -113.0 -22.77 10.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.675 0.274 . . . . 0.0 111.153 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.01 32.1 66.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.872 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.52 141.05 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.732 0.301 . . . . 0.0 110.821 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.31 138.45 47.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.246 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.08 113.05 26.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.487 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 -179.775 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo . . . . . 0 N--CA 1.461 -0.402 0 CA-C-O 120.791 0.246 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.99 170.69 17.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 mt -80.26 139.12 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.457 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.6 m -156.79 48.46 0.45 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 111.505 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -173.12 133.51 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.11 0.481 . . . . 0.0 111.545 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.3 152.03 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.96 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.69 155.61 17.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.107 0.48 . . . . 0.0 111.432 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.55 38.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.723 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.86 29.68 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.643 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 p -122.11 137.46 27.5 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -43.98 -29.2 2.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.511 2.141 . . . . 0.0 112.829 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.51 -43.21 99.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.793 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 27.2 tp10 -78.3 -49.53 13.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -8.41 55.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.554 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -28.16 15.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.769 0.318 . . . . 0.0 110.96 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.22 45.35 95.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.412 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.9 p -170.06 41.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.019 0.438 . . . . 0.0 111.074 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.6 145.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -142.3 -175.43 4.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.821 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.447 HG21 HD13 ' A' ' 74' ' ' ILE . 31.5 mm -78.93 77.51 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.58 41.02 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.623 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -112.09 119.23 37.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.333 . . . . 0.0 110.701 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 93.65 9.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.207 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.8 t -71.19 134.34 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.54 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -157.21 29.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 111.298 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -179.22 68.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.9 mp -90.6 120.03 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.4 p30 45.41 29.64 0.61 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.286 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 107.55 -36.15 4.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.356 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.5 mm -77.12 110.82 13.28 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.503 0.192 . . . . 0.0 111.218 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 89.3 Cg_endo . . . . . 0 N--CA 1.456 -0.678 0 C-N-CA 122.789 2.326 . . . . 0.0 112.448 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.844 0.354 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.75 -50.89 71.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -59.55 -34.14 72.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.533 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -62.63 -40.19 96.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.641 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mt -67.87 -37.53 81.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.512 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.8 mt -70.26 -39.94 74.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.626 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -65.38 -34.13 77.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.26 -10.27 59.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.276 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.447 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 5.1 m -79.22 -33.44 43.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 110.736 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -32.72 74.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.81 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.17 -58.01 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.51 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 t -96.17 1.54 52.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.234 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.3 t 69.98 9.75 7.2 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.577 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 1.5 ttmp? -156.56 155.86 32.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.895 0.379 . . . . 0.0 111.05 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.22 155.7 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.576 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.48 117.99 28.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.146 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -114.19 132.3 56.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.973 0.416 . . . . 0.0 111.989 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.41 109.48 21.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.43 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.403 HG13 HG22 ' A' ' 25' ' ' THR . 0.2 OUTLIER -116.59 143.13 27.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.052 -178.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -95.62 118.72 32.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.056 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 29.6 p90 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.001 0.429 . . . . 0.0 111.461 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 1.9 m . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.129 0.49 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -178.1 176.94 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.678 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.81 130.82 55.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.651 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 t -122.61 135.3 54.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.019 0.437 . . . . 0.0 111.487 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -99.22 99.07 9.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.449 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.429 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.49 115.33 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.303 -178.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.2 p -83.3 122.01 36.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.118 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -108.92 160.82 15.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.424 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.8 m -123.06 153.36 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.859 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.446 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -93.86 141.11 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.47 144.65 29.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.49 -0.26 10.45 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.705 2.27 . . . . 0.0 112.819 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.15 -52.59 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.728 0.299 . . . . 0.0 111.168 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -119.71 -57.19 1.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.35 -110.33 0.62 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.56 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.446 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 55.2 m-85 -112.3 -32.4 6.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.739 0.304 . . . . 0.0 110.758 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.61 8.49 63.34 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.518 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.1 tp -97.12 130.43 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.997 0.398 . . . . 0.0 110.781 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.93 147.0 47.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.089 0.471 . . . . 0.0 111.406 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.425 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 4.8 mt -118.51 163.2 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.638 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.441 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.988 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 C--O 1.232 0.2 0 CA-C-O 120.721 0.217 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.52 163.45 32.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.0 111.177 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.407 ' CG1' ' CD2' ' A' ' 41' ' ' LEU . 5.0 mt -76.07 141.54 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.578 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 m -168.28 41.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.688 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -177.24 125.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.029 0.442 . . . . 0.0 111.529 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -137.33 152.6 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.095 179.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.43 155.36 21.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.067 0.461 . . . . 0.0 111.442 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -88.03 41.06 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.722 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 168.52 31.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.854 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.3 m -119.3 143.91 35.29 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-O 120.716 0.293 . . . . 0.0 110.911 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.56 -28.39 8.93 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.916 2.41 . . . . 0.0 112.738 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.51 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 110.956 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 9.5 tp10 -78.15 -39.81 39.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.829 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.06 -19.36 64.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.364 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -41.08 68.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 110.879 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.24 -12.35 64.83 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.827 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 m -98.79 -32.41 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 111.184 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.0 mt -74.91 128.46 35.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.866 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -141.06 148.5 40.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.05 114.51 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.07 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.21 -27.07 2.29 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -63.39 138.01 58.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.709 0.29 . . . . 0.0 110.837 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.431 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 51.9 mtt180 -109.24 100.95 10.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.406 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 111' ' ' ILE . 29.5 m -64.55 122.69 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.4 ptm -151.37 30.35 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.1 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -178.35 52.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.025 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.4 mt -82.36 128.76 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.058 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 43.67 31.52 0.46 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.235 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.77 -43.85 1.67 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.463 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.6 mm -71.28 113.27 17.95 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.471 0.176 . . . . 0.0 111.316 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo . . . . . 0 N--CA 1.461 -0.427 0 C-N-CA 122.74 2.293 . . . . 0.0 112.796 -179.699 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' CB ' ' CD1' ' A' ' 41' ' ' LEU . . . -60.72 -33.22 72.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.985 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -64.27 -48.33 76.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.826 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -33.89 75.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.647 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.02 -41.41 97.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.6 mt -67.71 -40.19 84.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.757 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -65.26 -30.12 70.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.49 -7.34 51.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.37 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 m -71.87 -16.01 62.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.175 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -58.56 -27.01 64.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.045 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.9 mm -52.9 -41.11 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 111.309 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.8 t -120.01 -2.07 10.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.293 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 62.6 26.32 15.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.05 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -156.19 144.83 20.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.2 p -153.97 156.9 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.02 0.438 . . . . 0.0 111.888 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.07 125.44 46.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.934 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.21 136.64 54.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.098 0.475 . . . . 0.0 111.928 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.89 106.71 15.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.334 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.429 ' CD1' ' CG2' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -107.49 157.84 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.139 0.495 . . . . 0.0 112.322 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.91 119.56 35.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.482 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' A' ' 22' ' ' THR . 4.8 p90 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 3.0 m . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.875 0.369 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.9 mm-40 -151.62 177.36 10.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.114 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.0 p -107.39 129.51 54.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.134 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.503 HG21 HG12 ' A' ' 111' ' ' ILE . 1.9 t -114.59 137.32 52.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.122 0.487 . . . . 0.0 111.83 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.15 99.32 10.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.152 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -102.7 107.71 22.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.281 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.416 ' CG2' ' HD2' ' A' ' 106' ' ' LYS . 13.7 p -88.67 113.84 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.036 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 54.5 mt -102.91 164.97 11.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.955 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.2 m -128.68 141.15 51.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.09 119.71 24.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.231 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.66 140.41 31.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.98 59.74 3.63 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.615 2.21 . . . . 0.0 112.502 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.6 t -154.88 -59.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -122.31 -42.73 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.823 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.57 -119.4 3.03 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -103.64 -26.93 12.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.86 39.72 92.01 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.649 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.2 tt -136.5 127.1 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.953 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 127.83 56.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.75 103.15 12.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.711 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.878 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.579 0.158 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 mp -150.71 142.77 24.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.115 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.6 mt -80.91 122.5 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.62 51.63 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -178.16 126.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.002 0.43 . . . . 0.0 111.365 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.77 152.09 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.1 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -102.05 155.53 18.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.019 0.438 . . . . 0.0 111.507 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.73 43.09 0.95 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.781 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 p30 178.32 28.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.861 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.402 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -128.81 137.02 30.07 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.277 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 69' ' ' CYS . 1.0 OUTLIER -43.76 -33.84 5.26 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.876 2.384 . . . . 0.0 112.649 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.78 85.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.843 0.354 . . . . 0.0 111.15 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -78.35 -50.23 12.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.216 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -71.32 -8.44 53.71 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.1 t -53.0 -33.63 52.5 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.824 0.345 . . . . 0.0 110.775 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.64 31.47 76.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.07 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.14 -65.78 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.098 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.73 150.28 44.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.147 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.4 -177.92 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.8 tt -84.51 56.59 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 111.269 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.29 39.83 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB3' ' CB ' ' A' ' 111' ' ' ILE . 67.3 m-20 -82.7 147.27 28.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.618 0.247 . . . . 0.0 110.74 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -94.86 76.24 3.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.709 0.29 . . . . 0.0 111.503 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.412 ' CG1' HG22 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -58.28 128.36 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.709 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.35 29.38 0.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.097 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 178.34 66.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 0.0 111.065 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.1 mt -96.91 119.82 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.98 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 44.05 30.61 0.44 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.407 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.88 -48.62 0.92 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.8 mm -69.78 111.76 10.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.602 0.239 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 C--N 1.347 0.485 0 C-N-CA 122.536 2.157 . . . . 0.0 112.844 -179.836 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.438 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.792 0.329 . . . . 0.0 110.88 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.51 -53.87 53.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.179 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -56.93 -34.8 68.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.88 -46.92 85.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.171 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 7.1 mt -60.38 -43.45 96.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.141 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.87 -32.59 57.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.459 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -78.99 -29.13 43.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.751 0.31 . . . . 0.0 111.178 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -66.34 -15.56 63.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.49 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 3.8 m -83.39 -15.39 49.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.321 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.2 t -58.36 -29.51 66.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.9 mm -54.07 -38.24 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.346 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.3 t -118.02 -3.91 11.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.199 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 101' ' ' SER . 1.1 m 65.81 42.16 3.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.109 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 3.1 tppt? -156.04 128.93 7.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 111.342 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.49 ' HB ' ' CB ' ' A' ' 101' ' ' SER . 14.7 p -137.48 145.42 29.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.135 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.82 105.6 10.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.314 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.21 124.81 49.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.018 0.437 . . . . 0.0 111.685 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -107.11 105.65 15.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.584 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.503 HG12 HG21 ' A' ' 25' ' ' THR . 0.2 OUTLIER -110.26 165.13 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.301 0.572 . . . . 0.0 112.27 -178.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -113.23 121.65 45.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.694 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 22' ' ' THR . 18.4 p90 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.881 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.464 0.243 0 CA-C-O 121.117 0.484 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -177.99 168.09 2.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.2 p -87.75 143.43 27.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.446 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 t -129.47 156.4 44.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.141 0.496 . . . . 0.0 111.355 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.57 98.71 7.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.82 103.14 14.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.477 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 t -82.78 115.04 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.592 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.4 mt -111.59 127.3 55.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.032 0.444 . . . . 0.0 110.918 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -99.05 144.45 28.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.775 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.23 124.94 27.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.949 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.42 136.81 52.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.67 -3.65 14.2 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.584 2.189 . . . . 0.0 112.609 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.42 -49.47 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.227 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.5 p -118.99 -57.07 2.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.9 -108.38 0.63 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.519 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.443 ' CZ ' ' CB ' ' A' ' 101' ' ' SER . 26.0 m-85 -114.66 -32.46 5.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.704 0.288 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.72 40.32 70.71 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.785 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -142.42 140.85 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.343 . . . . 0.0 110.92 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -123.29 145.14 48.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.222 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.41 105.37 15.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.738 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.867 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 C--O 1.23 0.111 0 CA-C-O 120.821 0.259 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.58 146.66 44.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.156 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.401 HG13 ' CG2' ' A' ' 78' ' ' VAL . 47.1 mt -60.64 133.61 26.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.28 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.454 ' HA ' HG13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -159.72 40.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 111.464 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CD1' ' HB2' ' A' ' 40' ' ' GLN . 34.2 t80 -167.08 131.12 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 111.198 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.79 152.33 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.03 155.33 17.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.989 0.423 . . . . 0.0 111.16 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.83 44.4 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.961 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER 168.39 32.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.666 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.78 146.45 55.2 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.926 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -43.82 -35.93 7.36 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.801 2.334 . . . . 0.0 112.867 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.17 -39.47 82.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 111.023 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.69 -50.34 13.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.722 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -72.31 -8.36 54.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.557 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.72 -26.22 8.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.719 0.295 . . . . 0.0 111.254 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.05 45.21 96.03 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.438 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -173.1 -44.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.974 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.7 mt -60.91 164.69 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.714 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -154.8 171.8 19.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 0.0 111.203 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.454 HG13 ' HA ' ' A' ' 58' ' ' SER . 2.7 tt -84.85 56.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.136 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.24 59.1 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.765 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -101.24 125.06 47.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.759 0.314 . . . . 0.0 110.755 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -69.34 71.98 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.249 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 3.0 t -63.37 146.64 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.18 27.4 0.14 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.392 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 173.34 79.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.786 0.327 . . . . 0.0 111.203 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.1 mt -100.52 126.73 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.045 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.2 30.1 0.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 102.14 -41.8 2.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.678 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 mm -75.53 109.86 8.98 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.569 0.223 . . . . 0.0 111.352 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 96.8 Cg_endo . . . . . 0 N--CA 1.455 -0.779 0 C-N-CA 123.051 2.501 . . . . 0.0 112.264 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.489 0.185 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.69 -52.41 65.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.029 0.442 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -55.85 -35.93 66.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.235 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -62.67 -39.59 94.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.29 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.22 -43.09 96.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.096 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 41.6 mt -76.57 -30.58 57.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.865 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -35.8 81.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.323 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -72.33 -9.41 58.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.556 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.443 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 4.9 m -69.6 -24.65 63.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 0.0 110.802 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.9 p -63.2 -55.33 25.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.662 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.7 mm -55.19 -40.65 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.32 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.3 m -80.41 -21.96 41.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t 77.58 -6.74 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.838 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -156.74 149.85 24.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.602 0.239 . . . . 0.0 110.82 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.4 p -150.08 141.87 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.96 113.35 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.988 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.2 142.97 35.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 112.065 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -104.73 105.92 16.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.537 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -116.92 150.51 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.401 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -112.1 120.84 43.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.138 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.6 p90 . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 120.959 0.409 . . . . 0.0 111.365 -179.424 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.513 -0.452 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -170.45 171.85 6.32 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.524 -177.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 74.2 p -99.2 132.52 44.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -109.53 135.39 50.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.224 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 99.07 9.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.631 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.97 122.84 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.034 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 t -90.46 120.8 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.252 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 10.9 mp -112.47 143.82 42.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.612 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 82.3 m -105.25 144.06 32.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.19 89.54 8.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.92 138.74 97.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.12 56.5 5.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.581 2.187 . . . . 0.0 112.447 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.9 t -155.33 -66.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 t -111.36 -29.8 7.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.63 -130.03 10.11 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.481 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 101' ' ' SER . 74.5 m-85 -99.53 -23.55 15.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.712 0.291 . . . . 0.0 111.023 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.58 34.88 56.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.903 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.1 tt -132.65 143.83 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.79 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.42 148.93 48.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.07 157.68 16.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.837 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.808 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.939 0.308 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.49 136.99 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.7 118.77 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.166 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.417 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . 94.2 p -139.68 46.65 1.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 111.745 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -174.23 129.13 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.132 0.491 . . . . 0.0 111.493 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -147.53 151.96 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.002 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.58 155.55 17.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.123 0.487 . . . . 0.0 111.483 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.5 42.03 1.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.86 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 168.15 33.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.757 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.55 150.08 60.27 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.037 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.01 -31.87 29.09 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.912 2.408 . . . . 0.0 112.51 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.59 81.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.028 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -78.11 -39.64 40.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -8.76 56.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.56 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.91 -24.85 10.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.704 0.288 . . . . 0.0 110.996 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.84 73.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.305 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 12.6 p -170.57 33.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.953 0.406 . . . . 0.0 110.972 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.68 153.01 50.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -168.97 161.9 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.417 ' CG2' ' HA ' ' A' ' 58' ' ' SER . 62.5 mt -71.13 117.25 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.081 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.01 -21.96 4.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.666 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.79 136.57 33.53 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.688 0.28 . . . . 0.0 110.768 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -96.86 82.2 3.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.055 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 7.2 p -68.78 159.02 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.052 0.453 . . . . 0.0 111.323 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -152.0 -81.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.134 179.485 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 85' ' ' PRO . . . -75.82 100.16 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 0.0 111.809 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.471 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 17.0 mt -119.38 125.88 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.357 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.9 p30 51.9 24.31 2.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.308 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 104.32 -39.0 2.98 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.753 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mm -84.18 108.86 15.7 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.42 0.156 . . . . 0.0 111.42 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 79' ' ' MET . 98.4 Cg_endo . . . . . 0 N--CA 1.451 -1.028 0 C-N-CA 122.779 2.319 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.408 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 7.0 mm-40 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.67 -44.67 85.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.807 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -56.77 -40.72 76.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.102 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -62.95 -35.95 81.83 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.267 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 24.3 mt -60.86 -48.1 83.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.782 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.9 mt -74.64 -24.95 58.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -35.7 66.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.185 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -77.57 -4.48 46.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.5 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.445 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 14.8 m -62.72 -26.75 68.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.758 0.313 . . . . 0.0 111.022 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 t -58.75 -30.35 67.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.997 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.1 mm -53.09 -56.45 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.943 0.402 . . . . 0.0 111.44 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 t -94.99 -1.42 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.144 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.36 10.76 8.05 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.442 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 21.5 ttmt -156.64 154.95 30.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.861 0.363 . . . . 0.0 111.008 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.89 145.95 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.598 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.65 112.92 25.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.3 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.31 131.54 45.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.5 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -114.93 104.53 12.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.888 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -114.67 154.79 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 120.951 0.405 . . . . 0.0 112.007 -178.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -108.21 129.24 55.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.864 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 23' ' ' GLU . 5.5 p90 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.878 0.371 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -175.65 167.55 3.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.062 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.17 140.77 29.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.554 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.96 147.5 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.048 0.451 . . . . 0.0 111.403 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.35 98.03 7.36 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -101.63 107.09 20.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.141 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.404 ' CG1' ' HD3' ' A' ' 106' ' ' LYS . 7.9 t -82.63 120.61 34.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.195 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.0 mt -112.47 164.19 13.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.0 m -124.66 133.26 53.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.443 ' CB ' ' CE2' ' A' ' 37' ' ' PHE . . . -80.1 92.09 5.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -73.02 146.69 87.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.12 49.04 2.9 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.934 2.422 . . . . 0.0 112.569 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -153.35 -59.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.814 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 p -114.49 -16.71 11.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.085 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.6 -121.73 5.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.324 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 95.0 m-85 -109.08 -26.82 9.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.659 0.266 . . . . 0.0 110.788 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.94 48.26 30.98 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.944 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.59 125.17 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.806 0.336 . . . . 0.0 111.069 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.41 122.84 47.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -111.06 100.88 9.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.811 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.819 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo . . . . . 0 CA--C 1.526 0.107 0 CA-C-O 120.752 0.23 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.86 130.59 2.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.096 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 40.6 mt -81.59 139.74 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.676 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 m -160.28 37.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.819 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -173.95 140.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.953 0.406 . . . . 0.0 111.682 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -149.49 152.76 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.229 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.03 155.78 23.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.082 0.467 . . . . 0.0 111.428 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.98 40.37 0.94 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.789 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.55 31.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -120.26 144.18 37.43 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.824 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -46.29 -29.36 6.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.937 2.424 . . . . 0.0 112.573 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.24 81.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.03 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.426 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 8.6 tp10 -78.63 -33.44 47.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.077 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -80.04 -8.84 59.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.002 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.0 p -55.97 -29.86 60.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.06 46.2 93.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.44 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 t -144.58 -67.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 111.286 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.71 165.0 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.13 -170.27 2.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.695 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.5 mm -82.47 79.28 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.83 61.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.677 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -112.24 152.22 28.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.714 0.292 . . . . 0.0 110.71 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.52 83.62 2.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.893 0.378 . . . . 0.0 111.664 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.438 ' CG1' ' CG2' ' A' ' 111' ' ' ILE . 1.6 m -62.45 126.91 21.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.68 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.33 30.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.205 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 178.29 52.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 111.079 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.1 mt -79.01 126.5 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.025 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.41 31.73 0.44 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.481 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.5 -45.5 1.32 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.541 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mm -71.25 112.89 15.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.605 0.241 . . . . 0.0 111.267 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo . . . . . 0 N--CA 1.46 -0.462 0 C-N-CA 122.752 2.302 . . . . 0.0 112.837 -179.905 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.411 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.9 tp10 . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.842 0.353 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.66 -51.31 70.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.967 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.41 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 25.3 m-20 -58.36 -35.24 71.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.492 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -37.98 88.8 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.666 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 1.3 mt -65.81 -48.02 73.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.493 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.41 ' CD2' ' HA ' ' A' ' 95' ' ' ASN . 1.5 pp -75.84 -24.15 55.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.27 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -71.14 -36.32 72.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -7.55 54.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.393 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.447 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.0 m -67.38 -18.69 65.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.723 0.297 . . . . 0.0 111.112 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.5 m -58.69 -33.11 69.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.13 -61.43 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.184 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.1 t -85.63 -6.75 59.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.093 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 101' ' ' SER . 33.2 t 62.93 25.19 14.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.301 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.404 ' HD3' ' CG1' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -156.47 150.51 25.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.945 0.402 . . . . 0.0 111.449 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.417 HG11 ' CE1' ' A' ' 37' ' ' PHE . 13.0 p -153.38 157.43 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.47 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.57 107.33 12.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.2 127.38 33.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.714 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -118.01 104.68 11.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.756 178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.438 ' CG2' ' CG1' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -125.89 165.29 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.112 0.482 . . . . 0.0 112.119 -178.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -121.63 128.19 51.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.745 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 10.6 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 120.917 0.389 . . . . 0.0 111.09 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.633 0.254 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' CG ' ' CZ ' ' A' ' 113' ' ' PHE . 17.5 pt-20 -177.97 171.66 1.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.066 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 p -87.84 148.22 24.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.636 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.414 HG23 ' CD1' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -129.7 159.69 35.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 111.101 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -113.33 99.37 7.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.13 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.07 102.61 14.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.494 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.68 115.61 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.937 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.56 128.97 55.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 111.005 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 67.8 m -110.63 134.01 52.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.99 153.63 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.059 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -130.65 137.46 30.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.83 60.14 5.23 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.584 2.189 . . . . 0.0 112.302 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.75 -65.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -131.4 17.9 4.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.3 -116.41 5.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.563 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -113.36 -30.48 6.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.861 0.362 . . . . 0.0 111.257 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.71 23.9 63.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.687 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.405 ' HB ' ' CB ' ' A' ' 66' ' ' ALA . 3.6 tt -124.69 139.75 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.725 0.298 . . . . 0.0 110.877 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -135.18 149.5 49.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.049 0.452 . . . . 0.0 111.297 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.89 168.94 9.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.376 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.082 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.465 -0.165 0 CA-C-O 120.825 0.26 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -176.42 156.68 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.0 mt -68.75 147.71 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.8 47.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 111.573 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -176.76 134.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 111.583 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.418 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -151.94 152.0 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.934 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.03 155.0 17.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 111.289 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -86.8 39.6 0.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.869 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 28.1 t0 174.06 31.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.607 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.9 m -122.54 144.26 41.82 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.055 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -42.34 -36.53 4.41 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.958 2.439 . . . . 0.0 112.947 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -57.88 -40.1 79.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.841 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -78.13 -51.88 9.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.766 179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -12.75 61.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.482 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.28 -30.28 62.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 0.0 110.838 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.69 24.94 57.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.571 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.2 m -136.58 10.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.585 0.231 . . . . 0.0 111.603 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.56 158.67 44.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.874 0.369 . . . . 0.0 111.023 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -154.45 150.45 27.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.619 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mt -57.17 107.46 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.72 40.14 0.19 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.595 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -114.83 127.72 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 110.575 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -88.18 89.97 8.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.441 ' CG2' ' CG2' ' A' ' 111' ' ' ILE . 13.3 t -69.02 139.64 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.627 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 ttp -164.42 31.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.61 0.243 . . . . 0.0 111.452 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 178.21 69.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.005 0.431 . . . . 0.0 111.319 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.408 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 37.8 mt -98.78 118.19 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.957 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 44.55 31.64 0.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.303 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.54 -47.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.453 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mm -72.39 121.12 83.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.59 0.233 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 C--N 1.348 0.508 0 C-N-CA 122.688 2.259 . . . . 0.0 112.952 -179.898 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.738 0.304 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.03 -45.49 86.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.008 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -60.81 -42.89 98.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.561 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -62.95 -32.87 74.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.516 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.1 mt -65.71 -48.07 73.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.69 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.67 -28.56 66.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.53 -36.81 76.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.56 -5.69 48.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.38 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 m -60.14 -20.15 57.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.207 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.7 m -63.13 -31.51 72.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.61 -59.2 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.133 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 t -83.24 -7.88 59.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.294 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 p 80.82 -8.65 1.43 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 5.5 ptpt -156.5 163.37 39.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 111.166 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.4 147.97 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.709 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.74 112.05 23.27 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.245 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.85 125.62 52.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.934 0.397 . . . . 0.0 111.946 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -93.11 104.87 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.441 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -110.09 158.53 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.179 -178.555 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -116.82 119.0 34.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.247 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CZ ' ' CG ' ' A' ' 23' ' ' GLU . 23.0 p90 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.142 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.701 0.286 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -155.69 169.6 23.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 111.052 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.0 p -94.66 130.66 41.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.457 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.433 HG23 HG12 ' A' ' 111' ' ' ILE . 4.6 t -111.79 135.29 52.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.828 0.346 . . . . 0.0 111.409 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.1 pt-20 -99.82 98.82 9.58 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.19 111.54 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.94 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.413 ' CG1' ' HD3' ' A' ' 106' ' ' LYS . 10.6 t -82.7 121.85 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.092 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 4.1 mm? -111.9 140.58 46.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 26.8 m -105.34 147.85 27.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.808 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.37 104.25 16.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.243 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.24 135.18 76.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.677 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.12 55.79 5.48 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.558 2.172 . . . . 0.0 112.489 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.9 t -155.21 -49.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.942 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -125.4 -44.11 1.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.968 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.76 -121.09 4.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.425 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 101' ' ' SER . 40.4 m-85 -110.97 -26.2 9.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.705 0.288 . . . . 0.0 111.082 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.96 33.66 79.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.794 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.1 tt -136.95 140.76 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.428 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 68.2 mm-40 -131.7 136.69 47.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.127 0.489 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.25 130.36 55.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.717 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--O 1.23 0.122 0 CA-C-O 120.819 0.258 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 mp -157.16 136.67 12.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.353 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 68.1 mt -71.51 144.84 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.436 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.2 p -163.4 55.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.986 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.428 ' CD1' ' HG2' ' A' ' 40' ' ' GLN . 11.2 t80 -177.95 132.68 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 111.618 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.432 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -152.89 152.03 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.751 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -96.87 155.13 16.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.38 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.97 41.91 0.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.918 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.428 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 1.2 p30 168.88 32.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.705 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.78 145.86 44.35 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.697 0.284 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -44.96 -37.21 12.07 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.769 2.313 . . . . 0.0 112.578 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.95 80.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.977 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -76.16 -50.18 15.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.687 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.428 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.9 -8.74 56.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.667 -179.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -24.89 60.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.664 0.268 . . . . 0.0 110.79 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.14 30.24 77.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.148 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 t -142.3 -49.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.348 . . . . 0.0 111.068 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.5 mt -69.22 159.62 32.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.032 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 -171.14 3.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.7 mm -93.58 49.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.76 39.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.65 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -89.95 146.15 24.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.762 0.315 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.6 85.31 2.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.052 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 2.6 t -55.54 159.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -50.49 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.45 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.27 86.29 1.76 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.808 0.337 . . . . 0.0 111.641 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.428 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 4.3 mt -77.51 111.81 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 p30 46.53 28.42 0.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.228 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 112.94 -49.57 0.84 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.418 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.9 mm -69.33 109.12 3.89 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.548 0.213 . . . . 0.0 111.182 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 87.0 Cg_endo . . . . . 0 N--CA 1.452 -0.944 0 C-N-CA 122.907 2.405 . . . . 0.0 112.458 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.848 0.356 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.441 ' HA ' HD23 ' A' ' 97' ' ' LEU . . . -67.46 -42.51 82.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.36 -41.7 84.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.441 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -64.33 -53.05 54.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.222 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 94' ' ' ALA . 4.2 pp -57.89 -35.19 70.66 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.159 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.428 ' N ' ' CD1' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -78.47 -35.5 46.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.727 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -27.84 67.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -15.3 63.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.175 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.431 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -73.33 -21.57 60.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.885 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.0 t -70.03 -32.38 70.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.815 0.341 . . . . 0.0 110.408 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -82.03 -41.73 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.681 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.0 m -79.74 -20.28 46.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.856 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.6 m 76.78 -1.76 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.789 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HD3' ' CG1' ' A' ' 28' ' ' VAL . 10.1 tttt -156.56 152.24 27.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.825 0.345 . . . . 0.0 111.501 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.8 p -150.65 151.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.239 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.95 109.45 20.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.988 0.423 . . . . 0.0 110.531 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.5 127.94 35.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.512 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -119.25 104.6 10.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.097 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -124.92 162.7 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.091 0.472 . . . . 0.0 112.088 -178.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.52 118.61 37.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.779 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 29.3 p90 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.309 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.929 0.395 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.26 146.18 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.067 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.69 126.73 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.098 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.41 ' CE1' ' OE2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -127.83 -173.55 2.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.927 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 174.77 102.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.381 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 2.6 mm-40 -144.34 176.87 9.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.967 0.413 . . . . 0.0 111.169 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -110.9 134.95 52.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.432 HG23 HG13 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -115.66 146.9 41.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.257 0.551 . . . . 0.0 111.415 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.3 99.26 8.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.087 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.403 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -102.15 102.37 13.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.768 -178.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -85.97 119.32 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.466 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.8 mt -110.63 164.14 13.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.945 0.403 . . . . 0.0 111.221 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 90.4 m -130.31 127.71 40.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.581 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.24 112.27 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.416 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.04 146.02 99.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.24 -7.3 20.87 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.659 2.239 . . . . 0.0 112.902 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -98.81 -67.05 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.061 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.8 p -105.6 -51.33 3.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.46 -75.3 0.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.744 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.451 ' C ' ' H ' ' A' ' 39' ' ' ILE . 95.9 m-85 -138.72 76.25 1.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.955 0.407 . . . . 0.0 110.423 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.28 0.64 1.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.911 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.451 ' H ' ' C ' ' A' ' 37' ' ' PHE . 17.8 tt -95.86 132.89 38.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 116.861 0.331 . . . . 0.0 110.599 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -116.95 145.61 43.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.133 0.492 . . . . 0.0 111.731 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.76 122.71 37.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.01 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -104.59 137.45 42.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 0.0 111.296 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.758 ' HA2' ' HA ' ' A' ' 55' ' ' PRO . . . -93.55 45.81 2.36 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.49 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 3.2 m 53.97 61.46 3.06 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.219 0.533 . . . . 0.0 109.958 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.45 ' HA ' ' CD2' ' A' ' 51' ' ' LEU . 2.4 p -155.3 -39.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.702 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 19.9 t80 -94.17 28.11 2.62 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.895 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.45 134.03 17.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.965 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.13 -16.61 53.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.736 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.61 101.94 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.9 m 58.14 164.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.163 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' CD2' ' HA ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -158.83 178.59 9.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.998 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.44 26.5 15.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.134 0.493 . . . . 0.0 111.113 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.436 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -112.43 170.08 5.66 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.134 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 53' ' ' SER . 38.4 Cg_endo -67.27 174.36 7.24 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.709 2.273 . . . . 0.0 112.746 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.758 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 85.4 Cg_endo -84.19 144.14 10.45 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.005 2.47 . . . . 0.0 113.112 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -158.48 161.03 37.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.75 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.2 mt -80.22 138.57 19.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.7 t -164.34 41.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.241 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -176.32 123.19 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 0.0 111.48 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.448 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 3.6 mt -133.73 152.51 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.084 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -100.57 155.62 17.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.07 0.462 . . . . 0.0 111.36 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.15 43.25 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.902 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER 168.18 31.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.676 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -112.97 144.38 30.97 Favored Pre-proline 0 CA--C 1.527 0.088 0 CA-C-O 120.707 0.289 . . . . 0.0 110.782 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -45.1 -32.89 7.3 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.638 2.225 . . . . 0.0 112.661 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.411 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -66.39 -46.03 78.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.788 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.448 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -65.34 -39.13 91.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.632 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.429 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -87.37 -8.49 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.652 -179.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.0 t -53.43 -25.03 14.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 111.033 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.64 27.24 73.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.201 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 71' ' ' VAL . 12.3 p -170.97 34.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.406 . . . . 0.0 111.007 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.4 mt -141.42 147.67 38.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.009 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -168.95 171.69 8.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.725 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.9 mt -70.46 123.63 24.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.088 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.42 -24.6 3.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.607 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.431 ' HB3' ' CG2' ' A' ' 111' ' ' ILE . 69.7 m-20 -57.73 123.62 16.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.762 0.315 . . . . 0.0 110.732 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -94.34 98.42 10.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.433 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.528 ' HA ' HG22 ' A' ' 111' ' ' ILE . 2.6 m -75.89 118.31 21.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.972 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.3 ttp -141.14 27.48 1.94 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -178.86 61.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 0.0 110.932 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.6 mt -92.45 130.82 40.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.216 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 43.93 31.14 0.47 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.316 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.84 -44.44 1.64 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.602 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 mm -71.77 110.78 8.41 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.501 0.191 . . . . 0.0 111.289 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -90.95 15.87 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.814 2.343 . . . . 0.0 112.686 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 p 61.68 150.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.836 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -114.06 111.62 21.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.164 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 61.94 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.129 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.8 p -161.02 114.82 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 p -146.73 92.8 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.97 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -58.67 -44.22 90.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.604 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -60.26 -32.32 71.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.733 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -45.07 84.87 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.604 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.9 75.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.679 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -58.01 -36.77 73.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.545 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -43.95 97.52 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.653 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.71 -42.49 93.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.613 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 mt -62.86 -37.13 85.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -77.74 -28.42 50.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.126 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.41 -6.72 49.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.463 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 3.5 m -72.68 -26.24 61.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.74 0.305 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.92 -26.85 64.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.218 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.8 mm -53.9 -49.32 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.494 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 t -104.73 -1.06 26.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 78.97 -4.54 2.1 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.791 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -156.58 152.64 27.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.868 0.366 . . . . 0.0 111.111 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 p -131.13 157.54 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.778 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.56 106.87 12.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.86 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -100.64 120.15 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 111.871 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.96 112.12 22.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.454 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -118.43 164.97 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.361 0.6 . . . . 0.0 112.443 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -123.12 124.87 44.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.833 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 49.9 p90 -114.65 152.66 31.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.955 0.407 . . . . 0.0 111.263 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.84 97.73 5.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.451 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.7 t -68.38 126.99 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.238 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -140.65 46.19 1.79 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.014 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -179.82 53.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.815 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.852 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.865 0.364 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.74 77.84 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.173 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.6 106.65 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.975 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.415 ' O ' ' OG1' ' A' ' 22' ' ' THR . 0.9 OUTLIER -92.93 176.74 6.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.245 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 21' ' ' HIS . 1.4 m 167.55 132.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.22 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 22.1 pt-20 -175.15 177.08 1.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.969 0.414 . . . . 0.0 111.212 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 15.8 p -89.53 128.19 35.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.109 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 t -107.28 136.0 47.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.277 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.79 99.38 11.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -101.02 103.18 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.718 -178.435 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 10.9 t -83.59 113.95 23.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.406 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.418 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 8.7 mt -110.08 137.64 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.009 0.433 . . . . 0.0 111.251 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 96.7 m -109.91 137.89 47.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.577 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.67 146.62 51.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.214 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.02 139.46 28.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.794 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.0 57.23 5.1 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.61 2.207 . . . . 0.0 112.432 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.4 t -155.42 -68.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 -29.76 6.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.011 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.75 -110.93 3.15 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.406 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 29' ' ' LEU . 52.3 m-85 -114.61 -33.01 5.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.51 31.87 82.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.77 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.96 140.96 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 110.959 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.24 159.18 42.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.039 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.49 121.64 31.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.733 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.34 171.3 13.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.9 75.9 0.41 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.52 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.405 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . 13.4 p -172.46 171.6 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 111.213 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 53' ' ' SER . 72.6 t -123.71 -41.46 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.277 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 173.38 44.46 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -175.57 114.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.239 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.6 p -58.07 -21.28 45.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.261 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.4 ' O ' ' CG2' ' A' ' 50' ' ' THR . 10.1 mm-40 -92.67 136.06 33.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.728 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 49' ' ' GLU . 14.5 t 46.29 -170.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.424 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.405 ' CD1' ' HA ' ' A' ' 44' ' ' SER . 18.1 tp -177.52 133.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.574 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.98 14.26 15.02 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.466 ' HB2' ' CG2' ' A' ' 45' ' ' VAL . 1.4 m -136.44 139.79 30.61 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.996 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.98 173.07 2.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.354 2.036 . . . . 0.0 111.933 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.08 166.38 18.92 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.484 2.123 . . . . 0.0 112.105 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -152.52 150.29 29.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.069 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.7 mt -74.52 147.93 8.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.402 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -175.4 50.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.153 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -173.79 134.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 0.0 111.437 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -150.69 151.88 12.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.219 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.75 155.36 18.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 0.0 111.582 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.87 41.0 1.02 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.863 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER 171.82 33.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.521 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 m -127.11 143.67 47.82 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.07 -32.81 7.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.729 2.286 . . . . 0.0 112.809 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.99 -51.66 68.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.986 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 10.6 tp10 -69.67 -43.14 73.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.69 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -67.15 -14.11 62.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.402 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.91 -27.44 52.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.941 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.18 31.58 65.93 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.239 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.4 t -137.29 -58.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 111.206 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.38 166.09 24.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.053 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -164.86 169.23 16.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.707 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 58' ' ' SER . 18.0 mt -67.54 114.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.068 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.67 22.17 4.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.648 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.45 141.52 31.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.679 0.276 . . . . 0.0 110.673 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.84 89.66 4.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.345 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.458 ' CG2' ' CG2' ' A' ' 111' ' ' ILE . 5.4 t -74.82 145.85 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.602 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -170.29 29.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 110' ' ' GLU . . . -176.18 46.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 111.661 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.402 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 16.5 mt -67.8 112.99 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.029 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 44.06 35.69 1.25 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.436 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.59 -49.7 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.386 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.11 120.29 77.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.534 0.207 . . . . 0.0 111.138 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -86.07 19.29 1.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.719 2.28 . . . . 0.0 112.915 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.6 p 58.55 107.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.88 126.72 28.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.952 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -65.91 78.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.832 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.94 -49.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.51 136.48 14.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.05 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -61.56 -22.63 65.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.967 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -53.56 -30.59 42.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.012 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 4.2 mt-10 -63.76 -47.78 79.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.962 0.411 . . . . 0.0 110.21 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.41 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . . . -60.32 -38.54 84.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.764 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -61.93 -43.67 98.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -62.56 -38.06 88.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.446 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.434 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 12.2 mt -61.71 -40.7 95.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.248 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.4 mt -78.02 -32.17 50.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.363 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -65.89 -25.86 67.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.916 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.54 15.02 10.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.522 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 m -79.32 -23.22 43.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.81 0.338 . . . . 0.0 110.853 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 p -58.59 -35.25 72.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.807 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.9 mm -53.95 -54.37 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.4 p -86.93 -8.69 57.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.984 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 79.35 -5.02 1.99 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.025 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -156.62 166.8 32.37 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.853 0.358 . . . . 0.0 111.187 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 11.4 p -151.13 148.32 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.902 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.33 107.19 15.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.087 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -101.83 126.16 48.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.776 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -92.5 120.53 33.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.62 178.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -133.79 165.48 31.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.383 -178.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -116.86 126.75 53.49 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.102 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.421 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 34.5 p90 -118.09 148.48 42.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.15 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -123.1 97.8 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.503 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.3 m -59.17 168.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.266 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -174.51 48.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.964 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -174.04 48.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.929 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 p . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.894 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.859 0.361 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.18 75.09 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.3 p -147.82 139.49 18.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.024 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.454 ' HA ' ' N ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER 64.17 46.45 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.749 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' A' ' 21' ' ' HIS . 0.2 OUTLIER 167.13 105.79 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.226 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.6 OUTLIER -168.26 154.18 7.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.393 . . . . 0.0 111.572 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 72.5 p -89.85 127.06 35.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.265 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.402 HG21 HG12 ' A' ' 111' ' ' ILE . 7.3 t -114.61 131.07 56.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.925 0.393 . . . . 0.0 111.366 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.18 99.42 11.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.724 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.411 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -107.69 133.64 51.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.081 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.6 t -94.28 117.42 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.405 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.17 126.1 52.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.331 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.0 t -103.11 165.88 10.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.215 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.99 30.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.081 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.25 140.22 79.57 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.769 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.02 -0.69 10.83 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.659 2.239 . . . . 0.0 112.874 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.4 t -108.04 -35.69 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.002 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.9 p -133.91 -66.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.72 -109.1 0.57 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.434 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -118.41 -35.43 3.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 111.097 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.7 26.0 38.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.776 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 tt -111.16 127.18 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.994 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 125.14 51.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 mt -108.84 116.3 31.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.756 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.408 ' HA ' ' CD2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -84.59 145.43 28.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.56 -7.05 65.37 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.618 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -119.4 165.36 14.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.785 0.326 . . . . 0.0 111.009 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.1 t -123.28 -3.22 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.695 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -171.6 132.66 0.75 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.342 . . . . 0.0 111.041 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 59.24 110.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.399 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -65.8 -14.51 61.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.62 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -94.4 22.83 5.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.236 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -167.65 177.57 5.79 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.838 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.03 137.75 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.844 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.78 22.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.506 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.84 157.91 32.07 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.78 171.7 10.6 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.542 2.161 . . . . 0.0 112.066 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.07 174.35 4.09 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.441 2.094 . . . . 0.0 111.979 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 1.7 pt? -178.08 169.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.62 141.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.429 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.9 t -117.34 -31.29 5.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.849 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -165.56 167.43 17.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.194 0.521 . . . . 0.0 111.886 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.445 HD11 HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -144.94 153.18 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.922 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -86.37 155.46 20.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.086 0.469 . . . . 0.0 111.516 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.87 38.34 0.8 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.82 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -179.72 26.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.992 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.5 p -120.62 134.58 24.25 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.626 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.52 -29.21 2.03 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.492 2.128 . . . . 0.0 112.752 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.85 99.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.983 0.42 . . . . 0.0 110.815 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 8.8 tp10 -78.48 -50.22 12.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.152 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -8.36 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.916 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -24.95 11.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.771 0.32 . . . . 0.0 111.0 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.84 30.71 63.22 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.237 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.4 t -145.03 -52.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.926 0.393 . . . . 0.0 111.116 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.69 130.68 39.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.047 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 -170.99 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.798 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.9 mm -92.16 75.61 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.187 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.88 42.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.891 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -85.18 -176.03 5.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.583 0.23 . . . . 0.0 110.534 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.91 79.27 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 111.203 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.448 ' CG1' ' CG1' ' A' ' 81' ' ' ILE . 12.2 t -58.45 147.82 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.054 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 11.9 tpt -134.98 -65.36 0.62 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.07 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -125.37 96.95 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.448 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 9.7 mt -88.48 122.96 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.943 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.6 p30 46.53 31.63 1.4 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.01 -34.23 5.2 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.219 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mm -87.72 110.85 37.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.511 0.196 . . . . 0.0 111.155 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -90.57 24.8 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.669 2.246 . . . . 0.0 112.56 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 p 63.45 142.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.795 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -80.78 106.85 13.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.3 t70 62.95 -79.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.027 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 p -179.8 106.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.14 128.38 12.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.806 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 42' ' ' GLN . 27.2 t80 -59.28 -43.76 92.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -62.45 -30.9 71.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -52.4 62.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.45 73.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -58.16 -36.36 72.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.582 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.92 -43.95 97.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.724 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 mt -60.5 -43.75 96.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.721 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.3 mt -70.96 -31.24 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -67.55 -32.68 73.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.98 -5.82 50.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.233 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -75.55 -23.18 56.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.751 0.31 . . . . 0.0 111.017 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.6 p -63.7 -30.98 72.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.714 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -65.14 -56.14 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.995 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 105' ' ' SER . 42.7 p -77.61 -11.7 59.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.126 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 104' ' ' THR . 1.8 p 84.19 -18.3 0.42 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.925 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 8.6 ptpt -156.43 160.53 39.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 111.284 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 9.8 p -144.67 155.27 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.713 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.99 121.85 46.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.206 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.07 143.84 44.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.446 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -115.18 104.71 12.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.983 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' THR . 0.2 OUTLIER -116.55 161.31 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -93.59 133.57 36.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.689 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 30.6 p90 -131.78 164.99 24.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.979 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.438 ' HB3' ' CG ' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -119.31 97.77 5.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.72 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.454 ' N ' ' HA ' ' A' ' 21' ' ' HIS . 13.5 p -93.88 158.99 2.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.34 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -128.17 48.82 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.047 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -171.9 73.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.883 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.803 0.335 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.4 t -70.7 66.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.945 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -177.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.27 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.524 ' O ' ' CZ ' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -154.03 119.94 5.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.631 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.736 ' N ' ' HB ' ' A' ' 115' ' ' VAL . 5.6 t -62.81 112.55 2.59 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER 179.26 177.28 0.55 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.739 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 19.7 p -86.61 127.58 34.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.29 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.403 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 9.9 t -113.98 140.77 48.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.37 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 99.01 9.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.4 ' CG2' HD12 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -101.64 103.17 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.305 -178.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.45 ' CG2' ' HD2' ' A' ' 106' ' ' LYS . 14.4 p -82.74 115.25 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.929 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.78 147.99 37.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.117 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.2 m -108.11 144.7 35.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.1 108.82 17.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.3 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -68.3 140.6 92.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.99 41.38 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.771 2.314 . . . . 0.0 112.814 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.88 -47.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.799 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -127.39 -43.42 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.977 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.17 -118.57 2.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.52 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' A' ' 101' ' ' SER . 29.9 m-85 -108.07 -25.49 11.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.761 0.315 . . . . 0.0 110.943 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.53 41.88 99.65 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.532 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.428 ' HB ' ' CB ' ' A' ' 66' ' ' ALA . 18.8 tt -150.66 126.63 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.775 0.321 . . . . 0.0 111.098 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' A' ' 59' ' ' TYR . 2.8 pm0 -124.28 156.54 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.037 0.446 . . . . 0.0 111.268 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 2.6 mp -103.67 162.3 13.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.01 169.76 6.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.98 34.41 52.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.419 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 3.2 t -101.4 67.05 1.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.883 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' A' ' 45' ' ' VAL . 74.3 t 65.69 -0.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.077 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -138.69 101.87 4.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.773 0.321 . . . . 0.0 110.905 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -175.77 134.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.049 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.0 m 61.97 -100.92 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.01 -75.56 0.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.654 0.264 . . . . 0.0 110.914 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.0 m -165.69 115.12 1.01 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.023 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -124.1 173.61 8.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.902 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 m -136.41 105.09 5.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.941 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.08 141.94 0.22 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.763 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.84 170.13 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.42 2.08 . . . . 0.0 112.053 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.37 133.24 27.69 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.376 2.051 . . . . 0.0 112.029 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.39 145.12 36.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.198 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 6.3 mt -59.64 145.27 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.516 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 m -147.45 16.84 1.16 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 4.0 t80 -162.26 149.84 14.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.222 0.534 . . . . 0.0 111.799 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.41 152.36 11.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.788 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -94.45 155.63 16.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 111.825 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -87.86 41.48 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.716 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 169.6 31.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.71 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.9 m -120.83 144.15 38.31 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.795 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.45 -27.25 7.03 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.885 2.39 . . . . 0.0 112.547 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.428 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -66.29 -46.84 75.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.976 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 2.9 tp10 -78.06 -39.73 40.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.6 -19.16 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.78 -30.12 31.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.075 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.1 23.56 52.53 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.816 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.39 -38.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.763 0.316 . . . . 0.0 111.232 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 pp -93.59 148.63 21.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.955 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -125.86 169.09 12.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.686 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.9 mm -67.44 107.07 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.047 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.87 4.39 6.7 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.073 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.91 133.18 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.86 0.33 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -98.28 95.71 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.219 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.517 ' CG2' ' CG2' ' A' ' 111' ' ' ILE . 2.7 t -76.19 129.82 36.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.546 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -150.77 31.87 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.274 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 179.36 81.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 41.7 mt -111.91 126.7 69.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.234 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.8 p30 45.19 31.35 0.76 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.234 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.41 -34.75 5.05 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.312 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.0 mm -82.15 111.68 29.55 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.455 0.169 . . . . 0.0 111.083 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -86.06 11.0 3.45 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.682 2.254 . . . . 0.0 112.713 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p 71.33 6.59 5.83 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.545 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 52.61 22.45 2.21 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.5 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 43.53 33.65 0.68 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.697 0.284 . . . . 0.0 111.462 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.57 -79.01 0.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.1 p -129.34 160.26 33.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.98 0.419 . . . . 0.0 111.027 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -70.23 -25.72 63.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.993 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -54.97 -40.31 69.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.975 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 35.0 mt-10 -59.84 -49.27 78.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.701 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.36 -43.02 83.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -56.59 -40.94 76.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.058 0.456 . . . . 0.0 110.054 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -63.03 -38.03 89.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.32 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 41.3 mt -61.02 -39.0 88.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 mt -78.09 -28.59 48.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.053 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -74.91 -35.8 62.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.412 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -78.39 -3.2 42.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.652 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.46 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 67.0 m -69.77 -25.02 63.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.858 0.361 . . . . 0.0 110.733 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.03 -27.22 65.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 21.9 mm -49.92 -47.2 23.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.824 0.345 . . . . 0.0 111.241 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 t -108.75 0.94 20.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.057 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 t 62.81 18.06 10.41 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.256 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 0.5 OUTLIER -156.94 144.14 18.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.865 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.427 HG13 ' CE2' ' A' ' 37' ' ' PHE . 10.4 p -152.36 151.94 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.705 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 p -122.15 104.32 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.007 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -102.41 149.17 24.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.181 0.515 . . . . 0.0 112.183 -178.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.27 124.87 50.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.252 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.517 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -138.18 133.31 43.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 35.2 tt0 -92.7 118.64 31.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.524 ' CZ ' ' O ' ' A' ' 21' ' ' HIS . 18.8 p90 -109.89 152.8 25.34 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.783 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 113' ' ' PHE . 5.9 t0 -66.8 163.11 20.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.348 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.736 ' HB ' ' N ' ' A' ' 22' ' ' THR . 8.4 p -117.38 161.05 16.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.052 0.453 . . . . 0.0 112.135 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.98 -169.11 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.117 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -135.02 85.46 2.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.893 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.289 -0.863 . . . . 0.0 110.872 -179.912 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.63 109.75 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.5 HG22 ' HB ' ' A' ' 115' ' ' VAL . 3.9 p -58.59 140.02 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.836 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -154.02 36.89 0.44 Allowed 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.431 HG21 ' N ' ' A' ' 23' ' ' GLU . 96.5 m 62.13 146.85 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.991 0.424 . . . . 0.0 111.307 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -178.31 168.31 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.726 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 12.5 p -87.78 151.68 22.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.71 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.427 HG21 HG12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -132.15 143.49 50.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.032 0.444 . . . . 0.0 111.53 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.28 99.61 9.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.55 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.42 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -105.4 106.89 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.616 -178.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.6 p -90.01 114.98 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.703 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.27 164.42 11.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 0.0 110.961 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 m -121.19 142.54 49.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.608 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.85 114.54 23.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 111.121 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.64 147.83 71.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.96 18.64 1.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.968 2.445 . . . . 0.0 112.853 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.84 -41.28 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.801 0.334 . . . . 0.0 111.078 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 t -136.04 -45.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.074 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.4 -109.98 0.93 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.512 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 101' ' ' SER . 87.1 m-85 -118.7 -31.7 4.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.631 0.253 . . . . 0.0 111.191 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.48 35.78 90.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.648 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tt -135.39 131.33 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.965 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.9 155.78 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.041 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.65 135.9 38.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -90.8 171.17 9.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.59 155.41 17.63 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.279 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p -48.75 173.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 111.169 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.3 t -146.76 -80.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 111.243 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.19 116.43 3.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.845 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.14 100.45 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.147 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 t 175.67 -33.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.148 0.499 . . . . 0.0 110.958 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -164.4 -65.69 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.785 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -52.02 174.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -54.41 106.15 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.37 . . . . 0.0 110.831 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.92 89.19 2.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.8 134.74 0.4 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.844 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.76 178.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.488 2.125 . . . . 0.0 111.972 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -43.02 94.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.601 2.201 . . . . 0.0 112.368 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -115.95 151.2 35.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.124 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.4 HG13 ' CG2' ' A' ' 78' ' ' VAL . 29.2 mt -84.37 154.1 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.92 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 t -177.81 51.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.064 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -175.53 133.86 0.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.971 0.415 . . . . 0.0 111.288 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.419 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -150.58 152.18 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.357 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.99 155.46 17.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.652 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.0 41.63 1.01 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.811 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER 172.19 32.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.589 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -126.73 145.61 54.08 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.73 -31.73 15.28 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.991 2.461 . . . . 0.0 112.591 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.8 -45.25 90.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 11.8 tp10 -77.96 -41.9 34.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.775 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.424 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -69.38 -11.77 61.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.402 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.1 t -52.98 -30.67 36.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.821 0.343 . . . . 0.0 111.112 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.09 27.89 68.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.44 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 m -152.54 30.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.347 . . . . 0.0 111.179 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 mt -136.92 162.23 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.75 159.07 43.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.3 mm -75.66 98.05 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.244 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.67 38.52 0.61 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.618 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -82.1 126.84 32.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 110.73 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -84.68 90.04 7.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.073 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.404 ' HA ' HG22 ' A' ' 111' ' ' ILE . 2.1 t -70.66 144.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.42 28.47 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.212 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 172.16 89.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 111.278 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.4 mt -116.54 115.09 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.785 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.9 p30 49.6 26.75 1.87 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.248 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.12 -44.25 1.55 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.698 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.9 mm -74.35 111.65 13.7 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.531 0.205 . . . . 0.0 111.191 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -91.11 16.65 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.858 2.372 . . . . 0.0 112.777 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.4 p 55.42 98.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -87.13 146.04 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 58.79 167.61 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.077 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.9 m -74.77 92.37 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.813 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.98 86.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.954 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -57.92 -23.34 53.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.949 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -54.21 -37.26 64.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.742 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.67 -47.45 85.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.272 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.89 -35.37 70.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.076 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.4 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 7.2 m-20 -62.78 -39.4 94.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.178 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -62.34 -40.3 95.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.09 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.7 mt -59.34 -47.04 86.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.617 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.4 ' CD2' ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -78.01 -26.71 48.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.873 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -73.93 -30.44 62.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.32 7.24 29.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.441 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.439 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -74.22 -17.53 60.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.726 0.298 . . . . 0.0 111.259 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.1 m -59.14 -30.77 68.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.913 0.387 . . . . 0.0 110.615 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.4 mt -57.04 -66.3 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 t -84.98 -2.75 58.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.159 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.85 19.6 11.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.244 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.37 153.91 29.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 111.423 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.41 HG11 ' CE2' ' A' ' 37' ' ' PHE . 13.8 p -145.73 143.67 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.19 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.16 120.89 39.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.488 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.54 132.86 54.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.552 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -107.26 104.68 14.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.821 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -110.99 163.89 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -114.52 121.3 43.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.784 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.445 ' CZ ' ' HG3' ' A' ' 23' ' ' GLU . 39.2 p90 -112.33 140.53 46.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 111.733 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.99 162.95 15.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.144 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.5 ' HB ' HG22 ' A' ' 20' ' ' VAL . 3.6 m -144.75 -166.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.058 0.456 . . . . 0.0 111.962 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.98 101.55 11.11 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.972 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -60.86 92.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.956 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.686 0.279 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.7 p 32.89 47.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.478 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 21' ' ' HIS . 47.5 t -129.61 156.32 41.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.154 0.502 . . . . 0.0 111.571 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.531 ' O ' ' CB ' ' A' ' 22' ' ' THR . 6.6 m-70 64.81 44.59 3.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.899 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 1.1 m 154.05 102.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.85 0.357 . . . . 0.0 111.361 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -147.85 149.77 32.91 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.317 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -88.76 127.12 35.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.814 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.485 HG21 HG13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -114.79 152.4 32.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.244 0.545 . . . . 0.0 111.401 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.32 99.14 6.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.261 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.403 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.03 129.53 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.554 -178.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.17 113.58 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.464 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.473 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -102.12 124.66 48.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.374 . . . . 0.0 110.935 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 67.8 m -105.85 115.31 30.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.08 140.29 44.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.355 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.03 157.36 34.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.41 -1.33 11.5 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.935 2.423 . . . . 0.0 112.753 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 t -104.03 -67.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.33 . . . . 0.0 111.285 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.5 p -105.05 -71.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.62 -72.37 0.28 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.578 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 29' ' ' LEU . 45.7 m-85 -145.41 -43.88 0.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 111.018 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.4 26.86 70.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.733 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tt -124.55 130.71 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 110.922 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.79 148.08 41.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.13 120.83 35.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.651 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -82.65 140.76 32.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.31 4.56 83.47 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.827 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.5 t -126.5 172.35 10.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.804 0.335 . . . . 0.0 111.063 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 46' ' ' PHE . 3.7 p -125.79 -45.29 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.29 0.567 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.456 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -156.25 38.04 0.34 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.002 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.37 98.73 7.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.0 p -58.67 -19.82 42.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.498 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -136.77 144.06 43.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.777 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.6 m 59.71 165.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 52' ' ' SER . 15.0 tp -67.86 151.68 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.902 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.449 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -114.02 -158.64 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.662 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.419 ' CB ' ' CD ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -50.4 177.56 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.099 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 53' ' ' SER . 99.2 Cg_exo -44.12 154.16 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.616 2.211 . . . . 0.0 112.654 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.2 178.28 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.681 2.254 . . . . 0.0 112.512 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -177.89 141.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.768 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.6 mt -64.02 134.83 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 t -159.97 42.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -172.44 135.9 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.081 0.467 . . . . 0.0 111.222 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.424 HG22 HD13 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -151.37 152.52 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.234 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.52 155.24 17.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 111.272 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.67 42.37 0.96 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.138 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.421 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER 168.97 33.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.727 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.57 144.57 44.63 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -43.5 -37.75 8.09 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.798 2.332 . . . . 0.0 112.766 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.44 77.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.991 0.424 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.416 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -75.73 -50.52 15.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.683 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.421 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.36 -8.95 57.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.697 -179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.1 t -56.38 -25.24 49.03 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.806 0.336 . . . . 0.0 110.835 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.08 31.76 81.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.293 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.4 t -143.69 -52.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 0.0 111.067 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt -58.96 150.44 24.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.018 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -144.09 160.59 40.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.5 mm -71.67 89.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.26 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.19 35.17 0.83 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.784 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.93 130.94 40.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.785 0.326 . . . . 0.0 110.75 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -85.32 79.33 9.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.733 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 5.8 t -56.88 158.53 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.75 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.342 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.21 96.0 4.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.377 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.4 mt -86.63 121.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.775 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 44.83 30.51 0.56 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.242 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.96 -37.49 3.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.646 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mm -84.77 111.07 32.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.499 0.19 . . . . 0.0 111.208 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -90.54 23.36 0.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.742 2.295 . . . . 0.0 112.72 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 p 54.22 71.77 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.955 0.407 . . . . 0.0 111.059 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.98 -43.5 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -77.11 -68.89 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.68 165.38 11.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.992 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 p -107.57 -77.93 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -69.98 -41.07 74.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.34 -38.13 86.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.06 -48.61 75.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.29 -44.74 88.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.176 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -60.26 -39.63 87.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.781 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -62.45 -41.55 98.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.2 mt -62.21 -48.17 81.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.9 mt -59.89 -33.85 72.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -29.61 39.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -6.01 49.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.478 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.2 t -79.25 -27.22 42.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.691 0.282 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.2 m -59.43 -34.96 73.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.1 mm -52.48 -46.78 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.496 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 t -101.48 -4.32 27.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.098 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 78.41 -3.31 2.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.77 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 5.0 ptpt -156.8 165.01 37.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.94 0.4 . . . . 0.0 111.131 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.3 146.54 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.525 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.96 109.56 20.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.299 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.25 143.94 39.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 0.0 111.653 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -106.6 121.43 44.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.93 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.485 HG13 HG21 ' A' ' 25' ' ' THR . 0.2 OUTLIER -119.4 164.48 15.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.15 0.5 . . . . 0.0 111.984 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -122.57 118.65 28.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.301 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 22' ' ' THR . 5.4 p90 -117.84 164.86 14.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.26 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -114.57 96.78 5.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.764 0.316 . . . . 0.0 110.721 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.498 ' N ' ' HA ' ' A' ' 21' ' ' HIS . 0.9 OUTLIER 178.28 -169.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.647 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.407 ' N ' HG12 ' A' ' 115' ' ' VAL . . . 178.76 142.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.972 0.415 . . . . 0.0 111.507 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -127.03 40.94 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.223 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.831 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.916 0.389 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.6 p -73.21 64.26 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 21' ' ' HIS . 14.4 p -148.66 162.41 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.546 ' O ' ' HB ' ' A' ' 22' ' ' THR . 78.1 m-70 65.36 52.98 1.34 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.246 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.546 ' HB ' ' O ' ' A' ' 21' ' ' HIS . 6.7 t 171.76 111.05 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.959 0.409 . . . . 0.0 110.551 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -168.94 156.09 7.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.408 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 7.9 p -87.68 129.27 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.813 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.411 HG21 ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -117.37 148.09 42.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.033 0.444 . . . . 0.0 110.995 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.56 98.98 9.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.414 ' CG2' ' CG1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -100.96 100.36 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.104 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.425 ' CG2' ' HD2' ' A' ' 106' ' ' LYS . 12.6 p -85.38 117.94 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.045 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.22 152.9 26.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.8 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.5 m -116.53 150.45 37.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.714 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.401 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -92.58 103.84 16.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.162 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -74.89 154.66 86.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.791 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.21 0.02 9.49 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.762 2.308 . . . . 0.0 112.729 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -66.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.821 0.343 . . . . 0.0 110.981 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -108.96 -43.21 4.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.62 -85.72 0.86 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 101' ' ' SER . 96.4 m-85 -133.27 73.66 1.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.975 0.417 . . . . 0.0 110.098 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.89 10.43 0.56 Allowed Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.135 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.474 ' H ' ' C ' ' A' ' 37' ' ' PHE . 13.1 tt -96.16 130.25 45.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.891 0.377 . . . . 0.0 110.788 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.72 136.8 50.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -127.64 114.79 17.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.029 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.09 151.77 34.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.34 21.62 45.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.576 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 t -177.01 -172.73 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.965 0.412 . . . . 0.0 111.097 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.93 -3.82 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.541 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.4 87.33 1.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.369 . . . . 0.0 110.853 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.37 80.04 9.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.128 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 m -165.91 -40.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 111.19 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.82 140.6 0.97 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.57 77.8 0.31 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.7 tt -97.49 124.24 41.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.17 23.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.419 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.76 149.03 39.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.942 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.0 171.12 2.32 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.636 2.224 . . . . 0.0 112.148 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.48 154.1 69.31 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.478 2.119 . . . . 0.0 112.245 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mp -149.2 127.45 12.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.014 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 69.7 mt -75.63 141.15 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.616 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.7 t -164.04 49.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.723 0.297 . . . . 0.0 111.683 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -176.15 133.81 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.031 0.443 . . . . 0.0 111.504 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.413 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.33 152.05 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.035 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.92 155.5 18.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 111.357 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.27 43.49 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.842 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.84 32.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.609 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -121.47 144.62 40.63 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.04 -35.2 4.47 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.812 2.341 . . . . 0.0 112.86 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.36 96.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.413 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.9 OUTLIER -71.15 -46.73 60.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.842 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -8.68 57.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.633 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 53.5 t -52.0 -40.9 61.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.894 0.378 . . . . 0.0 111.006 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.57 -27.4 15.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.466 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -117.51 26.12 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.757 0.313 . . . . 0.0 111.303 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 mt -124.82 143.48 50.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -169.12 153.39 5.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.785 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.9 mt -59.34 110.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.53 -15.56 3.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.767 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -59.04 139.32 56.97 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.814 0.34 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.28 96.16 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.08 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 2.8 t -65.33 152.04 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.2 tpt -137.05 -63.28 0.61 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.232 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -125.2 93.9 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.338 . . . . 0.0 111.356 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 mt -82.66 124.08 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 44.35 31.77 0.62 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.154 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.09 -37.57 3.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.3 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mm -85.75 112.66 46.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.57 0.224 . . . . 0.0 111.179 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -89.17 19.87 1.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.632 2.222 . . . . 0.0 112.716 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 p 63.13 129.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.998 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -155.49 149.3 25.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.719 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.32 25.65 15.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.0 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 m 179.96 -48.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.674 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.55 -71.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.298 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.22 -48.23 57.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.246 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -69.04 -43.59 74.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -63.41 -45.33 91.48 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.82 0.343 . . . . 0.0 110.7 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.67 -45.99 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.678 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.08 -38.04 78.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.241 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -62.68 -46.38 88.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.472 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.63 -31.72 71.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.182 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.06 -31.49 50.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.612 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.24 -30.62 38.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.87 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -10.58 59.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.243 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.505 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 16.6 m -72.43 -19.33 61.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.041 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.5 p -65.91 -37.09 85.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.882 0.373 . . . . 0.0 110.746 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -58.55 -55.77 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.3 p -83.19 -9.48 59.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.992 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.28 17.21 9.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.347 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.425 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 tppt? -156.81 146.18 20.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 0.0 111.021 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.403 ' HB ' ' OG ' ' A' ' 101' ' ' SER . 11.7 p -154.8 149.89 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -122.65 124.84 44.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.059 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.15 148.22 48.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.088 0.47 . . . . 0.0 111.993 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -102.1 129.65 48.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.693 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.414 ' CG1' ' CG2' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -138.39 156.62 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.923 0.392 . . . . 0.0 111.815 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -93.9 126.11 38.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.248 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 24.5 p90 -118.95 164.58 15.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.672 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -120.61 97.73 5.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.454 ' N ' ' HA ' ' A' ' 21' ' ' HIS . 15.0 p -95.0 158.72 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.227 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.1 55.49 0.63 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.009 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -149.67 98.25 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.871 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.835 0.35 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.52 105.2 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.664 ' HB ' ' CG1' ' A' ' 115' ' ' VAL . 31.5 m -62.99 -166.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.554 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 22' ' ' THR . 0.1 OUTLIER 171.12 34.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 21' ' ' HIS . 57.0 m 58.99 146.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.997 0.427 . . . . 0.0 111.352 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HG2' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -178.6 166.9 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.174 179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.2 p -90.31 131.83 35.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.108 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.407 HG21 ' CD1' ' A' ' 111' ' ' ILE . 5.2 t -116.26 133.62 55.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.031 0.443 . . . . 0.0 111.936 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.34 98.98 10.43 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -100.88 119.17 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.723 -178.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.6 p -88.73 113.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.965 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.84 164.77 11.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.567 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.6 m -127.2 146.0 50.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.87 97.49 8.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.148 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.34 142.47 90.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.64 -3.86 14.45 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.61 2.207 . . . . 0.0 112.785 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.73 -61.0 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 t -125.57 -41.22 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.01 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.1 -105.06 0.49 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.462 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CE1' ' CG1' ' A' ' 107' ' ' VAL . 96.6 m-85 -113.85 -28.97 7.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.767 0.318 . . . . 0.0 111.005 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.26 47.28 83.09 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.836 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.87 127.63 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 0.0 111.075 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.58 147.87 46.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.909 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . 2.8 pp -131.68 127.0 36.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.408 ' NE2' ' CB ' ' A' ' 58' ' ' SER . 3.7 mt-30 -67.33 171.36 6.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.77 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.6 -134.98 6.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.617 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 53' ' ' SER . 0.8 OUTLIER -104.37 -169.3 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.04 0.447 . . . . 0.0 111.172 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -84.31 -161.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.456 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.44 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 46.9 m-85 54.48 26.95 7.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 111.009 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.47 133.91 26.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m 61.32 -120.97 0.79 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.403 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.43 -77.87 0.5 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.84 0.352 . . . . 0.0 110.741 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -166.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.402 ' CD1' HD23 ' A' ' 56' ' ' LEU . 12.5 tp 66.71 140.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.245 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.07 163.96 36.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.857 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 68.45 162.13 0.14 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.818 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 78.3 Cg_exo -50.45 -175.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.707 2.271 . . . . 0.0 112.457 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 54' ' ' PRO . 72.2 Cg_exo -48.76 136.03 27.91 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.099 . . . . 0.0 112.274 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.402 HD23 ' CD1' ' A' ' 51' ' ' LEU . 1.3 pt? -152.09 145.53 24.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.205 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.405 ' HA ' ' CB ' ' A' ' 41' ' ' LEU . 8.5 mt -77.59 143.49 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.612 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.408 ' CB ' ' NE2' ' A' ' 42' ' ' GLN . 3.7 t -162.79 48.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.281 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -172.9 131.54 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.099 0.476 . . . . 0.0 111.389 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.414 HG22 ' HA ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -149.61 152.31 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.031 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.83 155.45 17.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 111.261 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.63 39.88 0.9 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.752 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 175.55 29.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.773 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.62 136.14 26.94 Favored Pre-proline 0 C--O 1.231 0.127 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -43.52 -29.24 2.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.622 2.214 . . . . 0.0 112.807 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.72 -42.08 99.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.932 0.396 . . . . 0.0 111.01 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HA ' HG22 ' A' ' 60' ' ' ILE . 5.8 tp10 -78.31 -49.61 13.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -8.19 53.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.655 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.76 -28.03 14.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 111.001 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.0 26.36 69.05 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.66 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.5 -47.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 111.117 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.1 mt -58.76 156.56 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.18 156.07 18.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.3 mm -70.21 97.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.44 40.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.712 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.42 153.22 19.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.641 0.258 . . . . 0.0 110.508 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -111.91 82.93 1.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.167 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.422 ' CG1' ' CG1' ' A' ' 81' ' ' ILE . 3.6 t -61.8 143.48 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.67 34.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.642 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 174.26 54.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.849 0.357 . . . . 0.0 111.271 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.422 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 25.5 mt -76.12 118.16 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.1 p30 44.89 30.79 0.59 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.271 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.72 -35.43 5.07 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.38 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 mm -78.68 110.83 15.51 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 121.999 0.119 . . . . 0.0 111.198 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -86.17 99.67 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.563 2.175 . . . . 0.0 112.411 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.2 p -69.96 119.47 14.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.026 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.07 74.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.0 -76.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.8 p -178.16 -39.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 t -85.5 101.11 12.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -66.55 -22.28 66.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -53.37 -30.6 40.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.079 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -62.91 -47.15 84.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.168 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.09 87.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -61.18 -42.3 98.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.791 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -62.73 -34.8 77.92 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.764 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 8.8 mt -68.13 -37.75 81.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.631 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.9 -41.65 59.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -68.16 -31.89 71.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.993 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -5.13 49.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.35 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.407 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 69.7 m -69.62 -13.9 62.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.261 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -58.56 -28.38 65.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.0 mm -54.83 -30.9 23.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.172 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -117.45 -4.5 11.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.223 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 m 62.91 21.46 12.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.211 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -156.12 151.21 26.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.0 110.956 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.453 ' CG1' ' CE1' ' A' ' 37' ' ' PHE . 13.2 p -150.08 111.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.88 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.87 107.29 19.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.36 150.5 23.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 111.41 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -123.57 105.17 9.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.195 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.416 ' CD1' ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -111.04 159.71 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.097 0.475 . . . . 0.0 111.925 -178.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -110.18 118.49 36.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.517 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.417 ' CE1' ' HG2' ' A' ' 23' ' ' GLU . 14.6 p90 -121.61 154.02 37.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.343 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.04 97.8 5.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.664 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 1.3 p -80.75 145.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.743 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.97 126.63 30.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.283 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -68.55 135.01 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.834 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.894 0.378 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.71 149.21 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.235 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 p -58.05 141.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.26 157.79 19.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.027 0.441 . . . . 0.0 111.079 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.9 108.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.034 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 mt-10 -148.34 173.79 12.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.084 0.468 . . . . 0.0 111.423 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.8 p -108.42 134.15 51.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.288 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.419 HG21 HG13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -111.96 144.52 41.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.083 0.468 . . . . 0.0 111.691 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.9 pt-20 -104.07 100.17 9.93 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.412 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -99.87 102.85 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.826 -178.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.471 ' CG2' ' HD2' ' A' ' 106' ' ' LYS . 9.2 p -86.2 115.55 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.41 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 7.6 mt -115.58 152.44 33.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.018 0.437 . . . . 0.0 111.339 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.9 m -113.78 137.54 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.616 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.7 107.01 2.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.02 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.35 142.53 86.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.06 55.3 5.59 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.796 2.331 . . . . 0.0 112.482 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 t -153.2 -69.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.013 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -116.8 -24.55 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.18 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.67 -112.63 2.29 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.323 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 101' ' ' SER . 21.5 m-85 -113.03 -23.28 10.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 0.0 111.139 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 58.85 54.23 39.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.863 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 tt -147.88 127.2 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.731 0.3 . . . . 0.0 110.747 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.51 147.06 38.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.066 0.46 . . . . 0.0 111.53 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.25 169.09 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.372 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -147.11 149.04 32.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.879 0.371 . . . . 0.0 111.06 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 55' ' ' PRO . . . -96.74 36.62 3.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.35 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.01 128.52 19.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.944 0.402 . . . . 0.0 111.072 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.11 -32.86 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.027 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 178.69 115.14 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.801 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -169.5 54.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.121 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.4 m 67.6 -71.06 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.09 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -143.75 -62.48 0.39 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.746 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.7 t -55.88 -170.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.137 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -112.96 149.84 32.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -175.43 24.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.66 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.09 159.31 69.52 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.724 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.25 152.04 8.7 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.52 2.146 . . . . 0.0 112.319 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.413 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 51.7 Cg_endo -69.21 128.22 16.21 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.488 2.126 . . . . 0.0 112.345 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -135.65 160.01 39.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.939 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -85.96 143.9 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.736 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.5 m -165.32 50.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.29 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -176.52 132.76 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.979 0.419 . . . . 0.0 111.42 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -149.15 152.26 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.059 179.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.58 155.45 16.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.164 0.507 . . . . 0.0 111.275 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.67 38.85 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.846 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.0 t0 179.08 28.69 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.772 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.408 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 33.4 m -124.35 139.19 32.37 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.591 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -45.51 -27.95 3.82 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.865 2.377 . . . . 0.0 112.77 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.64 96.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.846 0.355 . . . . 0.0 110.843 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -78.56 -48.43 15.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.05 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -7.23 50.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.893 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.72 -25.89 4.88 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.841 0.353 . . . . 0.0 111.175 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.87 25.27 73.12 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.559 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 14.4 p -158.07 29.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.034 0.445 . . . . 0.0 110.874 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 mt -135.82 151.96 50.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.715 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -151.37 172.2 16.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.3 mm -83.01 73.0 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.77 37.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.66 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.7 123.07 48.35 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.75 105.85 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 111.744 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.436 ' CG1' ' CG2' ' A' ' 111' ' ' ILE . 1.3 m -71.45 138.26 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -148.05 21.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.261 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -174.26 59.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.931 0.396 . . . . 0.0 111.319 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.3 mt -88.65 124.61 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 44.24 31.21 0.53 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.324 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.31 -46.67 1.18 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mm -70.33 112.57 13.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.553 0.216 . . . . 0.0 111.166 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.12 13.61 2.69 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.636 2.224 . . . . 0.0 112.819 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.0 p 54.04 79.51 0.13 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.802 0.334 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -84.52 63.69 8.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.82 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.55 166.07 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.3 t -99.07 31.37 3.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.2 t -118.16 114.04 22.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -58.3 -23.92 57.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -54.74 -31.46 58.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.7 -53.48 50.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.521 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.68 -42.08 82.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.685 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -39.48 77.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.286 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -62.97 -41.49 99.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.341 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.3 mt -58.77 -41.9 87.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.591 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.3 mt -77.87 -30.67 50.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.82 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -38.98 92.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -75.33 -7.15 53.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.4 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.45 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 8.7 m -63.95 -22.19 66.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.972 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.89 -39.44 81.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.787 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.8 mm -49.3 -65.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.472 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.6 t -84.32 -4.81 59.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.039 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.0 21.0 12.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.236 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.471 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 0.4 OUTLIER -156.41 150.14 24.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.247 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.426 HG12 ' CE2' ' A' ' 37' ' ' PHE . 9.4 p -155.33 145.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.617 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.23 108.89 13.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.295 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.48 128.36 50.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.041 0.448 . . . . 0.0 111.836 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.41 107.46 19.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.634 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.436 ' CG2' ' CG1' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -109.36 159.9 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.22 0.533 . . . . 0.0 112.152 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -118.83 121.97 41.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.783 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.405 ' CD1' ' O ' ' A' ' 23' ' ' GLU . 52.0 p90 -112.31 135.49 52.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -112.8 97.56 6.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.42 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.79 152.0 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.247 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.16 53.08 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -128.65 47.9 2.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.842 179.938 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.712 0.291 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.0 p 34.54 47.67 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.253 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.479 HG21 ' N ' ' A' ' 21' ' ' HIS . 14.9 p -148.91 153.23 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.593 ' O ' ' CB ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -58.89 -161.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.91 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.593 ' CB ' ' O ' ' A' ' 21' ' ' HIS . 93.3 m 115.36 120.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.962 0.905 . . . . 0.0 109.503 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -178.44 177.97 0.9 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.989 0.423 . . . . 0.0 111.585 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 112' ' ' GLU . 68.1 p -87.23 143.14 27.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.509 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 t -132.72 135.09 45.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.6 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.02 99.25 11.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.51 130.48 53.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.97 122.06 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.092 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -116.09 147.97 40.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.635 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.5 m -130.43 144.13 51.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -82.84 147.53 28.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.098 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -110.61 156.13 41.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -80.15 0.11 10.26 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.938 2.425 . . . . 0.0 112.424 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 t -91.25 -55.22 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.157 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 t -135.31 -46.69 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.27 -111.99 0.6 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.452 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.449 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 67.0 m-85 -109.17 -24.86 10.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.766 0.317 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 64.88 42.94 96.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.934 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -143.41 128.4 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.875 0.369 . . . . 0.0 110.689 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -116.22 150.37 37.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 111.458 -179.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.83 160.89 21.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.474 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.93 158.67 25.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 111.111 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.88 88.31 1.2 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.381 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.0 t -162.38 112.25 1.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 0.0 110.748 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.8 t -107.73 -18.19 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.48 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.54 -26.42 6.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.219 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 46.71 42.19 11.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.607 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.8 m -92.52 -65.43 1.0 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.836 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -151.78 -81.3 0.1 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.719 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.2 t -69.17 166.05 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -119.58 121.11 38.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.957 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.6 23.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.578 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.35 151.82 44.7 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -51.22 153.92 8.77 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.726 2.284 . . . . 0.0 112.425 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.26 154.59 24.98 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.727 2.285 . . . . 0.0 112.592 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -160.54 -178.67 7.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.5 mt -87.18 141.19 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.698 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 m -161.85 49.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.392 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CG ' ' HB2' ' A' ' 40' ' ' GLN . 24.4 t80 -177.36 132.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 111.462 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.408 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -151.88 152.54 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.982 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.83 155.02 17.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 111.401 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.73 42.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.856 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.408 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER 170.4 31.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.821 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.408 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 3.9 m -122.84 145.29 45.08 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.002 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.54 -37.48 11.07 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.073 2.515 . . . . 0.0 112.6 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.51 77.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.408 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 1.2 tm-20 -78.24 -51.97 9.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.856 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.408 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -67.03 -11.27 56.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.827 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -24.65 51.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 110.874 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.31 30.58 73.55 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.174 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 t -145.47 -54.46 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.093 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.9 mt -59.58 145.67 43.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -160.88 167.87 25.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.778 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.7 mm -70.24 67.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.74 38.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.474 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -109.59 107.52 17.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.733 0.301 . . . . 0.0 110.554 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -82.21 93.89 7.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.306 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 111' ' ' ILE . 30.5 m -58.63 123.57 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.703 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.0 ttp -118.37 -16.01 9.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.808 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -167.12 98.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 111.551 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 86' ' ' THR . 3.9 mp -103.12 113.27 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.5 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 45.87 29.94 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.224 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.31 -44.38 1.52 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.767 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mm -80.89 113.74 42.87 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.505 0.193 . . . . 0.0 111.166 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.81 0.84 9.71 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.509 2.139 . . . . 0.0 112.866 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.411 HG23 HD11 ' A' ' 81' ' ' ILE . 2.5 p 59.9 22.28 11.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.045 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 55.7 -178.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 0.0 110.963 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -110.53 29.61 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 p -177.59 38.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.4 m -154.31 75.82 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -60.64 -26.05 66.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.057 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.78 -35.44 68.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.053 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -64.38 -45.66 86.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.71 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.8 -49.16 77.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -60.12 -34.82 74.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.525 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.61 -41.11 98.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.568 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.6 mt -70.08 -30.56 67.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.462 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.08 -46.44 84.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.927 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -73.64 -29.76 62.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.061 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -75.0 -5.61 44.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.503 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 58.1 m -66.44 -22.06 66.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 0.0 111.196 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -58.66 -27.31 64.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.007 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.5 mm -57.35 -48.98 81.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.477 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -100.79 -14.81 17.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.284 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.57 -3.79 2.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.949 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -156.78 129.62 7.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.858 0.361 . . . . 0.0 111.029 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 101' ' ' SER . 0.0 OUTLIER -120.38 166.82 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.86 106.75 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.794 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.93 138.28 35.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.001 0.429 . . . . 0.0 111.881 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -116.2 104.62 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.821 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.405 ' CG2' ' CG1' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -120.28 149.02 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 49.0 tt0 -103.62 118.79 37.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.871 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -115.76 144.13 44.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.301 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -100.01 162.19 13.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.494 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.409 ' CG2' HG21 ' A' ' 20' ' ' VAL . 3.2 m -134.0 171.61 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.306 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.08 105.6 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.322 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.434 ' HA ' HG22 ' A' ' 20' ' ' VAL . 27.4 mt-10 -73.62 83.61 1.56 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.974 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.029 179.831 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.801 0.334 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.39 113.98 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.154 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.95 124.92 71.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 11.2 m170 -87.85 173.23 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.908 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 173.08 108.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.202 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.402 ' O ' ' CD2' ' A' ' 113' ' ' PHE . 1.1 mt-10 -151.68 176.56 11.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 0.0 111.26 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 p -103.71 140.79 37.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.412 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.441 HG22 HG12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -116.89 142.07 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.064 0.459 . . . . 0.0 111.441 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.62 98.93 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.427 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -102.91 131.24 51.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.0 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.3 t -107.62 113.4 43.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.179 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.91 164.29 12.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.335 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.0 m -117.5 132.24 56.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 110.819 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.455 ' CB ' ' CE2' ' A' ' 37' ' ' PHE . . . -79.35 91.64 5.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.163 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.15 140.87 94.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.63 -4.96 16.28 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.476 2.117 . . . . 0.0 112.846 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.7 t -99.69 -54.18 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.066 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -108.3 -47.15 3.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.866 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.45 -91.17 1.17 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.672 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.507 ' C ' ' H ' ' A' ' 39' ' ' ILE . 80.9 m-85 -141.61 77.92 1.61 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.938 0.399 . . . . 0.0 110.223 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.48 18.93 0.4 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.072 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.507 ' H ' ' C ' ' A' ' 37' ' ' PHE . 3.4 tt -96.35 130.02 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.91 0.355 . . . . 0.0 110.611 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.07 145.81 37.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.987 0.422 . . . . 0.0 111.463 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.01 156.98 32.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.479 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -124.82 147.6 48.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.915 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.59 25.34 25.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.556 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.9 p -143.7 129.18 19.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 110.752 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.88 -74.98 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.64 88.22 0.7 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.948 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.44 114.86 8.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.06 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -58.44 -20.41 44.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.468 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -154.64 145.54 22.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.924 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.92 162.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.41 100.56 8.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.43 20.97 12.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.3 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.77 120.04 21.56 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.15 167.89 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.405 2.07 . . . . 0.0 112.274 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.71 168.12 12.33 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.55 2.167 . . . . 0.0 112.149 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -167.91 152.94 6.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.97 0.414 . . . . 0.0 111.109 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 76' ' ' ASP . 47.7 mt -72.9 152.48 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.835 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.18 44.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.537 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -176.58 129.38 0.19 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.209 0.528 . . . . 0.0 111.854 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.467 HD11 HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -142.21 152.14 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.374 179.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 63' ' ' ASP . 5.5 tp10 -109.88 154.93 22.36 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.078 0.466 . . . . 0.0 111.858 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.29 42.04 0.15 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.016 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER 175.11 31.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.192 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -122.21 135.05 25.09 Favored Pre-proline 0 CA--C 1.527 0.075 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 69' ' ' CYS . 3.5 Cg_endo -46.37 -30.54 8.34 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.506 2.137 . . . . 0.0 112.424 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.08 -33.27 71.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.768 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -75.04 -49.93 18.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.844 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.419 ' NH2' ' C ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -79.31 -8.26 58.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.943 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -51.53 -34.78 37.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.772 0.32 . . . . 0.0 111.082 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.26 27.12 70.13 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.591 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 p -136.08 -45.3 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.629 0.252 . . . . 0.0 111.131 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 pp -77.99 163.04 26.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.013 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.59 165.29 29.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.865 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.51 75.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.085 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.8 40.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.776 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.401 ' HB2' HD13 ' A' ' 57' ' ' ILE . 45.8 m-20 -99.95 119.13 37.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 110.56 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -86.13 85.64 7.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.218 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.424 ' HA ' HG22 ' A' ' 111' ' ' ILE . 3.5 t -65.54 138.64 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.118 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.2 ttp -171.14 34.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.128 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -179.88 49.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.13 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.418 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 8.7 mt -73.0 117.68 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.6 p30 45.55 30.48 0.77 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.56 -37.65 3.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.096 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.7 mm -74.28 112.04 15.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.552 0.215 . . . . 0.0 111.137 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -89.98 32.61 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.676 2.251 . . . . 0.0 112.488 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 p 58.29 22.28 9.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 47.95 94.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.487 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 t70 63.71 -77.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.276 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -164.13 120.25 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.89 0.376 . . . . 0.0 111.071 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -179.67 98.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.636 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -55.35 -33.05 63.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.171 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -43.02 83.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.839 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -41.31 97.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.799 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.73 -48.33 79.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.431 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 9.8 m-80 -61.86 -34.73 76.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.496 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -35.98 82.02 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.51 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.6 mt -69.74 -48.24 60.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.996 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.431 ' CD2' ' HA ' ' A' ' 95' ' ' ASN . 3.2 pp -70.1 -37.02 75.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.157 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 -69.87 -30.41 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.81 0.338 . . . . 0.0 111.009 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -89.16 4.78 47.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.369 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.446 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 0.4 OUTLIER -83.12 -12.12 57.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.338 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.5 p -57.68 -24.77 58.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.714 0.292 . . . . 0.0 110.887 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.7 mm -56.36 -31.51 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.954 0.406 . . . . 0.0 110.896 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -114.34 -5.93 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.058 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.9 t 69.42 23.81 5.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.399 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 150.38 25.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.952 0.406 . . . . 0.0 111.282 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.446 ' HB ' ' CB ' ' A' ' 101' ' ' SER . 13.9 p -144.14 136.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.28 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.32 113.39 25.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.225 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.97 125.2 53.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.966 0.412 . . . . 0.0 111.369 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -101.32 105.0 16.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.871 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -110.2 164.3 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 121.08 0.467 . . . . 0.0 112.07 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -104.19 120.41 41.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.916 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 23' ' ' GLU . 45.0 p90 -108.69 139.97 42.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.29 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.01 97.71 6.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.301 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 21' ' ' HIS . 2.4 t -71.76 144.14 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.158 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.87 48.03 1.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.965 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -142.47 60.72 1.44 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.8 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.767 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.903 0.383 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.1 54.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.436 ' O ' ' CG ' ' A' ' 21' ' ' HIS . 20.8 t -144.39 155.76 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.057 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.515 ' HA ' ' N ' ' A' ' 115' ' ' VAL . 13.8 p-80 43.68 63.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.863 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.421 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER 166.52 102.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.135 179.541 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 22.2 mt-10 -162.29 143.99 10.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.943 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 69.5 p -91.94 127.12 37.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.62 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.432 HG21 HG12 ' A' ' 111' ' ' ILE . 1.6 t -115.72 136.59 52.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 111.204 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.71 99.83 11.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.022 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.436 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -106.61 129.01 60.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -179.266 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 t -94.3 120.62 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.176 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.17 123.91 51.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 28.7 m -105.62 141.64 36.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.717 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.65 136.39 37.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.226 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.49 141.91 23.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.828 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.35 55.87 5.28 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.78 2.32 . . . . 0.0 112.56 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -155.41 -64.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.162 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -114.14 -44.48 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.93 -115.57 2.93 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.406 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 54.0 m-85 -113.96 -28.85 7.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.682 0.277 . . . . 0.0 110.971 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.99 24.64 43.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.691 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.44 140.55 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.967 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.54 164.81 28.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.099 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -117.28 160.07 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.7 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.19 171.67 3.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.957 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.12 75.52 1.0 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.571 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.6 p -100.84 -167.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.5 t -60.48 -17.78 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.563 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.12 84.39 2.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.633 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.54 131.67 53.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.253 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -73.35 63.5 0.76 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.5 34.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.081 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.1 m 53.45 82.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.206 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 tt -151.98 135.28 15.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -135.32 97.59 3.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.003 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 170.52 156.67 0.2 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.43 168.62 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.319 2.013 . . . . 0.0 112.005 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.42 137.07 38.63 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.465 2.11 . . . . 0.0 112.253 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.491 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -131.9 153.34 50.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 0.0 110.952 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.1 mt -59.87 145.39 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.684 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 m -165.37 44.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.801 0.334 . . . . 0.0 111.557 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -169.97 133.57 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.174 0.511 . . . . 0.0 111.534 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.424 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -151.88 152.52 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.879 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 1.4 mt-10 -103.55 155.39 18.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.065 0.46 . . . . 0.0 111.426 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.89 39.44 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.8 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.03 29.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.684 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.37 142.15 34.77 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.624 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -43.07 -29.48 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.65 2.233 . . . . 0.0 112.87 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.89 -40.26 97.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 2.4 mm-40 -78.12 -52.92 8.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.728 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.84 -8.63 55.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.743 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -38.37 56.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.811 0.339 . . . . 0.0 110.952 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.97 -18.66 55.55 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.819 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 m -128.09 39.24 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.836 0.35 . . . . 0.0 111.188 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.78 143.84 37.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -169.12 152.91 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.713 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.9 mt -58.36 107.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.22 -25.34 1.41 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.406 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -60.14 122.98 15.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.832 0.348 . . . . 0.0 110.662 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.13 105.74 17.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.214 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.415 ' CG1' ' CG1' ' A' ' 81' ' ' ILE . 14.8 t -70.54 146.12 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -165.17 27.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.462 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 174.07 78.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.969 0.414 . . . . 0.0 111.419 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.415 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 21.0 mt -103.83 118.09 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.846 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 45.1 30.57 0.62 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 108.9 -46.1 1.22 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.581 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.0 mm -70.62 109.96 6.08 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.548 0.214 . . . . 0.0 111.436 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 86.0 Cg_endo -92.25 103.09 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.861 2.374 . . . . 0.0 112.234 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.1 p -57.59 101.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.381 . . . . 0.0 111.109 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -123.69 -176.89 3.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 59.66 169.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.79 89.65 3.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.773 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 t -176.31 76.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.003 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -59.41 -23.93 63.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -54.77 -30.93 57.97 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.757 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.25 -51.81 67.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.431 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.27 85.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.884 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -60.25 -36.2 77.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.441 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -40.21 96.58 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.394 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -72.74 -28.31 62.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.515 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.92 -47.0 79.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.801 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.4 mpp_? -76.12 -28.57 57.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.966 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.95 -9.03 57.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.431 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.417 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 51.9 m -72.62 -23.72 60.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.098 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 p -58.95 -34.85 72.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 25.7 mm -53.64 -60.66 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.523 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 105' ' ' SER . 1.4 t -75.27 -8.86 57.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.388 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 104' ' ' THR . 0.9 OUTLIER 84.19 -16.3 0.53 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.009 179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 1.5 ptpt -156.65 158.08 36.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.758 0.313 . . . . 0.0 111.051 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.47 160.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.673 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.02 109.43 15.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.263 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.06 133.18 48.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 111.619 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' THR . 6.2 mt-10 -107.84 104.79 14.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.057 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 24' ' ' THR . 0.2 OUTLIER -109.37 159.47 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.08 0.467 . . . . 0.0 112.25 -178.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.79 119.24 38.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.884 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 23.4 p90 -112.59 165.09 12.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.964 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.31 97.01 4.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.211 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.515 ' N ' ' HA ' ' A' ' 21' ' ' HIS . 35.9 m -96.44 167.28 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.057 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.71 45.61 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.29 79.21 0.38 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.762 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.859 179.967 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.826 0.346 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.33 82.76 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.2 p -122.82 118.57 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.075 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.413 ' CB ' ' CG2' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -74.27 168.52 19.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.34 137.69 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.451 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 113' ' ' PHE . 1.8 pt-20 -177.99 176.91 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.1 p -101.81 127.36 48.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.403 HG22 HG13 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -101.49 158.78 15.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.194 0.521 . . . . 0.0 111.28 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.13 99.17 8.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -103.24 105.81 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.774 -178.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.97 116.01 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.437 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.52 141.59 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.916 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 87.4 m -115.46 142.17 47.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.84 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.93 141.61 29.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.147 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.61 138.26 22.53 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.865 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.06 58.68 5.64 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.547 2.165 . . . . 0.0 112.356 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 t -154.19 -68.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.055 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 p -110.63 -28.99 8.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -118.15 4.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.381 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 40.8 m-85 -113.0 -22.77 10.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.675 0.274 . . . . 0.0 111.153 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.01 32.1 66.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.872 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.52 141.05 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.732 0.301 . . . . 0.0 110.821 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.31 138.45 47.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.246 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.08 113.05 26.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.487 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -88.0 137.42 32.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.18 25.34 22.68 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.529 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.1 p -136.8 159.29 42.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.9 t -126.94 -3.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.631 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -152.96 166.12 33.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.06 100.7 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.979 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -165.67 -38.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.239 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.03 109.55 2.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.184 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 57.59 -171.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.328 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.29 122.64 14.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.32 23.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.98 0.419 . . . . 0.0 111.559 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.07 154.88 38.76 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.939 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.48 148.94 59.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.575 2.183 . . . . 0.0 112.256 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -85.82 146.04 9.1 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.818 2.345 . . . . 0.0 112.504 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.99 170.69 17.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 mt -80.26 139.12 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.457 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.6 m -156.79 48.46 0.45 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 111.505 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -173.12 133.51 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.11 0.481 . . . . 0.0 111.545 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.3 152.03 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.96 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.69 155.61 17.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.107 0.48 . . . . 0.0 111.432 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.55 38.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.723 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.86 29.68 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.643 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 p -122.11 137.46 27.5 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -43.98 -29.2 2.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.511 2.141 . . . . 0.0 112.829 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.51 -43.21 99.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.793 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 27.2 tp10 -78.3 -49.53 13.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -8.41 55.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.554 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -28.16 15.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.769 0.318 . . . . 0.0 110.96 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.22 45.35 95.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.412 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.9 p -170.06 41.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.019 0.438 . . . . 0.0 111.074 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.6 145.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -142.3 -175.43 4.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.821 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.447 HG21 HD13 ' A' ' 74' ' ' ILE . 31.5 mm -78.93 77.51 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.58 41.02 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.623 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -112.09 119.23 37.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.333 . . . . 0.0 110.701 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 93.65 9.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.207 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.8 t -71.19 134.34 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.54 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -157.21 29.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 111.298 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -179.22 68.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.9 mp -90.6 120.03 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.4 p30 45.41 29.64 0.61 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.286 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 107.55 -36.15 4.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.356 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.5 mm -77.12 110.82 13.28 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.503 0.192 . . . . 0.0 111.218 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 89.3 Cg_endo -91.47 72.33 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.789 2.326 . . . . 0.0 112.448 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 t -57.47 103.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.34 123.88 27.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.914 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.0 30.65 19.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.9 p -102.26 -169.71 1.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.94 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.2 m -86.56 162.11 18.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -59.6 -28.05 66.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.71 -33.1 69.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.113 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.83 -52.64 64.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.714 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.75 -50.89 71.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -59.55 -34.14 72.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.533 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -62.63 -40.19 96.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.641 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mt -67.87 -37.53 81.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.512 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.8 mt -70.26 -39.94 74.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.626 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -65.38 -34.13 77.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.26 -10.27 59.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.276 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.447 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 5.1 m -79.22 -33.44 43.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 110.736 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -32.72 74.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.81 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.17 -58.01 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.51 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 t -96.17 1.54 52.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.234 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.3 t 69.98 9.75 7.2 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.577 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 1.5 ttmp? -156.56 155.86 32.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.895 0.379 . . . . 0.0 111.05 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.22 155.7 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.576 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.48 117.99 28.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.146 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -114.19 132.3 56.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.973 0.416 . . . . 0.0 111.989 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.41 109.48 21.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.43 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.403 HG13 HG22 ' A' ' 25' ' ' THR . 0.2 OUTLIER -116.59 143.13 27.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.052 -178.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -95.62 118.72 32.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.056 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 29.6 p90 -111.37 156.07 22.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.001 0.429 . . . . 0.0 111.461 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -133.35 97.47 3.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.316 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.413 ' CG2' ' CB ' ' A' ' 21' ' ' HIS . 11.7 m -74.88 139.1 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.332 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -137.67 47.6 2.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.959 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -135.61 47.54 2.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.0 p . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.868 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.412 ' O ' HG11 ' A' ' 20' ' ' VAL . 30.2 t -82.7 103.92 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.982 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 21' ' ' HIS . 0.3 OUTLIER 46.76 -170.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.358 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.463 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 0.1 OUTLIER 72.65 42.42 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.047 0.451 . . . . 0.0 110.865 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 1.9 m 79.08 139.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.388 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -178.1 176.94 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.678 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.81 130.82 55.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.651 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 t -122.61 135.3 54.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.019 0.437 . . . . 0.0 111.487 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -99.22 99.07 9.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.449 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.429 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.49 115.33 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.303 -178.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.2 p -83.3 122.01 36.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.118 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -108.92 160.82 15.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.424 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.8 m -123.06 153.36 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.859 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.446 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -93.86 141.11 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.47 144.65 29.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.49 -0.26 10.45 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.705 2.27 . . . . 0.0 112.819 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.15 -52.59 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.728 0.299 . . . . 0.0 111.168 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -119.71 -57.19 1.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.35 -110.33 0.62 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.56 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.446 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 55.2 m-85 -112.3 -32.4 6.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.739 0.304 . . . . 0.0 110.758 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.61 8.49 63.34 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.518 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.1 tp -97.12 130.43 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.997 0.398 . . . . 0.0 110.781 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.93 147.0 47.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.089 0.471 . . . . 0.0 111.406 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.425 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 4.8 mt -118.51 163.2 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.638 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.441 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -174.16 172.06 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.988 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.2 82.07 0.58 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.743 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 p -132.06 -175.06 3.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.672 0.273 . . . . 0.0 110.659 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 46' ' ' PHE . 3.7 p -53.38 -43.79 52.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.358 0.599 . . . . 0.0 111.078 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.454 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 10.8 t80 -114.15 71.69 0.76 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.872 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.42 168.65 20.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.165 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 p 51.39 -138.33 1.08 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.64 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.85 -34.5 10.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.823 0.344 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.59 150.36 5.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.5 146.96 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.5 22.45 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.213 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.5 m -135.37 153.11 77.72 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.12 169.48 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.537 2.158 . . . . 0.0 112.131 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.94 150.32 82.95 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.552 2.168 . . . . 0.0 112.098 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.52 163.45 32.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.0 111.177 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.407 ' CG1' ' CD2' ' A' ' 41' ' ' LEU . 5.0 mt -76.07 141.54 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.578 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 m -168.28 41.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.688 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -177.24 125.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.029 0.442 . . . . 0.0 111.529 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -137.33 152.6 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.095 179.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.43 155.36 21.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.067 0.461 . . . . 0.0 111.442 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -88.03 41.06 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.722 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 168.52 31.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.854 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.3 m -119.3 143.91 35.29 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-O 120.716 0.293 . . . . 0.0 110.911 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.56 -28.39 8.93 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.916 2.41 . . . . 0.0 112.738 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.51 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 110.956 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 9.5 tp10 -78.15 -39.81 39.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.829 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.06 -19.36 64.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.364 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -41.08 68.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 110.879 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.24 -12.35 64.83 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.827 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 m -98.79 -32.41 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 111.184 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.0 mt -74.91 128.46 35.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.866 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -141.06 148.5 40.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.05 114.51 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.07 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.21 -27.07 2.29 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -63.39 138.01 58.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.709 0.29 . . . . 0.0 110.837 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.431 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 51.9 mtt180 -109.24 100.95 10.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.406 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 111' ' ' ILE . 29.5 m -64.55 122.69 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.4 ptm -151.37 30.35 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.1 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -178.35 52.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.025 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.4 mt -82.36 128.76 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.058 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 43.67 31.52 0.46 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.235 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.77 -43.85 1.67 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.463 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.6 mm -71.28 113.27 17.95 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.471 0.176 . . . . 0.0 111.316 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -88.36 25.26 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.74 2.293 . . . . 0.0 112.796 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.0 p 54.49 78.93 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.92 0.391 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.88 -26.51 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -56.62 -22.61 35.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.27 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.17 42.6 1.72 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.1 t -151.23 137.83 18.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.722 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -58.48 -28.21 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.136 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.89 -31.08 68.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -65.79 -52.32 51.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.644 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' CB ' ' CD1' ' A' ' 41' ' ' LEU . . . -60.72 -33.22 72.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.985 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -64.27 -48.33 76.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.826 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -33.89 75.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.647 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.02 -41.41 97.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.6 mt -67.71 -40.19 84.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.757 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -65.26 -30.12 70.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.49 -7.34 51.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.37 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 m -71.87 -16.01 62.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.175 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -58.56 -27.01 64.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.045 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.9 mm -52.9 -41.11 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 111.309 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.8 t -120.01 -2.07 10.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.293 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 62.6 26.32 15.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.05 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -156.19 144.83 20.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.2 p -153.97 156.9 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.02 0.438 . . . . 0.0 111.888 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.07 125.44 46.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.934 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.21 136.64 54.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.098 0.475 . . . . 0.0 111.928 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.89 106.71 15.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.334 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.429 ' CD1' ' CG2' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -107.49 157.84 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.139 0.495 . . . . 0.0 112.322 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.91 119.56 35.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.482 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' A' ' 22' ' ' THR . 4.8 p90 -133.98 165.15 25.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -124.56 135.16 52.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.377 178.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.428 HG12 ' CE2' ' A' ' 113' ' ' PHE . 3.1 p -147.26 147.37 17.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.019 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.77 78.58 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.067 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -122.72 58.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.975 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.914 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.81 0.338 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.78 120.82 44.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 20' ' ' VAL . 12.5 p 37.66 96.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.13 0.49 . . . . 0.0 112.14 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.405 ' O ' ' CB ' ' A' ' 22' ' ' THR . 1.8 t-160 -126.0 56.73 1.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 3.0 m 80.61 116.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.799 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.9 mm-40 -151.62 177.36 10.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.114 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.0 p -107.39 129.51 54.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.134 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.503 HG21 HG12 ' A' ' 111' ' ' ILE . 1.9 t -114.59 137.32 52.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.122 0.487 . . . . 0.0 111.83 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.15 99.32 10.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.152 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -102.7 107.71 22.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.281 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.416 ' CG2' ' HD2' ' A' ' 106' ' ' LYS . 13.7 p -88.67 113.84 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.036 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 54.5 mt -102.91 164.97 11.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.955 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.2 m -128.68 141.15 51.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.09 119.71 24.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.231 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.66 140.41 31.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.98 59.74 3.63 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.615 2.21 . . . . 0.0 112.502 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.6 t -154.88 -59.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -122.31 -42.73 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.823 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.57 -119.4 3.03 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -103.64 -26.93 12.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.86 39.72 92.01 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.649 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.2 tt -136.5 127.1 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.953 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 127.83 56.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.75 103.15 12.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.711 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.434 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 13.5 pt20 -61.83 156.84 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.878 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.66 30.53 7.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.544 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 t -141.11 165.47 27.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.41 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 66.6 t -96.68 -2.99 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.386 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.41 ' CG ' ' O ' ' A' ' 45' ' ' VAL . 42.2 m-85 -159.47 -40.22 0.06 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.173 0.511 . . . . 0.0 111.038 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.77 44.25 8.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.269 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.0 p -94.66 -13.84 25.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.19 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.69 -81.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.379 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 t -73.37 -170.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.516 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.74 149.07 39.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.998 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.5 m -94.92 -165.65 1.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.637 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.461 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -102.5 -65.74 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.368 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HD3' ' CB ' ' A' ' 53' ' ' SER . 84.6 Cg_endo -80.79 150.26 18.52 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.332 2.021 . . . . 0.0 112.593 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.36 164.53 34.93 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.443 2.095 . . . . 0.0 112.133 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 mp -150.71 142.77 24.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.115 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.6 mt -80.91 122.5 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.62 51.63 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -178.16 126.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.002 0.43 . . . . 0.0 111.365 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.77 152.09 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.1 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -102.05 155.53 18.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.019 0.438 . . . . 0.0 111.507 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.73 43.09 0.95 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.781 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 p30 178.32 28.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.861 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.402 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -128.81 137.02 30.07 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.277 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 69' ' ' CYS . 1.0 OUTLIER -43.76 -33.84 5.26 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.876 2.384 . . . . 0.0 112.649 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.78 85.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.843 0.354 . . . . 0.0 111.15 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -78.35 -50.23 12.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.216 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -71.32 -8.44 53.71 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.1 t -53.0 -33.63 52.5 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.824 0.345 . . . . 0.0 110.775 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.64 31.47 76.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.07 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.14 -65.78 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.098 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.73 150.28 44.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.147 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.4 -177.92 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.8 tt -84.51 56.59 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 111.269 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.29 39.83 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB3' ' CB ' ' A' ' 111' ' ' ILE . 67.3 m-20 -82.7 147.27 28.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.618 0.247 . . . . 0.0 110.74 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -94.86 76.24 3.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.709 0.29 . . . . 0.0 111.503 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.412 ' CG1' HG22 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -58.28 128.36 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.709 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.35 29.38 0.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.097 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 178.34 66.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 0.0 111.065 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.1 mt -96.91 119.82 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.98 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 44.05 30.61 0.44 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.407 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.88 -48.62 0.92 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.8 mm -69.78 111.76 10.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.602 0.239 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.21 -9.61 11.53 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.536 2.157 . . . . 0.0 112.844 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.0 p 56.35 95.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.891 0.377 . . . . 0.0 110.917 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.17 32.32 5.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -145.33 176.24 9.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.96 63.89 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.003 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -121.36 113.59 20.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.703 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -60.69 -45.67 93.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.341 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -54.95 -34.27 63.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.277 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.438 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -60.04 -52.76 63.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.88 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.51 -53.87 53.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.179 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -56.93 -34.8 68.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.88 -46.92 85.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.171 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 7.1 mt -60.38 -43.45 96.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.141 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.87 -32.59 57.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.459 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -78.99 -29.13 43.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.751 0.31 . . . . 0.0 111.178 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -66.34 -15.56 63.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.49 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 3.8 m -83.39 -15.39 49.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.321 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.2 t -58.36 -29.51 66.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.9 mm -54.07 -38.24 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.346 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.3 t -118.02 -3.91 11.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.199 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 101' ' ' SER . 1.1 m 65.81 42.16 3.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.109 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 3.1 tppt? -156.04 128.93 7.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 111.342 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.49 ' HB ' ' CB ' ' A' ' 101' ' ' SER . 14.7 p -137.48 145.42 29.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.135 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.82 105.6 10.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.314 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.21 124.81 49.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.018 0.437 . . . . 0.0 111.685 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -107.11 105.65 15.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.584 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.503 HG12 HG21 ' A' ' 25' ' ' THR . 0.2 OUTLIER -110.26 165.13 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.301 0.572 . . . . 0.0 112.27 -178.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -113.23 121.65 45.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.694 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 22' ' ' THR . 18.4 p90 -118.5 163.59 16.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.881 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.21 139.75 53.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.641 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.417 HG23 ' CD2' ' A' ' 113' ' ' PHE . 7.5 t -148.48 159.72 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.257 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 179.99 48.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.005 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -160.65 47.65 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.933 179.904 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.757 0.313 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -95.37 125.26 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t 56.34 105.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.283 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.538 ' O ' ' O ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -176.24 34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.233 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.538 ' O ' ' O ' ' A' ' 21' ' ' HIS . 6.6 t 52.17 138.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.62 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -177.99 168.09 2.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.2 p -87.75 143.43 27.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.446 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 t -129.47 156.4 44.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.141 0.496 . . . . 0.0 111.355 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.57 98.71 7.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.82 103.14 14.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.477 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 t -82.78 115.04 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.592 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.4 mt -111.59 127.3 55.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.032 0.444 . . . . 0.0 110.918 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -99.05 144.45 28.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.775 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.23 124.94 27.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.949 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.42 136.81 52.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.67 -3.65 14.2 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.584 2.189 . . . . 0.0 112.609 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.42 -49.47 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.227 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.5 p -118.99 -57.07 2.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.9 -108.38 0.63 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.519 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.443 ' CZ ' ' CB ' ' A' ' 101' ' ' SER . 26.0 m-85 -114.66 -32.46 5.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.704 0.288 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.72 40.32 70.71 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.785 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -142.42 140.85 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.343 . . . . 0.0 110.92 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -123.29 145.14 48.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.222 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.41 105.37 15.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.738 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -69.08 132.16 46.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.21 28.07 15.67 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.319 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.9 t -171.32 142.99 1.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.376 . . . . 0.0 110.93 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.43 118.47 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 0.3 OUTLIER 69.9 -168.04 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.666 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.82 128.24 30.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.28 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.3 t 44.57 43.88 6.82 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.518 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.424 ' HG3' ' CD2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -128.58 -65.3 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.58 97.53 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.86 116.46 27.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.915 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.64 21.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.4 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.33 144.88 52.31 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.911 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.33 172.41 11.24 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.508 2.138 . . . . 0.0 112.179 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.14 124.2 14.29 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.482 2.121 . . . . 0.0 112.038 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.58 146.66 44.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.156 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.401 HG13 ' CG2' ' A' ' 78' ' ' VAL . 47.1 mt -60.64 133.61 26.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.28 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.454 ' HA ' HG13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -159.72 40.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 111.464 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CD1' ' HB2' ' A' ' 40' ' ' GLN . 34.2 t80 -167.08 131.12 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 111.198 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.79 152.33 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.03 155.33 17.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.989 0.423 . . . . 0.0 111.16 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.83 44.4 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.961 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER 168.39 32.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.666 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.78 146.45 55.2 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.926 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -43.82 -35.93 7.36 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.801 2.334 . . . . 0.0 112.867 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.17 -39.47 82.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 111.023 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.69 -50.34 13.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.722 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -72.31 -8.36 54.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.557 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.72 -26.22 8.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.719 0.295 . . . . 0.0 111.254 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.05 45.21 96.03 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.438 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -173.1 -44.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.974 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.7 mt -60.91 164.69 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.714 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -154.8 171.8 19.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 0.0 111.203 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.454 HG13 ' HA ' ' A' ' 58' ' ' SER . 2.7 tt -84.85 56.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.136 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.24 59.1 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.765 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -101.24 125.06 47.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.759 0.314 . . . . 0.0 110.755 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -69.34 71.98 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.249 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 3.0 t -63.37 146.64 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.18 27.4 0.14 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.392 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 173.34 79.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.786 0.327 . . . . 0.0 111.203 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.1 mt -100.52 126.73 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.045 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.2 30.1 0.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 102.14 -41.8 2.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.678 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 mm -75.53 109.86 8.98 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.569 0.223 . . . . 0.0 111.352 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 96.8 Cg_endo -94.22 70.91 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.051 2.501 . . . . 0.0 112.264 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.7 t -53.19 93.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.015 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -123.25 66.9 0.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.894 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -161.0 29.18 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.998 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 t 56.44 88.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.035 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.414 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -154.44 106.98 2.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.063 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -70.46 -48.12 57.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.311 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -61.41 -41.35 97.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.763 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -59.8 -48.89 79.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.258 -179.452 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.69 -52.41 65.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.029 0.442 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -55.85 -35.93 66.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.235 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -62.67 -39.59 94.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.29 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.22 -43.09 96.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.096 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 41.6 mt -76.57 -30.58 57.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.865 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -35.8 81.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.323 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -72.33 -9.41 58.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.556 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.443 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 4.9 m -69.6 -24.65 63.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 0.0 110.802 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.9 p -63.2 -55.33 25.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.662 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.7 mm -55.19 -40.65 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.32 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.3 m -80.41 -21.96 41.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t 77.58 -6.74 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.838 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -156.74 149.85 24.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.602 0.239 . . . . 0.0 110.82 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.4 p -150.08 141.87 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.96 113.35 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.988 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.2 142.97 35.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 112.065 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -104.73 105.92 16.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.537 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -116.92 150.51 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.401 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -112.1 120.84 43.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.138 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -116.6 164.03 15.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.959 0.409 . . . . 0.0 111.365 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -134.96 107.63 7.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.367 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.7 152.41 5.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.241 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.02 45.29 1.46 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.016 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.19 47.11 2.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.875 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.19 141.74 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.093 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 113' ' ' PHE . 5.1 p -71.29 157.63 6.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.496 ' CA ' ' HB ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER -154.61 52.05 0.64 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.768 0.318 . . . . 0.0 111.18 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.468 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.2 OUTLIER 67.93 108.43 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.185 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -170.45 171.85 6.32 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.524 -177.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 74.2 p -99.2 132.52 44.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -109.53 135.39 50.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.224 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 99.07 9.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.631 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.97 122.84 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.034 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 t -90.46 120.8 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.252 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 10.9 mp -112.47 143.82 42.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.612 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 82.3 m -105.25 144.06 32.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.19 89.54 8.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.92 138.74 97.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.12 56.5 5.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.581 2.187 . . . . 0.0 112.447 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.9 t -155.33 -66.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 t -111.36 -29.8 7.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.63 -130.03 10.11 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.481 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 101' ' ' SER . 74.5 m-85 -99.53 -23.55 15.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.712 0.291 . . . . 0.0 111.023 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.58 34.88 56.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.903 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.1 tt -132.65 143.83 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.79 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.42 148.93 48.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.07 157.68 16.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.837 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.2 159.89 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.808 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.06 37.54 6.28 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.488 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.5 p -79.59 -177.12 5.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.802 0.334 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.0 t -72.85 -8.43 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.784 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.52 52.41 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.06 0.457 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.36 156.64 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -59.96 -18.67 47.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.465 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.53 24.53 12.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.095 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.7 m 62.15 146.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.178 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -171.0 -178.67 2.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.954 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.71 24.05 0.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 0.0 111.314 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.75 160.7 55.17 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.117 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 36.3 Cg_exo -57.23 174.92 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.73 2.286 . . . . 0.0 112.038 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 54' ' ' PRO . 55.8 Cg_endo -70.38 151.4 65.5 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.474 2.116 . . . . 0.0 112.34 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.49 136.99 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.7 118.77 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.166 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.417 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . 94.2 p -139.68 46.65 1.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 111.745 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -174.23 129.13 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.132 0.491 . . . . 0.0 111.493 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -147.53 151.96 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.002 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.58 155.55 17.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.123 0.487 . . . . 0.0 111.483 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.5 42.03 1.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.86 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 168.15 33.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.757 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.55 150.08 60.27 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.037 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.01 -31.87 29.09 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.912 2.408 . . . . 0.0 112.51 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.59 81.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.028 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -78.11 -39.64 40.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -8.76 56.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.56 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.91 -24.85 10.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.704 0.288 . . . . 0.0 110.996 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.84 73.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.305 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 12.6 p -170.57 33.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.953 0.406 . . . . 0.0 110.972 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.68 153.01 50.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -168.97 161.9 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.417 ' CG2' ' HA ' ' A' ' 58' ' ' SER . 62.5 mt -71.13 117.25 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.081 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.01 -21.96 4.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.666 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.79 136.57 33.53 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.688 0.28 . . . . 0.0 110.768 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -96.86 82.2 3.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.055 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 7.2 p -68.78 159.02 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.052 0.453 . . . . 0.0 111.323 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -152.0 -81.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.134 179.485 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 85' ' ' PRO . . . -75.82 100.16 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 0.0 111.809 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.471 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 17.0 mt -119.38 125.88 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.357 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.9 p30 51.9 24.31 2.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.308 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 104.32 -39.0 2.98 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.753 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mm -84.18 108.86 15.7 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.42 0.156 . . . . 0.0 111.42 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 79' ' ' MET . 98.4 Cg_endo -94.03 123.77 0.44 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.779 2.319 . . . . 0.0 112.508 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 p -89.35 106.01 18.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.763 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -134.4 37.97 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -177.11 -40.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.74 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -67.18 -177.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.9 p -92.25 174.66 7.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -60.41 -25.43 65.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -55.97 -39.46 71.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 7.0 mm-40 -59.94 -46.02 90.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.604 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.67 -44.67 85.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.807 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -56.77 -40.72 76.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.102 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -62.95 -35.95 81.83 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.267 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 24.3 mt -60.86 -48.1 83.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.782 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.9 mt -74.64 -24.95 58.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -35.7 66.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.185 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -77.57 -4.48 46.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.5 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.445 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 14.8 m -62.72 -26.75 68.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.758 0.313 . . . . 0.0 111.022 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 t -58.75 -30.35 67.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.997 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.1 mm -53.09 -56.45 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.943 0.402 . . . . 0.0 111.44 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 t -94.99 -1.42 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.144 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.36 10.76 8.05 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.442 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 21.5 ttmt -156.64 154.95 30.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.861 0.363 . . . . 0.0 111.008 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.89 145.95 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.598 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.65 112.92 25.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.3 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.31 131.54 45.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.5 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -114.93 104.53 12.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.888 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -114.67 154.79 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 120.951 0.405 . . . . 0.0 112.007 -178.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -108.21 129.24 55.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.864 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 20' ' ' VAL . 5.5 p90 -137.21 164.11 29.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -96.16 132.61 41.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.806 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.496 ' HB ' ' CA ' ' A' ' 21' ' ' HIS . 0.2 OUTLIER -44.49 134.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.68 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.42 132.67 33.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.924 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -55.42 112.15 1.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.064 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.935 179.984 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.615 0.245 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 p 31.75 46.59 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.36 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.411 ' CG2' HG23 ' A' ' 115' ' ' VAL . 12.6 p -125.87 159.91 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -157.6 46.5 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.07 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m 77.29 124.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.518 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -175.65 167.55 3.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.062 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.17 140.77 29.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.554 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.96 147.5 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.048 0.451 . . . . 0.0 111.403 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.35 98.03 7.36 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -101.63 107.09 20.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.141 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.404 ' CG1' ' HD3' ' A' ' 106' ' ' LYS . 7.9 t -82.63 120.61 34.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.195 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.0 mt -112.47 164.19 13.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.0 m -124.66 133.26 53.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.443 ' CB ' ' CE2' ' A' ' 37' ' ' PHE . . . -80.1 92.09 5.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -73.02 146.69 87.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.12 49.04 2.9 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.934 2.422 . . . . 0.0 112.569 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -153.35 -59.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.814 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 p -114.49 -16.71 11.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.085 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.6 -121.73 5.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.324 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 95.0 m-85 -109.08 -26.82 9.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.659 0.266 . . . . 0.0 110.788 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.94 48.26 30.98 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.944 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.59 125.17 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.806 0.336 . . . . 0.0 111.069 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.41 122.84 47.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -111.06 100.88 9.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.811 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -62.41 152.76 33.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.819 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.76 40.06 2.65 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.501 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -178.11 179.06 0.86 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.975 0.417 . . . . 0.0 111.203 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.463 HG13 ' CD2' ' A' ' 46' ' ' PHE . 11.9 p -69.08 -48.97 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.42 0.628 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.463 ' CD2' HG13 ' A' ' 45' ' ' VAL . 2.1 p90 -161.31 154.22 20.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.813 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -103.59 109.28 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.213 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 175.66 81.07 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.729 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 60.35 39.37 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.98 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.7 146.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 tt -177.0 107.7 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.06 24.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.435 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.1 m -110.97 154.75 43.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.79 172.54 3.67 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.635 2.223 . . . . 0.0 112.294 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.01 154.91 2.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.637 2.225 . . . . 0.0 112.462 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.86 130.59 2.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.096 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 40.6 mt -81.59 139.74 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.676 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 m -160.28 37.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.819 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -173.95 140.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.953 0.406 . . . . 0.0 111.682 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -149.49 152.76 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.229 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.03 155.78 23.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.082 0.467 . . . . 0.0 111.428 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.98 40.37 0.94 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.789 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.55 31.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -120.26 144.18 37.43 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.824 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -46.29 -29.36 6.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.937 2.424 . . . . 0.0 112.573 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.24 81.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.03 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 8.6 tp10 -78.63 -33.44 47.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.077 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -80.04 -8.84 59.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.002 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.0 p -55.97 -29.86 60.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.06 46.2 93.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.44 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 t -144.58 -67.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 111.286 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.71 165.0 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.13 -170.27 2.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.695 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.5 mm -82.47 79.28 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.83 61.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.677 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -112.24 152.22 28.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.714 0.292 . . . . 0.0 110.71 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.52 83.62 2.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.893 0.378 . . . . 0.0 111.664 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.438 ' CG1' ' CG2' ' A' ' 111' ' ' ILE . 1.6 m -62.45 126.91 21.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.68 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.33 30.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.205 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 178.29 52.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 111.079 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.1 mt -79.01 126.5 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.025 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 43.41 31.73 0.44 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.481 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.5 -45.5 1.32 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.541 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mm -71.25 112.89 15.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.605 0.241 . . . . 0.0 111.267 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -89.12 22.48 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.752 2.302 . . . . 0.0 112.837 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 p 56.23 100.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -117.66 -49.66 2.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.97 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -67.19 -76.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.402 ' CB ' ' CG ' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -101.31 -170.41 1.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.81 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.82 -71.37 0.68 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.087 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -70.32 -48.3 57.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.996 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.402 ' CG ' ' CB ' ' A' ' 89' ' ' SER . 13.8 pt-20 -72.14 -35.17 69.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.411 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.9 tp10 -67.96 -50.64 54.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.66 -51.31 70.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.967 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.41 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 25.3 m-20 -58.36 -35.24 71.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.492 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -37.98 88.8 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.666 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 1.3 mt -65.81 -48.02 73.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.493 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.41 ' CD2' ' HA ' ' A' ' 95' ' ' ASN . 1.5 pp -75.84 -24.15 55.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.27 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -71.14 -36.32 72.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -7.55 54.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.393 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.447 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.0 m -67.38 -18.69 65.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.723 0.297 . . . . 0.0 111.112 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.5 m -58.69 -33.11 69.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.13 -61.43 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.184 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.1 t -85.63 -6.75 59.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.093 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 101' ' ' SER . 33.2 t 62.93 25.19 14.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.301 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.404 ' HD3' ' CG1' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -156.47 150.51 25.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.945 0.402 . . . . 0.0 111.449 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.417 HG11 ' CE1' ' A' ' 37' ' ' PHE . 13.0 p -153.38 157.43 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.47 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.57 107.33 12.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.2 127.38 33.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.714 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -118.01 104.68 11.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.756 178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.438 ' CG2' ' CG1' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -125.89 165.29 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.112 0.482 . . . . 0.0 112.119 -178.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -121.63 128.19 51.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.745 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.462 ' CD2' HG22 ' A' ' 115' ' ' VAL . 10.6 p90 -127.42 150.06 49.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.917 0.389 . . . . 0.0 111.09 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.47 141.36 37.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.699 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.462 HG22 ' CD2' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -163.71 179.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.109 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -173.93 44.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.88 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -107.1 41.59 1.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.728 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.94 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.816 0.341 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.57 127.5 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 21' ' ' HIS . 38.1 t 58.81 156.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.132 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.414 ' CB ' ' CG2' ' A' ' 115' ' ' VAL . 6.1 m-70 -150.08 157.4 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.4 t 177.56 144.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.355 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' CG ' ' CZ ' ' A' ' 113' ' ' PHE . 17.5 pt-20 -177.97 171.66 1.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.066 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 p -87.84 148.22 24.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.636 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.414 HG23 ' CD1' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -129.7 159.69 35.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 111.101 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -113.33 99.37 7.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.13 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.07 102.61 14.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.494 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.68 115.61 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.937 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.56 128.97 55.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 111.005 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 67.8 m -110.63 134.01 52.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.99 153.63 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.059 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -130.65 137.46 30.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.83 60.14 5.23 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.584 2.189 . . . . 0.0 112.302 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.75 -65.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -131.4 17.9 4.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.3 -116.41 5.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.563 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -113.36 -30.48 6.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.861 0.362 . . . . 0.0 111.257 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.71 23.9 63.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.687 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.405 ' HB ' ' CB ' ' A' ' 66' ' ' ALA . 3.6 tt -124.69 139.75 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.725 0.298 . . . . 0.0 110.877 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -135.18 149.5 49.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.049 0.452 . . . . 0.0 111.297 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.89 168.94 9.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.376 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.27 155.5 9.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.082 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.93 97.58 1.87 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.326 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m -164.76 93.18 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 111.09 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.2 t -105.85 -5.02 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.375 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.35 34.34 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.597 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.2 121.11 6.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.447 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 173.35 -32.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.966 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -40.52 0.47 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 t -167.25 164.18 15.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.91 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.6 tp -101.36 140.92 35.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.144 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.85 25.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.307 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.1 m -127.61 156.51 75.31 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.084 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.32 176.1 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.645 2.23 . . . . 0.0 112.259 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.28 171.23 18.11 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.619 2.212 . . . . 0.0 112.421 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -176.42 156.68 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.0 mt -68.75 147.71 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.8 47.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 111.573 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -176.76 134.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 111.583 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.418 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -151.94 152.0 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.934 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.03 155.0 17.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 111.289 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -86.8 39.6 0.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.869 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 28.1 t0 174.06 31.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.607 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.9 m -122.54 144.26 41.82 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.055 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -42.34 -36.53 4.41 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.958 2.439 . . . . 0.0 112.947 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -57.88 -40.1 79.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.841 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -78.13 -51.88 9.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.766 179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -12.75 61.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.482 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.28 -30.28 62.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 0.0 110.838 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.69 24.94 57.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.571 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.2 m -136.58 10.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.585 0.231 . . . . 0.0 111.603 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.56 158.67 44.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.874 0.369 . . . . 0.0 111.023 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -154.45 150.45 27.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.619 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mt -57.17 107.46 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.72 40.14 0.19 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.595 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -114.83 127.72 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 110.575 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -88.18 89.97 8.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.441 ' CG2' ' CG2' ' A' ' 111' ' ' ILE . 13.3 t -69.02 139.64 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.627 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 ttp -164.42 31.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.61 0.243 . . . . 0.0 111.452 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 178.21 69.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.005 0.431 . . . . 0.0 111.319 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.408 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 37.8 mt -98.78 118.19 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.957 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 44.55 31.64 0.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.303 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.54 -47.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.453 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mm -72.39 121.12 83.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.59 0.233 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -85.14 19.8 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.688 2.259 . . . . 0.0 112.952 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.9 p 57.61 23.62 9.52 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 111.158 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.22 -167.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.048 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.3 124.16 51.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.37 36.15 17.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 62.3 m -139.44 78.0 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -61.96 -24.64 67.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.047 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -55.28 -34.83 64.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.55 -45.68 74.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.03 -45.49 86.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.008 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -60.81 -42.89 98.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.561 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -62.95 -32.87 74.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.516 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.1 mt -65.71 -48.07 73.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.69 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.67 -28.56 66.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.53 -36.81 76.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.56 -5.69 48.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.38 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 m -60.14 -20.15 57.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.207 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.7 m -63.13 -31.51 72.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.61 -59.2 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.133 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 t -83.24 -7.88 59.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.294 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 p 80.82 -8.65 1.43 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 5.5 ptpt -156.5 163.37 39.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 111.166 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.4 147.97 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.709 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.74 112.05 23.27 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.245 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.85 125.62 52.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.934 0.397 . . . . 0.0 111.946 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -93.11 104.87 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.441 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -110.09 158.53 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.179 -178.555 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -116.82 119.0 34.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.247 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CZ ' ' CG ' ' A' ' 23' ' ' GLU . 23.0 p90 -109.28 140.67 42.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.142 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -119.69 97.5 5.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.288 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.414 ' CG2' ' CB ' ' A' ' 21' ' ' HIS . 30.5 m -86.92 151.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.376 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.28 45.44 2.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -95.61 44.54 1.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.765 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.87 -179.952 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.727 0.299 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.1 t -74.3 79.12 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 t -73.23 116.21 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -90.38 176.62 6.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 170.39 110.42 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.398 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -155.69 169.6 23.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 111.052 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.0 p -94.66 130.66 41.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.457 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.433 HG23 HG12 ' A' ' 111' ' ' ILE . 4.6 t -111.79 135.29 52.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.828 0.346 . . . . 0.0 111.409 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.1 pt-20 -99.82 98.82 9.58 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.19 111.54 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.94 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.413 ' CG1' ' HD3' ' A' ' 106' ' ' LYS . 10.6 t -82.7 121.85 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.092 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 4.1 mm? -111.9 140.58 46.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 26.8 m -105.34 147.85 27.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.808 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.37 104.25 16.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.243 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.24 135.18 76.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.677 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.12 55.79 5.48 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.558 2.172 . . . . 0.0 112.489 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.9 t -155.21 -49.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.942 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -125.4 -44.11 1.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.968 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.76 -121.09 4.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.425 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 101' ' ' SER . 40.4 m-85 -110.97 -26.2 9.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.705 0.288 . . . . 0.0 111.082 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.96 33.66 79.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.794 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.1 tt -136.95 140.76 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.428 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 68.2 mm-40 -131.7 136.69 47.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.127 0.489 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.25 130.36 55.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.717 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -82.24 137.1 34.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.65 -20.44 46.64 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.54 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.415 ' CB ' ' HG ' ' A' ' 51' ' ' LEU . 12.2 p -155.49 -177.42 6.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.964 0.411 . . . . 0.0 111.055 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' A' ' 53' ' ' SER . 69.2 t -63.48 -81.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.061 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.53 132.48 10.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.29 105.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.081 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 p -58.04 -20.56 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.343 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -144.76 122.73 12.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.894 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 62.21 172.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.007 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.415 ' HG ' ' CB ' ' A' ' 44' ' ' SER . 9.5 tt -107.22 140.34 40.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.13 21.57 0.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.818 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.406 ' HB3' ' CG2' ' A' ' 45' ' ' VAL . 3.2 m -141.77 160.53 55.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.054 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.25 151.97 71.98 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.586 2.19 . . . . 0.0 112.251 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.38 146.78 95.99 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.641 2.227 . . . . 0.0 112.284 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 mp -157.16 136.67 12.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.353 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 68.1 mt -71.51 144.84 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.436 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.2 p -163.4 55.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.986 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.428 ' CD1' ' HG2' ' A' ' 40' ' ' GLN . 11.2 t80 -177.95 132.68 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 111.618 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.432 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -152.89 152.03 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.751 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -96.87 155.13 16.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.38 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.97 41.91 0.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.918 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.428 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 1.2 p30 168.88 32.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.705 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.78 145.86 44.35 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.697 0.284 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -44.96 -37.21 12.07 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.769 2.313 . . . . 0.0 112.578 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.95 80.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.977 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -76.16 -50.18 15.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.687 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.428 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.9 -8.74 56.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.667 -179.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -24.89 60.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.664 0.268 . . . . 0.0 110.79 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.14 30.24 77.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.148 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 t -142.3 -49.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.348 . . . . 0.0 111.068 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.5 mt -69.22 159.62 32.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.032 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 -171.14 3.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.7 mm -93.58 49.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.76 39.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.65 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -89.95 146.15 24.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.762 0.315 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.6 85.31 2.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.052 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 2.6 t -55.54 159.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -50.49 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.45 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.27 86.29 1.76 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.808 0.337 . . . . 0.0 111.641 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.428 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 4.3 mt -77.51 111.81 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 p30 46.53 28.42 0.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.228 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 112.94 -49.57 0.84 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.418 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.9 mm -69.33 109.12 3.89 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.548 0.213 . . . . 0.0 111.182 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 87.0 Cg_endo -94.63 155.98 1.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.907 2.405 . . . . 0.0 112.458 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p -130.95 114.15 14.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.407 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -116.63 -70.66 0.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.424 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -110.61 112.73 24.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 111.286 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.2 m 47.14 83.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.242 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.16 30.96 1.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.799 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -58.28 -47.87 82.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.721 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -45.66 91.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.572 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -62.31 -30.55 71.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.441 ' HA ' HD23 ' A' ' 97' ' ' LEU . . . -67.46 -42.51 82.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.36 -41.7 84.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.441 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -64.33 -53.05 54.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.222 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 94' ' ' ALA . 4.2 pp -57.89 -35.19 70.66 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.159 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.428 ' N ' ' CD1' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -78.47 -35.5 46.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.727 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -27.84 67.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -15.3 63.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.175 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.431 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -73.33 -21.57 60.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.885 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.0 t -70.03 -32.38 70.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.815 0.341 . . . . 0.0 110.408 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -82.03 -41.73 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.681 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.0 m -79.74 -20.28 46.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.856 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.6 m 76.78 -1.76 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.789 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HD3' ' CG1' ' A' ' 28' ' ' VAL . 10.1 tttt -156.56 152.24 27.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.825 0.345 . . . . 0.0 111.501 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.8 p -150.65 151.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.239 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.95 109.45 20.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.988 0.423 . . . . 0.0 110.531 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.5 127.94 35.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.512 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -119.25 104.6 10.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.097 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -124.92 162.7 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.091 0.472 . . . . 0.0 112.088 -178.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.52 118.61 37.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.779 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 29.3 p90 -107.36 161.39 14.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.309 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -133.74 97.42 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.394 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.41 HG23 ' CE1' ' A' ' 113' ' ' PHE . 3.4 t -86.53 141.01 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -147.27 47.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.52 56.4 1.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.861 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.96 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.085 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 2.6 mm-40 -144.34 176.87 9.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.967 0.413 . . . . 0.0 111.169 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -110.9 134.95 52.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.498 HG23 HG13 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -115.66 146.9 41.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.257 0.551 . . . . 0.0 111.415 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.3 99.26 8.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.087 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.759 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -102.15 102.37 13.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.768 -178.437 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.4 p -85.97 119.32 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.466 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.8 mt -110.63 164.14 13.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.945 0.403 . . . . 0.0 111.221 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 105' ' ' SER . 90.4 m -130.31 127.71 40.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.581 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -55.24 112.27 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.416 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.04 146.02 99.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.24 -7.3 20.87 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.659 2.239 . . . . 0.0 112.902 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -98.81 -67.05 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.061 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.8 p -105.6 -51.33 3.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.46 -75.3 0.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.744 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 95.9 m-85 -138.72 76.25 1.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.955 0.407 . . . . 0.0 110.423 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.28 0.64 1.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.911 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.852 HD11 HG21 ' A' ' 57' ' ' ILE . 17.8 tt -95.86 132.89 38.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 116.861 0.331 . . . . 0.0 110.599 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -116.95 145.61 43.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.133 0.492 . . . . 0.0 111.731 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -125.76 122.71 37.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.01 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 0.0 111.296 -179.345 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.547 ' C ' HD13 ' A' ' 56' ' ' LEU . 85.4 Cg_endo . . . . . 0 N--CA 1.463 -0.281 0 N-CA-C 113.112 0.389 . . . . 0.0 113.112 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -158.48 161.03 37.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.75 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.852 HG21 HD11 ' A' ' 39' ' ' ILE . 5.2 mt -80.22 138.57 19.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.897 ' HA ' HG23 ' A' ' 74' ' ' ILE . 8.7 t -164.34 41.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.241 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -176.32 123.19 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 0.0 111.48 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.539 HD11 ' HA ' ' A' ' 73' ' ' GLN . 3.6 mt -133.73 152.51 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.084 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -100.57 155.62 17.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.07 0.462 . . . . 0.0 111.36 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.15 43.25 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.902 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER 168.18 31.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.676 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -112.97 144.38 30.97 Favored Pre-proline 0 CA--C 1.527 0.088 0 CA-C-O 120.707 0.289 . . . . 0.0 110.782 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -45.1 -32.89 7.3 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.638 2.225 . . . . 0.0 112.661 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.422 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -66.39 -46.03 78.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.788 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -65.34 -39.13 91.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.632 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.434 ' NE ' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -87.37 -8.49 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.652 -179.406 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' A' ' 71' ' ' VAL . 35.0 t -53.43 -25.03 14.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 111.033 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.64 27.24 73.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.201 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.651 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.3 p -170.97 34.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.406 . . . . 0.0 111.007 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.416 HD21 HG21 ' A' ' 27' ' ' VAL . 14.4 mt -141.42 147.67 38.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.009 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.539 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.1 mm-40 -168.95 171.69 8.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.725 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.897 HG23 ' HA ' ' A' ' 58' ' ' SER . 36.9 mt -70.46 123.63 24.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.088 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.42 -24.6 3.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.607 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.676 ' HB3' HG21 ' A' ' 111' ' ' ILE . 69.7 m-20 -57.73 123.62 16.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.762 0.315 . . . . 0.0 110.732 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.635 ' C ' HG22 ' A' ' 111' ' ' ILE . 4.4 mtm-85 -94.34 98.42 10.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.433 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.654 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.6 m -75.89 118.31 21.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.972 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.3 ttp -141.14 27.48 1.94 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.873 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -178.86 61.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.643 HD11 ' HB ' ' A' ' 78' ' ' VAL . 25.6 mt -92.45 130.82 40.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.216 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.433 ' OD1' HD22 ' A' ' 97' ' ' LEU . 1.9 p-10 43.93 31.14 0.47 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.316 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.84 -44.44 1.64 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.602 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.461 ' HB ' HD21 ' A' ' 97' ' ' LEU . 7.6 mm -71.77 110.78 8.41 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.501 0.191 . . . . 0.0 111.289 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 0 N--CA 1.458 -0.606 0 C-N-CA 122.814 2.343 . . . . 0.0 112.686 -179.839 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.931 0.396 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.865 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -58.02 -49.9 75.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.679 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -58.01 -36.77 73.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.545 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -43.95 97.52 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.653 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 94' ' ' ALA . 5.3 mt -59.71 -42.49 93.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.613 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 41' ' ' LEU . 61.3 mt -62.86 -37.13 85.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -77.74 -28.42 50.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.126 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.41 -6.72 49.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.463 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 3.5 m -72.68 -26.24 61.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.74 0.305 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.92 -26.85 64.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.218 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.8 mm -53.9 -49.32 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.494 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.1 t -104.73 -1.06 26.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.599 ' O ' HG23 ' A' ' 30' ' ' THR . 1.5 m 78.97 -4.54 2.1 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.791 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.646 ' O ' HG23 ' A' ' 104' ' ' THR . 0.0 OUTLIER -156.58 152.64 27.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.868 0.366 . . . . 0.0 111.111 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 108' ' ' THR . 10.7 p -131.13 157.54 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.778 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.447 ' N ' HG22 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -120.56 106.87 12.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.86 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.421 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -100.64 120.15 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 111.871 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.873 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -87.96 112.12 22.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.454 178.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.759 HD11 ' CG2' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -118.43 164.97 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.361 0.6 . . . . 0.0 112.443 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -123.12 124.87 44.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.833 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.422 ' CE1' ' HB2' ' A' ' 23' ' ' GLU . 49.9 p90 . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.955 0.407 . . . . 0.0 111.263 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 22.1 pt-20 -175.15 177.08 1.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.969 0.414 . . . . 0.0 111.212 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 15.8 p -89.53 128.19 35.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.109 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.587 HG23 ' CD1' ' A' ' 111' ' ' ILE . 2.7 t -107.28 136.0 47.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.277 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.79 99.38 11.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.639 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -101.02 103.18 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.718 -178.435 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 108' ' ' THR . 10.9 t -83.59 113.95 23.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.406 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.431 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 8.7 mt -110.08 137.64 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.009 0.433 . . . . 0.0 111.251 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 105' ' ' SER . 96.7 m -109.91 137.89 47.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.577 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.67 146.62 51.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.214 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.02 139.46 28.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.794 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.0 57.23 5.1 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.61 2.207 . . . . 0.0 112.432 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.4 t -155.42 -68.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 -29.76 6.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.011 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.75 -110.93 3.15 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.406 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.562 ' HB3' HG22 ' A' ' 39' ' ' ILE . 52.3 m-85 -114.61 -33.01 5.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.51 31.87 82.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.77 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.912 HD13 HD13 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -140.96 140.96 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 110.959 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -141.24 159.18 42.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.039 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.538 HD13 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -127.49 121.64 31.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.733 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.704 ' C ' HD13 ' A' ' 56' ' ' LEU . 35.1 Cg_endo . . . . . 0 C--O 1.232 0.198 0 CA-C-O 120.627 0.178 . . . . 0.0 112.105 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.704 HD13 ' C ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -152.52 150.29 29.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.069 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.447 HD12 HG21 ' A' ' 111' ' ' ILE . 80.7 mt -74.52 147.93 8.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.861 ' HA ' HG23 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -175.4 50.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.153 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -173.79 134.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 0.0 111.437 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -150.69 151.88 12.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.219 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.75 155.36 18.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 0.0 111.582 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.87 41.0 1.02 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.863 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER 171.82 33.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.521 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 m -127.11 143.67 47.82 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.07 -32.81 7.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.729 2.286 . . . . 0.0 112.809 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.99 -51.66 68.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.986 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.558 ' HB2' HG22 ' A' ' 60' ' ' ILE . 10.6 tp10 -69.67 -43.14 73.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.69 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.434 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -67.15 -14.11 62.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.402 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.694 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -55.91 -27.44 52.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.941 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.18 31.58 65.93 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.239 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 69' ' ' CYS . 10.4 t -137.29 -58.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 111.206 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.912 HD13 HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -75.38 166.09 24.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.053 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.432 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.1 pp0? -164.86 169.23 16.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.707 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.861 HG23 ' HA ' ' A' ' 58' ' ' SER . 18.0 mt -67.54 114.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.068 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.67 22.17 4.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.648 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.431 ' HB3' HG21 ' A' ' 111' ' ' ILE . 1.3 m-20 -83.45 141.52 31.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.679 0.276 . . . . 0.0 110.673 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.409 ' HB3' ' HB3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -98.84 89.66 4.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.345 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.896 HG22 ' CG2' ' A' ' 111' ' ' ILE . 5.4 t -74.82 145.85 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.602 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -170.29 29.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.771 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . . . -176.18 46.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 111.661 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.598 HG22 ' OD1' ' A' ' 82' ' ' ASN . 16.5 mt -67.8 112.99 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.029 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.598 ' OD1' HG22 ' A' ' 81' ' ' ILE . 5.2 p-10 44.06 35.69 1.25 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.436 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.59 -49.7 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.386 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.11 120.29 77.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.534 0.207 . . . . 0.0 111.138 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 N--CA 1.461 -0.387 0 C-N-CA 122.719 2.28 . . . . 0.0 112.915 -179.771 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 4.2 mt-10 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.962 0.411 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.882 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.32 -38.54 84.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.764 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -61.93 -43.67 98.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -62.56 -38.06 88.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.446 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.882 HD12 ' HA ' ' A' ' 94' ' ' ALA . 12.2 mt -61.71 -40.7 95.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.248 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.4 mt -78.02 -32.17 50.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.363 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -65.89 -25.86 67.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.916 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.54 15.02 10.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.522 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 m -79.32 -23.22 43.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.81 0.338 . . . . 0.0 110.853 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 p -58.59 -35.25 72.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.807 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.9 mm -53.95 -54.37 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.4 p -86.93 -8.69 57.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.984 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.789 ' O ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER 79.35 -5.02 1.99 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.025 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -156.62 166.8 32.37 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.853 0.358 . . . . 0.0 111.187 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 11.4 p -151.13 148.32 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.902 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.891 HG22 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -112.33 107.19 15.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.087 179.252 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -101.83 126.16 48.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.776 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.771 ' CB ' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -92.5 120.53 33.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.62 178.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.896 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -133.79 165.48 31.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.383 -178.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 77' ' ' ARG . 21.1 tt0 -116.86 126.75 53.49 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.102 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.445 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 34.5 p90 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.15 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.219 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.6 OUTLIER -168.26 154.18 7.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.393 . . . . 0.0 111.572 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 72.5 p -89.85 127.06 35.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.265 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.553 HG23 ' CD1' ' A' ' 111' ' ' ILE . 7.3 t -114.61 131.07 56.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.925 0.393 . . . . 0.0 111.366 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.18 99.42 11.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.724 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.633 HG11 ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -107.69 133.64 51.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.081 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.703 HG22 HG22 ' A' ' 108' ' ' THR . 21.6 t -94.28 117.42 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.405 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.652 HD11 ' N ' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -109.17 126.1 52.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.331 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.0 t -103.11 165.88 10.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.215 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.8 115.99 30.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.081 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.25 140.22 79.57 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.769 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.02 -0.69 10.83 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.659 2.239 . . . . 0.0 112.874 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.4 t -108.04 -35.69 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.002 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.9 p -133.91 -66.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.72 -109.1 0.57 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.434 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 35.6 m-85 -118.41 -35.43 3.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.7 26.0 38.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.776 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.544 HG23 HD13 ' A' ' 98' ' ' LEU . 3.0 tt -111.16 127.18 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.994 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 125.14 51.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.922 HD11 HD11 ' A' ' 98' ' ' LEU . 2.1 mt -108.84 116.3 31.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.756 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.818 0.257 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 56' ' ' LEU . 1.7 pt? -178.08 169.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.622 HD13 ' HB2' ' A' ' 76' ' ' ASP . 3.4 mp -75.62 141.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.429 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.9 t -117.34 -31.29 5.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.849 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -165.56 167.43 17.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.194 0.521 . . . . 0.0 111.886 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.523 HG13 HD13 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -144.94 153.18 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.922 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -86.37 155.46 20.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.086 0.469 . . . . 0.0 111.516 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.87 38.34 0.8 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.82 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -179.72 26.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.992 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.5 p -120.62 134.58 24.25 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.626 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.466 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 89.2 Cg_exo -43.52 -29.21 2.03 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.492 2.128 . . . . 0.0 112.752 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.652 ' N ' HD11 ' A' ' 29' ' ' LEU . . . -62.24 -42.85 99.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.983 0.42 . . . . 0.0 110.815 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' CA ' HG21 ' A' ' 60' ' ' ILE . 8.8 tp10 -78.48 -50.22 12.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.152 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.466 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.88 -8.36 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.916 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -24.95 11.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.771 0.32 . . . . 0.0 111.0 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.84 30.71 63.22 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.237 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.633 ' HB ' HG11 ' A' ' 27' ' ' VAL . 5.4 t -145.03 -52.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.926 0.393 . . . . 0.0 111.116 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.414 HD21 HD12 ' A' ' 111' ' ' ILE . 12.1 mt -75.69 130.68 39.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.047 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 -170.99 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.798 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.523 HD13 HG13 ' A' ' 60' ' ' ILE . 12.9 mm -92.16 75.61 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.187 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.88 42.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.891 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.622 ' HB2' HD13 ' A' ' 57' ' ' ILE . 32.9 m-20 -85.18 -176.03 5.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.583 0.23 . . . . 0.0 110.534 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.91 79.27 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 111.203 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.032 HG11 HD11 ' A' ' 81' ' ' ILE . 12.2 t -58.45 147.82 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.054 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 11.9 tpt -134.98 -65.36 0.62 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.07 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -125.37 96.95 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.032 HD11 HG11 ' A' ' 78' ' ' VAL . 9.7 mt -88.48 122.96 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.943 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 46.53 31.63 1.4 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.01 -34.23 5.2 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.219 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.558 ' HB ' HD22 ' A' ' 97' ' ' LEU . 4.1 mm -87.72 110.85 37.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.511 0.196 . . . . 0.0 111.155 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 N--CA 1.458 -0.615 0 C-N-CA 122.669 2.246 . . . . 0.0 112.56 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.804 0.335 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.878 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.86 -50.45 73.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -58.16 -36.36 72.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.582 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.92 -43.95 97.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.724 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' A' ' 94' ' ' ALA . 3.8 mt -60.5 -43.75 96.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.721 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.922 HD11 HD11 ' A' ' 41' ' ' LEU . 57.3 mt -70.96 -31.24 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -67.55 -32.68 73.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.98 -5.82 50.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.233 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -75.55 -23.18 56.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.751 0.31 . . . . 0.0 111.017 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.6 p -63.7 -30.98 72.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.714 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -65.14 -56.14 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.995 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 105' ' ' SER . 42.7 p -77.61 -11.7 59.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.126 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 104' ' ' THR . 1.8 p 84.19 -18.3 0.42 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.925 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 8.6 ptpt -156.43 160.53 39.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 111.284 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 9.8 p -144.67 155.27 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.713 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.703 HG22 HG22 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -110.99 121.85 46.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.206 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.512 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -115.07 143.84 44.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.446 -179.224 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -115.18 104.71 12.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.983 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.667 HG22 HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -116.55 161.31 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -93.59 133.57 36.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.689 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 30.6 p90 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.979 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 22' ' ' THR . 5.6 t . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER 179.26 177.28 0.55 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.739 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 19.7 p -86.61 127.58 34.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.29 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.598 HG22 HD12 ' A' ' 111' ' ' ILE . 9.9 t -113.98 140.77 48.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.37 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 99.01 9.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.5 HG21 HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -101.64 103.17 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.305 -178.583 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.4 p -82.74 115.25 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.929 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.401 HD22 ' C ' ' A' ' 28' ' ' VAL . 4.4 mm? -113.78 147.99 37.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.117 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 105' ' ' SER . 82.2 m -108.11 144.7 35.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.873 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.722 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -84.1 108.82 17.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.3 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -68.3 140.6 92.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.99 41.38 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.771 2.314 . . . . 0.0 112.814 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.88 -47.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.799 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -127.39 -43.42 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.977 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.17 -118.57 2.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.52 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 29.9 m-85 -108.07 -25.49 11.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.761 0.315 . . . . 0.0 110.943 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.53 41.88 99.65 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.532 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.645 HG23 HD13 ' A' ' 98' ' ' LEU . 18.8 tt -150.66 126.63 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.775 0.321 . . . . 0.0 111.098 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' A' ' 59' ' ' TYR . 2.8 pm0 -124.28 156.54 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.037 0.446 . . . . 0.0 111.268 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.733 HD13 ' CB ' ' A' ' 94' ' ' ALA . 2.6 mp -103.67 162.3 13.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.779 0.241 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -140.39 145.12 36.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.198 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 6.3 mt -59.64 145.27 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.516 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 m -147.45 16.84 1.16 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.432 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 4.0 t80 -162.26 149.84 14.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.222 0.534 . . . . 0.0 111.799 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.712 HD11 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -151.41 152.36 11.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.788 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -94.45 155.63 16.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 111.825 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -87.86 41.48 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.716 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 169.6 31.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.71 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.9 m -120.83 144.15 38.31 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.795 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.45 -27.25 7.03 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.885 2.39 . . . . 0.0 112.547 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -66.29 -46.84 75.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.976 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 2.9 tp10 -78.06 -39.73 40.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.432 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.6 -19.16 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.476 ' HB3' HG22 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -52.78 -30.12 31.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.075 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.1 23.56 52.53 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.816 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 69' ' ' CYS . 2.9 m -122.39 -38.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.763 0.316 . . . . 0.0 111.232 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 pp -93.59 148.63 21.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.955 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -125.86 169.09 12.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.686 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.712 HD13 HD11 ' A' ' 60' ' ' ILE . 32.9 mm -67.44 107.07 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.047 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.87 4.39 6.7 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.073 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.91 133.18 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.86 0.33 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -98.28 95.71 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.219 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.963 HG11 HD11 ' A' ' 81' ' ' ILE . 2.7 t -76.19 129.82 36.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.546 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -150.77 31.87 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.274 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.931 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 179.36 81.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.963 HD11 HG11 ' A' ' 78' ' ' VAL . 41.7 mt -111.91 126.7 69.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.234 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 45.19 31.35 0.76 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.234 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.41 -34.75 5.05 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.312 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.0 mm -82.15 111.68 29.55 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.455 0.169 . . . . 0.0 111.083 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 N--CA 1.46 -0.498 0 C-N-CA 122.682 2.254 . . . . 0.0 112.713 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.454 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 35.0 mt-10 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.736 0.303 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.733 ' CB ' HD13 ' A' ' 41' ' ' LEU . . . -57.36 -43.02 83.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -56.59 -40.94 76.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.058 0.456 . . . . 0.0 110.054 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -63.03 -38.03 89.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.32 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.514 HD12 HD12 ' A' ' 81' ' ' ILE . 41.3 mt -61.02 -39.0 88.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.645 HD13 HG23 ' A' ' 39' ' ' ILE . 60.6 mt -78.09 -28.59 48.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.053 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -74.91 -35.8 62.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.412 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -78.39 -3.2 42.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.652 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.486 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 67.0 m -69.77 -25.02 63.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.858 0.361 . . . . 0.0 110.733 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.03 -27.22 65.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 21.9 mm -49.92 -47.2 23.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.824 0.345 . . . . 0.0 111.241 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.1 t -108.75 0.94 20.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.057 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.752 ' O ' HG23 ' A' ' 30' ' ' THR . 1.4 t 62.81 18.06 10.41 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.256 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 0.5 OUTLIER -156.94 144.14 18.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.865 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.518 HG12 ' CE2' ' A' ' 37' ' ' PHE . 10.4 p -152.36 151.94 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.705 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 p -122.15 104.32 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.007 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -102.41 149.17 24.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.181 0.515 . . . . 0.0 112.183 -178.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.931 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 1.3 tt0 -107.27 124.87 50.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.252 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.958 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -138.18 133.31 43.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.177 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 35.2 tt0 -92.7 118.64 31.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 22' ' ' THR . 18.8 p90 . . . . . 0 C--O 1.239 0.546 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.783 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 113' ' ' PHE . 96.5 m . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 120.991 0.424 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -178.31 168.31 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.726 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 12.5 p -87.78 151.68 22.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.71 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.858 HG23 ' CD1' ' A' ' 111' ' ' ILE . 0.6 OUTLIER -132.15 143.49 50.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.032 0.444 . . . . 0.0 111.53 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.28 99.61 9.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.55 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.638 HG12 ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -105.4 106.89 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.616 -178.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.794 HG22 ' HD3' ' A' ' 106' ' ' LYS . 13.6 p -90.01 114.98 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.703 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 66' ' ' ALA . 10.8 mt -104.27 164.42 11.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 0.0 110.961 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 105' ' ' SER . 11.5 m -121.19 142.54 49.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.608 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.642 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -86.85 114.54 23.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 111.121 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.64 147.83 71.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.96 18.64 1.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.968 2.445 . . . . 0.0 112.853 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.84 -41.28 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.801 0.334 . . . . 0.0 111.078 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 t -136.04 -45.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.074 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.4 -109.98 0.93 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.512 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.642 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 87.1 m-85 -118.7 -31.7 4.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.631 0.253 . . . . 0.0 111.191 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.48 35.78 90.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.648 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 57' ' ' ILE . 1.7 tt -135.39 131.33 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.965 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.9 155.78 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.041 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.656 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -136.65 135.9 38.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 -179.814 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo . . . . . 0 N--CA 1.466 -0.133 0 CA-C-O 120.969 0.321 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 56' ' ' LEU . 2.6 pt? -115.95 151.2 35.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.124 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 39' ' ' ILE . 29.2 mt -84.37 154.1 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.92 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 57' ' ' ILE . 44.3 t -177.81 51.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -175.53 133.86 0.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.971 0.415 . . . . 0.0 111.288 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.433 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -150.58 152.18 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.357 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.99 155.46 17.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.652 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.0 41.63 1.01 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.811 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER 172.19 32.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.589 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -126.73 145.61 54.08 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.73 -31.73 15.28 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.991 2.461 . . . . 0.0 112.591 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.494 ' HA ' HD21 ' A' ' 29' ' ' LEU . . . -58.8 -45.25 90.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.953 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 11.8 tp10 -77.96 -41.9 34.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.775 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.424 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -69.38 -11.77 61.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.402 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.425 ' O ' HG22 ' A' ' 71' ' ' VAL . 1.1 t -52.98 -30.67 36.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.821 0.343 . . . . 0.0 111.112 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.09 27.89 68.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.44 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.638 ' CG2' HG12 ' A' ' 27' ' ' VAL . 2.8 m -152.54 30.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.347 . . . . 0.0 111.179 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.469 HD23 ' OD2' ' A' ' 76' ' ' ASP . 3.3 mt -136.92 162.23 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.75 159.07 43.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.3 mm -75.66 98.05 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.244 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.67 38.52 0.61 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.618 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' OD2' HD23 ' A' ' 72' ' ' LEU . 28.8 m-20 -82.1 126.84 32.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 110.73 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -84.68 90.04 7.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.073 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.029 HG11 HD11 ' A' ' 81' ' ' ILE . 2.1 t -70.66 144.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.522 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -163.42 28.47 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.212 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . 172.16 89.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 111.278 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.029 HD11 HG11 ' A' ' 78' ' ' VAL . 20.4 mt -116.54 115.09 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.785 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 1.0 OUTLIER 49.6 26.75 1.87 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.248 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.12 -44.25 1.55 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.698 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.506 HG21 HD21 ' A' ' 97' ' ' LEU . 6.9 mm -74.35 111.65 13.7 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.531 0.205 . . . . 0.0 111.191 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo . . . . . 0 N--CA 1.455 -0.745 0 C-N-CA 122.858 2.372 . . . . 0.0 112.777 -179.854 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.953 0.406 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 41' ' ' LEU . . . -57.89 -35.37 70.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.076 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.51 ' HA ' HD23 ' A' ' 98' ' ' LEU . 7.2 m-20 -62.78 -39.4 94.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.178 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -62.34 -40.3 95.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.09 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.506 HD21 HG21 ' A' ' 84' ' ' ILE . 11.7 mt -59.34 -47.04 86.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.617 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -78.01 -26.71 48.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.873 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -73.93 -30.44 62.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.32 7.24 29.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.441 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.448 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -74.22 -17.53 60.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.726 0.298 . . . . 0.0 111.259 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.1 m -59.14 -30.77 68.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.913 0.387 . . . . 0.0 110.615 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.4 mt -57.04 -66.3 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 t -84.98 -2.75 58.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.159 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.661 ' O ' HG23 ' A' ' 30' ' ' THR . 0.9 OUTLIER 64.85 19.6 11.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.244 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.794 ' HD3' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -156.37 153.91 29.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 111.423 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.445 HG12 ' CE2' ' A' ' 37' ' ' PHE . 13.8 p -145.73 143.67 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.19 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -118.16 120.89 39.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.488 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -121.54 132.86 54.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.552 -179.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 26.9 mt-10 -107.26 104.68 14.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.821 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.858 ' CD1' HG23 ' A' ' 25' ' ' THR . 0.2 OUTLIER -110.99 163.89 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -114.52 121.3 43.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.784 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.786 ' O ' HG23 ' A' ' 22' ' ' THR . 39.2 p90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 111.733 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 1.1 m . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.85 0.357 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -147.85 149.77 32.91 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.317 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -88.76 127.12 35.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.814 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.658 HG23 HG13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -114.79 152.4 32.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.244 0.545 . . . . 0.0 111.401 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.32 99.14 6.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.261 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.702 HG21 HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.03 129.53 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.554 -178.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.716 HG22 ' CG2' ' A' ' 108' ' ' THR . 21.3 t -105.17 113.58 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.464 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.539 HD12 ' HD1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -102.12 124.66 48.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.374 . . . . 0.0 110.935 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 67.8 m -105.85 115.31 30.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.08 140.29 44.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.355 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.03 157.36 34.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.41 -1.33 11.5 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.935 2.423 . . . . 0.0 112.753 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 t -104.03 -67.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.33 . . . . 0.0 111.285 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.5 p -105.05 -71.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.62 -72.37 0.28 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.578 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.539 ' HD1' HD12 ' A' ' 29' ' ' LEU . 45.7 m-85 -145.41 -43.88 0.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 111.018 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.4 26.86 70.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.733 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.947 HD13 HD13 ' A' ' 72' ' ' LEU . 1.7 tt -124.55 130.71 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 110.922 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.79 148.08 41.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.876 HD13 ' HB1' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -122.13 120.83 35.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.651 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.579 ' C ' HD23 ' A' ' 56' ' ' LEU . 31.7 Cg_exo . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.898 0.291 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -177.89 141.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.768 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.857 HG21 HD11 ' A' ' 39' ' ' ILE . 23.6 mt -64.02 134.83 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.83 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 t -159.97 42.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -172.44 135.9 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.081 0.467 . . . . 0.0 111.222 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.411 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -151.37 152.52 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.234 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.52 155.24 17.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 111.272 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.67 42.37 0.96 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.138 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.421 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER 168.97 33.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.727 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.57 144.57 44.63 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -43.5 -37.75 8.09 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.798 2.332 . . . . 0.0 112.766 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.44 77.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.991 0.424 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -75.73 -50.52 15.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.683 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.421 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.36 -8.95 57.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.697 -179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.517 ' O ' HG23 ' A' ' 71' ' ' VAL . 42.1 t -56.38 -25.24 49.03 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.806 0.336 . . . . 0.0 110.835 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.08 31.76 81.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.293 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.635 HG11 HG13 ' A' ' 27' ' ' VAL . 5.4 t -143.69 -52.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 0.0 111.067 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.947 HD13 HD13 ' A' ' 39' ' ' ILE . 76.5 mt -58.96 150.44 24.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.018 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -144.09 160.59 40.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.5 mm -71.67 89.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.26 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.19 35.17 0.83 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.784 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.652 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -74.93 130.94 40.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.785 0.326 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -85.32 79.33 9.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.733 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.913 HG11 HD11 ' A' ' 81' ' ' ILE . 5.8 t -56.88 158.53 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.425 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -137.75 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.342 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.21 96.0 4.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.377 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.913 HD11 HG11 ' A' ' 78' ' ' VAL . 21.4 mt -86.63 121.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.775 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.794 ' OD1' HD22 ' A' ' 97' ' ' LEU . 4.2 p-10 44.83 30.51 0.56 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.242 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.96 -37.49 3.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.646 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.682 ' HB ' HD21 ' A' ' 97' ' ' LEU . 4.2 mm -84.77 111.07 32.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.499 0.19 . . . . 0.0 111.208 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 N--CA 1.459 -0.554 0 C-N-CA 122.742 2.295 . . . . 0.0 112.72 -179.746 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.909 0.385 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.883 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -58.29 -44.74 88.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.176 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -60.26 -39.63 87.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.781 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -62.45 -41.55 98.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.883 HD12 ' HA ' ' A' ' 94' ' ' ALA . 5.2 mt -62.21 -48.17 81.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.55 HD11 HD11 ' A' ' 41' ' ' LEU . 73.9 mt -59.89 -33.85 72.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -29.61 39.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -6.01 49.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.478 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.2 t -79.25 -27.22 42.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.691 0.282 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.2 m -59.43 -34.96 73.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.1 mm -52.48 -46.78 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.496 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.3 t -101.48 -4.32 27.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.098 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER 78.41 -3.31 2.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.77 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.639 ' O ' HG23 ' A' ' 104' ' ' THR . 5.0 ptpt -156.8 165.01 37.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.94 0.4 . . . . 0.0 111.131 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.3 146.54 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.525 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.716 ' CG2' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -109.96 109.56 20.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.299 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.897 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -110.25 143.94 39.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 0.0 111.653 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -106.6 121.43 44.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.93 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.702 HD11 HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -119.4 164.48 15.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.15 0.5 . . . . 0.0 111.984 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -122.57 118.65 28.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.301 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 22' ' ' THR . 5.4 p90 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.26 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 22' ' ' THR . 6.7 t . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.959 0.409 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -168.94 156.09 7.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.408 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 7.9 p -87.68 129.27 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.813 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.431 HG22 ' HD2' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -117.37 148.09 42.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.033 0.444 . . . . 0.0 110.995 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.56 98.98 9.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.627 ' CG1' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -100.96 100.36 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.104 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.6 p -85.38 117.94 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.045 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.962 HD23 HD21 ' A' ' 109' ' ' LEU . 3.5 mm? -111.22 152.9 26.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.8 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 105' ' ' SER . 27.5 m -116.53 150.45 37.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.714 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.79 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -92.58 103.84 16.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.162 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 86.1 m-20 -74.89 154.66 86.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.791 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 32' ' ' ASP . 2.9 Cg_exo -75.21 0.02 9.49 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.762 2.308 . . . . 0.0 112.729 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -66.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.821 0.343 . . . . 0.0 110.981 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -108.96 -43.21 4.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.62 -85.72 0.86 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.79 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 96.4 m-85 -133.27 73.66 1.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.975 0.417 . . . . 0.0 110.098 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.89 10.43 0.56 Allowed Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.135 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 66' ' ' ALA . 13.1 tt -96.16 130.25 45.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.891 0.377 . . . . 0.0 110.788 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.72 136.8 50.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -127.64 114.79 17.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.029 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.86 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.84 ' O ' HD12 ' A' ' 56' ' ' LEU . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.754 0.231 . . . . 0.0 112.245 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 55' ' ' PRO . 4.8 mp -149.2 127.45 12.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.014 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 76' ' ' ASP . 69.7 mt -75.63 141.15 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.616 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.935 ' HA ' HG23 ' A' ' 74' ' ' ILE . 46.7 t -164.04 49.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.723 0.297 . . . . 0.0 111.683 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' O ' HG13 ' A' ' 39' ' ' ILE . 70.4 t80 -176.15 133.81 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.031 0.443 . . . . 0.0 111.504 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.411 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.33 152.05 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.035 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.92 155.5 18.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 111.357 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.27 43.49 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.842 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.84 32.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.609 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -121.47 144.62 40.63 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.04 -35.2 4.47 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.812 2.341 . . . . 0.0 112.86 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 39' ' ' ILE . . . -60.67 -44.36 96.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.9 OUTLIER -71.15 -46.73 60.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.842 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -8.68 57.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.633 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.48 ' SG ' HG22 ' A' ' 71' ' ' VAL . 53.5 t -52.0 -40.9 61.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.894 0.378 . . . . 0.0 111.006 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.57 -27.4 15.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.466 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.627 HG23 ' CG1' ' A' ' 27' ' ' VAL . 30.2 m -117.51 26.12 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.757 0.313 . . . . 0.0 111.303 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 66' ' ' ALA . 5.9 mt -124.82 143.48 50.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -169.12 153.39 5.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.785 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.935 HG23 ' HA ' ' A' ' 58' ' ' SER . 40.9 mt -59.34 110.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.53 -15.56 3.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.767 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.559 ' HB2' HD12 ' A' ' 57' ' ' ILE . 65.0 m-20 -59.04 139.32 56.97 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.814 0.34 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.28 96.16 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.08 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.665 HG22 ' CG2' ' A' ' 111' ' ' ILE . 2.8 t -65.33 152.04 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.2 tpt -137.05 -63.28 0.61 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.232 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -125.2 93.9 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.338 . . . . 0.0 111.356 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.885 HG23 ' HB3' ' A' ' 109' ' ' LEU . 10.6 mt -82.66 124.08 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.433 ' OD1' HG22 ' A' ' 81' ' ' ILE . 4.1 p-10 44.35 31.77 0.62 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.154 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.09 -37.57 3.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.3 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mm -85.75 112.66 46.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.57 0.224 . . . . 0.0 111.179 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo . . . . . 0 N--CA 1.459 -0.558 0 C-N-CA 122.632 2.222 . . . . 0.0 112.716 -179.782 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 120.82 0.343 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.67 -45.99 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.678 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.08 -38.04 78.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.241 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -62.68 -46.38 88.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.472 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.63 -31.72 71.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.182 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -78.06 -31.49 50.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.612 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.24 -30.62 38.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.87 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -10.58 59.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.243 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.532 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 16.6 m -72.43 -19.33 61.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.041 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.5 p -65.91 -37.09 85.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.882 0.373 . . . . 0.0 110.746 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -58.55 -55.77 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.3 p -83.19 -9.48 59.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.992 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.79 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER 62.28 17.21 9.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.347 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' HG22 ' A' ' 28' ' ' VAL . 2.9 tppt? -156.81 146.18 20.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 0.0 111.021 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.414 ' HB ' ' OG ' ' A' ' 101' ' ' SER . 11.7 p -154.8 149.89 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 28' ' ' VAL . 1.2 p -122.65 124.84 44.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.059 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.962 HD21 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -125.15 148.22 48.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.088 0.47 . . . . 0.0 111.993 -179.048 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -102.1 129.65 48.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.693 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.665 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -138.39 156.62 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.923 0.392 . . . . 0.0 111.815 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -93.9 126.11 38.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.248 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 24.5 p90 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.672 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.813 HG23 ' O ' ' A' ' 113' ' ' PHE . 57.0 m . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.997 0.427 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HG2' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -178.6 166.9 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.174 179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.2 p -90.31 131.83 35.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.108 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.469 HG23 HD11 ' A' ' 111' ' ' ILE . 5.2 t -116.26 133.62 55.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.031 0.443 . . . . 0.0 111.936 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.34 98.98 10.43 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.552 ' CG1' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -100.88 119.17 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.723 -178.556 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 28' ' ' VAL . 13.6 p -88.73 113.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.965 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 66' ' ' ALA . 3.5 mm? -104.84 164.77 11.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.567 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 105' ' ' SER . 37.6 m -127.2 146.0 50.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.871 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -82.87 97.49 8.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.148 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.34 142.47 90.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.64 -3.86 14.45 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.61 2.207 . . . . 0.0 112.785 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.73 -61.0 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 t -125.57 -41.22 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.01 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.1 -105.06 0.49 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.462 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.695 ' CE1' HG12 ' A' ' 107' ' ' VAL . 96.6 m-85 -113.85 -28.97 7.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.767 0.318 . . . . 0.0 111.005 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.26 47.28 83.09 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.836 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.838 HD13 HD13 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -146.87 127.63 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 0.0 111.075 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.58 147.87 46.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.909 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.83 ' O ' HD12 ' A' ' 41' ' ' LEU . 2.8 pp -131.68 127.0 36.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.77 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.783 0.243 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.419 ' N ' HD23 ' A' ' 56' ' ' LEU . 1.3 pt? -152.09 145.53 24.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.205 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.631 HD11 HG22 ' A' ' 78' ' ' VAL . 8.5 mt -77.59 143.49 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.612 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 t -162.79 48.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.281 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -172.9 131.54 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.099 0.476 . . . . 0.0 111.389 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.685 HG13 HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -149.61 152.31 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.031 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.83 155.45 17.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 111.261 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.63 39.88 0.9 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.752 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 175.55 29.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.773 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.62 136.14 26.94 Favored Pre-proline 0 C--O 1.231 0.127 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 92.2 Cg_exo -43.52 -29.24 2.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.622 2.214 . . . . 0.0 112.807 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.521 ' HB1' HD13 ' A' ' 39' ' ' ILE . . . -62.72 -42.08 99.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.932 0.396 . . . . 0.0 111.01 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.462 ' HB2' HG22 ' A' ' 60' ' ' ILE . 5.8 tp10 -78.31 -49.61 13.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -72.14 -8.19 53.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.655 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.76 -28.03 14.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 111.001 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.0 26.36 69.05 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.66 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' CG1' ' A' ' 27' ' ' VAL . 1.1 m -145.5 -47.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 111.117 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.838 HD13 HD13 ' A' ' 39' ' ' ILE . 27.1 mt -58.76 156.56 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -163.18 156.07 18.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.685 HD11 HG13 ' A' ' 60' ' ' ILE . 30.3 mm -70.21 97.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.44 40.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.712 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB3' HD12 ' A' ' 57' ' ' ILE . 2.3 m-20 -101.42 153.22 19.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.641 0.258 . . . . 0.0 110.508 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -111.91 82.93 1.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.167 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.745 HG21 HD22 ' A' ' 41' ' ' LEU . 3.6 t -61.8 143.48 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -168.67 34.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.642 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.917 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 174.26 54.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.849 0.357 . . . . 0.0 111.271 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.742 HD11 HG11 ' A' ' 78' ' ' VAL . 25.5 mt -76.12 118.16 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.445 ' OD1' HG22 ' A' ' 81' ' ' ILE . 0.9 OUTLIER 44.89 30.79 0.59 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.271 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.72 -35.43 5.07 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.38 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 mm -78.68 110.83 15.51 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 121.999 0.119 . . . . 0.0 111.198 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 N--CA 1.458 -0.56 0 C-N-CA 122.563 2.175 . . . . 0.0 112.411 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 20.4 pt-20 . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.948 0.404 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.917 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -59.21 -41.09 87.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -61.18 -42.3 98.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.791 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -62.73 -34.8 77.92 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.764 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 94' ' ' ALA . 8.8 mt -68.13 -37.75 81.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.631 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.9 -41.65 59.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -68.16 -31.89 71.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.993 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -5.13 49.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.35 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.417 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 69.7 m -69.62 -13.9 62.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.261 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -58.56 -28.38 65.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.0 mm -54.83 -30.9 23.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.172 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -117.45 -4.5 11.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.223 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.682 ' O ' HG23 ' A' ' 30' ' ' THR . 1.4 m 62.91 21.46 12.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.211 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 5.6 mttt -156.12 151.21 26.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.0 110.956 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.695 HG12 ' CE1' ' A' ' 37' ' ' PHE . 13.2 p -150.08 111.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.88 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.435 HG23 HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -90.87 107.29 19.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.36 150.5 23.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 111.41 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.917 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 3.6 tt0 -123.57 105.17 9.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.195 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.688 HG22 HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -111.04 159.71 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.097 0.475 . . . . 0.0 111.925 -178.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -110.18 118.49 36.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.517 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.813 ' O ' HG23 ' A' ' 22' ' ' THR . 14.6 p90 . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.343 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 mt-10 -148.34 173.79 12.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.084 0.468 . . . . 0.0 111.423 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 112' ' ' GLU . 44.8 p -108.42 134.15 51.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.288 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.666 HG23 HG13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -111.96 144.52 41.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.083 0.468 . . . . 0.0 111.691 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.9 pt-20 -104.07 100.17 9.93 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.676 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -99.87 102.85 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.826 -178.001 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.976 HG23 HG23 ' A' ' 108' ' ' THR . 9.2 p -86.2 115.55 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.41 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.438 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 7.6 mt -115.58 152.44 33.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.018 0.437 . . . . 0.0 111.339 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 105' ' ' SER . 97.9 m -113.78 137.54 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.616 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -68.7 107.01 2.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.02 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.35 142.53 86.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.06 55.3 5.59 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.796 2.331 . . . . 0.0 112.482 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 t -153.2 -69.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.013 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -116.8 -24.55 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.18 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.67 -112.63 2.29 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.323 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.572 ' CE2' HG12 ' A' ' 107' ' ' VAL . 21.5 m-85 -113.03 -23.28 10.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 0.0 111.139 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.41 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 58.85 54.23 39.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.863 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 57' ' ' ILE . 2.0 tt -147.88 127.2 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.731 0.3 . . . . 0.0 110.747 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.51 147.06 38.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.066 0.46 . . . . 0.0 111.53 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.657 HD23 HG13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -121.25 169.09 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.372 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 120.879 0.371 . . . . 0.0 111.06 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo . . . . . 0 C--O 1.232 0.22 0 CA-C-O 120.891 0.288 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 56' ' ' LEU . 2.1 pt? -135.65 160.01 39.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.939 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.758 HG21 HD11 ' A' ' 39' ' ' ILE . 5.6 mt -85.96 143.9 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.736 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.488 ' HA ' HG23 ' A' ' 74' ' ' ILE . 11.5 m -165.32 50.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.29 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -176.52 132.76 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.979 0.419 . . . . 0.0 111.42 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.402 HG21 ' HA ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -149.15 152.26 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.059 179.541 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.58 155.45 16.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.164 0.507 . . . . 0.0 111.275 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.67 38.85 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.846 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.0 t0 179.08 28.69 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.772 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.41 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 33.4 m -124.35 139.19 32.37 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.591 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 2.8 Cg_endo -45.51 -27.95 3.82 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.865 2.377 . . . . 0.0 112.77 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.64 96.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.846 0.355 . . . . 0.0 110.843 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' HA ' HG21 ' A' ' 60' ' ' ILE . 3.6 tp10 -78.56 -48.43 15.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.05 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -73.06 -7.23 50.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.893 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.72 -25.89 4.88 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.841 0.353 . . . . 0.0 111.175 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.87 25.27 73.12 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.559 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.644 ' O ' HG22 ' A' ' 71' ' ' VAL . 14.4 p -158.07 29.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.034 0.445 . . . . 0.0 110.874 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 mt -135.82 151.96 50.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.715 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -151.37 172.2 16.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.488 HG23 ' HA ' ' A' ' 58' ' ' SER . 22.3 mm -83.01 73.0 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.77 37.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.66 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.7 123.07 48.35 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.75 105.85 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 111.744 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.865 ' CG1' HG23 ' A' ' 111' ' ' ILE . 1.3 m -71.45 138.26 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -148.05 21.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.261 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -174.26 59.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.931 0.396 . . . . 0.0 111.319 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 78' ' ' VAL . 32.3 mt -88.65 124.61 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 44.24 31.21 0.53 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.324 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.31 -46.67 1.18 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mm -70.33 112.57 13.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.553 0.216 . . . . 0.0 111.166 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 C--N 1.347 0.477 0 C-N-CA 122.636 2.224 . . . . 0.0 112.819 -179.901 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.862 0.363 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HB3' HD13 ' A' ' 41' ' ' LEU . . . -57.68 -42.08 82.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.685 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -39.48 77.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.286 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -62.97 -41.49 99.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.341 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.419 HD12 HD12 ' A' ' 81' ' ' ILE . 13.3 mt -58.77 -41.9 87.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.591 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.3 mt -77.87 -30.67 50.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.82 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -38.98 92.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -75.33 -7.15 53.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.4 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.473 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 8.7 m -63.95 -22.19 66.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.972 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.89 -39.44 81.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.787 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.8 mm -49.3 -65.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.472 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 106' ' ' LYS . 7.6 t -84.32 -4.81 59.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.039 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.838 ' O ' HG23 ' A' ' 30' ' ' THR . 0.4 OUTLIER 63.0 21.0 12.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.236 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.764 ' HD2' HG22 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -156.41 150.14 24.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.247 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.572 HG12 ' CE2' ' A' ' 37' ' ' PHE . 9.4 p -155.33 145.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.617 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.976 HG23 HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -122.23 108.89 13.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.295 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -103.48 128.36 50.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.041 0.448 . . . . 0.0 111.836 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -92.41 107.46 19.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.634 178.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.865 HG23 ' CG1' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -109.36 159.9 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.22 0.533 . . . . 0.0 112.152 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.582 ' HG3' HG22 ' A' ' 24' ' ' THR . 6.5 tt0 -118.83 121.97 41.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.783 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.405 ' CD1' ' O ' ' A' ' 23' ' ' GLU . 52.0 p90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -178.44 177.97 0.9 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.989 0.423 . . . . 0.0 111.585 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.525 HG22 ' HB2' ' A' ' 112' ' ' GLU . 68.1 p -87.23 143.14 27.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.509 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 t -132.72 135.09 45.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.6 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.02 99.25 11.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.645 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -103.51 130.48 53.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' VAL . 9.6 p -82.97 122.06 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.092 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.508 HD11 ' HA ' ' A' ' 66' ' ' ALA . 1.7 mm? -116.09 147.97 40.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.635 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 105' ' ' SER . 74.5 m -130.43 144.13 51.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.872 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -82.84 147.53 28.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.098 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 2.4 m-20 -110.61 156.13 41.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 32' ' ' ASP . 3.1 Cg_exo -80.15 0.11 10.26 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.938 2.425 . . . . 0.0 112.424 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 t -91.25 -55.22 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.157 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 t -135.31 -46.69 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.27 -111.99 0.6 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.452 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.872 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 67.0 m-85 -109.17 -24.86 10.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.766 0.317 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 64.88 42.94 96.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.934 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -143.41 128.4 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.875 0.369 . . . . 0.0 110.689 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.439 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -116.22 150.37 37.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 111.458 -179.425 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.783 HD13 ' CB ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -119.83 160.89 21.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.474 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 111.111 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.664 ' C ' HD13 ' A' ' 56' ' ' LEU . 97.7 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.849 0.27 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.664 HD13 ' C ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -160.54 -178.67 7.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.871 HG21 HD11 ' A' ' 39' ' ' ILE . 26.5 mt -87.18 141.19 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.698 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 m -161.85 49.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.392 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.439 ' CG ' ' HB2' ' A' ' 40' ' ' GLN . 24.4 t80 -177.36 132.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 111.462 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.407 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -151.88 152.54 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.982 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.83 155.02 17.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 111.401 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.73 42.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.856 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.408 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER 170.4 31.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.821 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.411 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 3.9 m -122.84 145.29 45.08 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.002 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.54 -37.48 11.07 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.073 2.515 . . . . 0.0 112.6 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.508 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -58.51 -38.51 77.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 1.2 tm-20 -78.24 -51.97 9.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.856 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.408 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -67.03 -11.27 56.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.827 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -24.65 51.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 110.874 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.31 30.58 73.55 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.174 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.536 ' CB ' HG11 ' A' ' 27' ' ' VAL . 4.4 t -145.47 -54.46 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.093 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.9 mt -59.58 145.67 43.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -160.88 167.87 25.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.778 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.7 mm -70.24 67.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.74 38.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.474 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.478 ' HB3' HG21 ' A' ' 111' ' ' ILE . 56.2 m-20 -109.59 107.52 17.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.733 0.301 . . . . 0.0 110.554 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -82.21 93.89 7.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.306 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.901 ' HB ' HD11 ' A' ' 81' ' ' ILE . 30.5 m -58.63 123.57 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.703 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.0 ttp -118.37 -16.01 9.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.808 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -167.12 98.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 111.551 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.901 HD11 ' HB ' ' A' ' 78' ' ' VAL . 3.9 mp -103.12 113.27 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.5 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 45.87 29.94 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.224 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.31 -44.38 1.52 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.767 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mm -80.89 113.74 42.87 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.505 0.193 . . . . 0.0 111.166 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 C--N 1.348 0.504 0 C-N-CA 122.509 2.139 . . . . 0.0 112.866 -179.882 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.7 mt-10 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.816 0.341 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.783 ' CB ' HD13 ' A' ' 41' ' ' LEU . . . -57.8 -49.16 77.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -60.12 -34.82 74.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.525 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.61 -41.11 98.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.568 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 94' ' ' ALA . 3.6 mt -70.08 -30.56 67.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.462 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 94' ' ' ALA . 3.4 mm? -64.08 -46.44 84.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.927 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -73.64 -29.76 62.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.061 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -75.0 -5.61 44.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.503 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.445 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 58.1 m -66.44 -22.06 66.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 0.0 111.196 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -58.66 -27.31 64.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.007 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.5 mm -57.35 -48.98 81.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.477 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -100.79 -14.81 17.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.284 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER 77.57 -3.79 2.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.949 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -156.78 129.62 7.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.858 0.361 . . . . 0.0 111.029 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.441 HG21 ' OG ' ' A' ' 101' ' ' SER . 0.0 OUTLIER -120.38 166.82 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.86 106.75 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.794 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.93 138.28 35.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.001 0.429 . . . . 0.0 111.881 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -116.2 104.62 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.821 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.645 HD11 ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -120.28 149.02 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.655 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.525 ' HB2' HG22 ' A' ' 24' ' ' THR . 49.0 tt0 -103.62 118.79 37.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.871 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.301 -179.363 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.46 0.072 0 CA-C-O 120.725 0.298 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.402 ' O ' ' CD2' ' A' ' 113' ' ' PHE . 1.1 mt-10 -151.68 176.56 11.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 0.0 111.26 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 p -103.71 140.79 37.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.412 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.828 HG23 ' CD1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -116.89 142.07 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.064 0.459 . . . . 0.0 111.441 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.62 98.93 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.783 HG23 HD12 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -102.91 131.24 51.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.0 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.845 HG22 HG22 ' A' ' 108' ' ' THR . 12.3 t -107.62 113.4 43.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.179 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 65' ' ' PRO . 3.1 mm? -99.91 164.29 12.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.335 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 105' ' ' SER . 17.0 m -117.5 132.24 56.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 110.819 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.775 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -79.35 91.64 5.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.163 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.15 140.87 94.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.63 -4.96 16.28 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.476 2.117 . . . . 0.0 112.846 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.7 t -99.69 -54.18 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.066 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.446 HG23 ' N ' ' A' ' 36' ' ' GLY . 10.9 t -108.3 -47.15 3.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.446 ' N ' HG23 ' A' ' 35' ' ' THR . . . 97.45 -91.17 1.17 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.672 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.775 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 80.9 m-85 -141.61 77.92 1.61 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.938 0.399 . . . . 0.0 110.223 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.48 18.93 0.4 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.072 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.744 HD11 HG21 ' A' ' 57' ' ' ILE . 3.4 tt -96.35 130.02 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.91 0.355 . . . . 0.0 110.611 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.603 ' C ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -111.07 145.81 37.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.987 0.422 . . . . 0.0 111.463 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.696 HD22 HG12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -122.01 156.98 32.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.479 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.915 -179.914 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo . . . . . 0 C--O 1.231 0.142 0 CA-C-O 120.866 0.277 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.563 ' N ' HD23 ' A' ' 56' ' ' LEU . 2.3 pt? -167.91 152.94 6.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.97 0.414 . . . . 0.0 111.109 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.744 HG21 HD11 ' A' ' 39' ' ' ILE . 47.7 mt -72.9 152.48 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.835 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.18 44.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.537 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -176.58 129.38 0.19 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.209 0.528 . . . . 0.0 111.854 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.509 HD13 HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -142.21 152.14 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.374 179.213 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 63' ' ' ASP . 5.5 tp10 -109.88 154.93 22.36 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.078 0.466 . . . . 0.0 111.858 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.29 42.04 0.15 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.016 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER 175.11 31.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.192 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -122.21 135.05 25.09 Favored Pre-proline 0 CA--C 1.527 0.075 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.665 ' HB2' HD12 ' A' ' 29' ' ' LEU . 3.5 Cg_endo -46.37 -30.54 8.34 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.506 2.137 . . . . 0.0 112.424 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.734 ' HA ' HD21 ' A' ' 72' ' ' LEU . . . -70.08 -33.27 71.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.768 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.452 ' HA ' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -75.04 -49.93 18.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.844 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.419 ' NH2' ' C ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -79.31 -8.26 58.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.943 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.53 -34.78 37.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.772 0.32 . . . . 0.0 111.082 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.26 27.12 70.13 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.591 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 72' ' ' LEU . 11.2 p -136.08 -45.3 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.629 0.252 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.734 HD21 ' HA ' ' A' ' 66' ' ' ALA . 2.5 pp -77.99 163.04 26.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.013 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.59 165.29 29.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.865 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.51 75.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.085 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.8 40.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.776 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.524 ' HB2' HD12 ' A' ' 57' ' ' ILE . 45.8 m-20 -99.95 119.13 37.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 110.56 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -86.13 85.64 7.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.218 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 111' ' ' ILE . 3.5 t -65.54 138.64 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.118 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.2 ttp -171.14 34.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.128 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.807 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -179.88 49.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.13 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.638 HD11 HG11 ' A' ' 78' ' ' VAL . 8.7 mt -73.0 117.68 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER 45.55 30.48 0.77 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.56 -37.65 3.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.096 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.778 HG21 HD21 ' A' ' 97' ' ' LEU . 7.7 mm -74.28 112.04 15.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.552 0.215 . . . . 0.0 111.137 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 N--CA 1.458 -0.617 0 C-N-CA 122.676 2.251 . . . . 0.0 112.488 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.856 0.36 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.73 -48.33 79.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.503 ' HA ' HD21 ' A' ' 98' ' ' LEU . 7.7 m120 -61.86 -34.73 76.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.496 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -35.98 82.02 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.51 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 94' ' ' ALA . 4.6 mt -69.74 -48.24 60.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.996 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HA ' HG21 ' A' ' 107' ' ' VAL . 3.2 pp -70.1 -37.02 75.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.157 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.548 ' N ' HD12 ' A' ' 98' ' ' LEU . 4.7 mtt85 -69.87 -30.41 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.81 0.338 . . . . 0.0 111.009 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -89.16 4.78 47.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.369 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.453 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 0.4 OUTLIER -83.12 -12.12 57.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.338 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.5 p -57.68 -24.77 58.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.714 0.292 . . . . 0.0 110.887 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.7 mm -56.36 -31.51 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.954 0.406 . . . . 0.0 110.896 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -114.34 -5.93 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.058 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.583 ' O ' HG23 ' A' ' 30' ' ' THR . 8.9 t 69.42 23.81 5.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.399 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.583 ' HD3' HG11 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -156.23 150.38 25.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.952 0.406 . . . . 0.0 111.282 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.606 HG21 ' HA ' ' A' ' 98' ' ' LEU . 13.9 p -144.14 136.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.28 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.845 HG22 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -111.32 113.39 25.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.225 179.471 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.783 HD12 HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -113.97 125.2 53.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.966 0.412 . . . . 0.0 111.369 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.807 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 12.9 tt0 -101.32 105.0 16.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.871 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.907 HG22 HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -110.2 164.3 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 121.08 0.467 . . . . 0.0 112.07 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -104.19 120.41 41.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.916 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 23' ' ' GLU . 45.0 p90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.29 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.421 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.586 0.232 . . . . 0.0 111.135 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 22.2 mt-10 -162.29 143.99 10.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.943 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 69.5 p -91.94 127.12 37.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.62 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.812 HG23 ' CD1' ' A' ' 111' ' ' ILE . 1.6 t -115.72 136.59 52.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 111.204 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.71 99.83 11.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.022 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.473 HG11 HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -106.61 129.01 60.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -179.266 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.681 HG22 ' CG2' ' A' ' 108' ' ' THR . 19.5 t -94.3 120.62 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.176 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB2' HD21 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -111.17 123.91 51.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.855 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 105' ' ' SER . 28.7 m -105.62 141.64 36.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.717 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.65 136.39 37.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.226 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.49 141.91 23.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.828 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.35 55.87 5.28 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.78 2.32 . . . . 0.0 112.56 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -155.41 -64.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.162 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -114.14 -44.48 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.93 -115.57 2.93 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.406 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.694 ' HB3' HG22 ' A' ' 39' ' ' ILE . 54.0 m-85 -113.96 -28.85 7.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.682 0.277 . . . . 0.0 110.971 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.99 24.64 43.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.691 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.748 HD11 HG21 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -130.44 140.55 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.967 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.702 ' C ' HD13 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -139.54 164.81 28.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.099 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.702 HD13 ' C ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -117.28 160.07 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.7 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.957 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.713 0.214 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.747 HD22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -131.9 153.34 50.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 0.0 110.952 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.748 HG21 HD11 ' A' ' 39' ' ' ILE . 12.1 mt -59.87 145.39 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.684 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.881 ' HA ' HG23 ' A' ' 74' ' ' ILE . 3.0 m -165.37 44.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.801 0.334 . . . . 0.0 111.557 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.593 ' O ' HD12 ' A' ' 39' ' ' ILE . 30.8 t80 -169.97 133.57 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.174 0.511 . . . . 0.0 111.534 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.423 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -151.88 152.52 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.879 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 1.4 mt-10 -103.55 155.39 18.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.065 0.46 . . . . 0.0 111.426 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.89 39.44 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.8 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.03 29.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.684 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.37 142.15 34.77 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.624 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.487 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 97.0 Cg_exo -43.07 -29.48 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.65 2.233 . . . . 0.0 112.87 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.407 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -62.89 -40.26 97.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.423 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 2.4 mm-40 -78.12 -52.92 8.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.728 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.84 -8.63 55.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.743 -179.413 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -38.37 56.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.811 0.339 . . . . 0.0 110.952 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.97 -18.66 55.55 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.819 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.473 HG23 HG11 ' A' ' 27' ' ' VAL . 7.7 m -128.09 39.24 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.836 0.35 . . . . 0.0 111.188 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -139.78 143.84 37.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -169.12 152.91 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.713 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 58' ' ' SER . 24.9 mt -58.36 107.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.048 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.22 -25.34 1.41 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.406 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.452 ' CB ' HD12 ' A' ' 57' ' ' ILE . 16.6 m-20 -60.14 122.98 15.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.832 0.348 . . . . 0.0 110.662 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.4 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -96.13 105.74 17.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.214 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.119 HG11 HD11 ' A' ' 81' ' ' ILE . 14.8 t -70.54 146.12 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -165.17 27.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.462 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.786 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . 174.07 78.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.969 0.414 . . . . 0.0 111.419 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.119 HD11 HG11 ' A' ' 78' ' ' VAL . 21.0 mt -103.83 118.09 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.846 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 45.1 30.57 0.62 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 108.9 -46.1 1.22 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.581 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.696 HG21 HD21 ' A' ' 97' ' ' LEU . 9.0 mm -70.62 109.96 6.08 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.548 0.214 . . . . 0.0 111.436 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 86.0 Cg_endo . . . . . 0 N--CA 1.456 -0.72 0 C-N-CA 122.861 2.374 . . . . 0.0 112.234 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.869 0.366 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.739 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.85 -46.27 85.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.884 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.686 ' N ' HD23 ' A' ' 41' ' ' LEU . 11.2 m-20 -60.25 -36.2 77.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.441 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -40.21 96.58 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.394 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.739 HD12 ' HA ' ' A' ' 94' ' ' ALA . 1.7 mt -72.74 -28.31 62.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.515 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.92 -47.0 79.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.801 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.4 mpp_? -76.12 -28.57 57.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.966 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.95 -9.03 57.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.431 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.435 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 51.9 m -72.62 -23.72 60.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.098 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 p -58.95 -34.85 72.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 25.7 mm -53.64 -60.66 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.523 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.4 t -75.27 -8.86 57.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.388 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 30' ' ' THR . 0.9 OUTLIER 84.19 -16.3 0.53 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.009 179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.595 ' O ' HG23 ' A' ' 104' ' ' THR . 1.5 ptpt -156.65 158.08 36.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.758 0.313 . . . . 0.0 111.051 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 108' ' ' THR . 12.1 p -146.47 160.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.673 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.681 ' CG2' HG22 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -119.02 109.43 15.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.263 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -103.06 133.18 48.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 111.619 -179.422 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 6.2 mt-10 -107.84 104.79 14.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.057 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.812 ' CD1' HG23 ' A' ' 25' ' ' THR . 0.2 OUTLIER -109.37 159.47 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.08 0.467 . . . . 0.0 112.25 -178.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.79 119.24 38.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.884 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 23.4 p90 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.964 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 120.633 0.254 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.456 ' HG2' ' CZ ' ' A' ' 113' ' ' PHE . 1.8 pt-20 -177.99 176.91 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.1 p -101.81 127.36 48.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.532 HG23 HG13 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -101.49 158.78 15.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.194 0.521 . . . . 0.0 111.28 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.13 99.17 8.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.622 HG21 HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.24 105.81 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.774 -178.311 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 28' ' ' VAL . 10.0 p -82.97 116.01 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.437 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.634 HD11 ' HA ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -106.52 141.59 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.916 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 105' ' ' SER . 87.4 m -115.46 142.17 47.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.84 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.784 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -85.93 141.61 29.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.147 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.61 138.26 22.53 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.865 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.06 58.68 5.64 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.547 2.165 . . . . 0.0 112.356 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 t -154.19 -68.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.055 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 p -110.63 -28.99 8.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -118.15 4.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.381 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.784 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 40.8 m-85 -113.0 -22.77 10.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.675 0.274 . . . . 0.0 111.153 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.01 32.1 66.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.872 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.618 HG22 ' HB3' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -140.52 141.05 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.732 0.301 . . . . 0.0 110.821 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -132.31 138.45 47.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.246 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.806 HD23 HG21 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -107.08 113.05 26.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.487 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 -179.775 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.663 ' C ' HD13 ' A' ' 56' ' ' LEU . 98.0 Cg_endo . . . . . 0 N--CA 1.461 -0.402 0 CA-C-O 120.791 0.246 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.663 HD13 ' C ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -162.99 170.69 17.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.577 HG21 HD11 ' A' ' 39' ' ' ILE . 7.6 mt -80.26 139.12 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.457 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.6 m -156.79 48.46 0.45 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 111.505 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -173.12 133.51 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.11 0.481 . . . . 0.0 111.545 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.595 HG22 ' HB2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.3 152.03 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.96 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.69 155.61 17.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.107 0.48 . . . . 0.0 111.432 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.55 38.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.723 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.86 29.68 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.643 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 p -122.11 137.46 27.5 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.478 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 82.9 Cg_exo -43.98 -29.2 2.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.511 2.141 . . . . 0.0 112.829 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.732 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -62.51 -43.21 99.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.793 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.595 ' HB2' HG22 ' A' ' 60' ' ' ILE . 27.2 tp10 -78.3 -49.53 13.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -73.6 -8.41 55.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.554 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.426 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -51.9 -28.16 15.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.769 0.318 . . . . 0.0 110.96 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.22 45.35 95.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.412 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.9 p -170.06 41.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.019 0.438 . . . . 0.0 111.074 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.732 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -176.6 145.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -142.3 -175.43 4.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.821 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 60' ' ' ILE . 31.5 mm -78.93 77.51 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.58 41.02 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.623 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -112.09 119.23 37.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.333 . . . . 0.0 110.701 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 93.65 9.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.207 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.806 HG21 HD23 ' A' ' 41' ' ' LEU . 1.8 t -71.19 134.34 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.54 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -157.21 29.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 111.298 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.826 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -179.22 68.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.131 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.711 ' HB ' HD22 ' A' ' 97' ' ' LEU . 3.9 mp -90.6 120.03 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.416 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 0.5 OUTLIER 45.41 29.64 0.61 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.286 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 107.55 -36.15 4.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.356 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.5 mm -77.12 110.82 13.28 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.503 0.192 . . . . 0.0 111.218 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 89.3 Cg_endo . . . . . 0 N--CA 1.456 -0.678 0 C-N-CA 122.789 2.326 . . . . 0.0 112.448 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.844 0.354 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.821 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.75 -50.89 71.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -59.55 -34.14 72.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.533 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -62.63 -40.19 96.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.641 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.821 HD12 ' HA ' ' A' ' 94' ' ' ALA . 1.8 mt -67.87 -37.53 81.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.512 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.44 HD11 ' CD1' ' A' ' 41' ' ' LEU . 49.8 mt -70.26 -39.94 74.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.626 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -65.38 -34.13 77.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.26 -10.27 59.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.276 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.472 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 5.1 m -79.22 -33.44 43.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 110.736 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -32.72 74.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.81 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.17 -58.01 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.51 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.8 t -96.17 1.54 52.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.234 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.736 ' O ' HG23 ' A' ' 30' ' ' THR . 8.3 t 69.98 9.75 7.2 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.577 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 104' ' ' THR . 1.5 ttmp? -156.56 155.86 32.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.895 0.379 . . . . 0.0 111.05 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.413 HG22 ' N ' ' A' ' 108' ' ' THR . 12.0 p -153.22 155.7 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.576 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 107' ' ' VAL . 0.6 OUTLIER -121.48 117.99 28.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.146 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.469 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -114.19 132.3 56.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.973 0.416 . . . . 0.0 111.989 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.826 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -95.41 109.48 21.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.43 178.516 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.738 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -116.59 143.13 27.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.052 -178.56 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -95.62 118.72 32.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.056 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.456 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 29.6 p90 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.001 0.429 . . . . 0.0 111.461 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 1.9 m . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.129 0.49 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -178.1 176.94 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.678 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.81 130.82 55.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.651 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 t -122.61 135.3 54.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.019 0.437 . . . . 0.0 111.487 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -99.22 99.07 9.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.449 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.648 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.49 115.33 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.303 -178.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 28' ' ' VAL . 10.2 p -83.3 122.01 36.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.118 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.92 160.82 15.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.424 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 105' ' ' SER . 19.8 m -123.06 153.36 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.859 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.742 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -93.86 141.11 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.47 144.65 29.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.49 -0.26 10.45 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.705 2.27 . . . . 0.0 112.819 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.15 -52.59 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.728 0.299 . . . . 0.0 111.168 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -119.71 -57.19 1.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.35 -110.33 0.62 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.56 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.742 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 55.2 m-85 -112.3 -32.4 6.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.739 0.304 . . . . 0.0 110.758 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 70.61 8.49 63.34 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.518 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.902 HD11 ' CG2' ' A' ' 57' ' ' ILE . 6.1 tp -97.12 130.43 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.997 0.398 . . . . 0.0 110.781 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.93 147.0 47.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.089 0.471 . . . . 0.0 111.406 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 4.8 mt -118.51 163.2 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.638 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.988 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 C--O 1.232 0.2 0 CA-C-O 120.721 0.217 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.52 163.45 32.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.0 111.177 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.902 ' CG2' HD11 ' A' ' 39' ' ' ILE . 5.0 mt -76.07 141.54 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.578 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.876 ' HA ' HG23 ' A' ' 74' ' ' ILE . 3.0 m -168.28 41.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.688 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -177.24 125.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.029 0.442 . . . . 0.0 111.529 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.581 HD12 ' OE1' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -137.33 152.6 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.095 179.425 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.43 155.36 21.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.067 0.461 . . . . 0.0 111.442 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -88.03 41.06 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.722 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 168.52 31.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.854 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.401 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 49.3 m -119.3 143.91 35.29 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-O 120.716 0.293 . . . . 0.0 110.911 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.56 -28.39 8.93 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.916 2.41 . . . . 0.0 112.738 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -66.0 -46.51 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 110.956 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.581 ' OE1' HD12 ' A' ' 60' ' ' ILE . 9.5 tp10 -78.15 -39.81 39.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.829 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.432 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.06 -19.36 64.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.364 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -41.08 68.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 110.879 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.24 -12.35 64.83 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.827 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 m -98.79 -32.41 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 111.184 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.83 HD13 HD13 ' A' ' 39' ' ' ILE . 11.0 mt -74.91 128.46 35.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.866 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -141.06 148.5 40.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 58' ' ' SER . 34.9 mt -64.05 114.51 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.07 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.21 -27.07 2.29 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.495 ' HB2' HD12 ' A' ' 57' ' ' ILE . 10.2 m-20 -63.39 138.01 58.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.709 0.29 . . . . 0.0 110.837 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.434 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 51.9 mtt180 -109.24 100.95 10.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.406 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.633 ' CA ' HG22 ' A' ' 111' ' ' ILE . 29.5 m -64.55 122.69 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.4 ptm -151.37 30.35 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.1 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -178.35 52.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.025 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.429 HD11 ' HB ' ' A' ' 78' ' ' VAL . 29.4 mt -82.36 128.76 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.058 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 43.67 31.52 0.46 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.235 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.77 -43.85 1.67 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.463 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.6 mm -71.28 113.27 17.95 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.471 0.176 . . . . 0.0 111.316 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo . . . . . 0 N--CA 1.461 -0.427 0 C-N-CA 122.74 2.293 . . . . 0.0 112.796 -179.699 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.929 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.72 -33.22 72.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.985 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -64.27 -48.33 76.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.826 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -33.89 75.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.647 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.929 HD12 ' HA ' ' A' ' 94' ' ' ALA . 17.2 mt -64.02 -41.41 97.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.461 HD13 ' CG2' ' A' ' 39' ' ' ILE . 62.6 mt -67.71 -40.19 84.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.757 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -65.26 -30.12 70.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.49 -7.34 51.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.37 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 m -71.87 -16.01 62.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.175 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -58.56 -27.01 64.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.045 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.9 mm -52.9 -41.11 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 111.309 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.8 t -120.01 -2.07 10.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.293 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.702 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 1.3 m 62.6 26.32 15.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.05 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HE2' HG21 ' A' ' 28' ' ' VAL . 2.1 mmtp -156.19 144.83 20.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.844 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.502 HG13 HD21 ' A' ' 109' ' ' LEU . 10.2 p -153.97 156.9 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.02 0.438 . . . . 0.0 111.888 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -122.07 125.44 46.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.934 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.502 HD21 HG13 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -119.21 136.64 54.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.098 0.475 . . . . 0.0 111.928 -178.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.743 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -111.89 106.71 15.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.334 178.62 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -107.49 157.84 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.139 0.495 . . . . 0.0 112.322 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.91 119.56 35.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.482 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 22' ' ' THR . 4.8 p90 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 3.0 m . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.875 0.369 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.9 mm-40 -151.62 177.36 10.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.114 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.0 p -107.39 129.51 54.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.134 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.536 HG23 ' CD1' ' A' ' 111' ' ' ILE . 1.9 t -114.59 137.32 52.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.122 0.487 . . . . 0.0 111.83 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.15 99.32 10.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.152 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -102.7 107.71 22.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.281 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 28' ' ' VAL . 13.7 p -88.67 113.84 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.036 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.403 ' HB2' ' CG1' ' A' ' 107' ' ' VAL . 54.5 mt -102.91 164.97 11.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.955 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 105' ' ' SER . 76.2 m -128.68 141.15 51.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.822 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.715 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -83.09 119.71 24.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.231 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.66 140.41 31.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.98 59.74 3.63 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.615 2.21 . . . . 0.0 112.502 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.6 t -154.88 -59.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -122.31 -42.73 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.823 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.57 -119.4 3.03 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.559 ' CE1' HG12 ' A' ' 107' ' ' VAL . 38.0 m-85 -103.64 -26.93 12.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.86 39.72 92.01 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.649 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.865 HD11 HG21 ' A' ' 57' ' ' ILE . 3.2 tt -136.5 127.1 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.953 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 127.83 56.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.91 HD22 HG12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -105.75 103.15 12.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.711 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.878 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.755 ' O ' HD12 ' A' ' 56' ' ' LEU . 64.5 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.579 0.158 . . . . 0.0 112.133 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 55' ' ' PRO . 5.8 mp -150.71 142.77 24.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.115 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.91 HG12 HD22 ' A' ' 41' ' ' LEU . 40.6 mt -80.91 122.5 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.744 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.62 51.63 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -178.16 126.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.002 0.43 . . . . 0.0 111.365 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.464 HG21 ' HA ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -142.77 152.09 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.1 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -102.05 155.53 18.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.019 0.438 . . . . 0.0 111.507 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.73 43.09 0.95 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.781 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 p30 178.32 28.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.861 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.402 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -128.81 137.02 30.07 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.277 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.46 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -43.76 -33.84 5.26 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.876 2.384 . . . . 0.0 112.649 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.466 ' HB1' HD12 ' A' ' 39' ' ' ILE . . . -57.86 -42.78 85.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.843 0.354 . . . . 0.0 111.15 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' HA ' HG21 ' A' ' 60' ' ' ILE . 17.1 tp10 -78.35 -50.23 12.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.216 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.32 -8.44 53.71 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.1 t -53.0 -33.63 52.5 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.824 0.345 . . . . 0.0 110.775 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.64 31.47 76.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.07 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.14 -65.78 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.098 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -71.73 150.28 44.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.147 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.4 -177.92 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 74' ' ' ILE . 19.8 tt -84.51 56.59 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 111.269 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.29 39.83 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.474 ' HB3' HG21 ' A' ' 111' ' ' ILE . 67.3 m-20 -82.7 147.27 28.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.618 0.247 . . . . 0.0 110.74 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -94.86 76.24 3.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.709 0.29 . . . . 0.0 111.503 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.591 ' HA ' HG22 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -58.28 128.36 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.709 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.416 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -158.35 29.38 0.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.097 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.863 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 178.34 66.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 0.0 111.065 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.409 HG22 ' OD1' ' A' ' 82' ' ' ASN . 9.1 mt -96.91 119.82 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.98 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.409 ' OD1' HG22 ' A' ' 81' ' ' ILE . 1.4 p-10 44.05 30.61 0.44 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.407 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.88 -48.62 0.92 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.543 ' HB ' HD13 ' A' ' 97' ' ' LEU . 8.8 mm -69.78 111.76 10.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.602 0.239 . . . . 0.0 111.113 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 C--N 1.347 0.485 0 C-N-CA 122.536 2.157 . . . . 0.0 112.844 -179.836 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.447 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.792 0.329 . . . . 0.0 110.88 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.818 ' HB1' HD12 ' A' ' 41' ' ' LEU . . . -57.51 -53.87 53.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.179 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.494 ' HA ' HD23 ' A' ' 98' ' ' LEU . 7.4 m-80 -56.93 -34.8 68.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.88 -46.92 85.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.171 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.543 HD13 ' HB ' ' A' ' 84' ' ' ILE . 7.1 mt -60.38 -43.45 96.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.141 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -76.87 -32.59 57.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.459 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -78.99 -29.13 43.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.751 0.31 . . . . 0.0 111.178 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -66.34 -15.56 63.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.503 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 3.8 m -83.39 -15.39 49.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.321 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.2 t -58.36 -29.51 66.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.9 mm -54.07 -38.24 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.346 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.3 t -118.02 -3.91 11.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.199 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.784 ' O ' HG23 ' A' ' 30' ' ' THR . 1.1 m 65.81 42.16 3.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.109 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 3.1 tppt? -156.04 128.93 7.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 111.342 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.559 HG12 ' CE1' ' A' ' 37' ' ' PHE . 14.7 p -137.48 145.42 29.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.135 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.523 HG23 HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -120.82 105.6 10.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.314 179.36 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -104.21 124.81 49.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.018 0.437 . . . . 0.0 111.685 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 18.1 tt0 -107.11 105.65 15.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.584 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -110.26 165.13 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.301 0.572 . . . . 0.0 112.27 -178.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -113.23 121.65 45.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.694 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 22' ' ' THR . 18.4 p90 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.881 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.464 0.243 0 CA-C-O 121.117 0.484 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -177.99 168.09 2.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.2 p -87.75 143.43 27.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.446 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.654 HG23 HG13 ' A' ' 111' ' ' ILE . 2.9 t -129.47 156.4 44.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.141 0.496 . . . . 0.0 111.355 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.57 98.71 7.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.457 ' CG1' HG11 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -100.82 103.14 14.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.477 -178.411 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 108' ' ' THR . 4.2 t -82.78 115.04 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.592 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.654 HD11 ' CD1' ' A' ' 72' ' ' LEU . 14.4 mt -111.59 127.3 55.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.032 0.444 . . . . 0.0 110.918 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 105' ' ' SER . 3.0 m -99.05 144.45 28.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HB2' ' HE1' ' A' ' 37' ' ' PHE . . . -74.23 124.94 27.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.949 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.42 136.81 52.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.67 -3.65 14.2 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.584 2.189 . . . . 0.0 112.609 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.42 -49.47 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.227 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.5 p -118.99 -57.07 2.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.9 -108.38 0.63 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.519 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.646 ' HB3' HG22 ' A' ' 39' ' ' ILE . 26.0 m-85 -114.66 -32.46 5.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.704 0.288 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.72 40.32 70.71 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.785 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.652 HD11 ' CG2' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -142.42 140.85 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.343 . . . . 0.0 110.92 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.427 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -123.29 145.14 48.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.222 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.714 HD23 HD11 ' A' ' 98' ' ' LEU . 1.1 mm? -104.41 105.37 15.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.738 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.867 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 C--O 1.23 0.111 0 CA-C-O 120.821 0.259 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.58 146.66 44.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.156 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.72 HD12 HG21 ' A' ' 111' ' ' ILE . 47.1 mt -60.64 133.61 26.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.28 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' HG13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -159.72 40.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 111.464 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CG ' ' HB2' ' A' ' 40' ' ' GLN . 34.2 t80 -167.08 131.12 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 111.198 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.79 152.33 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.03 155.33 17.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.989 0.423 . . . . 0.0 111.16 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.83 44.4 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.961 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER 168.39 32.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.666 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.78 146.45 55.2 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.926 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -43.82 -35.93 7.36 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.801 2.334 . . . . 0.0 112.867 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB1' HD13 ' A' ' 39' ' ' ILE . . . -59.17 -39.47 82.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 111.023 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.69 -50.34 13.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.722 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -72.31 -8.36 54.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.557 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.445 ' SG ' HD21 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -51.72 -26.22 8.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.719 0.295 . . . . 0.0 111.254 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.05 45.21 96.03 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.438 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 72' ' ' LEU . 8.1 p -173.1 -44.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.974 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.654 ' CD1' HD11 ' A' ' 29' ' ' LEU . 11.7 mt -60.91 164.69 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -154.8 171.8 19.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 0.0 111.203 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 74' ' ' ILE . 2.7 tt -84.85 56.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.136 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.24 59.1 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.765 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -101.24 125.06 47.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.759 0.314 . . . . 0.0 110.755 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -69.34 71.98 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.249 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.924 HG22 HG22 ' A' ' 111' ' ' ILE . 3.0 t -63.37 146.64 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -161.18 27.4 0.14 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.392 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 173.34 79.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.786 0.327 . . . . 0.0 111.203 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.814 HD11 HG11 ' A' ' 78' ' ' VAL . 38.1 mt -100.52 126.73 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.045 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.2 30.1 0.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 102.14 -41.8 2.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.678 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 mm -75.53 109.86 8.98 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.569 0.223 . . . . 0.0 111.352 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 96.8 Cg_endo . . . . . 0 N--CA 1.455 -0.779 0 C-N-CA 123.051 2.501 . . . . 0.0 112.264 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.489 0.185 . . . . 0.0 111.258 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.69 -52.41 65.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.029 0.442 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -55.85 -35.93 66.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.235 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -62.67 -39.59 94.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.29 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.477 HD12 HD12 ' A' ' 81' ' ' ILE . 12.6 mt -60.22 -43.09 96.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.096 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.714 HD11 HD23 ' A' ' 41' ' ' LEU . 41.6 mt -76.57 -30.58 57.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.865 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -35.8 81.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.323 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -72.33 -9.41 58.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.556 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 4.9 m -69.6 -24.65 63.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 0.0 110.802 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.9 p -63.2 -55.33 25.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.662 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.7 mm -55.19 -40.65 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.32 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.3 m -80.41 -21.96 41.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 30' ' ' THR . 1.9 t 77.58 -6.74 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.838 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -156.74 149.85 24.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.602 0.239 . . . . 0.0 110.82 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 29' ' ' LEU . 14.4 p -150.08 141.87 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 1.019 HG22 HG22 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -112.96 113.35 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.988 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.547 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -106.2 142.97 35.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 112.065 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.864 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 14.5 tt0 -104.73 105.92 16.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.537 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.924 HG22 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -116.92 150.51 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.401 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -112.1 120.84 43.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.138 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.6 p90 . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 120.959 0.409 . . . . 0.0 111.365 -179.424 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.513 -0.452 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -170.45 171.85 6.32 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.524 -177.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 74.2 p -99.2 132.52 44.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -109.53 135.39 50.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.224 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 99.07 9.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.631 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.549 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -105.97 122.84 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.034 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.027 HG22 HG22 ' A' ' 108' ' ' THR . 3.7 t -90.46 120.8 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.252 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.7 HD21 ' HA ' ' A' ' 66' ' ' ALA . 10.9 mp -112.47 143.82 42.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.612 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.773 HG23 ' O ' ' A' ' 105' ' ' SER . 82.3 m -105.25 144.06 32.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -87.19 89.54 8.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.92 138.74 97.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.12 56.5 5.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.581 2.187 . . . . 0.0 112.447 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.9 t -155.33 -66.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 t -111.36 -29.8 7.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.63 -130.03 10.11 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.481 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.675 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 74.5 m-85 -99.53 -23.55 15.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.712 0.291 . . . . 0.0 111.023 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.58 34.88 56.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.903 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.779 HD11 ' CG2' ' A' ' 57' ' ' ILE . 2.1 tt -132.65 143.83 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.79 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.42 148.93 48.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.571 HD13 ' HA ' ' A' ' 57' ' ' ILE . 3.2 mm? -104.07 157.68 16.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.837 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.808 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.939 0.308 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 56' ' ' LEU . 2.6 mp -133.49 136.99 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.965 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.779 ' CG2' HD11 ' A' ' 39' ' ' ILE . 33.2 mt -61.7 118.77 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.166 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.877 ' HA ' HG23 ' A' ' 74' ' ' ILE . 94.2 p -139.68 46.65 1.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 111.745 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -174.23 129.13 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.132 0.491 . . . . 0.0 111.493 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -147.53 151.96 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.002 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.58 155.55 17.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.123 0.487 . . . . 0.0 111.483 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.4 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -88.5 42.03 1.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.86 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 168.15 33.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.757 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.55 150.08 60.27 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.037 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.01 -31.87 29.09 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.912 2.408 . . . . 0.0 112.51 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.7 ' HA ' HD21 ' A' ' 29' ' ' LEU . . . -59.63 -48.59 81.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.028 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -78.11 -39.64 40.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.4 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -72.54 -8.76 56.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.56 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.526 ' SG ' HD11 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -52.91 -24.85 10.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.704 0.288 . . . . 0.0 110.996 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.84 73.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.305 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.646 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.6 p -170.57 33.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.953 0.406 . . . . 0.0 110.972 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.68 153.01 50.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -168.97 161.9 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.877 HG23 ' HA ' ' A' ' 58' ' ' SER . 62.5 mt -71.13 117.25 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.081 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.01 -21.96 4.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.666 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.553 ' HB2' HD12 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -52.79 136.57 33.53 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.688 0.28 . . . . 0.0 110.768 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -96.86 82.2 3.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.055 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.075 HG21 HD11 ' A' ' 81' ' ' ILE . 7.2 p -68.78 159.02 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.052 0.453 . . . . 0.0 111.323 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.663 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -152.0 -81.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.134 179.485 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.409 ' HB3' ' CD ' ' A' ' 110' ' ' GLU . . . -75.82 100.16 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 0.0 111.809 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.075 HD11 HG21 ' A' ' 78' ' ' VAL . 17.0 mt -119.38 125.88 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.357 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.576 ' HB3' HG23 ' A' ' 107' ' ' VAL . 0.7 OUTLIER 51.9 24.31 2.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.308 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.442 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 104.32 -39.0 2.98 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.753 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mm -84.18 108.86 15.7 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.42 0.156 . . . . 0.0 111.42 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 79' ' ' MET . 98.4 Cg_endo . . . . . 0 N--CA 1.451 -1.028 0 C-N-CA 122.779 2.319 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 7.0 mm-40 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.536 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -57.67 -44.67 85.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.807 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -56.77 -40.72 76.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.102 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -62.95 -35.95 81.83 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.267 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' A' ' 81' ' ' ILE . 24.3 mt -60.86 -48.1 83.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.782 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 81' ' ' ILE . 12.9 mt -74.64 -24.95 58.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -35.7 66.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.185 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -77.57 -4.48 46.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.5 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.463 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 14.8 m -62.72 -26.75 68.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.758 0.313 . . . . 0.0 111.022 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 t -58.75 -30.35 67.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.997 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.1 mm -53.09 -56.45 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.943 0.402 . . . . 0.0 111.44 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.8 t -94.99 -1.42 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.144 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.773 ' O ' HG23 ' A' ' 30' ' ' THR . 0.5 OUTLIER 68.36 10.76 8.05 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.442 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.624 ' HD3' HG11 ' A' ' 28' ' ' VAL . 21.5 ttmt -156.64 154.95 30.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.861 0.363 . . . . 0.0 111.008 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 82' ' ' ASN . 9.8 p -152.89 145.95 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.598 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 1.027 HG22 HG22 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -107.65 112.92 25.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.3 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.655 HD11 HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -99.31 131.54 45.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.5 -179.373 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.409 ' CD ' ' HB3' ' A' ' 80' ' ' ALA . 25.6 mt-10 -114.93 104.53 12.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.888 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.637 HG22 ' CA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -114.67 154.79 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 120.951 0.405 . . . . 0.0 112.007 -178.881 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -108.21 129.24 55.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.864 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 23' ' ' GLU . 5.5 p90 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.878 0.371 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -175.65 167.55 3.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.062 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.17 140.77 29.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.554 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.495 HG23 HG12 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -119.96 147.5 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.048 0.451 . . . . 0.0 111.403 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -110.35 98.03 7.36 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.696 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.457 HG23 HD11 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -101.63 107.09 20.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.141 -178.627 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.93 HG22 HG22 ' A' ' 108' ' ' THR . 7.9 t -82.63 120.61 34.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.195 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.0 mt -112.47 164.19 13.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 105' ' ' SER . 28.0 m -124.66 133.26 53.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.795 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -80.1 92.09 5.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -73.02 146.69 87.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.12 49.04 2.9 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.934 2.422 . . . . 0.0 112.569 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -153.35 -59.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.814 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 p -114.49 -16.71 11.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.085 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.6 -121.73 5.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.324 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.795 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 95.0 m-85 -109.08 -26.82 9.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.659 0.266 . . . . 0.0 110.788 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.94 48.26 30.98 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.944 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.695 HD11 HG21 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -132.59 125.17 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.806 0.336 . . . . 0.0 111.069 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.41 122.84 47.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.721 HD11 ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -111.06 100.88 9.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.811 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.819 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.945 ' HB2' HG23 ' A' ' 78' ' ' VAL . 71.0 Cg_exo . . . . . 0 CA--C 1.526 0.107 0 CA-C-O 120.752 0.23 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.591 HD11 ' NE ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -164.86 130.59 2.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.096 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.695 HG21 HD11 ' A' ' 39' ' ' ILE . 40.6 mt -81.59 139.74 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.676 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 m -160.28 37.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.819 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -173.95 140.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.953 0.406 . . . . 0.0 111.682 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -149.49 152.76 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.229 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.03 155.78 23.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.082 0.467 . . . . 0.0 111.428 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -87.98 40.37 0.94 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.789 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.55 31.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.26 144.18 37.43 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.824 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -46.29 -29.36 6.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.937 2.424 . . . . 0.0 112.573 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -61.8 -48.24 81.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.03 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.442 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 8.6 tp10 -78.63 -33.44 47.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.077 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -80.04 -8.84 59.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.002 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.0 p -55.97 -29.86 60.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.06 46.2 93.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.44 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 t -144.58 -67.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 111.286 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -75.71 165.0 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.13 -170.27 2.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.695 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.5 mm -82.47 79.28 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.83 61.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.677 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.455 ' HB2' HD12 ' A' ' 57' ' ' ILE . 67.0 m-20 -112.24 152.22 28.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.714 0.292 . . . . 0.0 110.71 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.591 ' NE ' HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -103.52 83.62 2.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.893 0.378 . . . . 0.0 111.664 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.945 HG23 ' HB2' ' A' ' 55' ' ' PRO . 1.6 m -62.45 126.91 21.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.68 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -160.33 30.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.205 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 178.29 52.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 111.079 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.477 ' HB ' HD12 ' A' ' 97' ' ' LEU . 3.1 mt -79.01 126.5 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.025 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.41 ' OD1' HG22 ' A' ' 81' ' ' ILE . 1.1 p-10 43.41 31.73 0.44 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.481 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.5 -45.5 1.32 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.541 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.775 ' HB ' HD13 ' A' ' 97' ' ' LEU . 8.4 mm -71.25 112.89 15.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.605 0.241 . . . . 0.0 111.267 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo . . . . . 0 N--CA 1.46 -0.462 0 C-N-CA 122.752 2.302 . . . . 0.0 112.837 -179.905 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.9 tp10 . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.842 0.353 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.66 -51.31 70.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.967 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.421 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 25.3 m-20 -58.36 -35.24 71.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.492 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -37.98 88.8 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.666 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.775 HD13 ' HB ' ' A' ' 84' ' ' ILE . 1.3 mt -65.81 -48.02 73.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.493 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.721 ' CD2' HD11 ' A' ' 41' ' ' LEU . 1.5 pp -75.84 -24.15 55.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.27 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -71.14 -36.32 72.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -7.55 54.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.393 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.462 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.0 m -67.38 -18.69 65.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.723 0.297 . . . . 0.0 111.112 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.5 m -58.69 -33.11 69.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.13 -61.43 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.184 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 106' ' ' LYS . 5.1 t -85.63 -6.75 59.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.093 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.69 ' O ' HG23 ' A' ' 30' ' ' THR . 33.2 t 62.93 25.19 14.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.301 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HE2' HG11 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -156.47 150.51 25.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.945 0.402 . . . . 0.0 111.449 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.605 HG12 ' CE1' ' A' ' 37' ' ' PHE . 13.0 p -153.38 157.43 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.47 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.93 HG22 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -120.57 107.33 12.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.558 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.416 HD13 HG12 ' A' ' 81' ' ' ILE . 4.0 mm? -83.2 127.38 33.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.714 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 21.9 tt0 -118.01 104.68 11.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.756 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.757 HG22 ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -125.89 165.29 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.112 0.482 . . . . 0.0 112.119 -178.759 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -121.63 128.19 51.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.745 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 10.6 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 120.917 0.389 . . . . 0.0 111.09 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.633 0.254 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' CG ' ' CZ ' ' A' ' 113' ' ' PHE . 17.5 pt-20 -177.97 171.66 1.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.066 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 p -87.84 148.22 24.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.636 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.816 HG23 HG13 ' A' ' 111' ' ' ILE . 0.8 OUTLIER -129.7 159.69 35.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 111.101 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -113.33 99.37 7.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.13 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.499 HG21 HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -105.07 102.61 14.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.494 -178.659 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 108' ' ' THR . 16.2 t -83.68 115.61 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.937 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.584 HD12 ' CD1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -107.56 128.97 55.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 111.005 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 105' ' ' SER . 67.8 m -110.63 134.01 52.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.99 153.63 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.059 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -130.65 137.46 30.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.83 60.14 5.23 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.584 2.189 . . . . 0.0 112.302 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.75 -65.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -131.4 17.9 4.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.3 -116.41 5.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.563 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.733 ' HB3' HG22 ' A' ' 39' ' ' ILE . 49.6 m-85 -113.36 -30.48 6.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.861 0.362 . . . . 0.0 111.257 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.71 23.9 63.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.687 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 37' ' ' PHE . 3.6 tt -124.69 139.75 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.725 0.298 . . . . 0.0 110.877 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -135.18 149.5 49.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.049 0.452 . . . . 0.0 111.297 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.637 HD23 HG13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -114.89 168.94 9.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.376 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.082 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.465 -0.165 0 CA-C-O 120.825 0.26 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -176.42 156.68 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.673 HD12 ' HB2' ' A' ' 76' ' ' ASP . 10.0 mt -68.75 147.71 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.888 ' HA ' HG23 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -171.8 47.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 111.573 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -176.76 134.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 111.583 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -151.94 152.0 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.934 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.03 155.0 17.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 111.289 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -86.8 39.6 0.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.869 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 28.1 t0 174.06 31.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.607 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.9 m -122.54 144.26 41.82 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.055 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -42.34 -36.53 4.41 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.958 2.439 . . . . 0.0 112.947 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.62 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -57.88 -40.1 79.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.841 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -78.13 -51.88 9.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.766 179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -12.75 61.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.482 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.577 ' HB3' HG22 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -56.28 -30.28 62.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 0.0 110.838 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.69 24.94 57.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.571 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.577 HG22 ' HB3' ' A' ' 69' ' ' CYS . 29.2 m -136.58 10.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.585 0.231 . . . . 0.0 111.603 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.62 HD11 ' O ' ' A' ' 66' ' ' ALA . 4.2 pp -147.56 158.67 44.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.874 0.369 . . . . 0.0 111.023 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -154.45 150.45 27.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.619 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.888 HG23 ' HA ' ' A' ' 58' ' ' SER . 21.2 mt -57.17 107.46 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.72 40.14 0.19 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.595 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.673 ' HB2' HD12 ' A' ' 57' ' ' ILE . 59.2 m-20 -114.83 127.72 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 110.575 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -88.18 89.97 8.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.064 HG11 HD11 ' A' ' 81' ' ' ILE . 13.3 t -69.02 139.64 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.627 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 1.8 ttp -164.42 31.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.61 0.243 . . . . 0.0 111.452 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.882 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 178.21 69.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.005 0.431 . . . . 0.0 111.319 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.064 HD11 HG11 ' A' ' 78' ' ' VAL . 37.8 mt -98.78 118.19 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.957 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.426 ' OD1' HG22 ' A' ' 81' ' ' ILE . 4.7 p-10 44.55 31.64 0.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.303 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.54 -47.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.453 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.433 ' CB ' HD21 ' A' ' 97' ' ' LEU . 7.8 mm -72.39 121.12 83.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.59 0.233 . . . . 0.0 111.13 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 C--N 1.348 0.508 0 C-N-CA 122.688 2.259 . . . . 0.0 112.952 -179.898 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.738 0.304 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.858 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -58.03 -45.49 86.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.008 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.69 ' HA ' HD23 ' A' ' 98' ' ' LEU . 70.8 m-80 -60.81 -42.89 98.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.561 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.95 -32.87 74.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.516 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.858 HD12 ' HA ' ' A' ' 94' ' ' ALA . 21.1 mt -65.71 -48.07 73.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.69 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -68.67 -28.56 66.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.53 -36.81 76.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.56 -5.69 48.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.38 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 m -60.14 -20.15 57.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.207 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.7 m -63.13 -31.51 72.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.61 -59.2 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.133 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.4 t -83.24 -7.88 59.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.294 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.731 ' O ' HG23 ' A' ' 30' ' ' THR . 1.9 p 80.82 -8.65 1.43 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.628 ' O ' HG23 ' A' ' 104' ' ' THR . 5.5 ptpt -156.5 163.37 39.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 111.166 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.4 147.97 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.709 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.833 HG22 HG22 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -112.74 112.05 23.27 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.245 179.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -108.85 125.62 52.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.934 0.397 . . . . 0.0 111.946 -179.157 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.882 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 6.8 tt0 -93.11 104.87 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.881 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -110.09 158.53 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.179 -178.555 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -116.82 119.0 34.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.247 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CZ ' ' CG ' ' A' ' 23' ' ' GLU . 23.0 p90 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.142 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.701 0.286 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -155.69 169.6 23.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 111.052 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.0 p -94.66 130.66 41.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.457 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.639 HG23 HD11 ' A' ' 111' ' ' ILE . 4.6 t -111.79 135.29 52.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.828 0.346 . . . . 0.0 111.409 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.1 pt-20 -99.82 98.82 9.58 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.737 HG11 ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -105.19 111.54 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.94 -179.203 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.872 HG22 HG22 ' A' ' 108' ' ' THR . 10.6 t -82.7 121.85 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.092 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' A' ' 65' ' ' PRO . 4.1 mm? -111.9 140.58 46.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 105' ' ' SER . 26.8 m -105.34 147.85 27.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.808 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.618 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -90.37 104.25 16.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.243 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.24 135.18 76.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.677 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.12 55.79 5.48 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.558 2.172 . . . . 0.0 112.489 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.9 t -155.21 -49.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.942 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -125.4 -44.11 1.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.968 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.76 -121.09 4.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.425 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.618 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 40.4 m-85 -110.97 -26.2 9.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.705 0.288 . . . . 0.0 111.082 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.96 33.66 79.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.794 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.537 HG22 ' HB3' ' A' ' 37' ' ' PHE . 1.1 tt -136.95 140.76 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.448 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 18.2 mm100 -131.7 136.69 47.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.127 0.489 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.975 HD13 ' HB1' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -112.25 130.36 55.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.717 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--O 1.23 0.122 0 CA-C-O 120.819 0.258 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 mp -157.16 136.67 12.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.353 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.541 ' CD1' HG21 ' A' ' 111' ' ' ILE . 68.1 mt -71.51 144.84 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.436 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.2 p -163.4 55.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.986 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.448 ' CD1' ' HG2' ' A' ' 40' ' ' GLN . 11.2 t80 -177.95 132.68 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 111.618 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.431 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -152.89 152.03 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.751 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -96.87 155.13 16.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.38 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.97 41.91 0.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.918 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.428 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 1.2 p30 168.88 32.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.705 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.78 145.86 44.35 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.697 0.284 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.678 ' HB2' HD12 ' A' ' 29' ' ' LEU . 82.0 Cg_exo -44.96 -37.21 12.07 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.769 2.313 . . . . 0.0 112.578 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.505 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -59.07 -38.95 80.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.977 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -76.16 -50.18 15.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.687 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.428 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.9 -8.74 56.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.667 -179.497 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.511 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -58.25 -24.89 60.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.664 0.268 . . . . 0.0 110.79 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.14 30.24 77.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.148 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.737 ' HB ' HG11 ' A' ' 27' ' ' VAL . 9.3 t -142.3 -49.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.348 . . . . 0.0 111.068 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 39' ' ' ILE . 9.5 mt -69.22 159.62 32.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.032 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 -171.14 3.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' O ' HG22 ' A' ' 74' ' ' ILE . 24.7 mm -93.58 49.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.76 39.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.65 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -89.95 146.15 24.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.762 0.315 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.6 85.31 2.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.052 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.918 HG11 HD11 ' A' ' 81' ' ' ILE . 2.6 t -55.54 159.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -50.49 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.45 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.27 86.29 1.76 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.808 0.337 . . . . 0.0 111.641 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.918 HD11 HG11 ' A' ' 78' ' ' VAL . 4.3 mt -77.51 111.81 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 46.53 28.42 0.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.228 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 112.94 -49.57 0.84 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.418 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.9 mm -69.33 109.12 3.89 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.548 0.213 . . . . 0.0 111.182 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 87.0 Cg_endo . . . . . 0 N--CA 1.452 -0.944 0 C-N-CA 122.907 2.405 . . . . 0.0 112.458 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.848 0.356 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.975 ' HB1' HD13 ' A' ' 41' ' ' LEU . . . -67.46 -42.51 82.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.442 ' HA ' HD23 ' A' ' 98' ' ' LEU . 2.0 m-80 -67.36 -41.7 84.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.441 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -64.33 -53.05 54.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.222 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 98' ' ' LEU . 4.2 pp -57.89 -35.19 70.66 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.159 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.888 ' N ' HD12 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -78.47 -35.5 46.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.727 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -27.84 67.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -15.3 63.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.175 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.455 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -73.33 -21.57 60.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.885 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.0 t -70.03 -32.38 70.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.815 0.341 . . . . 0.0 110.408 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -82.03 -41.73 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.681 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.0 m -79.74 -20.28 46.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.856 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.669 ' O ' HG23 ' A' ' 30' ' ' THR . 2.6 m 76.78 -1.76 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.789 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' CE ' HG11 ' A' ' 28' ' ' VAL . 10.1 tttt -156.56 152.24 27.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.825 0.345 . . . . 0.0 111.501 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.415 HG12 ' CE2' ' A' ' 37' ' ' PHE . 13.8 p -150.65 151.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.239 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.872 HG22 HG22 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -107.95 109.45 20.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.988 0.423 . . . . 0.0 110.531 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.76 HD22 HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -87.5 127.94 35.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.512 -179.35 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -119.25 104.6 10.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.097 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -124.92 162.7 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.091 0.472 . . . . 0.0 112.088 -178.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.52 118.61 37.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.779 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 29.3 p90 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.309 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.929 0.395 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.776 HG12 ' HA ' ' A' ' 118' ' ' SER . 9.3 p -76.26 146.18 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.067 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.69 126.73 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.098 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.637 ' O ' HG23 ' A' ' 22' ' ' THR . 0.2 OUTLIER -127.83 -173.55 2.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.927 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 21' ' ' HIS . 0.1 OUTLIER 174.77 102.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.381 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 2.6 mm-40 -144.34 176.87 9.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.967 0.413 . . . . 0.0 111.169 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -110.9 134.95 52.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.498 HG23 HG13 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -115.66 146.9 41.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.257 0.551 . . . . 0.0 111.415 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.3 99.26 8.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.087 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.759 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -102.15 102.37 13.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.768 -178.437 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.4 p -85.97 119.32 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.466 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.8 mt -110.63 164.14 13.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.945 0.403 . . . . 0.0 111.221 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 105' ' ' SER . 90.4 m -130.31 127.71 40.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.581 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -55.24 112.27 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.416 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.04 146.02 99.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.24 -7.3 20.87 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.659 2.239 . . . . 0.0 112.902 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -98.81 -67.05 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.061 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.8 p -105.6 -51.33 3.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.46 -75.3 0.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.744 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 95.9 m-85 -138.72 76.25 1.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.955 0.407 . . . . 0.0 110.423 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.28 0.64 1.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.911 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.852 HD11 HG21 ' A' ' 57' ' ' ILE . 17.8 tt -95.86 132.89 38.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 116.861 0.331 . . . . 0.0 110.599 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -116.95 145.61 43.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.133 0.492 . . . . 0.0 111.731 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -125.76 122.71 37.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.01 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -104.59 137.45 42.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 0.0 111.296 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.736 ' HA2' ' HA ' ' A' ' 55' ' ' PRO . . . -93.55 45.81 2.36 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.49 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.439 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 3.2 m 53.97 61.46 3.06 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.219 0.533 . . . . 0.0 109.958 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.665 HG23 HD21 ' A' ' 51' ' ' LEU . 2.4 p -155.3 -39.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.702 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 19.9 t80 -94.17 28.11 2.62 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.895 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.45 134.03 17.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.965 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.13 -16.61 53.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.736 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.61 101.94 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.9 m 58.14 164.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.163 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.665 HD21 HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -158.83 178.59 9.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.998 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.612 ' H ' HD23 ' A' ' 51' ' ' LEU . 0.3 OUTLIER 59.44 26.5 15.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.134 0.493 . . . . 0.0 111.113 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.445 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -112.43 170.08 5.66 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.134 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 53' ' ' SER . 38.4 Cg_endo -67.27 174.36 7.24 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.709 2.273 . . . . 0.0 112.746 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.736 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 85.4 Cg_endo -84.19 144.14 10.45 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.005 2.47 . . . . 0.0 113.112 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -158.48 161.03 37.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.75 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.852 HG21 HD11 ' A' ' 39' ' ' ILE . 5.2 mt -80.22 138.57 19.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.897 ' HA ' HG23 ' A' ' 74' ' ' ILE . 8.7 t -164.34 41.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.241 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -176.32 123.19 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 0.0 111.48 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.539 HD11 ' HA ' ' A' ' 73' ' ' GLN . 3.6 mt -133.73 152.51 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.084 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -100.57 155.62 17.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.07 0.462 . . . . 0.0 111.36 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.15 43.25 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.902 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER 168.18 31.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.676 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -112.97 144.38 30.97 Favored Pre-proline 0 CA--C 1.527 0.088 0 CA-C-O 120.707 0.289 . . . . 0.0 110.782 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -45.1 -32.89 7.3 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.638 2.225 . . . . 0.0 112.661 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.422 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -66.39 -46.03 78.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.788 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -65.34 -39.13 91.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.632 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' NE ' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -87.37 -8.49 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.652 -179.406 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' A' ' 71' ' ' VAL . 35.0 t -53.43 -25.03 14.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 111.033 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.64 27.24 73.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.201 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.651 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.3 p -170.97 34.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.406 . . . . 0.0 111.007 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.416 HD21 HG21 ' A' ' 27' ' ' VAL . 14.4 mt -141.42 147.67 38.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.009 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.539 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.1 mm-40 -168.95 171.69 8.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.725 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.897 HG23 ' HA ' ' A' ' 58' ' ' SER . 36.9 mt -70.46 123.63 24.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.088 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.42 -24.6 3.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.607 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.676 ' HB3' HG21 ' A' ' 111' ' ' ILE . 69.7 m-20 -57.73 123.62 16.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.762 0.315 . . . . 0.0 110.732 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.635 ' C ' HG22 ' A' ' 111' ' ' ILE . 4.4 mtm-85 -94.34 98.42 10.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.433 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.654 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.6 m -75.89 118.31 21.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.972 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.3 ttp -141.14 27.48 1.94 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.873 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -178.86 61.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.643 HD11 ' HB ' ' A' ' 78' ' ' VAL . 25.6 mt -92.45 130.82 40.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.216 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.433 ' OD1' HD22 ' A' ' 97' ' ' LEU . 1.9 p-10 43.93 31.14 0.47 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.316 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.84 -44.44 1.64 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.602 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.461 ' HB ' HD21 ' A' ' 97' ' ' LEU . 7.6 mm -71.77 110.78 8.41 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.501 0.191 . . . . 0.0 111.289 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -90.95 15.87 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.814 2.343 . . . . 0.0 112.686 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.665 HG21 ' HG3' ' A' ' 55' ' ' PRO . 2.8 p 61.68 150.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.836 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -114.06 111.62 21.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.164 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 61.94 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.129 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.8 p -161.02 114.82 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 p -146.73 92.8 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.97 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -58.67 -44.22 90.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.604 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -60.26 -32.32 71.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.733 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -45.07 84.87 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.604 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.865 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -58.02 -49.9 75.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.679 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -58.01 -36.77 73.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.545 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -43.95 97.52 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.653 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 94' ' ' ALA . 5.3 mt -59.71 -42.49 93.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.613 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 41' ' ' LEU . 61.3 mt -62.86 -37.13 85.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -77.74 -28.42 50.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.126 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.41 -6.72 49.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.463 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 3.5 m -72.68 -26.24 61.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.74 0.305 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.92 -26.85 64.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.218 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.8 mm -53.9 -49.32 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.494 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.1 t -104.73 -1.06 26.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.599 ' O ' HG23 ' A' ' 30' ' ' THR . 1.5 m 78.97 -4.54 2.1 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.791 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.646 ' O ' HG23 ' A' ' 104' ' ' THR . 0.0 OUTLIER -156.58 152.64 27.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.868 0.366 . . . . 0.0 111.111 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 108' ' ' THR . 10.7 p -131.13 157.54 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.778 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.447 ' N ' HG22 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -120.56 106.87 12.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.86 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.421 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -100.64 120.15 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 111.871 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.873 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -87.96 112.12 22.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.454 178.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.759 HD11 ' CG2' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -118.43 164.97 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.361 0.6 . . . . 0.0 112.443 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -123.12 124.87 44.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.833 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.422 ' CE1' ' HB2' ' A' ' 23' ' ' GLU . 49.9 p90 -114.65 152.66 31.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.955 0.407 . . . . 0.0 111.263 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.84 97.73 5.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.451 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.7 t -68.38 126.99 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.238 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -140.65 46.19 1.79 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.014 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -179.82 53.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.815 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.776 ' HA ' HG12 ' A' ' 19' ' ' VAL . 5.4 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.865 0.364 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.42 HG12 ' OG ' ' A' ' 118' ' ' SER . 22.0 t -100.74 77.84 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.173 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.6 106.65 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.975 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.4 ' CG ' HG21 ' A' ' 115' ' ' VAL . 0.9 OUTLIER -92.93 176.74 6.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.245 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m 167.55 132.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.22 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 22.1 pt-20 -175.15 177.08 1.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.969 0.414 . . . . 0.0 111.212 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 15.8 p -89.53 128.19 35.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.109 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.587 HG23 ' CD1' ' A' ' 111' ' ' ILE . 2.7 t -107.28 136.0 47.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.277 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.79 99.38 11.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.639 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -101.02 103.18 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.718 -178.435 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 108' ' ' THR . 10.9 t -83.59 113.95 23.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.406 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.431 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 8.7 mt -110.08 137.64 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.009 0.433 . . . . 0.0 111.251 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 105' ' ' SER . 96.7 m -109.91 137.89 47.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.577 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.67 146.62 51.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.214 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.02 139.46 28.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.794 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.0 57.23 5.1 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.61 2.207 . . . . 0.0 112.432 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.4 t -155.42 -68.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 -29.76 6.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.011 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.75 -110.93 3.15 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.406 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.562 ' HB3' HG22 ' A' ' 39' ' ' ILE . 52.3 m-85 -114.61 -33.01 5.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.51 31.87 82.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.77 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.912 HD13 HD13 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -140.96 140.96 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 110.959 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -141.24 159.18 42.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.039 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.538 HD13 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -127.49 121.64 31.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.733 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.34 171.3 13.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' O ' HD22 ' A' ' 51' ' ' LEU . . . -131.9 75.9 0.41 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.52 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.419 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . 13.4 p -172.46 171.6 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 111.213 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.724 HG21 ' OG ' ' A' ' 53' ' ' SER . 72.6 t -123.71 -41.46 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.277 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 173.38 44.46 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -175.57 114.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.239 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.6 p -58.07 -21.28 45.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.261 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 50' ' ' THR . 10.1 mm-40 -92.67 136.06 33.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.728 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 49' ' ' GLU . 14.5 t 46.29 -170.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.424 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.552 HD11 HG23 ' A' ' 45' ' ' VAL . 18.1 tp -177.52 133.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.574 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.98 14.26 15.02 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.724 ' OG ' HG21 ' A' ' 45' ' ' VAL . 1.4 m -136.44 139.79 30.61 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.996 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.98 173.07 2.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.354 2.036 . . . . 0.0 111.933 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.704 ' C ' HD13 ' A' ' 56' ' ' LEU . 35.1 Cg_endo -65.08 166.38 18.92 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.484 2.123 . . . . 0.0 112.105 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.704 HD13 ' C ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -152.52 150.29 29.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.069 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.447 HD12 HG21 ' A' ' 111' ' ' ILE . 80.7 mt -74.52 147.93 8.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.861 ' HA ' HG23 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -175.4 50.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.153 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -173.79 134.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 0.0 111.437 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -150.69 151.88 12.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.219 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.75 155.36 18.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 0.0 111.582 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.87 41.0 1.02 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.863 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER 171.82 33.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.521 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 m -127.11 143.67 47.82 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.07 -32.81 7.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.729 2.286 . . . . 0.0 112.809 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.99 -51.66 68.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.986 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.558 ' HB2' HG22 ' A' ' 60' ' ' ILE . 10.6 tp10 -69.67 -43.14 73.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.69 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -67.15 -14.11 62.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.402 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.694 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -55.91 -27.44 52.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.941 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.18 31.58 65.93 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.239 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 69' ' ' CYS . 10.4 t -137.29 -58.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 111.206 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.912 HD13 HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -75.38 166.09 24.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.053 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.432 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.1 pp0? -164.86 169.23 16.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.707 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.861 HG23 ' HA ' ' A' ' 58' ' ' SER . 18.0 mt -67.54 114.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.068 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.67 22.17 4.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.648 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.431 ' HB3' HG21 ' A' ' 111' ' ' ILE . 1.3 m-20 -83.45 141.52 31.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.679 0.276 . . . . 0.0 110.673 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.409 ' HB3' ' HB3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -98.84 89.66 4.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.345 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.896 HG22 ' CG2' ' A' ' 111' ' ' ILE . 5.4 t -74.82 145.85 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.602 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -170.29 29.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.771 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . . . -176.18 46.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 111.661 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.598 HG22 ' OD1' ' A' ' 82' ' ' ASN . 16.5 mt -67.8 112.99 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.029 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.598 ' OD1' HG22 ' A' ' 81' ' ' ILE . 5.2 p-10 44.06 35.69 1.25 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.436 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.59 -49.7 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.386 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.55 HG22 ' H ' ' A' ' 86' ' ' THR . 13.0 mm -70.11 120.29 77.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.534 0.207 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -86.07 19.29 1.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.719 2.28 . . . . 0.0 112.915 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.575 HG22 HD12 ' A' ' 81' ' ' ILE . 4.6 p 58.55 107.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.88 126.72 28.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.952 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -65.91 78.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.832 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.94 -49.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.51 136.48 14.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.05 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -61.56 -22.63 65.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.967 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -53.56 -30.59 42.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.012 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 4.2 mt-10 -63.76 -47.78 79.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.962 0.411 . . . . 0.0 110.21 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.882 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.32 -38.54 84.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.764 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -61.93 -43.67 98.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -62.56 -38.06 88.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.446 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.882 HD12 ' HA ' ' A' ' 94' ' ' ALA . 12.2 mt -61.71 -40.7 95.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.248 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.4 mt -78.02 -32.17 50.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.363 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -65.89 -25.86 67.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.916 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.54 15.02 10.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.522 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 m -79.32 -23.22 43.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.81 0.338 . . . . 0.0 110.853 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 p -58.59 -35.25 72.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.807 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.9 mm -53.95 -54.37 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.4 p -86.93 -8.69 57.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.984 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.789 ' O ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER 79.35 -5.02 1.99 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.025 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -156.62 166.8 32.37 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.853 0.358 . . . . 0.0 111.187 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 11.4 p -151.13 148.32 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.902 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.891 HG22 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -112.33 107.19 15.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.087 179.252 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -101.83 126.16 48.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.776 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.771 ' CB ' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -92.5 120.53 33.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.62 178.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.896 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -133.79 165.48 31.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.383 -178.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 77' ' ' ARG . 21.1 tt0 -116.86 126.75 53.49 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.102 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.445 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 34.5 p90 -118.09 148.48 42.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.15 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -123.1 97.8 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.503 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.4 HG21 ' CG ' ' A' ' 21' ' ' HIS . 33.3 m -59.17 168.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.266 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -174.51 48.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.964 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -174.04 48.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.929 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.42 ' OG ' HG12 ' A' ' 19' ' ' VAL . 29.8 p . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.859 0.361 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.18 75.09 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.3 p -147.82 139.49 18.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.024 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.654 ' O ' HG23 ' A' ' 22' ' ' THR . 0.5 OUTLIER 64.17 46.45 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.749 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 21' ' ' HIS . 0.2 OUTLIER 167.13 105.79 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.226 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.6 OUTLIER -168.26 154.18 7.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.393 . . . . 0.0 111.572 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 72.5 p -89.85 127.06 35.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.265 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.553 HG23 ' CD1' ' A' ' 111' ' ' ILE . 7.3 t -114.61 131.07 56.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.925 0.393 . . . . 0.0 111.366 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.18 99.42 11.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.724 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.633 HG11 ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -107.69 133.64 51.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.081 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.703 HG22 HG22 ' A' ' 108' ' ' THR . 21.6 t -94.28 117.42 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.405 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.652 HD11 ' N ' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -109.17 126.1 52.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.331 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.0 t -103.11 165.88 10.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.215 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.8 115.99 30.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.081 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.25 140.22 79.57 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.769 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.02 -0.69 10.83 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.659 2.239 . . . . 0.0 112.874 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.4 t -108.04 -35.69 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.002 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.9 p -133.91 -66.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.72 -109.1 0.57 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.434 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 35.6 m-85 -118.41 -35.43 3.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.7 26.0 38.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.776 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.544 HG23 HD13 ' A' ' 98' ' ' LEU . 3.0 tt -111.16 127.18 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.994 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 125.14 51.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.922 HD11 HD11 ' A' ' 98' ' ' LEU . 2.1 mt -108.84 116.3 31.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.756 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.417 ' HA ' ' CD2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -84.59 145.43 28.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.546 ' O ' HD21 ' A' ' 51' ' ' LEU . . . -91.56 -7.05 65.37 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.618 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -119.4 165.36 14.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.785 0.326 . . . . 0.0 111.009 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 45' ' ' VAL . 33.1 t -123.28 -3.22 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.695 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -171.6 132.66 0.75 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.342 . . . . 0.0 111.041 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 59.24 110.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.399 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -65.8 -14.51 61.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.62 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -94.4 22.83 5.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.236 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -167.65 177.57 5.79 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.838 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 43' ' ' GLY . 0.6 OUTLIER -164.03 137.75 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.844 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.78 22.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.506 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.84 157.91 32.07 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.78 171.7 10.6 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.542 2.161 . . . . 0.0 112.066 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.51 ' HG3' HG21 ' A' ' 86' ' ' THR . 32.4 Cg_endo -64.07 174.35 4.09 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.441 2.094 . . . . 0.0 111.979 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 56' ' ' LEU . 1.7 pt? -178.08 169.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.622 HD13 ' HB2' ' A' ' 76' ' ' ASP . 3.4 mp -75.62 141.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.429 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.9 t -117.34 -31.29 5.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.849 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -165.56 167.43 17.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.194 0.521 . . . . 0.0 111.886 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.523 HG13 HD13 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -144.94 153.18 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.922 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -86.37 155.46 20.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.086 0.469 . . . . 0.0 111.516 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.87 38.34 0.8 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.82 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -179.72 26.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.992 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.5 p -120.62 134.58 24.25 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.626 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.466 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 89.2 Cg_exo -43.52 -29.21 2.03 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.492 2.128 . . . . 0.0 112.752 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.652 ' N ' HD11 ' A' ' 29' ' ' LEU . . . -62.24 -42.85 99.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.983 0.42 . . . . 0.0 110.815 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' CA ' HG21 ' A' ' 60' ' ' ILE . 8.8 tp10 -78.48 -50.22 12.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.152 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.466 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.88 -8.36 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.916 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -24.95 11.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.771 0.32 . . . . 0.0 111.0 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.84 30.71 63.22 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.237 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.633 ' HB ' HG11 ' A' ' 27' ' ' VAL . 5.4 t -145.03 -52.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.926 0.393 . . . . 0.0 111.116 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.414 HD21 HD12 ' A' ' 111' ' ' ILE . 12.1 mt -75.69 130.68 39.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.047 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 -170.99 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.798 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.523 HD13 HG13 ' A' ' 60' ' ' ILE . 12.9 mm -92.16 75.61 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.187 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.88 42.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.891 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.622 ' HB2' HD13 ' A' ' 57' ' ' ILE . 32.9 m-20 -85.18 -176.03 5.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.583 0.23 . . . . 0.0 110.534 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.91 79.27 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 111.203 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.032 HG11 HD11 ' A' ' 81' ' ' ILE . 12.2 t -58.45 147.82 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.054 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 11.9 tpt -134.98 -65.36 0.62 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.07 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -125.37 96.95 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.032 HD11 HG11 ' A' ' 78' ' ' VAL . 9.7 mt -88.48 122.96 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.943 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 46.53 31.63 1.4 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.01 -34.23 5.2 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.219 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.558 ' HB ' HD22 ' A' ' 97' ' ' LEU . 4.1 mm -87.72 110.85 37.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.511 0.196 . . . . 0.0 111.155 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -90.57 24.8 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.669 2.246 . . . . 0.0 112.56 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.51 HG21 ' HG3' ' A' ' 55' ' ' PRO . 2.0 p 63.45 142.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.795 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -80.78 106.85 13.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.3 t70 62.95 -79.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.027 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 p -179.8 106.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.14 128.38 12.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.806 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 42' ' ' GLN . 27.2 t80 -59.28 -43.76 92.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -62.45 -30.9 71.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -52.4 62.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.878 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.86 -50.45 73.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -58.16 -36.36 72.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.582 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.92 -43.95 97.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.724 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' A' ' 94' ' ' ALA . 3.8 mt -60.5 -43.75 96.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.721 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.922 HD11 HD11 ' A' ' 41' ' ' LEU . 57.3 mt -70.96 -31.24 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -67.55 -32.68 73.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.98 -5.82 50.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.233 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -75.55 -23.18 56.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.751 0.31 . . . . 0.0 111.017 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.6 p -63.7 -30.98 72.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.714 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -65.14 -56.14 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.995 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 105' ' ' SER . 42.7 p -77.61 -11.7 59.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.126 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 104' ' ' THR . 1.8 p 84.19 -18.3 0.42 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.925 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 8.6 ptpt -156.43 160.53 39.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 111.284 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 9.8 p -144.67 155.27 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.713 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.703 HG22 HG22 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -110.99 121.85 46.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.206 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.512 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -115.07 143.84 44.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.446 -179.224 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -115.18 104.71 12.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.983 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.667 HG22 HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -116.55 161.31 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -93.59 133.57 36.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.689 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 30.6 p90 -131.78 164.99 24.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.979 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.453 ' HB3' ' CE1' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -119.31 97.77 5.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.72 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 116' ' ' ALA . 13.5 p -93.88 158.99 2.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.34 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.494 ' N ' HG22 ' A' ' 115' ' ' VAL . . . -128.17 48.82 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -171.9 73.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.883 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.416 ' O ' HG22 ' A' ' 20' ' ' VAL . 25.5 mt-30 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.803 0.335 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.4 t -70.7 66.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.945 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.69 HG23 ' H ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -68.37 -177.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.27 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.524 ' O ' ' CZ ' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -154.03 119.94 5.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.631 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.752 ' N ' ' HB ' ' A' ' 115' ' ' VAL . 5.6 t -62.81 112.55 2.59 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER 179.26 177.28 0.55 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.739 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 19.7 p -86.61 127.58 34.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.29 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.598 HG22 HD12 ' A' ' 111' ' ' ILE . 9.9 t -113.98 140.77 48.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.37 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 99.01 9.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.5 HG21 HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -101.64 103.17 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.305 -178.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.4 p -82.74 115.25 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.929 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.401 HD22 ' C ' ' A' ' 28' ' ' VAL . 4.4 mm? -113.78 147.99 37.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.117 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 105' ' ' SER . 82.2 m -108.11 144.7 35.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.873 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.722 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -84.1 108.82 17.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.3 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -68.3 140.6 92.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.99 41.38 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.771 2.314 . . . . 0.0 112.814 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.88 -47.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.799 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -127.39 -43.42 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.977 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.17 -118.57 2.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.52 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 29.9 m-85 -108.07 -25.49 11.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.761 0.315 . . . . 0.0 110.943 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.53 41.88 99.65 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.532 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.645 HG23 HD13 ' A' ' 98' ' ' LEU . 18.8 tt -150.66 126.63 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.775 0.321 . . . . 0.0 111.098 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' A' ' 59' ' ' TYR . 2.8 pm0 -124.28 156.54 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.037 0.446 . . . . 0.0 111.268 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.733 HD13 ' CB ' ' A' ' 94' ' ' ALA . 2.6 mp -103.67 162.3 13.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -171.01 169.76 6.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.465 ' HA2' HD21 ' A' ' 51' ' ' LEU . . . 74.98 34.41 52.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.419 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.423 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 3.2 t -101.4 67.05 1.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.883 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.614 ' H ' HD11 ' A' ' 51' ' ' LEU . 74.3 t 65.69 -0.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.077 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -138.69 101.87 4.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.773 0.321 . . . . 0.0 110.905 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.422 ' HB3' HD23 ' A' ' 51' ' ' LEU . . . -175.77 134.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.049 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.504 HG22 ' N ' ' A' ' 49' ' ' GLU . 93.0 m 61.97 -100.92 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' N ' HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -102.01 -75.56 0.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.654 0.264 . . . . 0.0 110.914 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.0 m -165.69 115.12 1.01 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.023 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.614 HD11 ' H ' ' A' ' 45' ' ' VAL . 3.1 pp -124.1 173.61 8.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.902 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.587 ' N ' HD12 ' A' ' 51' ' ' LEU . 3.8 m -136.41 105.09 5.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.941 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.08 141.94 0.22 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.763 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.84 170.13 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.42 2.08 . . . . 0.0 112.053 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.37 133.24 27.69 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.376 2.051 . . . . 0.0 112.029 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -140.39 145.12 36.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.198 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 6.3 mt -59.64 145.27 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.516 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 m -147.45 16.84 1.16 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 4.0 t80 -162.26 149.84 14.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.222 0.534 . . . . 0.0 111.799 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.712 HD11 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -151.41 152.36 11.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.788 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -94.45 155.63 16.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 111.825 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -87.86 41.48 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.716 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 169.6 31.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.71 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.9 m -120.83 144.15 38.31 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.795 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.45 -27.25 7.03 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.885 2.39 . . . . 0.0 112.547 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -66.29 -46.84 75.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.976 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 2.9 tp10 -78.06 -39.73 40.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.6 -19.16 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.476 ' HB3' HG22 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -52.78 -30.12 31.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.075 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.1 23.56 52.53 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.816 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 69' ' ' CYS . 2.9 m -122.39 -38.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.763 0.316 . . . . 0.0 111.232 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 pp -93.59 148.63 21.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.955 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -125.86 169.09 12.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.686 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.712 HD13 HD11 ' A' ' 60' ' ' ILE . 32.9 mm -67.44 107.07 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.047 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.87 4.39 6.7 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.073 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.91 133.18 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.86 0.33 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -98.28 95.71 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.219 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.963 HG11 HD11 ' A' ' 81' ' ' ILE . 2.7 t -76.19 129.82 36.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.546 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -150.77 31.87 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.274 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.931 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 179.36 81.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.963 HD11 HG11 ' A' ' 78' ' ' VAL . 41.7 mt -111.91 126.7 69.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.234 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 45.19 31.35 0.76 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.234 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.41 -34.75 5.05 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.312 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.465 HG22 ' H ' ' A' ' 86' ' ' THR . 5.0 mm -82.15 111.68 29.55 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.455 0.169 . . . . 0.0 111.083 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.512 ' C ' HG23 ' A' ' 86' ' ' THR . 83.6 Cg_endo -86.06 11.0 3.45 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.682 2.254 . . . . 0.0 112.713 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.512 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.2 p 71.33 6.59 5.83 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.545 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 52.61 22.45 2.21 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.5 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 43.53 33.65 0.68 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.697 0.284 . . . . 0.0 111.462 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.57 -79.01 0.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.1 p -129.34 160.26 33.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.98 0.419 . . . . 0.0 111.027 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -70.23 -25.72 63.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.993 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -54.97 -40.31 69.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.975 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.454 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 35.0 mt-10 -59.84 -49.27 78.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.701 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.733 ' CB ' HD13 ' A' ' 41' ' ' LEU . . . -57.36 -43.02 83.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -56.59 -40.94 76.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.058 0.456 . . . . 0.0 110.054 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -63.03 -38.03 89.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.32 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.514 HD12 HD12 ' A' ' 81' ' ' ILE . 41.3 mt -61.02 -39.0 88.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.645 HD13 HG23 ' A' ' 39' ' ' ILE . 60.6 mt -78.09 -28.59 48.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.053 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -74.91 -35.8 62.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.412 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -78.39 -3.2 42.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.652 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.486 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 67.0 m -69.77 -25.02 63.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.858 0.361 . . . . 0.0 110.733 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.03 -27.22 65.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 21.9 mm -49.92 -47.2 23.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.824 0.345 . . . . 0.0 111.241 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.1 t -108.75 0.94 20.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.057 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.752 ' O ' HG23 ' A' ' 30' ' ' THR . 1.4 t 62.81 18.06 10.41 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.256 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 0.5 OUTLIER -156.94 144.14 18.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.865 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.518 HG12 ' CE2' ' A' ' 37' ' ' PHE . 10.4 p -152.36 151.94 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.705 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 p -122.15 104.32 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.007 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -102.41 149.17 24.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.181 0.515 . . . . 0.0 112.183 -178.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.931 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 1.3 tt0 -107.27 124.87 50.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.252 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.958 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -138.18 133.31 43.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.177 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 35.2 tt0 -92.7 118.64 31.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.524 ' CZ ' ' O ' ' A' ' 21' ' ' HIS . 18.8 p90 -109.89 152.8 25.34 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.783 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 113' ' ' PHE . 5.9 t0 -66.8 163.11 20.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.348 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.752 ' HB ' ' N ' ' A' ' 22' ' ' THR . 8.4 p -117.38 161.05 16.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.052 0.453 . . . . 0.0 112.135 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.69 ' H ' HG23 ' A' ' 20' ' ' VAL . . . -104.98 -169.11 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.117 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -135.02 85.46 2.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.893 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.289 -0.863 . . . . 0.0 110.872 -179.912 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.63 109.75 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.737 HG22 HG21 ' A' ' 115' ' ' VAL . 3.9 p -58.59 140.02 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.836 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.4 ' O ' ' HB ' ' A' ' 22' ' ' THR . 10.2 m80 -154.02 36.89 0.44 Allowed 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 113' ' ' PHE . 96.5 m 62.13 146.85 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.991 0.424 . . . . 0.0 111.307 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -178.31 168.31 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.726 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 12.5 p -87.78 151.68 22.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.71 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.858 HG23 ' CD1' ' A' ' 111' ' ' ILE . 0.6 OUTLIER -132.15 143.49 50.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.032 0.444 . . . . 0.0 111.53 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.28 99.61 9.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.55 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.638 HG12 ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -105.4 106.89 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.616 -178.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.794 HG22 ' HD3' ' A' ' 106' ' ' LYS . 13.6 p -90.01 114.98 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.703 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 66' ' ' ALA . 10.8 mt -104.27 164.42 11.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 0.0 110.961 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 105' ' ' SER . 11.5 m -121.19 142.54 49.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.608 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.642 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -86.85 114.54 23.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 111.121 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.64 147.83 71.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.96 18.64 1.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.968 2.445 . . . . 0.0 112.853 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.84 -41.28 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.801 0.334 . . . . 0.0 111.078 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 t -136.04 -45.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.074 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.4 -109.98 0.93 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.512 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.642 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 87.1 m-85 -118.7 -31.7 4.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.631 0.253 . . . . 0.0 111.191 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.48 35.78 90.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.648 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 57' ' ' ILE . 1.7 tt -135.39 131.33 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.965 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.9 155.78 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.041 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.656 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -136.65 135.9 38.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -90.8 171.17 9.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.6 ' O ' HD12 ' A' ' 51' ' ' LEU . . . -123.59 155.41 17.63 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.279 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p -48.75 173.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 111.169 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.614 HG11 HG21 ' A' ' 50' ' ' THR . 88.3 t -146.76 -80.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 111.243 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.19 116.43 3.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.845 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.424 ' O ' ' HB ' ' A' ' 48' ' ' THR . . . -65.14 100.45 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.147 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 47' ' ' ALA . 3.1 t 175.67 -33.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.148 0.499 . . . . 0.0 110.958 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -164.4 -65.69 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.785 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.614 HG21 HG11 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -52.02 174.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.129 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.679 ' O ' HD13 ' A' ' 51' ' ' LEU . 2.3 tm? -54.41 106.15 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.37 . . . . 0.0 110.831 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.92 89.19 2.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.8 134.74 0.4 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.844 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.76 178.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.488 2.125 . . . . 0.0 111.972 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -43.02 94.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.601 2.201 . . . . 0.0 112.368 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 56' ' ' LEU . 2.6 pt? -115.95 151.2 35.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.124 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 39' ' ' ILE . 29.2 mt -84.37 154.1 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.92 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 57' ' ' ILE . 44.3 t -177.81 51.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -175.53 133.86 0.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.971 0.415 . . . . 0.0 111.288 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.433 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -150.58 152.18 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.357 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.99 155.46 17.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.652 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.0 41.63 1.01 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.811 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER 172.19 32.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.589 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -126.73 145.61 54.08 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.73 -31.73 15.28 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.991 2.461 . . . . 0.0 112.591 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.494 ' HA ' HD21 ' A' ' 29' ' ' LEU . . . -58.8 -45.25 90.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.953 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 11.8 tp10 -77.96 -41.9 34.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.775 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.424 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -69.38 -11.77 61.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.402 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.425 ' O ' HG22 ' A' ' 71' ' ' VAL . 1.1 t -52.98 -30.67 36.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.821 0.343 . . . . 0.0 111.112 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.09 27.89 68.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.44 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.638 ' CG2' HG12 ' A' ' 27' ' ' VAL . 2.8 m -152.54 30.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.347 . . . . 0.0 111.179 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.469 HD23 ' OD2' ' A' ' 76' ' ' ASP . 3.3 mt -136.92 162.23 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.75 159.07 43.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.3 mm -75.66 98.05 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.244 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.67 38.52 0.61 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.618 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' OD2' HD23 ' A' ' 72' ' ' LEU . 28.8 m-20 -82.1 126.84 32.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 110.73 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -84.68 90.04 7.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.073 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.029 HG11 HD11 ' A' ' 81' ' ' ILE . 2.1 t -70.66 144.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.522 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -163.42 28.47 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.212 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . 172.16 89.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 111.278 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.029 HD11 HG11 ' A' ' 78' ' ' VAL . 20.4 mt -116.54 115.09 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.785 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 1.0 OUTLIER 49.6 26.75 1.87 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.248 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.12 -44.25 1.55 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.698 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.506 HG21 HD21 ' A' ' 97' ' ' LEU . 6.9 mm -74.35 111.65 13.7 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.531 0.205 . . . . 0.0 111.191 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -91.11 16.65 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.858 2.372 . . . . 0.0 112.777 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.463 ' H ' HG22 ' A' ' 84' ' ' ILE . 11.4 p 55.42 98.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 0.0 110.88 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -87.13 146.04 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 58.79 167.61 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.077 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.9 m -74.77 92.37 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.813 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.98 86.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.954 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -57.92 -23.34 53.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.949 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -54.21 -37.26 64.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.742 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.67 -47.45 85.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.272 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 41' ' ' LEU . . . -57.89 -35.37 70.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.076 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.51 ' HA ' HD23 ' A' ' 98' ' ' LEU . 7.2 m-20 -62.78 -39.4 94.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.178 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -62.34 -40.3 95.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.09 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.506 HD21 HG21 ' A' ' 84' ' ' ILE . 11.7 mt -59.34 -47.04 86.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.617 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -78.01 -26.71 48.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.873 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -73.93 -30.44 62.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.32 7.24 29.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.441 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.448 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -74.22 -17.53 60.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.726 0.298 . . . . 0.0 111.259 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.1 m -59.14 -30.77 68.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.913 0.387 . . . . 0.0 110.615 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.4 mt -57.04 -66.3 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 t -84.98 -2.75 58.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.159 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.661 ' O ' HG23 ' A' ' 30' ' ' THR . 0.9 OUTLIER 64.85 19.6 11.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.244 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.794 ' HD3' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -156.37 153.91 29.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 111.423 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.445 HG12 ' CE2' ' A' ' 37' ' ' PHE . 13.8 p -145.73 143.67 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.19 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -118.16 120.89 39.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.488 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -121.54 132.86 54.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.552 -179.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 26.9 mt-10 -107.26 104.68 14.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.821 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.858 ' CD1' HG23 ' A' ' 25' ' ' THR . 0.2 OUTLIER -110.99 163.89 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -114.52 121.3 43.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.784 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.786 ' O ' HG23 ' A' ' 22' ' ' THR . 39.2 p90 -112.33 140.53 46.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 111.733 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.99 162.95 15.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.144 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.737 HG21 HG22 ' A' ' 20' ' ' VAL . 3.6 m -144.75 -166.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.058 0.456 . . . . 0.0 111.962 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.98 101.55 11.11 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.972 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -60.86 92.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.956 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.824 ' O ' HG23 ' A' ' 20' ' ' VAL . 6.3 mt-30 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.686 0.279 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.7 p 32.89 47.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.478 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.006 HG22 ' HB3' ' A' ' 116' ' ' ALA . 47.5 t -129.61 156.32 41.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.154 0.502 . . . . 0.0 111.571 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.531 ' O ' ' CB ' ' A' ' 22' ' ' THR . 6.6 m-70 64.81 44.59 3.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.899 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 1.1 m 154.05 102.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.85 0.357 . . . . 0.0 111.361 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -147.85 149.77 32.91 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.317 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -88.76 127.12 35.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.814 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.658 HG23 HG13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -114.79 152.4 32.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.244 0.545 . . . . 0.0 111.401 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.32 99.14 6.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.261 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.702 HG21 HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.03 129.53 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.554 -178.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.716 HG22 ' CG2' ' A' ' 108' ' ' THR . 21.3 t -105.17 113.58 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.464 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.539 HD12 ' HD1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -102.12 124.66 48.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.374 . . . . 0.0 110.935 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 67.8 m -105.85 115.31 30.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.08 140.29 44.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.355 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.03 157.36 34.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.41 -1.33 11.5 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.935 2.423 . . . . 0.0 112.753 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 t -104.03 -67.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.33 . . . . 0.0 111.285 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.5 p -105.05 -71.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.62 -72.37 0.28 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.578 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.539 ' HD1' HD12 ' A' ' 29' ' ' LEU . 45.7 m-85 -145.41 -43.88 0.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 111.018 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.4 26.86 70.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.733 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.947 HD13 HD13 ' A' ' 72' ' ' LEU . 1.7 tt -124.55 130.71 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 110.922 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.79 148.08 41.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.876 HD13 ' HB1' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -122.13 120.83 35.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.651 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -82.65 140.76 32.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.422 ' O ' HD11 ' A' ' 51' ' ' LEU . . . -84.31 4.56 83.47 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.827 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.535 ' O ' HD21 ' A' ' 56' ' ' LEU . 10.5 t -126.5 172.35 10.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.804 0.335 . . . . 0.0 111.063 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 46' ' ' PHE . 3.7 p -125.79 -45.29 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.29 0.567 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.456 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -156.25 38.04 0.34 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.002 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.37 98.73 7.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.0 p -58.67 -19.82 42.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.498 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -136.77 144.06 43.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.777 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 51' ' ' LEU . 9.6 m 59.71 165.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.83 HD21 HG21 ' A' ' 90' ' ' THR . 15.0 tp -67.86 151.68 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.902 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.465 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -114.02 -158.64 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.662 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.424 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -50.4 177.56 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.099 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.424 ' HD2' ' CB ' ' A' ' 53' ' ' SER . 99.2 Cg_exo -44.12 154.16 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.616 2.211 . . . . 0.0 112.654 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.586 ' HD3' HG22 ' A' ' 90' ' ' THR . 31.7 Cg_exo -58.2 178.28 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.681 2.254 . . . . 0.0 112.512 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -177.89 141.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.768 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.857 HG21 HD11 ' A' ' 39' ' ' ILE . 23.6 mt -64.02 134.83 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.83 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 t -159.97 42.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -172.44 135.9 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.081 0.467 . . . . 0.0 111.222 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.411 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -151.37 152.52 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.234 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.52 155.24 17.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 111.272 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.67 42.37 0.96 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.138 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.421 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER 168.97 33.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.727 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.57 144.57 44.63 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -43.5 -37.75 8.09 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.798 2.332 . . . . 0.0 112.766 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.44 77.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.991 0.424 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -75.73 -50.52 15.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.683 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.421 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.36 -8.95 57.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.697 -179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.517 ' O ' HG23 ' A' ' 71' ' ' VAL . 42.1 t -56.38 -25.24 49.03 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.806 0.336 . . . . 0.0 110.835 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.08 31.76 81.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.293 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.635 HG11 HG13 ' A' ' 27' ' ' VAL . 5.4 t -143.69 -52.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 0.0 111.067 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.947 HD13 HD13 ' A' ' 39' ' ' ILE . 76.5 mt -58.96 150.44 24.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.018 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -144.09 160.59 40.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.5 mm -71.67 89.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.26 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.19 35.17 0.83 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.784 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.652 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -74.93 130.94 40.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.785 0.326 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -85.32 79.33 9.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.733 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.913 HG11 HD11 ' A' ' 81' ' ' ILE . 5.8 t -56.88 158.53 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.425 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -137.75 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.342 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.21 96.0 4.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.377 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.913 HD11 HG11 ' A' ' 78' ' ' VAL . 21.4 mt -86.63 121.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.775 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.794 ' OD1' HD22 ' A' ' 97' ' ' LEU . 4.2 p-10 44.83 30.51 0.56 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.242 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.96 -37.49 3.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.646 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.682 ' HB ' HD21 ' A' ' 97' ' ' LEU . 4.2 mm -84.77 111.07 32.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.499 0.19 . . . . 0.0 111.208 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -90.54 23.36 0.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.742 2.295 . . . . 0.0 112.72 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 p 54.22 71.77 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.955 0.407 . . . . 0.0 111.059 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.98 -43.5 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -77.11 -68.89 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.68 165.38 11.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.992 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.83 HG21 HD21 ' A' ' 51' ' ' LEU . 2.9 p -107.57 -77.93 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -69.98 -41.07 74.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.34 -38.13 86.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.06 -48.61 75.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.883 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -58.29 -44.74 88.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.176 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -60.26 -39.63 87.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.781 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -62.45 -41.55 98.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.883 HD12 ' HA ' ' A' ' 94' ' ' ALA . 5.2 mt -62.21 -48.17 81.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.55 HD11 HD11 ' A' ' 41' ' ' LEU . 73.9 mt -59.89 -33.85 72.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -29.61 39.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -6.01 49.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.478 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.2 t -79.25 -27.22 42.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.691 0.282 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.2 m -59.43 -34.96 73.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.1 mm -52.48 -46.78 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.496 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.3 t -101.48 -4.32 27.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.098 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER 78.41 -3.31 2.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.77 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.639 ' O ' HG23 ' A' ' 104' ' ' THR . 5.0 ptpt -156.8 165.01 37.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.94 0.4 . . . . 0.0 111.131 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.3 146.54 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.525 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.716 ' CG2' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -109.96 109.56 20.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.299 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.897 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -110.25 143.94 39.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 0.0 111.653 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -106.6 121.43 44.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.93 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.702 HD11 HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -119.4 164.48 15.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.15 0.5 . . . . 0.0 111.984 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -122.57 118.65 28.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.301 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.895 ' CE1' HG12 ' A' ' 115' ' ' VAL . 5.4 p90 -117.84 164.86 14.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.26 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.424 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -114.57 96.78 5.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.764 0.316 . . . . 0.0 110.721 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.895 HG12 ' CE1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER 178.28 -169.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.647 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.006 ' HB3' HG22 ' A' ' 20' ' ' VAL . . . 178.76 142.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.972 0.415 . . . . 0.0 111.507 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -127.03 40.94 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.223 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.831 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.504 ' HB3' HG12 ' A' ' 20' ' ' VAL . 12.3 mt-30 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.916 0.389 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 19' ' ' VAL . 10.6 p -73.21 64.26 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 21' ' ' HIS . 14.4 p -148.66 162.41 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.615 ' O ' ' HB ' ' A' ' 22' ' ' THR . 78.1 m-70 65.36 52.98 1.34 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.246 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' A' ' 21' ' ' HIS . 6.7 t 171.76 111.05 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.959 0.409 . . . . 0.0 110.551 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -168.94 156.09 7.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.408 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 7.9 p -87.68 129.27 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.813 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.431 HG22 ' HD2' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -117.37 148.09 42.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.033 0.444 . . . . 0.0 110.995 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.56 98.98 9.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.627 ' CG1' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -100.96 100.36 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.104 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.6 p -85.38 117.94 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.045 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.962 HD23 HD21 ' A' ' 109' ' ' LEU . 3.5 mm? -111.22 152.9 26.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.8 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 105' ' ' SER . 27.5 m -116.53 150.45 37.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.714 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.79 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -92.58 103.84 16.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.162 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 86.1 m-20 -74.89 154.66 86.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.791 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 32' ' ' ASP . 2.9 Cg_exo -75.21 0.02 9.49 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.762 2.308 . . . . 0.0 112.729 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -66.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.821 0.343 . . . . 0.0 110.981 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -108.96 -43.21 4.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.62 -85.72 0.86 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.79 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 96.4 m-85 -133.27 73.66 1.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.975 0.417 . . . . 0.0 110.098 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.89 10.43 0.56 Allowed Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.135 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 66' ' ' ALA . 13.1 tt -96.16 130.25 45.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.891 0.377 . . . . 0.0 110.788 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.72 136.8 50.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -127.64 114.79 17.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.029 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.09 151.77 34.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.34 21.62 45.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.576 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 t -177.01 -172.73 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.965 0.412 . . . . 0.0 111.097 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.848 HG23 ' HB3' ' A' ' 53' ' ' SER . 58.7 t -110.93 -3.82 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.541 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.4 87.33 1.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.369 . . . . 0.0 110.853 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.37 80.04 9.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.128 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 m -165.91 -40.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 111.19 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.82 140.6 0.97 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.57 77.8 0.31 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 51' ' ' LEU . 6.7 tt -97.49 124.24 41.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.17 23.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.419 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.848 ' HB3' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -109.76 149.03 39.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.942 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.0 171.12 2.32 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.636 2.224 . . . . 0.0 112.148 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.84 ' O ' HD12 ' A' ' 56' ' ' LEU . 53.9 Cg_endo -69.48 154.1 69.31 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.478 2.119 . . . . 0.0 112.245 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 55' ' ' PRO . 4.8 mp -149.2 127.45 12.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.014 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 76' ' ' ASP . 69.7 mt -75.63 141.15 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.616 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.935 ' HA ' HG23 ' A' ' 74' ' ' ILE . 46.7 t -164.04 49.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.723 0.297 . . . . 0.0 111.683 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' O ' HG13 ' A' ' 39' ' ' ILE . 70.4 t80 -176.15 133.81 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.031 0.443 . . . . 0.0 111.504 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.411 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.33 152.05 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.035 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.92 155.5 18.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 111.357 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.27 43.49 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.842 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.84 32.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.609 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -121.47 144.62 40.63 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.04 -35.2 4.47 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.812 2.341 . . . . 0.0 112.86 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 39' ' ' ILE . . . -60.67 -44.36 96.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.9 OUTLIER -71.15 -46.73 60.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.842 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -8.68 57.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.633 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.48 ' SG ' HG22 ' A' ' 71' ' ' VAL . 53.5 t -52.0 -40.9 61.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.894 0.378 . . . . 0.0 111.006 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.57 -27.4 15.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.466 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.627 HG23 ' CG1' ' A' ' 27' ' ' VAL . 30.2 m -117.51 26.12 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.757 0.313 . . . . 0.0 111.303 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 66' ' ' ALA . 5.9 mt -124.82 143.48 50.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -169.12 153.39 5.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.785 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.935 HG23 ' HA ' ' A' ' 58' ' ' SER . 40.9 mt -59.34 110.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.53 -15.56 3.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.767 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.559 ' HB2' HD12 ' A' ' 57' ' ' ILE . 65.0 m-20 -59.04 139.32 56.97 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.814 0.34 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.28 96.16 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.08 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.665 HG22 ' CG2' ' A' ' 111' ' ' ILE . 2.8 t -65.33 152.04 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.2 tpt -137.05 -63.28 0.61 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.232 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -125.2 93.9 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.338 . . . . 0.0 111.356 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.885 HG23 ' HB3' ' A' ' 109' ' ' LEU . 10.6 mt -82.66 124.08 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.433 ' OD1' HG22 ' A' ' 81' ' ' ILE . 4.1 p-10 44.35 31.77 0.62 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.154 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.09 -37.57 3.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.3 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 86' ' ' THR . 4.2 mm -85.75 112.66 46.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.57 0.224 . . . . 0.0 111.179 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -89.17 19.87 1.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.632 2.222 . . . . 0.0 112.716 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.431 ' H ' HG22 ' A' ' 84' ' ' ILE . 1.9 p 63.13 129.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.998 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -155.49 149.3 25.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.719 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.32 25.65 15.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.0 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 m 179.96 -48.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.674 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.55 -71.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.298 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.22 -48.23 57.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.246 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -69.04 -43.59 74.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -63.41 -45.33 91.48 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.82 0.343 . . . . 0.0 110.7 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.67 -45.99 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.678 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.08 -38.04 78.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.241 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -62.68 -46.38 88.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.472 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.63 -31.72 71.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.182 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -78.06 -31.49 50.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.612 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.24 -30.62 38.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.87 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -10.58 59.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.243 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.532 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 16.6 m -72.43 -19.33 61.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.041 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.5 p -65.91 -37.09 85.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.882 0.373 . . . . 0.0 110.746 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -58.55 -55.77 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.3 p -83.19 -9.48 59.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.992 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.79 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER 62.28 17.21 9.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.347 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' HG22 ' A' ' 28' ' ' VAL . 2.9 tppt? -156.81 146.18 20.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 0.0 111.021 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.414 ' HB ' ' OG ' ' A' ' 101' ' ' SER . 11.7 p -154.8 149.89 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 28' ' ' VAL . 1.2 p -122.65 124.84 44.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.059 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.962 HD21 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -125.15 148.22 48.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.088 0.47 . . . . 0.0 111.993 -179.048 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -102.1 129.65 48.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.693 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.665 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -138.39 156.62 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.923 0.392 . . . . 0.0 111.815 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -93.9 126.11 38.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.248 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 24.5 p90 -118.95 164.58 15.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.672 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -120.61 97.73 5.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.493 HG22 ' N ' ' A' ' 116' ' ' ALA . 15.0 p -95.0 158.72 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.227 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 115' ' ' VAL . . . -109.1 55.49 0.63 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.009 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -149.67 98.25 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.871 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.835 0.35 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.8 p -82.52 105.2 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.878 HG21 HG22 ' A' ' 115' ' ' VAL . 31.5 m -62.99 -166.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.554 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 22' ' ' THR . 0.1 OUTLIER 171.12 34.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.813 HG23 ' O ' ' A' ' 113' ' ' PHE . 57.0 m 58.99 146.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.997 0.427 . . . . 0.0 111.352 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HG2' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -178.6 166.9 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.174 179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.2 p -90.31 131.83 35.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.108 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.469 HG23 HD11 ' A' ' 111' ' ' ILE . 5.2 t -116.26 133.62 55.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.031 0.443 . . . . 0.0 111.936 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.34 98.98 10.43 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.552 ' CG1' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -100.88 119.17 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.723 -178.556 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 28' ' ' VAL . 13.6 p -88.73 113.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.965 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 66' ' ' ALA . 3.5 mm? -104.84 164.77 11.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.567 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 105' ' ' SER . 37.6 m -127.2 146.0 50.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.871 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -82.87 97.49 8.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.148 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.34 142.47 90.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.64 -3.86 14.45 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.61 2.207 . . . . 0.0 112.785 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.73 -61.0 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 t -125.57 -41.22 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.01 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.1 -105.06 0.49 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.462 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.695 ' CE1' HG12 ' A' ' 107' ' ' VAL . 96.6 m-85 -113.85 -28.97 7.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.767 0.318 . . . . 0.0 111.005 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.26 47.28 83.09 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.836 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.838 HD13 HD13 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -146.87 127.63 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 0.0 111.075 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.58 147.87 46.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.909 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.83 ' O ' HD12 ' A' ' 41' ' ' LEU . 2.8 pp -131.68 127.0 36.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -67.33 171.36 6.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.77 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.402 ' N ' ' HB3' ' A' ' 91' ' ' PHE . . . -90.6 -134.98 6.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.617 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 53' ' ' SER . 0.8 OUTLIER -104.37 -169.3 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.04 0.447 . . . . 0.0 111.172 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.681 HG13 ' N ' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -84.31 -161.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.456 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.681 ' N ' HG13 ' A' ' 45' ' ' VAL . 46.9 m-85 54.48 26.95 7.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 111.009 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.47 133.91 26.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m 61.32 -120.97 0.79 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.403 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.43 -77.87 0.5 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.84 0.352 . . . . 0.0 110.741 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -63.15 -166.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.705 HD11 HD21 ' A' ' 56' ' ' LEU . 12.5 tp 66.71 140.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.245 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.552 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -149.07 163.96 36.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.857 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 68.45 162.13 0.14 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.818 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 78.3 Cg_exo -50.45 -175.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.707 2.271 . . . . 0.0 112.457 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 54' ' ' PRO . 72.2 Cg_exo -48.76 136.03 27.91 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.099 . . . . 0.0 112.274 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.705 HD21 HD11 ' A' ' 51' ' ' LEU . 1.3 pt? -152.09 145.53 24.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.205 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.631 HD11 HG22 ' A' ' 78' ' ' VAL . 8.5 mt -77.59 143.49 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.612 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 t -162.79 48.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.281 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -172.9 131.54 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.099 0.476 . . . . 0.0 111.389 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.685 HG13 HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -149.61 152.31 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.031 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.83 155.45 17.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 111.261 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.63 39.88 0.9 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.752 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 175.55 29.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.773 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.62 136.14 26.94 Favored Pre-proline 0 C--O 1.231 0.127 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 92.2 Cg_exo -43.52 -29.24 2.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.622 2.214 . . . . 0.0 112.807 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.521 ' HB1' HD13 ' A' ' 39' ' ' ILE . . . -62.72 -42.08 99.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.932 0.396 . . . . 0.0 111.01 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.462 ' HB2' HG22 ' A' ' 60' ' ' ILE . 5.8 tp10 -78.31 -49.61 13.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -72.14 -8.19 53.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.655 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.76 -28.03 14.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 111.001 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.0 26.36 69.05 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.66 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' CG1' ' A' ' 27' ' ' VAL . 1.1 m -145.5 -47.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 111.117 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.838 HD13 HD13 ' A' ' 39' ' ' ILE . 27.1 mt -58.76 156.56 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -163.18 156.07 18.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.685 HD11 HG13 ' A' ' 60' ' ' ILE . 30.3 mm -70.21 97.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.44 40.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.712 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB3' HD12 ' A' ' 57' ' ' ILE . 2.3 m-20 -101.42 153.22 19.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.641 0.258 . . . . 0.0 110.508 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -111.91 82.93 1.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.167 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.745 HG21 HD22 ' A' ' 41' ' ' LEU . 3.6 t -61.8 143.48 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -168.67 34.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.642 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.917 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 174.26 54.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.849 0.357 . . . . 0.0 111.271 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.742 HD11 HG11 ' A' ' 78' ' ' VAL . 25.5 mt -76.12 118.16 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.445 ' OD1' HG22 ' A' ' 81' ' ' ILE . 0.9 OUTLIER 44.89 30.79 0.59 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.271 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.72 -35.43 5.07 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.38 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 mm -78.68 110.83 15.51 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 121.999 0.119 . . . . 0.0 111.198 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -86.17 99.67 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.563 2.175 . . . . 0.0 112.411 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 94' ' ' ALA . 71.2 p -69.96 119.47 14.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.026 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.07 74.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.0 -76.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.8 p -178.16 -39.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 t -85.5 101.11 12.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.402 ' HB3' ' N ' ' A' ' 43' ' ' GLY . 45.0 p90 -66.55 -22.28 66.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -53.37 -30.6 40.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.079 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 20.4 pt-20 -62.91 -47.15 84.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.168 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.917 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -59.21 -41.09 87.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -61.18 -42.3 98.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.791 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -62.73 -34.8 77.92 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.764 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 94' ' ' ALA . 8.8 mt -68.13 -37.75 81.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.631 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.9 -41.65 59.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -68.16 -31.89 71.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.993 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -5.13 49.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.35 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.417 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 69.7 m -69.62 -13.9 62.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.261 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -58.56 -28.38 65.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.0 mm -54.83 -30.9 23.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.172 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -117.45 -4.5 11.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.223 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.682 ' O ' HG23 ' A' ' 30' ' ' THR . 1.4 m 62.91 21.46 12.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.211 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 5.6 mttt -156.12 151.21 26.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.0 110.956 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.695 HG12 ' CE1' ' A' ' 37' ' ' PHE . 13.2 p -150.08 111.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.88 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.435 HG23 HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -90.87 107.29 19.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.36 150.5 23.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 111.41 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.917 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 3.6 tt0 -123.57 105.17 9.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.195 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.688 HG22 HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -111.04 159.71 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.097 0.475 . . . . 0.0 111.925 -178.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -110.18 118.49 36.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.517 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.813 ' O ' HG23 ' A' ' 22' ' ' THR . 14.6 p90 -121.61 154.02 37.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.343 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.04 97.8 5.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.878 HG22 HG21 ' A' ' 20' ' ' VAL . 1.3 p -80.75 145.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.743 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.97 126.63 30.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.283 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.666 ' HA ' HG22 ' A' ' 20' ' ' VAL . 1.4 mp0 -68.55 135.01 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.834 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.894 0.378 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.71 149.21 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.235 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 p -58.05 141.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.401 ' CB ' ' HB ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -87.26 157.79 19.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.027 0.441 . . . . 0.0 111.079 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.9 108.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.034 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 mt-10 -148.34 173.79 12.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.084 0.468 . . . . 0.0 111.423 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 112' ' ' GLU . 44.8 p -108.42 134.15 51.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.288 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.666 HG23 HG13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -111.96 144.52 41.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.083 0.468 . . . . 0.0 111.691 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.9 pt-20 -104.07 100.17 9.93 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.676 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -99.87 102.85 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.826 -178.001 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.976 HG23 HG23 ' A' ' 108' ' ' THR . 9.2 p -86.2 115.55 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.41 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.438 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 7.6 mt -115.58 152.44 33.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.018 0.437 . . . . 0.0 111.339 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 105' ' ' SER . 97.9 m -113.78 137.54 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.616 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -68.7 107.01 2.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.02 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.35 142.53 86.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.06 55.3 5.59 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.796 2.331 . . . . 0.0 112.482 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 t -153.2 -69.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.013 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -116.8 -24.55 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.18 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.67 -112.63 2.29 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.323 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.572 ' CE2' HG12 ' A' ' 107' ' ' VAL . 21.5 m-85 -113.03 -23.28 10.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 0.0 111.139 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 58.85 54.23 39.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.863 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 57' ' ' ILE . 2.0 tt -147.88 127.2 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.731 0.3 . . . . 0.0 110.747 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.51 147.06 38.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.066 0.46 . . . . 0.0 111.53 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.657 HD23 HG13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -121.25 169.09 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.372 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -147.11 149.04 32.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.879 0.371 . . . . 0.0 111.06 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.74 36.62 3.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.35 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.443 ' O ' HD21 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -143.01 128.52 19.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.944 0.402 . . . . 0.0 111.072 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.69 HG22 HD22 ' A' ' 56' ' ' LEU . 85.4 t -115.11 -32.86 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.027 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 178.69 115.14 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.801 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -169.5 54.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.121 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.4 m 67.6 -71.06 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.09 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -143.75 -62.48 0.39 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.746 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.7 t -55.88 -170.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.137 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.567 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.2 pt? -112.96 149.84 32.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -175.43 24.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.66 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -129.09 159.31 69.52 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.724 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.25 152.04 8.7 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.52 2.146 . . . . 0.0 112.319 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.21 128.22 16.21 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.488 2.126 . . . . 0.0 112.345 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.69 HD22 HG22 ' A' ' 45' ' ' VAL . 2.1 pt? -135.65 160.01 39.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.939 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.758 HG21 HD11 ' A' ' 39' ' ' ILE . 5.6 mt -85.96 143.9 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.736 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.488 ' HA ' HG23 ' A' ' 74' ' ' ILE . 11.5 m -165.32 50.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.29 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -176.52 132.76 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.979 0.419 . . . . 0.0 111.42 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.402 HG21 ' HA ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -149.15 152.26 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.059 179.541 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.58 155.45 16.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.164 0.507 . . . . 0.0 111.275 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.67 38.85 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.846 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.0 t0 179.08 28.69 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.772 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.41 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 33.4 m -124.35 139.19 32.37 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.591 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 2.8 Cg_endo -45.51 -27.95 3.82 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.865 2.377 . . . . 0.0 112.77 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.64 96.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.846 0.355 . . . . 0.0 110.843 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' HA ' HG21 ' A' ' 60' ' ' ILE . 3.6 tp10 -78.56 -48.43 15.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.05 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -73.06 -7.23 50.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.893 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.72 -25.89 4.88 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.841 0.353 . . . . 0.0 111.175 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.87 25.27 73.12 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.559 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.644 ' O ' HG22 ' A' ' 71' ' ' VAL . 14.4 p -158.07 29.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.034 0.445 . . . . 0.0 110.874 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 mt -135.82 151.96 50.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.715 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -151.37 172.2 16.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.488 HG23 ' HA ' ' A' ' 58' ' ' SER . 22.3 mm -83.01 73.0 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.77 37.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.66 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.7 123.07 48.35 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.75 105.85 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 111.744 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.865 ' CG1' HG23 ' A' ' 111' ' ' ILE . 1.3 m -71.45 138.26 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -148.05 21.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.261 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -174.26 59.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.931 0.396 . . . . 0.0 111.319 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 78' ' ' VAL . 32.3 mt -88.65 124.61 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 44.24 31.21 0.53 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.324 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.31 -46.67 1.18 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 86' ' ' THR . 8.4 mm -70.33 112.57 13.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.553 0.216 . . . . 0.0 111.166 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.12 13.61 2.69 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.636 2.224 . . . . 0.0 112.819 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.536 ' H ' HG22 ' A' ' 84' ' ' ILE . 21.0 p 54.04 79.51 0.13 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.802 0.334 . . . . 0.0 111.055 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -84.52 63.69 8.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.82 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.632 ' HB3' HG22 ' A' ' 90' ' ' THR . 0.3 OUTLIER -174.55 166.07 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.3 t -99.07 31.37 3.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.632 HG22 ' HB3' ' A' ' 88' ' ' ASP . 4.2 t -118.16 114.04 22.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -58.3 -23.92 57.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -54.74 -31.46 58.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.7 -53.48 50.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.521 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HB3' HD13 ' A' ' 41' ' ' LEU . . . -57.68 -42.08 82.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.685 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -39.48 77.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.286 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -62.97 -41.49 99.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.341 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.419 HD12 HD12 ' A' ' 81' ' ' ILE . 13.3 mt -58.77 -41.9 87.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.591 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.3 mt -77.87 -30.67 50.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.82 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -38.98 92.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -75.33 -7.15 53.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.4 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.473 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 8.7 m -63.95 -22.19 66.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.972 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.89 -39.44 81.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.787 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.8 mm -49.3 -65.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.472 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 106' ' ' LYS . 7.6 t -84.32 -4.81 59.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.039 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.838 ' O ' HG23 ' A' ' 30' ' ' THR . 0.4 OUTLIER 63.0 21.0 12.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.236 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.764 ' HD2' HG22 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -156.41 150.14 24.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.247 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.572 HG12 ' CE2' ' A' ' 37' ' ' PHE . 9.4 p -155.33 145.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.617 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.976 HG23 HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -122.23 108.89 13.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.295 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -103.48 128.36 50.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.041 0.448 . . . . 0.0 111.836 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -92.41 107.46 19.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.634 178.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.865 HG23 ' CG1' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -109.36 159.9 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.22 0.533 . . . . 0.0 112.152 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.582 ' HG3' HG22 ' A' ' 24' ' ' THR . 6.5 tt0 -118.83 121.97 41.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.783 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.405 ' CD1' ' O ' ' A' ' 23' ' ' GLU . 52.0 p90 -112.31 135.49 52.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -112.8 97.56 6.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.42 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.401 ' HB ' ' CB ' ' A' ' 21' ' ' HIS . 3.0 t -75.79 152.0 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.247 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.16 53.08 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -128.65 47.9 2.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.842 179.938 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.712 0.291 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.492 ' O ' HG22 ' A' ' 19' ' ' VAL . 13.0 p 34.54 47.67 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.253 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.807 HG22 HG23 ' A' ' 115' ' ' VAL . 14.9 p -148.91 153.23 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.781 ' CB ' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -58.89 -161.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.91 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.622 HG23 ' HA ' ' A' ' 114' ' ' ASP . 93.3 m 115.36 120.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.962 0.905 . . . . 0.0 109.503 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -178.44 177.97 0.9 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.989 0.423 . . . . 0.0 111.585 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.525 HG22 ' HB2' ' A' ' 112' ' ' GLU . 68.1 p -87.23 143.14 27.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.509 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 t -132.72 135.09 45.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.6 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.02 99.25 11.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.645 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -103.51 130.48 53.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' VAL . 9.6 p -82.97 122.06 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.092 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.508 HD11 ' HA ' ' A' ' 66' ' ' ALA . 1.7 mm? -116.09 147.97 40.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.635 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 105' ' ' SER . 74.5 m -130.43 144.13 51.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.872 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -82.84 147.53 28.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.098 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 2.4 m-20 -110.61 156.13 41.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 32' ' ' ASP . 3.1 Cg_exo -80.15 0.11 10.26 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.938 2.425 . . . . 0.0 112.424 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 t -91.25 -55.22 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.157 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 t -135.31 -46.69 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.27 -111.99 0.6 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.452 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.872 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 67.0 m-85 -109.17 -24.86 10.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.766 0.317 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 64.88 42.94 96.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.934 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -143.41 128.4 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.875 0.369 . . . . 0.0 110.689 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.439 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -116.22 150.37 37.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 111.458 -179.425 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.783 HD13 ' CB ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -119.83 160.89 21.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.474 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.93 158.67 25.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 111.111 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.88 88.31 1.2 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.381 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.0 t -162.38 112.25 1.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 0.0 110.748 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 53' ' ' SER . 44.8 t -107.73 -18.19 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.48 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.54 -26.42 6.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.219 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 46.71 42.19 11.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.607 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.8 m -92.52 -65.43 1.0 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.836 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -151.78 -81.3 0.1 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.719 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.2 t -69.17 166.05 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 52' ' ' SER . 1.1 tt -119.58 121.11 38.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.957 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.55 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -163.6 23.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.578 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.659 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -113.35 151.82 44.7 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.897 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -51.22 153.92 8.77 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.726 2.284 . . . . 0.0 112.425 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.664 ' C ' HD13 ' A' ' 56' ' ' LEU . 97.7 Cg_endo -79.26 154.59 24.98 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.727 2.285 . . . . 0.0 112.592 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.664 HD13 ' C ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -160.54 -178.67 7.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.871 HG21 HD11 ' A' ' 39' ' ' ILE . 26.5 mt -87.18 141.19 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.698 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 m -161.85 49.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.392 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.439 ' CG ' ' HB2' ' A' ' 40' ' ' GLN . 24.4 t80 -177.36 132.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 111.462 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.407 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -151.88 152.54 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.982 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.83 155.02 17.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 111.401 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.73 42.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.856 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.408 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER 170.4 31.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.821 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.411 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 3.9 m -122.84 145.29 45.08 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.002 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.54 -37.48 11.07 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.073 2.515 . . . . 0.0 112.6 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.508 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -58.51 -38.51 77.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 1.2 tm-20 -78.24 -51.97 9.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.856 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.408 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -67.03 -11.27 56.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.827 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -24.65 51.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 110.874 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.31 30.58 73.55 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.174 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.536 ' CB ' HG11 ' A' ' 27' ' ' VAL . 4.4 t -145.47 -54.46 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.093 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.9 mt -59.58 145.67 43.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -160.88 167.87 25.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.778 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.7 mm -70.24 67.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.74 38.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.474 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.478 ' HB3' HG21 ' A' ' 111' ' ' ILE . 56.2 m-20 -109.59 107.52 17.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.733 0.301 . . . . 0.0 110.554 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -82.21 93.89 7.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.306 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.901 ' HB ' HD11 ' A' ' 81' ' ' ILE . 30.5 m -58.63 123.57 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.703 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.0 ttp -118.37 -16.01 9.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.808 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -167.12 98.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 111.551 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.901 HD11 ' HB ' ' A' ' 78' ' ' VAL . 3.9 mp -103.12 113.27 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.5 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 45.87 29.94 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.224 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.31 -44.38 1.52 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.767 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 86' ' ' THR . 5.2 mm -80.89 113.74 42.87 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.505 0.193 . . . . 0.0 111.166 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.81 0.84 9.71 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.509 2.139 . . . . 0.0 112.866 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.705 ' CG2' HD13 ' A' ' 81' ' ' ILE . 2.5 p 59.9 22.28 11.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.045 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 55.7 -178.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 0.0 110.963 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -110.53 29.61 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 p -177.59 38.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.4 m -154.31 75.82 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -60.64 -26.05 66.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.057 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.78 -35.44 68.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.053 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.7 mt-10 -64.38 -45.66 86.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.71 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.783 ' CB ' HD13 ' A' ' 41' ' ' LEU . . . -57.8 -49.16 77.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -60.12 -34.82 74.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.525 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.61 -41.11 98.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.568 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 94' ' ' ALA . 3.6 mt -70.08 -30.56 67.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.462 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 94' ' ' ALA . 3.4 mm? -64.08 -46.44 84.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.927 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -73.64 -29.76 62.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.061 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -75.0 -5.61 44.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.503 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.445 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 58.1 m -66.44 -22.06 66.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 0.0 111.196 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -58.66 -27.31 64.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.007 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.5 mm -57.35 -48.98 81.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.477 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -100.79 -14.81 17.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.284 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER 77.57 -3.79 2.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.949 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -156.78 129.62 7.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.858 0.361 . . . . 0.0 111.029 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.441 HG21 ' OG ' ' A' ' 101' ' ' SER . 0.0 OUTLIER -120.38 166.82 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.86 106.75 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.794 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.93 138.28 35.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.001 0.429 . . . . 0.0 111.881 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -116.2 104.62 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.821 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.645 HD11 ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -120.28 149.02 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.525 ' HB2' HG22 ' A' ' 24' ' ' THR . 49.0 tt0 -103.62 118.79 37.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.871 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -115.76 144.13 44.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.301 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.622 ' HA ' HG23 ' A' ' 22' ' ' THR . 13.0 m-20 -100.01 162.19 13.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.494 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.807 HG23 HG22 ' A' ' 20' ' ' VAL . 3.2 m -134.0 171.61 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.306 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.466 ' O ' HG21 ' A' ' 20' ' ' VAL . . . -57.08 105.6 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.322 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.604 ' HG2' HG11 ' A' ' 20' ' ' VAL . 27.4 mt-10 -73.62 83.61 1.56 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.974 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.029 179.831 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.801 0.334 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.558 ' O ' HG13 ' A' ' 19' ' ' VAL . 11.3 p -74.39 113.98 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.154 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 20' ' ' VAL . 11.3 p -122.95 124.92 71.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.64 ' O ' HG23 ' A' ' 22' ' ' THR . 11.2 m170 -87.85 173.23 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.908 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 21' ' ' HIS . 0.1 OUTLIER 173.08 108.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.202 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.402 ' O ' ' CD2' ' A' ' 113' ' ' PHE . 1.1 mt-10 -151.68 176.56 11.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 0.0 111.26 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 p -103.71 140.79 37.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.412 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.828 HG23 ' CD1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -116.89 142.07 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.064 0.459 . . . . 0.0 111.441 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.62 98.93 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.783 HG23 HD12 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -102.91 131.24 51.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.0 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.845 HG22 HG22 ' A' ' 108' ' ' THR . 12.3 t -107.62 113.4 43.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.179 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 65' ' ' PRO . 3.1 mm? -99.91 164.29 12.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.335 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 105' ' ' SER . 17.0 m -117.5 132.24 56.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 110.819 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.775 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -79.35 91.64 5.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.163 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.15 140.87 94.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.63 -4.96 16.28 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.476 2.117 . . . . 0.0 112.846 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.7 t -99.69 -54.18 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.066 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.446 HG23 ' N ' ' A' ' 36' ' ' GLY . 10.9 t -108.3 -47.15 3.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' N ' HG23 ' A' ' 35' ' ' THR . . . 97.45 -91.17 1.17 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.672 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.775 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 80.9 m-85 -141.61 77.92 1.61 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.938 0.399 . . . . 0.0 110.223 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.48 18.93 0.4 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.072 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.744 HD11 HG21 ' A' ' 57' ' ' ILE . 3.4 tt -96.35 130.02 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.91 0.355 . . . . 0.0 110.611 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.603 ' C ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -111.07 145.81 37.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.987 0.422 . . . . 0.0 111.463 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.696 HD22 HG12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -122.01 156.98 32.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.479 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -124.82 147.6 48.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.915 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.749 ' O ' HD11 ' A' ' 51' ' ' LEU . . . -95.59 25.34 25.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.556 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.9 p -143.7 129.18 19.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 110.752 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.433 HG22 HD22 ' A' ' 56' ' ' LEU . 58.9 t -94.88 -74.98 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.64 88.22 0.7 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.948 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.44 114.86 8.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.06 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -58.44 -20.41 44.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.468 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -154.64 145.54 22.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.924 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.92 162.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.749 HD11 ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -113.41 100.56 8.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.43 20.97 12.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.3 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.405 ' HB2' HG23 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -127.77 120.04 21.56 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.15 167.89 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.405 2.07 . . . . 0.0 112.274 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.71 168.12 12.33 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.55 2.167 . . . . 0.0 112.149 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.563 ' N ' HD23 ' A' ' 56' ' ' LEU . 2.3 pt? -167.91 152.94 6.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.97 0.414 . . . . 0.0 111.109 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.744 HG21 HD11 ' A' ' 39' ' ' ILE . 47.7 mt -72.9 152.48 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.835 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.18 44.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.537 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -176.58 129.38 0.19 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.209 0.528 . . . . 0.0 111.854 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.509 HD13 HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -142.21 152.14 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.374 179.213 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 63' ' ' ASP . 5.5 tp10 -109.88 154.93 22.36 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.078 0.466 . . . . 0.0 111.858 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.29 42.04 0.15 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.016 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER 175.11 31.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.192 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -122.21 135.05 25.09 Favored Pre-proline 0 CA--C 1.527 0.075 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.665 ' HB2' HD12 ' A' ' 29' ' ' LEU . 3.5 Cg_endo -46.37 -30.54 8.34 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.506 2.137 . . . . 0.0 112.424 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.734 ' HA ' HD21 ' A' ' 72' ' ' LEU . . . -70.08 -33.27 71.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.768 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.452 ' HA ' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -75.04 -49.93 18.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.844 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.419 ' NH2' ' C ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -79.31 -8.26 58.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.943 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.53 -34.78 37.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.772 0.32 . . . . 0.0 111.082 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.26 27.12 70.13 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.591 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 72' ' ' LEU . 11.2 p -136.08 -45.3 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.629 0.252 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.734 HD21 ' HA ' ' A' ' 66' ' ' ALA . 2.5 pp -77.99 163.04 26.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.013 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.59 165.29 29.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.865 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.51 75.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.085 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.8 40.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.776 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.524 ' HB2' HD12 ' A' ' 57' ' ' ILE . 45.8 m-20 -99.95 119.13 37.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 110.56 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -86.13 85.64 7.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.218 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 111' ' ' ILE . 3.5 t -65.54 138.64 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.118 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.2 ttp -171.14 34.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.128 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.807 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -179.88 49.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.13 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.638 HD11 HG11 ' A' ' 78' ' ' VAL . 8.7 mt -73.0 117.68 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER 45.55 30.48 0.77 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.56 -37.65 3.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.096 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.778 HG21 HD21 ' A' ' 97' ' ' LEU . 7.7 mm -74.28 112.04 15.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.552 0.215 . . . . 0.0 111.137 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -89.98 32.61 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.676 2.251 . . . . 0.0 112.488 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 p 58.29 22.28 9.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 47.95 94.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.487 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 t70 63.71 -77.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.276 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -164.13 120.25 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.89 0.376 . . . . 0.0 111.071 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -179.67 98.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.636 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -55.35 -33.05 63.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.171 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -43.02 83.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.839 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -41.31 97.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.799 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.73 -48.33 79.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.503 ' HA ' HD21 ' A' ' 98' ' ' LEU . 9.8 m-80 -61.86 -34.73 76.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.496 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -35.98 82.02 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.51 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 94' ' ' ALA . 4.6 mt -69.74 -48.24 60.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.996 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HA ' HG21 ' A' ' 107' ' ' VAL . 3.2 pp -70.1 -37.02 75.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.157 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.548 ' N ' HD12 ' A' ' 98' ' ' LEU . 4.7 mtt85 -69.87 -30.41 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.81 0.338 . . . . 0.0 111.009 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -89.16 4.78 47.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.369 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.453 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 0.4 OUTLIER -83.12 -12.12 57.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.338 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.5 p -57.68 -24.77 58.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.714 0.292 . . . . 0.0 110.887 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.7 mm -56.36 -31.51 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.954 0.406 . . . . 0.0 110.896 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -114.34 -5.93 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.058 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.583 ' O ' HG23 ' A' ' 30' ' ' THR . 8.9 t 69.42 23.81 5.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.399 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.583 ' HD3' HG11 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -156.23 150.38 25.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.952 0.406 . . . . 0.0 111.282 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.606 HG21 ' HA ' ' A' ' 98' ' ' LEU . 13.9 p -144.14 136.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.28 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.845 HG22 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -111.32 113.39 25.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.225 179.471 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.783 HD12 HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -113.97 125.2 53.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.966 0.412 . . . . 0.0 111.369 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.807 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 12.9 tt0 -101.32 105.0 16.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.871 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.907 HG22 HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -110.2 164.3 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 121.08 0.467 . . . . 0.0 112.07 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -104.19 120.41 41.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.916 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 23' ' ' GLU . 45.0 p90 -108.69 139.97 42.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.29 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.01 97.71 6.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.301 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 21' ' ' HIS . 2.4 t -71.76 144.14 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.158 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.87 48.03 1.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.965 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -142.47 60.72 1.44 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.8 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.767 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.903 0.383 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 19' ' ' VAL . 24.0 t -89.1 54.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.085 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.436 ' O ' ' CG ' ' A' ' 21' ' ' HIS . 20.8 t -144.39 155.76 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.057 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.67 ' O ' HG23 ' A' ' 22' ' ' THR . 13.8 p-80 43.68 63.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.863 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 21' ' ' HIS . 0.2 OUTLIER 166.52 102.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.135 179.541 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 22.2 mt-10 -162.29 143.99 10.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.943 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 69.5 p -91.94 127.12 37.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.62 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.812 HG23 ' CD1' ' A' ' 111' ' ' ILE . 1.6 t -115.72 136.59 52.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 111.204 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.71 99.83 11.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.022 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.473 HG11 HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -106.61 129.01 60.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -179.266 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.681 HG22 ' CG2' ' A' ' 108' ' ' THR . 19.5 t -94.3 120.62 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.176 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB2' HD21 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -111.17 123.91 51.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.855 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 105' ' ' SER . 28.7 m -105.62 141.64 36.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.717 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.65 136.39 37.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.226 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.49 141.91 23.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.828 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.35 55.87 5.28 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.78 2.32 . . . . 0.0 112.56 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -155.41 -64.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.162 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -114.14 -44.48 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.93 -115.57 2.93 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.406 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.694 ' HB3' HG22 ' A' ' 39' ' ' ILE . 54.0 m-85 -113.96 -28.85 7.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.682 0.277 . . . . 0.0 110.971 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.99 24.64 43.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.691 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.748 HD11 HG21 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -130.44 140.55 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.967 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.702 ' C ' HD13 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -139.54 164.81 28.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.099 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.702 HD13 ' C ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -117.28 160.07 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.7 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.19 171.67 3.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.957 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.12 75.52 1.0 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.571 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.417 ' O ' HD22 ' A' ' 51' ' ' LEU . 15.6 p -100.84 -167.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.5 t -60.48 -17.78 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.563 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.12 84.39 2.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.633 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 51' ' ' LEU . . . -122.54 131.67 53.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.253 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -73.35 63.5 0.76 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.5 34.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.081 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.1 m 53.45 82.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.206 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 52' ' ' SER . 6.8 tt -151.98 135.28 15.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.745 ' N ' HD23 ' A' ' 51' ' ' LEU . 1.7 m -135.32 97.59 3.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.003 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 170.52 156.67 0.2 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.43 168.62 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.319 2.013 . . . . 0.0 112.005 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.42 137.07 38.63 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.465 2.11 . . . . 0.0 112.253 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.747 HD22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -131.9 153.34 50.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 0.0 110.952 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.748 HG21 HD11 ' A' ' 39' ' ' ILE . 12.1 mt -59.87 145.39 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.684 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.881 ' HA ' HG23 ' A' ' 74' ' ' ILE . 3.0 m -165.37 44.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.801 0.334 . . . . 0.0 111.557 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.593 ' O ' HD12 ' A' ' 39' ' ' ILE . 30.8 t80 -169.97 133.57 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.174 0.511 . . . . 0.0 111.534 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.423 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -151.88 152.52 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.879 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 1.4 mt-10 -103.55 155.39 18.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.065 0.46 . . . . 0.0 111.426 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.89 39.44 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.8 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.03 29.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.684 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.37 142.15 34.77 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.624 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.487 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 97.0 Cg_exo -43.07 -29.48 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.65 2.233 . . . . 0.0 112.87 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.407 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -62.89 -40.26 97.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 2.4 mm-40 -78.12 -52.92 8.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.728 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.84 -8.63 55.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.743 -179.413 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -38.37 56.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.811 0.339 . . . . 0.0 110.952 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.97 -18.66 55.55 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.819 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.473 HG23 HG11 ' A' ' 27' ' ' VAL . 7.7 m -128.09 39.24 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.836 0.35 . . . . 0.0 111.188 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -139.78 143.84 37.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -169.12 152.91 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.713 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 58' ' ' SER . 24.9 mt -58.36 107.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.048 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.22 -25.34 1.41 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.406 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.452 ' CB ' HD12 ' A' ' 57' ' ' ILE . 16.6 m-20 -60.14 122.98 15.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.832 0.348 . . . . 0.0 110.662 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.4 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -96.13 105.74 17.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.214 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.119 HG11 HD11 ' A' ' 81' ' ' ILE . 14.8 t -70.54 146.12 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -165.17 27.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.462 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.786 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . 174.07 78.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.969 0.414 . . . . 0.0 111.419 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.119 HD11 HG11 ' A' ' 78' ' ' VAL . 21.0 mt -103.83 118.09 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.846 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 45.1 30.57 0.62 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 108.9 -46.1 1.22 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.581 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.696 HG21 HD21 ' A' ' 97' ' ' LEU . 9.0 mm -70.62 109.96 6.08 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.548 0.214 . . . . 0.0 111.436 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 86.0 Cg_endo -92.25 103.09 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.861 2.374 . . . . 0.0 112.234 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.746 HG21 ' HB2' ' A' ' 94' ' ' ALA . 55.1 p -57.59 101.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.381 . . . . 0.0 111.109 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -123.69 -176.89 3.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 59.66 169.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.79 89.65 3.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.773 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 t -176.31 76.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.003 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -59.41 -23.93 63.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -54.77 -30.93 57.97 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.757 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.25 -51.81 67.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.431 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.746 ' HB2' HG21 ' A' ' 86' ' ' THR . . . -57.85 -46.27 85.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.884 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.686 ' N ' HD23 ' A' ' 41' ' ' LEU . 11.2 m-20 -60.25 -36.2 77.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.441 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -40.21 96.58 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.394 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.739 HD12 ' HA ' ' A' ' 94' ' ' ALA . 1.7 mt -72.74 -28.31 62.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.515 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.92 -47.0 79.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.801 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.4 mpp_? -76.12 -28.57 57.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.966 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.95 -9.03 57.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.431 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.435 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 51.9 m -72.62 -23.72 60.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.098 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 p -58.95 -34.85 72.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 25.7 mm -53.64 -60.66 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.523 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.4 t -75.27 -8.86 57.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.388 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 30' ' ' THR . 0.9 OUTLIER 84.19 -16.3 0.53 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.009 179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.595 ' O ' HG23 ' A' ' 104' ' ' THR . 1.5 ptpt -156.65 158.08 36.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.758 0.313 . . . . 0.0 111.051 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 108' ' ' THR . 12.1 p -146.47 160.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.673 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.681 ' CG2' HG22 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -119.02 109.43 15.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.263 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -103.06 133.18 48.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 111.619 -179.422 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 6.2 mt-10 -107.84 104.79 14.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.057 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.812 ' CD1' HG23 ' A' ' 25' ' ' THR . 0.2 OUTLIER -109.37 159.47 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.08 0.467 . . . . 0.0 112.25 -178.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.79 119.24 38.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.884 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 115' ' ' VAL . 23.4 p90 -112.59 165.09 12.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.964 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 21' ' ' HIS . 0.6 OUTLIER -132.31 97.01 4.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.211 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 113' ' ' PHE . 35.9 m -96.44 167.28 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.057 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.71 45.61 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.29 79.21 0.38 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.762 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.402 ' HB2' HG22 ' A' ' 20' ' ' VAL . 18.8 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.826 0.346 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.33 82.76 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 20' ' ' VAL . 11.2 p -122.82 118.57 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.075 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.413 ' CB ' ' CG2' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -74.27 168.52 19.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.34 137.69 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.451 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' HG2' ' CZ ' ' A' ' 113' ' ' PHE . 1.8 pt-20 -177.99 176.91 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.1 p -101.81 127.36 48.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.532 HG23 HG13 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -101.49 158.78 15.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.194 0.521 . . . . 0.0 111.28 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.13 99.17 8.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.622 HG21 HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.24 105.81 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.774 -178.311 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 28' ' ' VAL . 10.0 p -82.97 116.01 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.437 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.634 HD11 ' HA ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -106.52 141.59 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.916 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 105' ' ' SER . 87.4 m -115.46 142.17 47.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.84 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.784 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -85.93 141.61 29.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.147 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.61 138.26 22.53 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.865 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.06 58.68 5.64 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.547 2.165 . . . . 0.0 112.356 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 t -154.19 -68.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.055 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 p -110.63 -28.99 8.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -118.15 4.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.381 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.784 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 40.8 m-85 -113.0 -22.77 10.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.675 0.274 . . . . 0.0 111.153 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.01 32.1 66.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.872 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.618 HG22 ' HB3' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -140.52 141.05 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.732 0.301 . . . . 0.0 110.821 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -132.31 138.45 47.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.246 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.806 HD23 HG21 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -107.08 113.05 26.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.487 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -88.0 137.42 32.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.18 25.34 22.68 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.529 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.812 ' HB3' HD11 ' A' ' 51' ' ' LEU . 13.1 p -136.8 159.29 42.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.925 HG22 HD11 ' A' ' 56' ' ' LEU . 33.9 t -126.94 -3.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.631 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -152.96 166.12 33.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.06 100.7 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.979 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -165.67 -38.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.239 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.03 109.55 2.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.184 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 57.59 -171.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.328 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' A' ' 44' ' ' SER . 0.8 OUTLIER -141.29 122.64 14.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.463 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -157.32 23.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.98 0.419 . . . . 0.0 111.559 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.509 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -96.07 154.88 38.76 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.939 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' O ' HG23 ' A' ' 45' ' ' VAL . 45.2 Cg_exo -56.48 148.94 59.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.575 2.183 . . . . 0.0 112.256 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.663 ' C ' HD13 ' A' ' 56' ' ' LEU . 98.0 Cg_endo -85.82 146.04 9.1 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.818 2.345 . . . . 0.0 112.504 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.925 HD11 HG22 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -162.99 170.69 17.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.577 HG21 HD11 ' A' ' 39' ' ' ILE . 7.6 mt -80.26 139.12 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.457 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.6 m -156.79 48.46 0.45 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 111.505 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -173.12 133.51 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.11 0.481 . . . . 0.0 111.545 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.595 HG22 ' HB2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.3 152.03 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.96 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.69 155.61 17.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.107 0.48 . . . . 0.0 111.432 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.55 38.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.723 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.86 29.68 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.643 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 p -122.11 137.46 27.5 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.478 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 82.9 Cg_exo -43.98 -29.2 2.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.511 2.141 . . . . 0.0 112.829 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.732 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -62.51 -43.21 99.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.793 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.595 ' HB2' HG22 ' A' ' 60' ' ' ILE . 27.2 tp10 -78.3 -49.53 13.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -73.6 -8.41 55.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.554 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.426 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -51.9 -28.16 15.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.769 0.318 . . . . 0.0 110.96 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.22 45.35 95.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.412 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.9 p -170.06 41.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.019 0.438 . . . . 0.0 111.074 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.732 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -176.6 145.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -142.3 -175.43 4.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.821 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 60' ' ' ILE . 31.5 mm -78.93 77.51 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.58 41.02 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.623 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -112.09 119.23 37.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.333 . . . . 0.0 110.701 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 93.65 9.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.207 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.806 HG21 HD23 ' A' ' 41' ' ' LEU . 1.8 t -71.19 134.34 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.54 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -157.21 29.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 111.298 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.826 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -179.22 68.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.131 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.711 ' HB ' HD22 ' A' ' 97' ' ' LEU . 3.9 mp -90.6 120.03 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.416 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 0.5 OUTLIER 45.41 29.64 0.61 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.286 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 107.55 -36.15 4.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.356 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.5 mm -77.12 110.82 13.28 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.503 0.192 . . . . 0.0 111.218 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 89.3 Cg_endo -91.47 72.33 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.789 2.326 . . . . 0.0 112.448 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.673 HG22 HD13 ' A' ' 81' ' ' ILE . 1.2 t -57.47 103.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.34 123.88 27.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.914 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.0 30.65 19.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.9 p -102.26 -169.71 1.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.94 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.2 m -86.56 162.11 18.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -59.6 -28.05 66.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.71 -33.1 69.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.113 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.83 -52.64 64.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.714 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.821 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.75 -50.89 71.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -59.55 -34.14 72.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.533 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -62.63 -40.19 96.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.641 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.821 HD12 ' HA ' ' A' ' 94' ' ' ALA . 1.8 mt -67.87 -37.53 81.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.512 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.44 HD11 ' CD1' ' A' ' 41' ' ' LEU . 49.8 mt -70.26 -39.94 74.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.626 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -65.38 -34.13 77.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.26 -10.27 59.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.276 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.472 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 5.1 m -79.22 -33.44 43.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 110.736 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -32.72 74.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.81 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.17 -58.01 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.51 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.8 t -96.17 1.54 52.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.234 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.736 ' O ' HG23 ' A' ' 30' ' ' THR . 8.3 t 69.98 9.75 7.2 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.577 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 104' ' ' THR . 1.5 ttmp? -156.56 155.86 32.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.895 0.379 . . . . 0.0 111.05 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.413 HG22 ' N ' ' A' ' 108' ' ' THR . 12.0 p -153.22 155.7 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.576 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 107' ' ' VAL . 0.6 OUTLIER -121.48 117.99 28.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.146 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.469 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -114.19 132.3 56.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.973 0.416 . . . . 0.0 111.989 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.826 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -95.41 109.48 21.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.43 178.516 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.738 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -116.59 143.13 27.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.052 -178.56 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -95.62 118.72 32.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.056 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.456 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 29.6 p90 -111.37 156.07 22.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.001 0.429 . . . . 0.0 111.461 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -133.35 97.47 3.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.316 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.417 HG13 ' CD1' ' A' ' 113' ' ' PHE . 11.7 m -74.88 139.1 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.332 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -137.67 47.6 2.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.959 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -135.61 47.54 2.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.0 p . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.868 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.2 t -82.7 103.92 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.982 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.953 HG22 HG13 ' A' ' 115' ' ' VAL . 0.3 OUTLIER 46.76 -170.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.358 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.695 ' N ' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER 72.65 42.42 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.047 0.451 . . . . 0.0 110.865 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 1.9 m 79.08 139.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.388 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -178.1 176.94 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.678 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.81 130.82 55.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.651 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 t -122.61 135.3 54.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.019 0.437 . . . . 0.0 111.487 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -99.22 99.07 9.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.449 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.648 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.49 115.33 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.303 -178.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 28' ' ' VAL . 10.2 p -83.3 122.01 36.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.118 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.92 160.82 15.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.424 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 105' ' ' SER . 19.8 m -123.06 153.36 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.859 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.742 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -93.86 141.11 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.47 144.65 29.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.49 -0.26 10.45 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.705 2.27 . . . . 0.0 112.819 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.15 -52.59 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.728 0.299 . . . . 0.0 111.168 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -119.71 -57.19 1.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.35 -110.33 0.62 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.56 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.742 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 55.2 m-85 -112.3 -32.4 6.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.739 0.304 . . . . 0.0 110.758 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 70.61 8.49 63.34 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.518 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.902 HD11 ' CG2' ' A' ' 57' ' ' ILE . 6.1 tp -97.12 130.43 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.997 0.398 . . . . 0.0 110.781 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.93 147.0 47.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.089 0.471 . . . . 0.0 111.406 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 4.8 mt -118.51 163.2 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.638 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.16 172.06 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.988 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.713 ' C ' HD13 ' A' ' 51' ' ' LEU . . . 77.2 82.07 0.58 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.743 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.609 ' H ' ' HB3' ' A' ' 47' ' ' ALA . 2.6 p -132.06 -175.06 3.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.672 0.273 . . . . 0.0 110.659 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 46' ' ' PHE . 3.7 p -53.38 -43.79 52.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.358 0.599 . . . . 0.0 111.078 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.454 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 10.8 t80 -114.15 71.69 0.76 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.872 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.609 ' HB3' ' H ' ' A' ' 44' ' ' SER . . . -163.42 168.65 20.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.165 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 p 51.39 -138.33 1.08 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.64 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.85 -34.5 10.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.823 0.344 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.59 150.36 5.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.713 HD13 ' C ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -176.5 146.96 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.5 22.45 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.213 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.5 m -135.37 153.11 77.72 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.12 169.48 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.537 2.158 . . . . 0.0 112.131 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 40.3 Cg_endo -66.94 150.32 82.95 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.552 2.168 . . . . 0.0 112.098 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.52 163.45 32.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.0 111.177 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.902 ' CG2' HD11 ' A' ' 39' ' ' ILE . 5.0 mt -76.07 141.54 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.578 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.876 ' HA ' HG23 ' A' ' 74' ' ' ILE . 3.0 m -168.28 41.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.688 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -177.24 125.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.029 0.442 . . . . 0.0 111.529 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.581 HD12 ' OE1' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -137.33 152.6 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.095 179.425 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.43 155.36 21.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.067 0.461 . . . . 0.0 111.442 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -88.03 41.06 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.722 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 168.52 31.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.854 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.401 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 49.3 m -119.3 143.91 35.29 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-O 120.716 0.293 . . . . 0.0 110.911 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.56 -28.39 8.93 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.916 2.41 . . . . 0.0 112.738 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -66.0 -46.51 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 110.956 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' OE1' HD12 ' A' ' 60' ' ' ILE . 9.5 tp10 -78.15 -39.81 39.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.829 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.06 -19.36 64.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.364 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -41.08 68.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 110.879 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.24 -12.35 64.83 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.827 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 m -98.79 -32.41 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 111.184 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.83 HD13 HD13 ' A' ' 39' ' ' ILE . 11.0 mt -74.91 128.46 35.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.866 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -141.06 148.5 40.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 58' ' ' SER . 34.9 mt -64.05 114.51 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.07 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.21 -27.07 2.29 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.495 ' HB2' HD12 ' A' ' 57' ' ' ILE . 10.2 m-20 -63.39 138.01 58.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.709 0.29 . . . . 0.0 110.837 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.434 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 51.9 mtt180 -109.24 100.95 10.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.406 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.633 ' CA ' HG22 ' A' ' 111' ' ' ILE . 29.5 m -64.55 122.69 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.4 ptm -151.37 30.35 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.1 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -178.35 52.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.025 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.429 HD11 ' HB ' ' A' ' 78' ' ' VAL . 29.4 mt -82.36 128.76 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.058 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 43.67 31.52 0.46 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.235 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.77 -43.85 1.67 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.463 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.456 HG22 ' H ' ' A' ' 86' ' ' THR . 10.6 mm -71.28 113.27 17.95 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.471 0.176 . . . . 0.0 111.316 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -88.36 25.26 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.74 2.293 . . . . 0.0 112.796 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.456 ' H ' HG22 ' A' ' 84' ' ' ILE . 18.0 p 54.49 78.93 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.92 0.391 . . . . 0.0 111.043 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.88 -26.51 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.534 ' HB3' HG22 ' A' ' 90' ' ' THR . 4.4 t0 -56.62 -22.61 35.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.27 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.17 42.6 1.72 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 88' ' ' ASP . 13.1 t -151.23 137.83 18.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.722 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.426 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 32.0 p90 -58.48 -28.21 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.136 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.89 -31.08 68.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -65.79 -52.32 51.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.644 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.929 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.72 -33.22 72.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.985 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -64.27 -48.33 76.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.826 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -33.89 75.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.647 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.929 HD12 ' HA ' ' A' ' 94' ' ' ALA . 17.2 mt -64.02 -41.41 97.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.461 HD13 ' CG2' ' A' ' 39' ' ' ILE . 62.6 mt -67.71 -40.19 84.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.757 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -65.26 -30.12 70.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.49 -7.34 51.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.37 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 m -71.87 -16.01 62.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.175 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -58.56 -27.01 64.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.045 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.9 mm -52.9 -41.11 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 111.309 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.8 t -120.01 -2.07 10.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.293 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.702 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 1.3 m 62.6 26.32 15.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.05 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HE2' HG21 ' A' ' 28' ' ' VAL . 2.1 mmtp -156.19 144.83 20.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.844 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.502 HG13 HD21 ' A' ' 109' ' ' LEU . 10.2 p -153.97 156.9 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.02 0.438 . . . . 0.0 111.888 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -122.07 125.44 46.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.934 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.502 HD21 HG13 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -119.21 136.64 54.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.098 0.475 . . . . 0.0 111.928 -178.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.743 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -111.89 106.71 15.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.334 178.62 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -107.49 157.84 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.139 0.495 . . . . 0.0 112.322 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.91 119.56 35.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.482 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 22' ' ' THR . 4.8 p90 -133.98 165.15 25.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -124.56 135.16 52.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.377 178.757 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.953 HG13 HG22 ' A' ' 20' ' ' VAL . 3.1 p -147.26 147.37 17.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.019 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.77 78.58 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.067 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -122.72 58.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.975 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.914 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.81 0.338 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.78 120.82 44.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.787 HG22 ' HB ' ' A' ' 115' ' ' VAL . 12.5 p 37.66 96.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.13 0.49 . . . . 0.0 112.14 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.405 ' O ' ' CB ' ' A' ' 22' ' ' THR . 1.8 t-160 -126.0 56.73 1.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 3.0 m 80.61 116.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.799 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.9 mm-40 -151.62 177.36 10.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.114 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.0 p -107.39 129.51 54.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.134 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.536 HG23 ' CD1' ' A' ' 111' ' ' ILE . 1.9 t -114.59 137.32 52.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.122 0.487 . . . . 0.0 111.83 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.15 99.32 10.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.152 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -102.7 107.71 22.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.281 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 28' ' ' VAL . 13.7 p -88.67 113.84 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.036 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.403 ' HB2' ' CG1' ' A' ' 107' ' ' VAL . 54.5 mt -102.91 164.97 11.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.955 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 105' ' ' SER . 76.2 m -128.68 141.15 51.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.822 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.715 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -83.09 119.71 24.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.231 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.66 140.41 31.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.98 59.74 3.63 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.615 2.21 . . . . 0.0 112.502 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.6 t -154.88 -59.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -122.31 -42.73 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.823 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.57 -119.4 3.03 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.559 ' CE1' HG12 ' A' ' 107' ' ' VAL . 38.0 m-85 -103.64 -26.93 12.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.86 39.72 92.01 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.649 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.865 HD11 HG21 ' A' ' 57' ' ' ILE . 3.2 tt -136.5 127.1 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.953 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 127.83 56.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.91 HD22 HG12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -105.75 103.15 12.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.711 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.446 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 13.5 pt20 -61.83 156.84 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.878 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.58 ' O ' HD11 ' A' ' 51' ' ' LEU . . . -94.66 30.53 7.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.544 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 t -141.11 165.47 27.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.657 HG23 ' CB ' ' A' ' 52' ' ' SER . 66.6 t -96.68 -2.99 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.386 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.41 ' CG ' ' O ' ' A' ' 45' ' ' VAL . 42.2 m-85 -159.47 -40.22 0.06 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.173 0.511 . . . . 0.0 111.038 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.77 44.25 8.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.269 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 46' ' ' PHE . 41.0 p -94.66 -13.84 25.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.19 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.69 -81.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.379 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 t -73.37 -170.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.516 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.58 HD11 ' O ' ' A' ' 43' ' ' GLY . 19.3 tp -115.74 149.07 39.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.998 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.657 ' CB ' HG23 ' A' ' 45' ' ' VAL . 15.5 m -94.92 -165.65 1.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.637 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.475 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -102.5 -65.74 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.368 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.475 ' HD3' ' CB ' ' A' ' 53' ' ' SER . 84.6 Cg_endo -80.79 150.26 18.52 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.332 2.021 . . . . 0.0 112.593 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.755 ' O ' HD12 ' A' ' 56' ' ' LEU . 64.5 Cg_endo -73.36 164.53 34.93 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.443 2.095 . . . . 0.0 112.133 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 55' ' ' PRO . 5.8 mp -150.71 142.77 24.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.115 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.91 HG12 HD22 ' A' ' 41' ' ' LEU . 40.6 mt -80.91 122.5 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.744 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.62 51.63 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -178.16 126.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.002 0.43 . . . . 0.0 111.365 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.464 HG21 ' HA ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -142.77 152.09 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.1 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -102.05 155.53 18.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.019 0.438 . . . . 0.0 111.507 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.73 43.09 0.95 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.781 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 p30 178.32 28.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.861 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.402 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -128.81 137.02 30.07 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.277 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.46 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -43.76 -33.84 5.26 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.876 2.384 . . . . 0.0 112.649 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.466 ' HB1' HD12 ' A' ' 39' ' ' ILE . . . -57.86 -42.78 85.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.843 0.354 . . . . 0.0 111.15 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' HA ' HG21 ' A' ' 60' ' ' ILE . 17.1 tp10 -78.35 -50.23 12.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.216 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.32 -8.44 53.71 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.1 t -53.0 -33.63 52.5 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.824 0.345 . . . . 0.0 110.775 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.64 31.47 76.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.07 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.14 -65.78 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.098 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -71.73 150.28 44.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.147 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.4 -177.92 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 74' ' ' ILE . 19.8 tt -84.51 56.59 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 111.269 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.29 39.83 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.474 ' HB3' HG21 ' A' ' 111' ' ' ILE . 67.3 m-20 -82.7 147.27 28.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.618 0.247 . . . . 0.0 110.74 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -94.86 76.24 3.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.709 0.29 . . . . 0.0 111.503 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.591 ' HA ' HG22 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -58.28 128.36 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.709 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.416 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -158.35 29.38 0.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.097 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.863 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 178.34 66.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 0.0 111.065 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.409 HG22 ' OD1' ' A' ' 82' ' ' ASN . 9.1 mt -96.91 119.82 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.98 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.409 ' OD1' HG22 ' A' ' 81' ' ' ILE . 1.4 p-10 44.05 30.61 0.44 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.407 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.88 -48.62 0.92 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.543 ' HB ' HD13 ' A' ' 97' ' ' LEU . 8.8 mm -69.78 111.76 10.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.602 0.239 . . . . 0.0 111.113 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.21 -9.61 11.53 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.536 2.157 . . . . 0.0 112.844 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.0 p 56.35 95.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.891 0.377 . . . . 0.0 110.917 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.17 32.32 5.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.438 ' HB3' HG22 ' A' ' 90' ' ' THR . 4.9 t0 -145.33 176.24 9.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.96 63.89 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.003 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.636 HG23 ' HB2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -121.36 113.59 20.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.703 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -60.69 -45.67 93.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.341 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -54.95 -34.27 63.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.277 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.636 ' HB2' HG23 ' A' ' 90' ' ' THR . 0.6 OUTLIER -60.04 -52.76 63.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.88 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.818 ' HB1' HD12 ' A' ' 41' ' ' LEU . . . -57.51 -53.87 53.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.179 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.494 ' HA ' HD23 ' A' ' 98' ' ' LEU . 7.4 m-80 -56.93 -34.8 68.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.88 -46.92 85.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.171 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.543 HD13 ' HB ' ' A' ' 84' ' ' ILE . 7.1 mt -60.38 -43.45 96.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.141 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -76.87 -32.59 57.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.459 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -78.99 -29.13 43.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.751 0.31 . . . . 0.0 111.178 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -66.34 -15.56 63.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.503 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 3.8 m -83.39 -15.39 49.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.321 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.2 t -58.36 -29.51 66.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.9 mm -54.07 -38.24 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.346 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.3 t -118.02 -3.91 11.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.199 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.784 ' O ' HG23 ' A' ' 30' ' ' THR . 1.1 m 65.81 42.16 3.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.109 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 3.1 tppt? -156.04 128.93 7.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 111.342 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.559 HG12 ' CE1' ' A' ' 37' ' ' PHE . 14.7 p -137.48 145.42 29.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.135 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.523 HG23 HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -120.82 105.6 10.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.314 179.36 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -104.21 124.81 49.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.018 0.437 . . . . 0.0 111.685 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 18.1 tt0 -107.11 105.65 15.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.584 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -110.26 165.13 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.301 0.572 . . . . 0.0 112.27 -178.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -113.23 121.65 45.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.694 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 22' ' ' THR . 18.4 p90 -118.5 163.59 16.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.881 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.21 139.75 53.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.641 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.787 ' HB ' HG22 ' A' ' 20' ' ' VAL . 7.5 t -148.48 159.72 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.257 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.448 ' N ' HG12 ' A' ' 115' ' ' VAL . . . 179.99 48.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.005 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -160.65 47.65 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.933 179.904 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.757 0.313 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -95.37 125.26 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG13 HG23 ' A' ' 115' ' ' VAL . 5.7 t 56.34 105.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.283 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.67 ' O ' HG22 ' A' ' 22' ' ' THR . 0.5 OUTLIER -176.24 34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.233 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 21' ' ' HIS . 6.6 t 52.17 138.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.62 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -177.99 168.09 2.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.2 p -87.75 143.43 27.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.446 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.654 HG23 HG13 ' A' ' 111' ' ' ILE . 2.9 t -129.47 156.4 44.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.141 0.496 . . . . 0.0 111.355 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.57 98.71 7.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.457 ' CG1' HG11 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -100.82 103.14 14.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.477 -178.411 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 108' ' ' THR . 4.2 t -82.78 115.04 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.592 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.654 HD11 ' CD1' ' A' ' 72' ' ' LEU . 14.4 mt -111.59 127.3 55.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.032 0.444 . . . . 0.0 110.918 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 105' ' ' SER . 3.0 m -99.05 144.45 28.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HB2' ' HE1' ' A' ' 37' ' ' PHE . . . -74.23 124.94 27.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.949 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.42 136.81 52.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.67 -3.65 14.2 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.584 2.189 . . . . 0.0 112.609 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.42 -49.47 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.227 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.5 p -118.99 -57.07 2.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.9 -108.38 0.63 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.519 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.646 ' HB3' HG22 ' A' ' 39' ' ' ILE . 26.0 m-85 -114.66 -32.46 5.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.704 0.288 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.72 40.32 70.71 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.785 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.652 HD11 ' CG2' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -142.42 140.85 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.343 . . . . 0.0 110.92 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.427 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -123.29 145.14 48.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.222 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.714 HD23 HD11 ' A' ' 98' ' ' LEU . 1.1 mm? -104.41 105.37 15.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.738 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -69.08 132.16 46.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.21 28.07 15.67 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.319 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.686 ' OG ' HD13 ' A' ' 51' ' ' LEU . 11.9 t -171.32 142.99 1.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.376 . . . . 0.0 110.93 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 53' ' ' SER . 0.0 OUTLIER -81.43 118.47 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 0.3 OUTLIER 69.9 -168.04 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.666 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' O ' HG22 ' A' ' 48' ' ' THR . . . -135.82 128.24 30.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.28 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 47' ' ' ALA . 13.3 t 44.57 43.88 6.82 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.518 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.426 ' HG3' ' CD2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -128.58 -65.3 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.58 97.53 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.686 HD13 ' OG ' ' A' ' 44' ' ' SER . 4.3 tp -88.86 116.46 27.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.915 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.563 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -157.64 21.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.4 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.484 ' HB3' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -127.33 144.88 52.31 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.911 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.33 172.41 11.24 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.508 2.138 . . . . 0.0 112.179 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.14 124.2 14.29 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.482 2.121 . . . . 0.0 112.038 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.58 146.66 44.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.156 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.72 HD12 HG21 ' A' ' 111' ' ' ILE . 47.1 mt -60.64 133.61 26.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.28 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' HG13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -159.72 40.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 111.464 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CG ' ' HB2' ' A' ' 40' ' ' GLN . 34.2 t80 -167.08 131.12 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 111.198 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.79 152.33 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.03 155.33 17.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.989 0.423 . . . . 0.0 111.16 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.83 44.4 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.961 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER 168.39 32.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.666 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.78 146.45 55.2 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.926 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -43.82 -35.93 7.36 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.801 2.334 . . . . 0.0 112.867 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB1' HD13 ' A' ' 39' ' ' ILE . . . -59.17 -39.47 82.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 111.023 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.69 -50.34 13.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.722 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -72.31 -8.36 54.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.557 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.445 ' SG ' HD21 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -51.72 -26.22 8.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.719 0.295 . . . . 0.0 111.254 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.05 45.21 96.03 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.438 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 72' ' ' LEU . 8.1 p -173.1 -44.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.974 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.654 ' CD1' HD11 ' A' ' 29' ' ' LEU . 11.7 mt -60.91 164.69 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -154.8 171.8 19.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 0.0 111.203 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 74' ' ' ILE . 2.7 tt -84.85 56.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.136 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.24 59.1 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.765 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -101.24 125.06 47.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.759 0.314 . . . . 0.0 110.755 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -69.34 71.98 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.249 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.924 HG22 HG22 ' A' ' 111' ' ' ILE . 3.0 t -63.37 146.64 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -161.18 27.4 0.14 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.392 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 173.34 79.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.786 0.327 . . . . 0.0 111.203 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.814 HD11 HG11 ' A' ' 78' ' ' VAL . 38.1 mt -100.52 126.73 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.045 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.2 30.1 0.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 102.14 -41.8 2.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.678 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 mm -75.53 109.86 8.98 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.569 0.223 . . . . 0.0 111.352 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 96.8 Cg_endo -94.22 70.91 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.051 2.501 . . . . 0.0 112.264 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.7 t -53.19 93.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.015 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -123.25 66.9 0.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.894 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -161.0 29.18 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.998 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 t 56.44 88.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.035 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -154.44 106.98 2.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.063 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -70.46 -48.12 57.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.311 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -61.41 -41.35 97.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.763 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -59.8 -48.89 79.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.258 -179.452 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.69 -52.41 65.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.029 0.442 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -55.85 -35.93 66.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.235 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -62.67 -39.59 94.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.29 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.477 HD12 HD12 ' A' ' 81' ' ' ILE . 12.6 mt -60.22 -43.09 96.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.096 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.714 HD11 HD23 ' A' ' 41' ' ' LEU . 41.6 mt -76.57 -30.58 57.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.865 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -35.8 81.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.323 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -72.33 -9.41 58.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.556 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 4.9 m -69.6 -24.65 63.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 0.0 110.802 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.9 p -63.2 -55.33 25.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.662 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.7 mm -55.19 -40.65 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.32 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.3 m -80.41 -21.96 41.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 30' ' ' THR . 1.9 t 77.58 -6.74 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.838 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -156.74 149.85 24.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.602 0.239 . . . . 0.0 110.82 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 29' ' ' LEU . 14.4 p -150.08 141.87 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 1.019 HG22 HG22 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -112.96 113.35 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.988 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.547 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -106.2 142.97 35.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 112.065 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.864 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 14.5 tt0 -104.73 105.92 16.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.537 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.924 HG22 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -116.92 150.51 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.401 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -112.1 120.84 43.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.138 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -116.6 164.03 15.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.959 0.409 . . . . 0.0 111.365 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -134.96 107.63 7.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.367 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.433 HG23 HG13 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -101.7 152.41 5.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.241 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.02 45.29 1.46 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.016 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.19 47.11 2.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.875 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.19 141.74 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.093 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.988 HG13 HG23 ' A' ' 115' ' ' VAL . 5.1 p -71.29 157.63 6.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.497 ' CA ' ' HB ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER -154.61 52.05 0.64 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.768 0.318 . . . . 0.0 111.18 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER 67.93 108.43 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.185 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -170.45 171.85 6.32 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.524 -177.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 74.2 p -99.2 132.52 44.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -109.53 135.39 50.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.224 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 99.07 9.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.631 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.549 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -105.97 122.84 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.034 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.027 HG22 HG22 ' A' ' 108' ' ' THR . 3.7 t -90.46 120.8 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.252 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.7 HD21 ' HA ' ' A' ' 66' ' ' ALA . 10.9 mp -112.47 143.82 42.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.612 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.773 HG23 ' O ' ' A' ' 105' ' ' SER . 82.3 m -105.25 144.06 32.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -87.19 89.54 8.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.92 138.74 97.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.12 56.5 5.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.581 2.187 . . . . 0.0 112.447 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.9 t -155.33 -66.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 t -111.36 -29.8 7.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.63 -130.03 10.11 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.481 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.675 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 74.5 m-85 -99.53 -23.55 15.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.712 0.291 . . . . 0.0 111.023 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.58 34.88 56.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.903 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.779 HD11 ' CG2' ' A' ' 57' ' ' ILE . 2.1 tt -132.65 143.83 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.79 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.42 148.93 48.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.571 HD13 ' HA ' ' A' ' 57' ' ' ILE . 3.2 mm? -104.07 157.68 16.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.837 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -174.2 159.89 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.808 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.06 37.54 6.28 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.488 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.5 p -79.59 -177.12 5.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.802 0.334 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 45' ' ' VAL . 30.0 t -72.85 -8.43 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.784 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.429 ' CB ' HG22 ' A' ' 90' ' ' THR . 0.1 OUTLIER -135.52 52.41 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.06 0.457 . . . . 0.0 110.88 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.36 156.64 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -59.96 -18.67 47.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.465 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.53 24.53 12.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.095 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.7 m 62.15 146.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.178 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -171.0 -178.67 2.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.954 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.71 24.05 0.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 0.0 111.314 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.453 ' C ' HG22 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -141.75 160.7 55.17 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.117 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 36.3 Cg_exo -57.23 174.92 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.73 2.286 . . . . 0.0 112.038 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 54' ' ' PRO . 55.8 Cg_endo -70.38 151.4 65.5 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.474 2.116 . . . . 0.0 112.34 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 56' ' ' LEU . 2.6 mp -133.49 136.99 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.965 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.779 ' CG2' HD11 ' A' ' 39' ' ' ILE . 33.2 mt -61.7 118.77 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.166 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.877 ' HA ' HG23 ' A' ' 74' ' ' ILE . 94.2 p -139.68 46.65 1.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 111.745 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -174.23 129.13 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.132 0.491 . . . . 0.0 111.493 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -147.53 151.96 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.002 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.58 155.55 17.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.123 0.487 . . . . 0.0 111.483 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.4 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -88.5 42.03 1.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.86 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 168.15 33.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.757 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.55 150.08 60.27 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.037 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.01 -31.87 29.09 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.912 2.408 . . . . 0.0 112.51 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.7 ' HA ' HD21 ' A' ' 29' ' ' LEU . . . -59.63 -48.59 81.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.028 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -78.11 -39.64 40.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.4 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -72.54 -8.76 56.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.56 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.526 ' SG ' HD11 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -52.91 -24.85 10.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.704 0.288 . . . . 0.0 110.996 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.84 73.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.305 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.646 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.6 p -170.57 33.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.953 0.406 . . . . 0.0 110.972 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.68 153.01 50.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -168.97 161.9 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.877 HG23 ' HA ' ' A' ' 58' ' ' SER . 62.5 mt -71.13 117.25 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.081 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.01 -21.96 4.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.666 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.553 ' HB2' HD12 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -52.79 136.57 33.53 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.688 0.28 . . . . 0.0 110.768 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -96.86 82.2 3.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.055 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.075 HG21 HD11 ' A' ' 81' ' ' ILE . 7.2 p -68.78 159.02 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.052 0.453 . . . . 0.0 111.323 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.663 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -152.0 -81.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.134 179.485 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.409 ' HB3' ' CD ' ' A' ' 110' ' ' GLU . . . -75.82 100.16 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 0.0 111.809 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.075 HD11 HG21 ' A' ' 78' ' ' VAL . 17.0 mt -119.38 125.88 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.357 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.576 ' HB3' HG23 ' A' ' 107' ' ' VAL . 0.7 OUTLIER 51.9 24.31 2.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.308 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.442 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 104.32 -39.0 2.98 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.753 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mm -84.18 108.86 15.7 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.42 0.156 . . . . 0.0 111.42 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 79' ' ' MET . 98.4 Cg_endo -94.03 123.77 0.44 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.779 2.319 . . . . 0.0 112.508 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 p -89.35 106.01 18.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.763 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -134.4 37.97 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -177.11 -40.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.74 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -67.18 -177.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.429 HG22 ' CB ' ' A' ' 46' ' ' PHE . 32.9 p -92.25 174.66 7.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -60.41 -25.43 65.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -55.97 -39.46 71.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 7.0 mm-40 -59.94 -46.02 90.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.604 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.536 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -57.67 -44.67 85.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.807 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -56.77 -40.72 76.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.102 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -62.95 -35.95 81.83 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.267 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' A' ' 81' ' ' ILE . 24.3 mt -60.86 -48.1 83.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.782 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 81' ' ' ILE . 12.9 mt -74.64 -24.95 58.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -35.7 66.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.185 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -77.57 -4.48 46.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.5 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.463 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 14.8 m -62.72 -26.75 68.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.758 0.313 . . . . 0.0 111.022 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 t -58.75 -30.35 67.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.997 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.1 mm -53.09 -56.45 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.943 0.402 . . . . 0.0 111.44 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.8 t -94.99 -1.42 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.144 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.773 ' O ' HG23 ' A' ' 30' ' ' THR . 0.5 OUTLIER 68.36 10.76 8.05 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.442 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.624 ' HD3' HG11 ' A' ' 28' ' ' VAL . 21.5 ttmt -156.64 154.95 30.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.861 0.363 . . . . 0.0 111.008 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 82' ' ' ASN . 9.8 p -152.89 145.95 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.598 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 1.027 HG22 HG22 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -107.65 112.92 25.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.3 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.655 HD11 HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -99.31 131.54 45.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.5 -179.373 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.409 ' CD ' ' HB3' ' A' ' 80' ' ' ALA . 25.6 mt-10 -114.93 104.53 12.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.888 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.637 HG22 ' CA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -114.67 154.79 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 120.951 0.405 . . . . 0.0 112.007 -178.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -108.21 129.24 55.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.864 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 20' ' ' VAL . 5.5 p90 -137.21 164.11 29.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.576 ' HA ' HG23 ' A' ' 22' ' ' THR . 1.7 t70 -96.16 132.61 41.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.806 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.988 HG23 HG13 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -44.49 134.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.68 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.42 132.67 33.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.924 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -55.42 112.15 1.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.064 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.935 179.984 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.615 0.245 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.1 p 31.75 46.59 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.36 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 21' ' ' HIS . 12.6 p -125.87 159.91 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.481 ' N ' HG22 ' A' ' 20' ' ' VAL . 2.3 t60 -157.6 46.5 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.07 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.808 HG23 ' HA ' ' A' ' 114' ' ' ASP . 2.0 m 77.29 124.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.518 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -175.65 167.55 3.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.062 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.17 140.77 29.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.554 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.495 HG23 HG12 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -119.96 147.5 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.048 0.451 . . . . 0.0 111.403 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -110.35 98.03 7.36 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.696 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.457 HG23 HD11 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -101.63 107.09 20.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.141 -178.627 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.93 HG22 HG22 ' A' ' 108' ' ' THR . 7.9 t -82.63 120.61 34.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.195 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.0 mt -112.47 164.19 13.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 105' ' ' SER . 28.0 m -124.66 133.26 53.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.795 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -80.1 92.09 5.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -73.02 146.69 87.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.12 49.04 2.9 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.934 2.422 . . . . 0.0 112.569 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -153.35 -59.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.814 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 p -114.49 -16.71 11.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.085 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.6 -121.73 5.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.324 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.795 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 95.0 m-85 -109.08 -26.82 9.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.659 0.266 . . . . 0.0 110.788 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.94 48.26 30.98 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.944 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.695 HD11 HG21 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -132.59 125.17 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.806 0.336 . . . . 0.0 111.069 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.41 122.84 47.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.721 HD11 ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -111.06 100.88 9.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.811 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -62.41 152.76 33.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.819 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.76 40.06 2.65 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.501 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -178.11 179.06 0.86 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.975 0.417 . . . . 0.0 111.203 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.552 HG13 ' N ' ' A' ' 46' ' ' PHE . 11.9 p -69.08 -48.97 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.42 0.628 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.552 ' N ' HG13 ' A' ' 45' ' ' VAL . 2.1 p90 -161.31 154.22 20.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.813 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.685 ' O ' HG23 ' A' ' 48' ' ' THR . . . -103.59 109.28 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.213 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER 175.66 81.07 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.729 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 50' ' ' THR . 5.8 mt-10 60.35 39.37 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.98 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER 179.7 146.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.824 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.433 ' C ' HD23 ' A' ' 51' ' ' LEU . 3.0 tt -177.0 107.7 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.06 24.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.435 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.1 m -110.97 154.75 43.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.79 172.54 3.67 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.635 2.223 . . . . 0.0 112.294 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.945 ' HB2' HG23 ' A' ' 78' ' ' VAL . 71.0 Cg_exo -49.01 154.91 2.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.637 2.225 . . . . 0.0 112.462 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.591 HD11 ' NE ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -164.86 130.59 2.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.096 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.695 HG21 HD11 ' A' ' 39' ' ' ILE . 40.6 mt -81.59 139.74 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.676 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 m -160.28 37.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.819 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -173.95 140.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.953 0.406 . . . . 0.0 111.682 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -149.49 152.76 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.229 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.03 155.78 23.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.082 0.467 . . . . 0.0 111.428 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -87.98 40.37 0.94 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.789 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.55 31.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.26 144.18 37.43 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.824 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -46.29 -29.36 6.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.937 2.424 . . . . 0.0 112.573 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -61.8 -48.24 81.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.03 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 8.6 tp10 -78.63 -33.44 47.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.077 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -80.04 -8.84 59.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.002 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.0 p -55.97 -29.86 60.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.06 46.2 93.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.44 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 t -144.58 -67.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 111.286 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -75.71 165.0 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.13 -170.27 2.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.695 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.5 mm -82.47 79.28 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.83 61.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.677 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.455 ' HB2' HD12 ' A' ' 57' ' ' ILE . 67.0 m-20 -112.24 152.22 28.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.714 0.292 . . . . 0.0 110.71 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.591 ' NE ' HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -103.52 83.62 2.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.893 0.378 . . . . 0.0 111.664 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.945 HG23 ' HB2' ' A' ' 55' ' ' PRO . 1.6 m -62.45 126.91 21.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.68 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -160.33 30.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.205 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 178.29 52.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 111.079 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.477 ' HB ' HD12 ' A' ' 97' ' ' LEU . 3.1 mt -79.01 126.5 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.025 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.41 ' OD1' HG22 ' A' ' 81' ' ' ILE . 1.1 p-10 43.41 31.73 0.44 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.481 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.5 -45.5 1.32 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.541 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.775 ' HB ' HD13 ' A' ' 97' ' ' LEU . 8.4 mm -71.25 112.89 15.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.605 0.241 . . . . 0.0 111.267 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -89.12 22.48 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.752 2.302 . . . . 0.0 112.837 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.509 ' H ' HG22 ' A' ' 84' ' ' ILE . 8.3 p 56.23 100.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.895 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -117.66 -49.66 2.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.97 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -67.19 -76.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.402 ' CB ' ' CG ' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -101.31 -170.41 1.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.81 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.485 HG22 ' HG3' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -126.82 -71.37 0.68 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.087 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -70.32 -48.3 57.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.996 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.402 ' CG ' ' CB ' ' A' ' 89' ' ' SER . 13.8 pt-20 -72.14 -35.17 69.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.9 tp10 -67.96 -50.64 54.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.66 -51.31 70.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.967 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.421 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 25.3 m-20 -58.36 -35.24 71.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.492 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -37.98 88.8 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.666 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.775 HD13 ' HB ' ' A' ' 84' ' ' ILE . 1.3 mt -65.81 -48.02 73.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.493 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.721 ' CD2' HD11 ' A' ' 41' ' ' LEU . 1.5 pp -75.84 -24.15 55.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.27 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -71.14 -36.32 72.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -7.55 54.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.393 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.462 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.0 m -67.38 -18.69 65.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.723 0.297 . . . . 0.0 111.112 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.5 m -58.69 -33.11 69.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.13 -61.43 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.184 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 106' ' ' LYS . 5.1 t -85.63 -6.75 59.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.093 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.69 ' O ' HG23 ' A' ' 30' ' ' THR . 33.2 t 62.93 25.19 14.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.301 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HE2' HG11 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -156.47 150.51 25.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.945 0.402 . . . . 0.0 111.449 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.605 HG12 ' CE1' ' A' ' 37' ' ' PHE . 13.0 p -153.38 157.43 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.47 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.93 HG22 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -120.57 107.33 12.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.558 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.416 HD13 HG12 ' A' ' 81' ' ' ILE . 4.0 mm? -83.2 127.38 33.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.714 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 21.9 tt0 -118.01 104.68 11.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.756 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.757 HG22 ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -125.89 165.29 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.112 0.482 . . . . 0.0 112.119 -178.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -121.63 128.19 51.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.745 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 10.6 p90 -127.42 150.06 49.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.917 0.389 . . . . 0.0 111.09 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.808 ' HA ' HG23 ' A' ' 22' ' ' THR . 0.7 OUTLIER -105.47 141.36 37.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.699 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -163.71 179.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.109 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -173.93 44.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.88 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -107.1 41.59 1.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.728 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.94 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.816 0.341 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.816 HG23 ' OG ' ' A' ' 118' ' ' SER . 12.1 p -66.57 127.5 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 21' ' ' HIS . 38.1 t 58.81 156.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.132 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.473 ' O ' ' HB ' ' A' ' 22' ' ' THR . 6.1 m-70 -150.08 157.4 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 21' ' ' HIS . 14.4 t 177.56 144.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.355 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' CG ' ' CZ ' ' A' ' 113' ' ' PHE . 17.5 pt-20 -177.97 171.66 1.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.066 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 p -87.84 148.22 24.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.636 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.816 HG23 HG13 ' A' ' 111' ' ' ILE . 0.8 OUTLIER -129.7 159.69 35.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 111.101 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -113.33 99.37 7.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.13 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.499 HG21 HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -105.07 102.61 14.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.494 -178.659 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 108' ' ' THR . 16.2 t -83.68 115.61 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.937 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.584 HD12 ' CD1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -107.56 128.97 55.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 111.005 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 105' ' ' SER . 67.8 m -110.63 134.01 52.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.99 153.63 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.059 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -130.65 137.46 30.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.83 60.14 5.23 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.584 2.189 . . . . 0.0 112.302 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.75 -65.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -131.4 17.9 4.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.3 -116.41 5.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.563 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.733 ' HB3' HG22 ' A' ' 39' ' ' ILE . 49.6 m-85 -113.36 -30.48 6.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.861 0.362 . . . . 0.0 111.257 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.71 23.9 63.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.687 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 37' ' ' PHE . 3.6 tt -124.69 139.75 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.725 0.298 . . . . 0.0 110.877 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -135.18 149.5 49.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.049 0.452 . . . . 0.0 111.297 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.637 HD23 HG13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -114.89 168.94 9.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.376 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.27 155.5 9.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.082 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 55' ' ' PRO . . . -98.93 97.58 1.87 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.326 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.4 ' HA ' HD13 ' A' ' 51' ' ' LEU . 1.7 m -164.76 93.18 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 111.09 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 45' ' ' VAL . 19.2 t -105.85 -5.02 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.375 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.35 34.34 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.597 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 48' ' ' THR . . . -53.2 121.11 6.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.447 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER 173.35 -32.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.966 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -40.52 0.47 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 t -167.25 164.18 15.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.91 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 43' ' ' GLY . 54.6 tp -101.36 140.92 35.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.144 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.85 25.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.307 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.1 m -127.61 156.51 75.31 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.084 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.32 176.1 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.645 2.23 . . . . 0.0 112.259 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.44 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 71.8 Cg_endo -77.28 171.23 18.11 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.619 2.212 . . . . 0.0 112.421 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -176.42 156.68 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.673 HD12 ' HB2' ' A' ' 76' ' ' ASP . 10.0 mt -68.75 147.71 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.888 ' HA ' HG23 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -171.8 47.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 111.573 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -176.76 134.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 111.583 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -151.94 152.0 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.934 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.03 155.0 17.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 111.289 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -86.8 39.6 0.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.869 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 28.1 t0 174.06 31.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.607 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.9 m -122.54 144.26 41.82 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.055 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -42.34 -36.53 4.41 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.958 2.439 . . . . 0.0 112.947 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.62 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -57.88 -40.1 79.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.841 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -78.13 -51.88 9.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.766 179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -12.75 61.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.482 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.577 ' HB3' HG22 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -56.28 -30.28 62.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 0.0 110.838 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.69 24.94 57.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.571 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.577 HG22 ' HB3' ' A' ' 69' ' ' CYS . 29.2 m -136.58 10.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.585 0.231 . . . . 0.0 111.603 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.62 HD11 ' O ' ' A' ' 66' ' ' ALA . 4.2 pp -147.56 158.67 44.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.874 0.369 . . . . 0.0 111.023 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -154.45 150.45 27.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.619 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.888 HG23 ' HA ' ' A' ' 58' ' ' SER . 21.2 mt -57.17 107.46 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.72 40.14 0.19 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.595 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.673 ' HB2' HD12 ' A' ' 57' ' ' ILE . 59.2 m-20 -114.83 127.72 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 110.575 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -88.18 89.97 8.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.064 HG11 HD11 ' A' ' 81' ' ' ILE . 13.3 t -69.02 139.64 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.627 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 1.8 ttp -164.42 31.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.61 0.243 . . . . 0.0 111.452 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.882 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 178.21 69.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.005 0.431 . . . . 0.0 111.319 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.064 HD11 HG11 ' A' ' 78' ' ' VAL . 37.8 mt -98.78 118.19 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.957 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.426 ' OD1' HG22 ' A' ' 81' ' ' ILE . 4.7 p-10 44.55 31.64 0.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.303 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.54 -47.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.453 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.589 HG22 ' H ' ' A' ' 86' ' ' THR . 7.8 mm -72.39 121.12 83.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.59 0.233 . . . . 0.0 111.13 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -85.14 19.8 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.688 2.259 . . . . 0.0 112.952 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.589 ' H ' HG22 ' A' ' 84' ' ' ILE . 4.9 p 57.61 23.62 9.52 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.22 -167.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.048 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.3 124.16 51.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.37 36.15 17.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 62.3 m -139.44 78.0 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.411 ' CA ' ' HB3' ' A' ' 55' ' ' PRO . 51.1 p90 -61.96 -24.64 67.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.047 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -55.28 -34.83 64.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.55 -45.68 74.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.858 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -58.03 -45.49 86.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.008 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.69 ' HA ' HD23 ' A' ' 98' ' ' LEU . 70.8 m-80 -60.81 -42.89 98.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.561 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.95 -32.87 74.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.516 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.858 HD12 ' HA ' ' A' ' 94' ' ' ALA . 21.1 mt -65.71 -48.07 73.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.69 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -68.67 -28.56 66.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.53 -36.81 76.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.56 -5.69 48.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.38 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 m -60.14 -20.15 57.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.207 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.7 m -63.13 -31.51 72.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.61 -59.2 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.133 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.4 t -83.24 -7.88 59.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.294 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.731 ' O ' HG23 ' A' ' 30' ' ' THR . 1.9 p 80.82 -8.65 1.43 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.628 ' O ' HG23 ' A' ' 104' ' ' THR . 5.5 ptpt -156.5 163.37 39.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 111.166 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.4 147.97 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.709 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.833 HG22 HG22 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -112.74 112.05 23.27 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.245 179.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -108.85 125.62 52.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.934 0.397 . . . . 0.0 111.946 -179.157 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.882 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 6.8 tt0 -93.11 104.87 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.881 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -110.09 158.53 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.179 -178.555 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -116.82 119.0 34.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.247 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CZ ' ' CG ' ' A' ' 23' ' ' GLU . 23.0 p90 -109.28 140.67 42.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.142 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -119.69 97.5 5.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.288 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.414 ' CG2' ' CB ' ' A' ' 21' ' ' HIS . 30.5 m -86.92 151.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.376 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.28 45.44 2.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -95.61 44.54 1.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.765 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.816 ' OG ' HG23 ' A' ' 19' ' ' VAL . 47.4 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.727 0.299 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.1 t -74.3 79.12 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 t -73.23 116.21 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.665 ' O ' HG23 ' A' ' 22' ' ' THR . 0.5 OUTLIER -90.38 176.62 6.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 21' ' ' HIS . 0.2 OUTLIER 170.39 110.42 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.398 -179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -155.69 169.6 23.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 111.052 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.0 p -94.66 130.66 41.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.457 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.639 HG23 HD11 ' A' ' 111' ' ' ILE . 4.6 t -111.79 135.29 52.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.828 0.346 . . . . 0.0 111.409 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.1 pt-20 -99.82 98.82 9.58 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.737 HG11 ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -105.19 111.54 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.94 -179.203 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.872 HG22 HG22 ' A' ' 108' ' ' THR . 10.6 t -82.7 121.85 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.092 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' A' ' 65' ' ' PRO . 4.1 mm? -111.9 140.58 46.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 105' ' ' SER . 26.8 m -105.34 147.85 27.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.808 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.618 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -90.37 104.25 16.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.243 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.24 135.18 76.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.677 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.12 55.79 5.48 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.558 2.172 . . . . 0.0 112.489 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.9 t -155.21 -49.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.942 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -125.4 -44.11 1.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.968 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.76 -121.09 4.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.425 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.618 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 40.4 m-85 -110.97 -26.2 9.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.705 0.288 . . . . 0.0 111.082 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.96 33.66 79.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.794 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.537 HG22 ' HB3' ' A' ' 37' ' ' PHE . 1.1 tt -136.95 140.76 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.448 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 18.2 mm100 -131.7 136.69 47.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.127 0.489 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.975 HD13 ' HB1' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -112.25 130.36 55.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.717 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -82.24 137.1 34.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.65 -20.44 46.64 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.54 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.417 ' CB ' ' HG ' ' A' ' 51' ' ' LEU . 12.2 p -155.49 -177.42 6.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.964 0.411 . . . . 0.0 111.055 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.803 HG22 HD13 ' A' ' 56' ' ' LEU . 69.2 t -63.48 -81.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.061 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.53 132.48 10.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.29 105.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.081 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 p -58.04 -20.56 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.343 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -144.76 122.73 12.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.894 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 62.21 172.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.007 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' H ' HG22 ' A' ' 50' ' ' THR . 9.5 tt -107.22 140.34 40.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.13 21.57 0.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.818 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.494 ' HB3' HG23 ' A' ' 45' ' ' VAL . 3.2 m -141.77 160.53 55.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.054 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.711 ' O ' HD12 ' A' ' 56' ' ' LEU . 53.7 Cg_endo -69.25 151.97 71.98 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.586 2.19 . . . . 0.0 112.251 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.38 146.78 95.99 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.641 2.227 . . . . 0.0 112.284 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.803 HD13 HG22 ' A' ' 45' ' ' VAL . 1.8 mp -157.16 136.67 12.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.353 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.541 ' CD1' HG21 ' A' ' 111' ' ' ILE . 68.1 mt -71.51 144.84 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.436 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.2 p -163.4 55.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.986 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.448 ' CD1' ' HG2' ' A' ' 40' ' ' GLN . 11.2 t80 -177.95 132.68 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 111.618 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.431 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -152.89 152.03 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.751 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -96.87 155.13 16.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.38 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.97 41.91 0.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.918 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.428 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 1.2 p30 168.88 32.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.705 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.78 145.86 44.35 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.697 0.284 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.678 ' HB2' HD12 ' A' ' 29' ' ' LEU . 82.0 Cg_exo -44.96 -37.21 12.07 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.769 2.313 . . . . 0.0 112.578 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.505 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -59.07 -38.95 80.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.977 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -76.16 -50.18 15.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.687 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.428 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.9 -8.74 56.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.667 -179.497 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.511 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -58.25 -24.89 60.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.664 0.268 . . . . 0.0 110.79 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.14 30.24 77.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.148 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.737 ' HB ' HG11 ' A' ' 27' ' ' VAL . 9.3 t -142.3 -49.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.348 . . . . 0.0 111.068 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 39' ' ' ILE . 9.5 mt -69.22 159.62 32.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.032 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 -171.14 3.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' O ' HG22 ' A' ' 74' ' ' ILE . 24.7 mm -93.58 49.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.76 39.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.65 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -89.95 146.15 24.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.762 0.315 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.6 85.31 2.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.052 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.918 HG11 HD11 ' A' ' 81' ' ' ILE . 2.6 t -55.54 159.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -50.49 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.45 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.27 86.29 1.76 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.808 0.337 . . . . 0.0 111.641 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.918 HD11 HG11 ' A' ' 78' ' ' VAL . 4.3 mt -77.51 111.81 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 46.53 28.42 0.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.228 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 112.94 -49.57 0.84 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.418 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.9 mm -69.33 109.12 3.89 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.548 0.213 . . . . 0.0 111.182 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 87.0 Cg_endo -94.63 155.98 1.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.907 2.405 . . . . 0.0 112.458 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p -130.95 114.15 14.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.407 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -116.63 -70.66 0.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.424 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -110.61 112.73 24.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 111.286 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.2 m 47.14 83.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.242 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.16 30.96 1.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.799 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -58.28 -47.87 82.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.721 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -45.66 91.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.572 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -62.31 -30.55 71.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.975 ' HB1' HD13 ' A' ' 41' ' ' LEU . . . -67.46 -42.51 82.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.442 ' HA ' HD23 ' A' ' 98' ' ' LEU . 2.0 m-80 -67.36 -41.7 84.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.441 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -64.33 -53.05 54.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.222 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 98' ' ' LEU . 4.2 pp -57.89 -35.19 70.66 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.159 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.888 ' N ' HD12 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -78.47 -35.5 46.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.727 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -27.84 67.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -15.3 63.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.175 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.455 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -73.33 -21.57 60.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.885 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.0 t -70.03 -32.38 70.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.815 0.341 . . . . 0.0 110.408 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -82.03 -41.73 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.681 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.0 m -79.74 -20.28 46.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.856 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.669 ' O ' HG23 ' A' ' 30' ' ' THR . 2.6 m 76.78 -1.76 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.789 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.459 ' CE ' HG11 ' A' ' 28' ' ' VAL . 10.1 tttt -156.56 152.24 27.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.825 0.345 . . . . 0.0 111.501 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.415 HG12 ' CE2' ' A' ' 37' ' ' PHE . 13.8 p -150.65 151.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.239 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.872 HG22 HG22 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -107.95 109.45 20.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.988 0.423 . . . . 0.0 110.531 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.76 HD22 HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -87.5 127.94 35.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.512 -179.35 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -119.25 104.6 10.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.097 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -124.92 162.7 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.091 0.472 . . . . 0.0 112.088 -178.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.52 118.61 37.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.779 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.45 ' CD1' HG23 ' A' ' 115' ' ' VAL . 29.3 p90 -107.36 161.39 14.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.309 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -133.74 97.42 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.394 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.45 HG23 ' CD1' ' A' ' 113' ' ' PHE . 3.4 t -86.53 141.01 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -147.27 47.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.52 56.4 1.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.861 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.96 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.085 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 2.6 mm-40 -144.34 176.87 9.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.967 0.413 . . . . 0.0 111.169 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -110.9 134.95 52.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.498 HG23 HG13 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -115.66 146.9 41.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.257 0.551 . . . . 0.0 111.415 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.3 99.26 8.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.087 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.759 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -102.15 102.37 13.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.768 -178.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.4 p -85.97 119.32 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.466 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.8 mt -110.63 164.14 13.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.945 0.403 . . . . 0.0 111.221 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 105' ' ' SER . 90.4 m -130.31 127.71 40.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.581 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -55.24 112.27 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.416 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.04 146.02 99.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.24 -7.3 20.87 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.659 2.239 . . . . 0.0 112.902 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -98.81 -67.05 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.061 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.8 p -105.6 -51.33 3.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.46 -75.3 0.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.744 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 95.9 m-85 -138.72 76.25 1.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.955 0.407 . . . . 0.0 110.423 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.28 0.64 1.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.911 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.852 HD11 HG21 ' A' ' 57' ' ' ILE . 17.8 tt -95.86 132.89 38.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 116.861 0.331 . . . . 0.0 110.599 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -116.95 145.61 43.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.133 0.492 . . . . 0.0 111.731 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -125.76 122.71 37.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.01 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 0.0 111.296 -179.345 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.547 ' C ' HD13 ' A' ' 56' ' ' LEU . 85.4 Cg_endo . . . . . 0 N--CA 1.463 -0.281 0 N-CA-C 113.112 0.389 . . . . 0.0 113.112 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -158.48 161.03 37.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.75 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.852 HG21 HD11 ' A' ' 39' ' ' ILE . 5.2 mt -80.22 138.57 19.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.897 ' HA ' HG23 ' A' ' 74' ' ' ILE . 8.7 t -164.34 41.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.241 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -176.32 123.19 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 0.0 111.48 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.539 HD11 ' HA ' ' A' ' 73' ' ' GLN . 3.6 mt -133.73 152.51 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.084 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -100.57 155.62 17.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.07 0.462 . . . . 0.0 111.36 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.15 43.25 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.902 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER 168.18 31.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.676 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -112.97 144.38 30.97 Favored Pre-proline 0 CA--C 1.527 0.088 0 CA-C-O 120.707 0.289 . . . . 0.0 110.782 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -45.1 -32.89 7.3 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.638 2.225 . . . . 0.0 112.661 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.422 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -66.39 -46.03 78.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.788 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -65.34 -39.13 91.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.632 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.434 ' NE ' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -87.37 -8.49 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.652 -179.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' A' ' 71' ' ' VAL . 35.0 t -53.43 -25.03 14.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 111.033 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.64 27.24 73.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.201 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.651 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.3 p -170.97 34.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.406 . . . . 0.0 111.007 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.416 HD21 HG21 ' A' ' 27' ' ' VAL . 14.4 mt -141.42 147.67 38.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.009 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.539 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.1 mm-40 -168.95 171.69 8.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.725 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.897 HG23 ' HA ' ' A' ' 58' ' ' SER . 36.9 mt -70.46 123.63 24.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.088 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.42 -24.6 3.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.607 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.676 ' HB3' HG21 ' A' ' 111' ' ' ILE . 69.7 m-20 -57.73 123.62 16.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.762 0.315 . . . . 0.0 110.732 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.635 ' C ' HG22 ' A' ' 111' ' ' ILE . 4.4 mtm-85 -94.34 98.42 10.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.433 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.654 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.6 m -75.89 118.31 21.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.972 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.3 ttp -141.14 27.48 1.94 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.873 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -178.86 61.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.643 HD11 ' HB ' ' A' ' 78' ' ' VAL . 25.6 mt -92.45 130.82 40.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.216 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.433 ' OD1' HD22 ' A' ' 97' ' ' LEU . 1.9 p-10 43.93 31.14 0.47 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.316 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.84 -44.44 1.64 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.602 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.461 ' HB ' HD21 ' A' ' 97' ' ' LEU . 7.6 mm -71.77 110.78 8.41 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.501 0.191 . . . . 0.0 111.289 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 0 N--CA 1.458 -0.606 0 C-N-CA 122.814 2.343 . . . . 0.0 112.686 -179.839 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.931 0.396 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.865 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -58.02 -49.9 75.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.679 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -58.01 -36.77 73.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.545 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -43.95 97.52 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.653 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 94' ' ' ALA . 5.3 mt -59.71 -42.49 93.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.613 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 41' ' ' LEU . 61.3 mt -62.86 -37.13 85.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -77.74 -28.42 50.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.126 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.41 -6.72 49.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.463 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 3.5 m -72.68 -26.24 61.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.74 0.305 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.92 -26.85 64.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.218 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.8 mm -53.9 -49.32 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.494 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.1 t -104.73 -1.06 26.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.599 ' O ' HG23 ' A' ' 30' ' ' THR . 1.5 m 78.97 -4.54 2.1 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.791 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.646 ' O ' HG23 ' A' ' 104' ' ' THR . 0.0 OUTLIER -156.58 152.64 27.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.868 0.366 . . . . 0.0 111.111 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 108' ' ' THR . 10.7 p -131.13 157.54 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.778 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.447 ' N ' HG22 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -120.56 106.87 12.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.86 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.421 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -100.64 120.15 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 111.871 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.873 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -87.96 112.12 22.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.454 178.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.759 HD11 ' CG2' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -118.43 164.97 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.361 0.6 . . . . 0.0 112.443 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -123.12 124.87 44.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.833 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.422 ' CE1' ' HB2' ' A' ' 23' ' ' GLU . 49.9 p90 . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.955 0.407 . . . . 0.0 111.263 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 22.1 pt-20 -175.15 177.08 1.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.969 0.414 . . . . 0.0 111.212 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 15.8 p -89.53 128.19 35.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.109 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.587 HG23 ' CD1' ' A' ' 111' ' ' ILE . 2.7 t -107.28 136.0 47.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.277 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.79 99.38 11.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.639 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -101.02 103.18 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.718 -178.435 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 108' ' ' THR . 10.9 t -83.59 113.95 23.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.406 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.431 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 8.7 mt -110.08 137.64 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.009 0.433 . . . . 0.0 111.251 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 105' ' ' SER . 96.7 m -109.91 137.89 47.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.577 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.67 146.62 51.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.214 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.02 139.46 28.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.794 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.0 57.23 5.1 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.61 2.207 . . . . 0.0 112.432 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.4 t -155.42 -68.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 -29.76 6.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.011 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.75 -110.93 3.15 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.406 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.562 ' HB3' HG22 ' A' ' 39' ' ' ILE . 52.3 m-85 -114.61 -33.01 5.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.51 31.87 82.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.77 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.912 HD13 HD13 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -140.96 140.96 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 110.959 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.24 159.18 42.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.039 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.538 HD13 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -127.49 121.64 31.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.733 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.704 ' C ' HD13 ' A' ' 56' ' ' LEU . 35.1 Cg_endo . . . . . 0 C--O 1.232 0.198 0 CA-C-O 120.627 0.178 . . . . 0.0 112.105 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.704 HD13 ' C ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -152.52 150.29 29.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.069 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.447 HD12 HG21 ' A' ' 111' ' ' ILE . 80.7 mt -74.52 147.93 8.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.861 ' HA ' HG23 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -175.4 50.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.153 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -173.79 134.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 0.0 111.437 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -150.69 151.88 12.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.219 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.75 155.36 18.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 0.0 111.582 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.87 41.0 1.02 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.863 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER 171.82 33.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.521 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 m -127.11 143.67 47.82 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.07 -32.81 7.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.729 2.286 . . . . 0.0 112.809 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.99 -51.66 68.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.986 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.558 ' HB2' HG22 ' A' ' 60' ' ' ILE . 10.6 tp10 -69.67 -43.14 73.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.69 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.434 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -67.15 -14.11 62.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.402 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.694 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -55.91 -27.44 52.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.941 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.18 31.58 65.93 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.239 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 69' ' ' CYS . 10.4 t -137.29 -58.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 111.206 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.912 HD13 HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -75.38 166.09 24.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.053 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.432 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.1 pp0? -164.86 169.23 16.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.707 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.861 HG23 ' HA ' ' A' ' 58' ' ' SER . 18.0 mt -67.54 114.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.068 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.67 22.17 4.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.648 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.431 ' HB3' HG21 ' A' ' 111' ' ' ILE . 1.3 m-20 -83.45 141.52 31.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.679 0.276 . . . . 0.0 110.673 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.409 ' HB3' ' HB3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -98.84 89.66 4.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.345 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.896 HG22 ' CG2' ' A' ' 111' ' ' ILE . 5.4 t -74.82 145.85 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.602 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -170.29 29.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.771 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . . . -176.18 46.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 111.661 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.598 HG22 ' OD1' ' A' ' 82' ' ' ASN . 16.5 mt -67.8 112.99 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.029 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.598 ' OD1' HG22 ' A' ' 81' ' ' ILE . 5.2 p-10 44.06 35.69 1.25 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.436 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.59 -49.7 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.386 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.11 120.29 77.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.534 0.207 . . . . 0.0 111.138 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 N--CA 1.461 -0.387 0 C-N-CA 122.719 2.28 . . . . 0.0 112.915 -179.771 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 4.2 mt-10 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.962 0.411 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.882 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.32 -38.54 84.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.764 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -61.93 -43.67 98.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -62.56 -38.06 88.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.446 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.882 HD12 ' HA ' ' A' ' 94' ' ' ALA . 12.2 mt -61.71 -40.7 95.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.248 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.4 mt -78.02 -32.17 50.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.363 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -65.89 -25.86 67.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.916 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.54 15.02 10.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.522 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 m -79.32 -23.22 43.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.81 0.338 . . . . 0.0 110.853 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 p -58.59 -35.25 72.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.807 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.9 mm -53.95 -54.37 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.4 p -86.93 -8.69 57.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.984 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.789 ' O ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER 79.35 -5.02 1.99 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.025 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -156.62 166.8 32.37 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.853 0.358 . . . . 0.0 111.187 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 11.4 p -151.13 148.32 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.902 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.891 HG22 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -112.33 107.19 15.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.087 179.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -101.83 126.16 48.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.776 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.771 ' CB ' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -92.5 120.53 33.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.62 178.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.896 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -133.79 165.48 31.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.383 -178.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 77' ' ' ARG . 21.1 tt0 -116.86 126.75 53.49 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.102 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.445 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 34.5 p90 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.15 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.219 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.6 OUTLIER -168.26 154.18 7.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.393 . . . . 0.0 111.572 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 72.5 p -89.85 127.06 35.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.265 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.553 HG23 ' CD1' ' A' ' 111' ' ' ILE . 7.3 t -114.61 131.07 56.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.925 0.393 . . . . 0.0 111.366 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.18 99.42 11.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.724 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.633 HG11 ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -107.69 133.64 51.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.081 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.703 HG22 HG22 ' A' ' 108' ' ' THR . 21.6 t -94.28 117.42 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.405 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.652 HD11 ' N ' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -109.17 126.1 52.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.331 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.0 t -103.11 165.88 10.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.215 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.8 115.99 30.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.081 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.25 140.22 79.57 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.769 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.02 -0.69 10.83 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.659 2.239 . . . . 0.0 112.874 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.4 t -108.04 -35.69 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.002 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.9 p -133.91 -66.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.72 -109.1 0.57 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.434 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 35.6 m-85 -118.41 -35.43 3.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.7 26.0 38.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.776 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.544 HG23 HD13 ' A' ' 98' ' ' LEU . 3.0 tt -111.16 127.18 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.994 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 125.14 51.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.922 HD11 HD11 ' A' ' 98' ' ' LEU . 2.1 mt -108.84 116.3 31.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.756 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.818 0.257 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 56' ' ' LEU . 1.7 pt? -178.08 169.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.622 HD13 ' HB2' ' A' ' 76' ' ' ASP . 3.4 mp -75.62 141.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.429 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.9 t -117.34 -31.29 5.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.849 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -165.56 167.43 17.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.194 0.521 . . . . 0.0 111.886 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.523 HG13 HD13 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -144.94 153.18 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.922 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -86.37 155.46 20.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.086 0.469 . . . . 0.0 111.516 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.87 38.34 0.8 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.82 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -179.72 26.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.992 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.5 p -120.62 134.58 24.25 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.626 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.466 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 89.2 Cg_exo -43.52 -29.21 2.03 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.492 2.128 . . . . 0.0 112.752 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.652 ' N ' HD11 ' A' ' 29' ' ' LEU . . . -62.24 -42.85 99.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.983 0.42 . . . . 0.0 110.815 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' CA ' HG21 ' A' ' 60' ' ' ILE . 8.8 tp10 -78.48 -50.22 12.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.152 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.466 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.88 -8.36 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.916 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -24.95 11.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.771 0.32 . . . . 0.0 111.0 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.84 30.71 63.22 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.237 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.633 ' HB ' HG11 ' A' ' 27' ' ' VAL . 5.4 t -145.03 -52.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.926 0.393 . . . . 0.0 111.116 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.414 HD21 HD12 ' A' ' 111' ' ' ILE . 12.1 mt -75.69 130.68 39.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.047 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 -170.99 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.798 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.523 HD13 HG13 ' A' ' 60' ' ' ILE . 12.9 mm -92.16 75.61 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.187 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.88 42.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.891 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.622 ' HB2' HD13 ' A' ' 57' ' ' ILE . 32.9 m-20 -85.18 -176.03 5.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.583 0.23 . . . . 0.0 110.534 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.91 79.27 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 111.203 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.032 HG11 HD11 ' A' ' 81' ' ' ILE . 12.2 t -58.45 147.82 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.054 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 11.9 tpt -134.98 -65.36 0.62 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.07 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -125.37 96.95 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.032 HD11 HG11 ' A' ' 78' ' ' VAL . 9.7 mt -88.48 122.96 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.943 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.724 HD22 HG22 ' A' ' 81' ' ' ILE . 9.6 p30 46.53 31.63 1.4 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.01 -34.23 5.2 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.219 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.558 ' HB ' HD22 ' A' ' 97' ' ' LEU . 4.1 mm -87.72 110.85 37.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.511 0.196 . . . . 0.0 111.155 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 N--CA 1.458 -0.615 0 C-N-CA 122.669 2.246 . . . . 0.0 112.56 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.804 0.335 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.878 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.86 -50.45 73.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -58.16 -36.36 72.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.582 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.92 -43.95 97.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.724 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' A' ' 94' ' ' ALA . 3.8 mt -60.5 -43.75 96.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.721 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.922 HD11 HD11 ' A' ' 41' ' ' LEU . 57.3 mt -70.96 -31.24 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -67.55 -32.68 73.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.98 -5.82 50.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.233 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -75.55 -23.18 56.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.751 0.31 . . . . 0.0 111.017 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.6 p -63.7 -30.98 72.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.714 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -65.14 -56.14 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.995 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 105' ' ' SER . 42.7 p -77.61 -11.7 59.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.126 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 104' ' ' THR . 1.8 p 84.19 -18.3 0.42 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.925 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 8.6 ptpt -156.43 160.53 39.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 111.284 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 9.8 p -144.67 155.27 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.713 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.703 HG22 HG22 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -110.99 121.85 46.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.206 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.512 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -115.07 143.84 44.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.446 -179.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -115.18 104.71 12.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.983 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.667 HG22 HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -116.55 161.31 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -93.59 133.57 36.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.689 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 30.6 p90 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.979 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 22' ' ' THR . 5.6 t . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER 179.26 177.28 0.55 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.739 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 19.7 p -86.61 127.58 34.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.29 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.598 HG22 HD12 ' A' ' 111' ' ' ILE . 9.9 t -113.98 140.77 48.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.37 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 99.01 9.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.5 HG21 HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -101.64 103.17 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.305 -178.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.4 p -82.74 115.25 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.929 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.401 HD22 ' C ' ' A' ' 28' ' ' VAL . 4.4 mm? -113.78 147.99 37.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.117 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 105' ' ' SER . 82.2 m -108.11 144.7 35.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.873 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.722 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -84.1 108.82 17.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.3 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -68.3 140.6 92.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.99 41.38 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.771 2.314 . . . . 0.0 112.814 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.88 -47.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.799 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -127.39 -43.42 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.977 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.17 -118.57 2.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.52 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 29.9 m-85 -108.07 -25.49 11.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.761 0.315 . . . . 0.0 110.943 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.53 41.88 99.65 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.532 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.645 HG23 HD13 ' A' ' 98' ' ' LEU . 18.8 tt -150.66 126.63 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.775 0.321 . . . . 0.0 111.098 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' A' ' 59' ' ' TYR . 2.8 pm0 -124.28 156.54 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.037 0.446 . . . . 0.0 111.268 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.733 HD13 ' CB ' ' A' ' 94' ' ' ALA . 2.6 mp -103.67 162.3 13.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.779 0.241 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -140.39 145.12 36.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.198 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 6.3 mt -59.64 145.27 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.516 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 m -147.45 16.84 1.16 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.432 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 4.0 t80 -162.26 149.84 14.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.222 0.534 . . . . 0.0 111.799 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.712 HD11 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -151.41 152.36 11.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.788 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -94.45 155.63 16.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 111.825 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -87.86 41.48 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.716 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 169.6 31.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.71 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.9 m -120.83 144.15 38.31 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.795 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.45 -27.25 7.03 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.885 2.39 . . . . 0.0 112.547 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -66.29 -46.84 75.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.976 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 2.9 tp10 -78.06 -39.73 40.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.432 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.6 -19.16 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.476 ' HB3' HG22 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -52.78 -30.12 31.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.075 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.1 23.56 52.53 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.816 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 69' ' ' CYS . 2.9 m -122.39 -38.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.763 0.316 . . . . 0.0 111.232 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 pp -93.59 148.63 21.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.955 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -125.86 169.09 12.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.686 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.712 HD13 HD11 ' A' ' 60' ' ' ILE . 32.9 mm -67.44 107.07 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.047 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.87 4.39 6.7 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.073 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.91 133.18 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.86 0.33 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -98.28 95.71 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.219 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.963 HG11 HD11 ' A' ' 81' ' ' ILE . 2.7 t -76.19 129.82 36.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.546 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -150.77 31.87 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.274 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.931 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 179.36 81.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.963 HD11 HG11 ' A' ' 78' ' ' VAL . 41.7 mt -111.91 126.7 69.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.234 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.745 HD22 HG22 ' A' ' 81' ' ' ILE . 11.8 p30 45.19 31.35 0.76 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.234 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.41 -34.75 5.05 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.312 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.0 mm -82.15 111.68 29.55 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.455 0.169 . . . . 0.0 111.083 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 N--CA 1.46 -0.498 0 C-N-CA 122.682 2.254 . . . . 0.0 112.713 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.454 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 35.0 mt-10 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.736 0.303 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.733 ' CB ' HD13 ' A' ' 41' ' ' LEU . . . -57.36 -43.02 83.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -56.59 -40.94 76.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.058 0.456 . . . . 0.0 110.054 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -63.03 -38.03 89.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.32 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.514 HD12 HD12 ' A' ' 81' ' ' ILE . 41.3 mt -61.02 -39.0 88.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.645 HD13 HG23 ' A' ' 39' ' ' ILE . 60.6 mt -78.09 -28.59 48.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.053 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -74.91 -35.8 62.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.412 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -78.39 -3.2 42.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.652 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.486 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 67.0 m -69.77 -25.02 63.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.858 0.361 . . . . 0.0 110.733 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.03 -27.22 65.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 21.9 mm -49.92 -47.2 23.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.824 0.345 . . . . 0.0 111.241 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.1 t -108.75 0.94 20.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.057 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.752 ' O ' HG23 ' A' ' 30' ' ' THR . 1.4 t 62.81 18.06 10.41 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.256 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 0.5 OUTLIER -156.94 144.14 18.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.865 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.518 HG12 ' CE2' ' A' ' 37' ' ' PHE . 10.4 p -152.36 151.94 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.705 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 p -122.15 104.32 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.007 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -102.41 149.17 24.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.181 0.515 . . . . 0.0 112.183 -178.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.931 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 1.3 tt0 -107.27 124.87 50.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.252 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.958 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -138.18 133.31 43.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.177 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 35.2 tt0 -92.7 118.64 31.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 22' ' ' THR . 18.8 p90 . . . . . 0 C--O 1.239 0.546 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.783 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 113' ' ' PHE . 96.5 m . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 120.991 0.424 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -178.31 168.31 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.726 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 12.5 p -87.78 151.68 22.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.71 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.858 HG23 ' CD1' ' A' ' 111' ' ' ILE . 0.6 OUTLIER -132.15 143.49 50.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.032 0.444 . . . . 0.0 111.53 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.28 99.61 9.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.55 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.638 HG12 ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -105.4 106.89 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.616 -178.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.794 HG22 ' HD3' ' A' ' 106' ' ' LYS . 13.6 p -90.01 114.98 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.703 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 66' ' ' ALA . 10.8 mt -104.27 164.42 11.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 0.0 110.961 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 105' ' ' SER . 11.5 m -121.19 142.54 49.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.608 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.642 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -86.85 114.54 23.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 111.121 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.64 147.83 71.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.96 18.64 1.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.968 2.445 . . . . 0.0 112.853 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.84 -41.28 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.801 0.334 . . . . 0.0 111.078 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 t -136.04 -45.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.074 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.4 -109.98 0.93 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.512 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.642 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 87.1 m-85 -118.7 -31.7 4.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.631 0.253 . . . . 0.0 111.191 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.48 35.78 90.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.648 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 57' ' ' ILE . 1.7 tt -135.39 131.33 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.965 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.9 155.78 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.041 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.656 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -136.65 135.9 38.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 -179.814 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo . . . . . 0 N--CA 1.466 -0.133 0 CA-C-O 120.969 0.321 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 56' ' ' LEU . 2.6 pt? -115.95 151.2 35.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.124 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 39' ' ' ILE . 29.2 mt -84.37 154.1 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.92 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 57' ' ' ILE . 44.3 t -177.81 51.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -175.53 133.86 0.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.971 0.415 . . . . 0.0 111.288 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.433 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -150.58 152.18 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.357 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.99 155.46 17.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.652 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.0 41.63 1.01 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.811 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER 172.19 32.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.589 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -126.73 145.61 54.08 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.73 -31.73 15.28 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.991 2.461 . . . . 0.0 112.591 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.494 ' HA ' HD21 ' A' ' 29' ' ' LEU . . . -58.8 -45.25 90.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.953 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 11.8 tp10 -77.96 -41.9 34.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.775 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.424 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -69.38 -11.77 61.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.402 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.425 ' O ' HG22 ' A' ' 71' ' ' VAL . 1.1 t -52.98 -30.67 36.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.821 0.343 . . . . 0.0 111.112 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.09 27.89 68.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.44 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.638 ' CG2' HG12 ' A' ' 27' ' ' VAL . 2.8 m -152.54 30.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.347 . . . . 0.0 111.179 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.469 HD23 ' OD2' ' A' ' 76' ' ' ASP . 3.3 mt -136.92 162.23 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.75 159.07 43.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.3 mm -75.66 98.05 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.244 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.67 38.52 0.61 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.618 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' OD2' HD23 ' A' ' 72' ' ' LEU . 28.8 m-20 -82.1 126.84 32.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 110.73 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -84.68 90.04 7.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.073 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.029 HG11 HD11 ' A' ' 81' ' ' ILE . 2.1 t -70.66 144.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.522 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -163.42 28.47 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.212 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . 172.16 89.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 111.278 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.029 HD11 HG11 ' A' ' 78' ' ' VAL . 20.4 mt -116.54 115.09 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.785 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.531 HD22 HG22 ' A' ' 81' ' ' ILE . 7.9 p30 49.6 26.75 1.87 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.248 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.12 -44.25 1.55 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.698 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.506 HG21 HD21 ' A' ' 97' ' ' LEU . 6.9 mm -74.35 111.65 13.7 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.531 0.205 . . . . 0.0 111.191 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo . . . . . 0 N--CA 1.455 -0.745 0 C-N-CA 122.858 2.372 . . . . 0.0 112.777 -179.854 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.953 0.406 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 41' ' ' LEU . . . -57.89 -35.37 70.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.076 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.51 ' HA ' HD23 ' A' ' 98' ' ' LEU . 7.2 m-20 -62.78 -39.4 94.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.178 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -62.34 -40.3 95.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.09 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.506 HD21 HG21 ' A' ' 84' ' ' ILE . 11.7 mt -59.34 -47.04 86.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.617 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -78.01 -26.71 48.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.873 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -73.93 -30.44 62.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.32 7.24 29.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.441 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.448 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -74.22 -17.53 60.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.726 0.298 . . . . 0.0 111.259 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.1 m -59.14 -30.77 68.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.913 0.387 . . . . 0.0 110.615 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.4 mt -57.04 -66.3 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 t -84.98 -2.75 58.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.159 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.661 ' O ' HG23 ' A' ' 30' ' ' THR . 0.9 OUTLIER 64.85 19.6 11.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.244 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.794 ' HD3' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -156.37 153.91 29.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 111.423 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.445 HG12 ' CE2' ' A' ' 37' ' ' PHE . 13.8 p -145.73 143.67 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.19 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -118.16 120.89 39.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.488 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -121.54 132.86 54.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.552 -179.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 26.9 mt-10 -107.26 104.68 14.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.821 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.858 ' CD1' HG23 ' A' ' 25' ' ' THR . 0.2 OUTLIER -110.99 163.89 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -114.52 121.3 43.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.784 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.786 ' O ' HG23 ' A' ' 22' ' ' THR . 39.2 p90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 111.733 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 1.1 m . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.85 0.357 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -147.85 149.77 32.91 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.317 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -88.76 127.12 35.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.814 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.658 HG23 HG13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -114.79 152.4 32.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.244 0.545 . . . . 0.0 111.401 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.32 99.14 6.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.261 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.702 HG21 HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.03 129.53 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.554 -178.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.716 HG22 ' CG2' ' A' ' 108' ' ' THR . 21.3 t -105.17 113.58 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.464 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.539 HD12 ' HD1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -102.12 124.66 48.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.374 . . . . 0.0 110.935 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 67.8 m -105.85 115.31 30.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.08 140.29 44.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.355 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.03 157.36 34.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.41 -1.33 11.5 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.935 2.423 . . . . 0.0 112.753 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 t -104.03 -67.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.33 . . . . 0.0 111.285 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.5 p -105.05 -71.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.62 -72.37 0.28 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.578 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.539 ' HD1' HD12 ' A' ' 29' ' ' LEU . 45.7 m-85 -145.41 -43.88 0.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 111.018 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.4 26.86 70.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.733 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.947 HD13 HD13 ' A' ' 72' ' ' LEU . 1.7 tt -124.55 130.71 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 110.922 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.79 148.08 41.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.876 HD13 ' HB1' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -122.13 120.83 35.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.651 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.579 ' C ' HD23 ' A' ' 56' ' ' LEU . 31.7 Cg_exo . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.898 0.291 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -177.89 141.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.768 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.857 HG21 HD11 ' A' ' 39' ' ' ILE . 23.6 mt -64.02 134.83 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.83 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 t -159.97 42.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -172.44 135.9 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.081 0.467 . . . . 0.0 111.222 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.411 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -151.37 152.52 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.234 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.52 155.24 17.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 111.272 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.67 42.37 0.96 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.138 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.421 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER 168.97 33.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.727 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.57 144.57 44.63 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -43.5 -37.75 8.09 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.798 2.332 . . . . 0.0 112.766 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.44 77.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.991 0.424 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -75.73 -50.52 15.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.683 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.421 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.36 -8.95 57.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.697 -179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.517 ' O ' HG23 ' A' ' 71' ' ' VAL . 42.1 t -56.38 -25.24 49.03 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.806 0.336 . . . . 0.0 110.835 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.08 31.76 81.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.293 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.635 HG11 HG13 ' A' ' 27' ' ' VAL . 5.4 t -143.69 -52.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 0.0 111.067 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.947 HD13 HD13 ' A' ' 39' ' ' ILE . 76.5 mt -58.96 150.44 24.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.018 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -144.09 160.59 40.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.5 mm -71.67 89.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.26 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.19 35.17 0.83 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.784 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.652 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -74.93 130.94 40.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.785 0.326 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -85.32 79.33 9.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.733 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.913 HG11 HD11 ' A' ' 81' ' ' ILE . 5.8 t -56.88 158.53 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.425 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -137.75 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.342 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.21 96.0 4.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.377 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.913 HD11 HG11 ' A' ' 78' ' ' VAL . 21.4 mt -86.63 121.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.775 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.794 ' OD1' HD22 ' A' ' 97' ' ' LEU . 4.2 p-10 44.83 30.51 0.56 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.242 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.96 -37.49 3.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.646 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.682 ' HB ' HD21 ' A' ' 97' ' ' LEU . 4.2 mm -84.77 111.07 32.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.499 0.19 . . . . 0.0 111.208 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 N--CA 1.459 -0.554 0 C-N-CA 122.742 2.295 . . . . 0.0 112.72 -179.746 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.909 0.385 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.883 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -58.29 -44.74 88.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.176 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -60.26 -39.63 87.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.781 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -62.45 -41.55 98.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.883 HD12 ' HA ' ' A' ' 94' ' ' ALA . 5.2 mt -62.21 -48.17 81.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.55 HD11 HD11 ' A' ' 41' ' ' LEU . 73.9 mt -59.89 -33.85 72.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -29.61 39.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -6.01 49.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.478 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.2 t -79.25 -27.22 42.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.691 0.282 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.2 m -59.43 -34.96 73.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.1 mm -52.48 -46.78 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.496 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.3 t -101.48 -4.32 27.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.098 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER 78.41 -3.31 2.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.77 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.639 ' O ' HG23 ' A' ' 104' ' ' THR . 5.0 ptpt -156.8 165.01 37.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.94 0.4 . . . . 0.0 111.131 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.3 146.54 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.525 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.716 ' CG2' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -109.96 109.56 20.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.299 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.897 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -110.25 143.94 39.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 0.0 111.653 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -106.6 121.43 44.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.93 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.702 HD11 HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -119.4 164.48 15.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.15 0.5 . . . . 0.0 111.984 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -122.57 118.65 28.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.301 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 22' ' ' THR . 5.4 p90 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.26 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 22' ' ' THR . 6.7 t . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.959 0.409 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -168.94 156.09 7.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.408 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 7.9 p -87.68 129.27 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.813 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.431 HG22 ' HD2' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -117.37 148.09 42.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.033 0.444 . . . . 0.0 110.995 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.56 98.98 9.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.627 ' CG1' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -100.96 100.36 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.104 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.6 p -85.38 117.94 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.045 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.962 HD23 HD21 ' A' ' 109' ' ' LEU . 3.5 mm? -111.22 152.9 26.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.8 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 105' ' ' SER . 27.5 m -116.53 150.45 37.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.714 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.79 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -92.58 103.84 16.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.162 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 86.1 m-20 -74.89 154.66 86.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.791 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 32' ' ' ASP . 2.9 Cg_exo -75.21 0.02 9.49 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.762 2.308 . . . . 0.0 112.729 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -66.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.821 0.343 . . . . 0.0 110.981 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -108.96 -43.21 4.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.62 -85.72 0.86 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.79 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 96.4 m-85 -133.27 73.66 1.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.975 0.417 . . . . 0.0 110.098 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.89 10.43 0.56 Allowed Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.135 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 66' ' ' ALA . 13.1 tt -96.16 130.25 45.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.891 0.377 . . . . 0.0 110.788 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.72 136.8 50.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -127.64 114.79 17.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.029 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.86 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.84 ' O ' HD12 ' A' ' 56' ' ' LEU . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.754 0.231 . . . . 0.0 112.245 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 55' ' ' PRO . 4.8 mp -149.2 127.45 12.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.014 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 76' ' ' ASP . 69.7 mt -75.63 141.15 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.616 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.935 ' HA ' HG23 ' A' ' 74' ' ' ILE . 46.7 t -164.04 49.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.723 0.297 . . . . 0.0 111.683 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' O ' HG13 ' A' ' 39' ' ' ILE . 70.4 t80 -176.15 133.81 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.031 0.443 . . . . 0.0 111.504 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.411 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.33 152.05 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.035 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.92 155.5 18.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 111.357 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.27 43.49 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.842 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.84 32.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.609 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -121.47 144.62 40.63 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.04 -35.2 4.47 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.812 2.341 . . . . 0.0 112.86 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 39' ' ' ILE . . . -60.67 -44.36 96.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.9 OUTLIER -71.15 -46.73 60.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.842 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -8.68 57.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.633 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.48 ' SG ' HG22 ' A' ' 71' ' ' VAL . 53.5 t -52.0 -40.9 61.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.894 0.378 . . . . 0.0 111.006 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.57 -27.4 15.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.466 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.627 HG23 ' CG1' ' A' ' 27' ' ' VAL . 30.2 m -117.51 26.12 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.757 0.313 . . . . 0.0 111.303 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 66' ' ' ALA . 5.9 mt -124.82 143.48 50.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -169.12 153.39 5.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.785 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.935 HG23 ' HA ' ' A' ' 58' ' ' SER . 40.9 mt -59.34 110.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.53 -15.56 3.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.767 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.559 ' HB2' HD12 ' A' ' 57' ' ' ILE . 65.0 m-20 -59.04 139.32 56.97 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.814 0.34 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.28 96.16 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.08 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.665 HG22 ' CG2' ' A' ' 111' ' ' ILE . 2.8 t -65.33 152.04 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.2 tpt -137.05 -63.28 0.61 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.232 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -125.2 93.9 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.338 . . . . 0.0 111.356 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.885 HG23 ' HB3' ' A' ' 109' ' ' LEU . 10.6 mt -82.66 124.08 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.433 ' OD1' HG22 ' A' ' 81' ' ' ILE . 4.1 p-10 44.35 31.77 0.62 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.154 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.09 -37.57 3.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.3 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mm -85.75 112.66 46.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.57 0.224 . . . . 0.0 111.179 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo . . . . . 0 N--CA 1.459 -0.558 0 C-N-CA 122.632 2.222 . . . . 0.0 112.716 -179.782 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 120.82 0.343 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.67 -45.99 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.678 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.08 -38.04 78.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.241 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -62.68 -46.38 88.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.472 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.63 -31.72 71.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.182 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -78.06 -31.49 50.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.612 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.24 -30.62 38.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.87 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -10.58 59.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.243 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.532 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 16.6 m -72.43 -19.33 61.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.041 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.5 p -65.91 -37.09 85.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.882 0.373 . . . . 0.0 110.746 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -58.55 -55.77 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.3 p -83.19 -9.48 59.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.992 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.79 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER 62.28 17.21 9.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.347 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' HG22 ' A' ' 28' ' ' VAL . 2.9 tppt? -156.81 146.18 20.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 0.0 111.021 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.414 ' HB ' ' OG ' ' A' ' 101' ' ' SER . 11.7 p -154.8 149.89 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 28' ' ' VAL . 1.2 p -122.65 124.84 44.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.059 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.962 HD21 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -125.15 148.22 48.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.088 0.47 . . . . 0.0 111.993 -179.048 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -102.1 129.65 48.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.693 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.665 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -138.39 156.62 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.923 0.392 . . . . 0.0 111.815 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -93.9 126.11 38.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.248 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 24.5 p90 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.672 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.813 HG23 ' O ' ' A' ' 113' ' ' PHE . 57.0 m . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.997 0.427 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HG2' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -178.6 166.9 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.174 179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.2 p -90.31 131.83 35.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.108 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.469 HG23 HD11 ' A' ' 111' ' ' ILE . 5.2 t -116.26 133.62 55.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.031 0.443 . . . . 0.0 111.936 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.34 98.98 10.43 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.552 ' CG1' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -100.88 119.17 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.723 -178.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 28' ' ' VAL . 13.6 p -88.73 113.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.965 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 66' ' ' ALA . 3.5 mm? -104.84 164.77 11.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.567 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 105' ' ' SER . 37.6 m -127.2 146.0 50.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.871 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -82.87 97.49 8.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.148 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.34 142.47 90.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.64 -3.86 14.45 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.61 2.207 . . . . 0.0 112.785 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.73 -61.0 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 t -125.57 -41.22 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.01 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.1 -105.06 0.49 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.462 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.695 ' CE1' HG12 ' A' ' 107' ' ' VAL . 96.6 m-85 -113.85 -28.97 7.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.767 0.318 . . . . 0.0 111.005 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.26 47.28 83.09 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.836 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.838 HD13 HD13 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -146.87 127.63 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 0.0 111.075 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.58 147.87 46.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.909 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.83 ' O ' HD12 ' A' ' 41' ' ' LEU . 2.8 pp -131.68 127.0 36.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.408 ' NE2' ' CB ' ' A' ' 58' ' ' SER . 3.7 mt-30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.77 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.783 0.243 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.419 ' N ' HD23 ' A' ' 56' ' ' LEU . 1.3 pt? -152.09 145.53 24.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.205 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.631 HD11 HG22 ' A' ' 78' ' ' VAL . 8.5 mt -77.59 143.49 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.612 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.408 ' CB ' ' NE2' ' A' ' 42' ' ' GLN . 3.7 t -162.79 48.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.281 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -172.9 131.54 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.099 0.476 . . . . 0.0 111.389 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.685 HG13 HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -149.61 152.31 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.031 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.83 155.45 17.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 111.261 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.63 39.88 0.9 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.752 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 175.55 29.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.773 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.62 136.14 26.94 Favored Pre-proline 0 C--O 1.231 0.127 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 92.2 Cg_exo -43.52 -29.24 2.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.622 2.214 . . . . 0.0 112.807 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.521 ' HB1' HD13 ' A' ' 39' ' ' ILE . . . -62.72 -42.08 99.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.932 0.396 . . . . 0.0 111.01 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.462 ' HB2' HG22 ' A' ' 60' ' ' ILE . 5.8 tp10 -78.31 -49.61 13.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -72.14 -8.19 53.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.655 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.76 -28.03 14.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 111.001 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.0 26.36 69.05 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.66 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' CG1' ' A' ' 27' ' ' VAL . 1.1 m -145.5 -47.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 111.117 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.838 HD13 HD13 ' A' ' 39' ' ' ILE . 27.1 mt -58.76 156.56 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.18 156.07 18.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.685 HD11 HG13 ' A' ' 60' ' ' ILE . 30.3 mm -70.21 97.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.44 40.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.712 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB3' HD12 ' A' ' 57' ' ' ILE . 2.3 m-20 -101.42 153.22 19.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.641 0.258 . . . . 0.0 110.508 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -111.91 82.93 1.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.167 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.745 HG21 HD22 ' A' ' 41' ' ' LEU . 3.6 t -61.8 143.48 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -168.67 34.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.642 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.917 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 174.26 54.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.849 0.357 . . . . 0.0 111.271 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.742 HD11 HG11 ' A' ' 78' ' ' VAL . 25.5 mt -76.12 118.16 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.619 HD22 HG22 ' A' ' 81' ' ' ILE . 15.1 p30 44.89 30.79 0.59 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.271 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.72 -35.43 5.07 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.38 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 mm -78.68 110.83 15.51 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 121.999 0.119 . . . . 0.0 111.198 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 N--CA 1.458 -0.56 0 C-N-CA 122.563 2.175 . . . . 0.0 112.411 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 20.4 pt-20 . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.948 0.404 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.917 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -59.21 -41.09 87.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -61.18 -42.3 98.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.791 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -62.73 -34.8 77.92 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.764 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 94' ' ' ALA . 8.8 mt -68.13 -37.75 81.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.631 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.9 -41.65 59.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -68.16 -31.89 71.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.993 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -5.13 49.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.35 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.417 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 69.7 m -69.62 -13.9 62.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.261 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -58.56 -28.38 65.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.0 mm -54.83 -30.9 23.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.172 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -117.45 -4.5 11.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.223 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.682 ' O ' HG23 ' A' ' 30' ' ' THR . 1.4 m 62.91 21.46 12.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.211 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 5.6 mttt -156.12 151.21 26.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.0 110.956 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.695 HG12 ' CE1' ' A' ' 37' ' ' PHE . 13.2 p -150.08 111.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.88 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.435 HG23 HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -90.87 107.29 19.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.36 150.5 23.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 111.41 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.917 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 3.6 tt0 -123.57 105.17 9.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.195 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.688 HG22 HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -111.04 159.71 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.097 0.475 . . . . 0.0 111.925 -178.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -110.18 118.49 36.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.517 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.813 ' O ' HG23 ' A' ' 22' ' ' THR . 14.6 p90 . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.343 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 mt-10 -148.34 173.79 12.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.084 0.468 . . . . 0.0 111.423 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 112' ' ' GLU . 44.8 p -108.42 134.15 51.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.288 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.666 HG23 HG13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -111.96 144.52 41.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.083 0.468 . . . . 0.0 111.691 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.9 pt-20 -104.07 100.17 9.93 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.676 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -99.87 102.85 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.826 -178.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.976 HG23 HG23 ' A' ' 108' ' ' THR . 9.2 p -86.2 115.55 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.41 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.438 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 7.6 mt -115.58 152.44 33.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.018 0.437 . . . . 0.0 111.339 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 105' ' ' SER . 97.9 m -113.78 137.54 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.616 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -68.7 107.01 2.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.02 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.35 142.53 86.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.06 55.3 5.59 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.796 2.331 . . . . 0.0 112.482 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 t -153.2 -69.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.013 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -116.8 -24.55 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.18 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.67 -112.63 2.29 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.323 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.572 ' CE2' HG12 ' A' ' 107' ' ' VAL . 21.5 m-85 -113.03 -23.28 10.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 0.0 111.139 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.41 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 58.85 54.23 39.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.863 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 57' ' ' ILE . 2.0 tt -147.88 127.2 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.731 0.3 . . . . 0.0 110.747 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.51 147.06 38.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.066 0.46 . . . . 0.0 111.53 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.657 HD23 HG13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -121.25 169.09 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.372 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 120.879 0.371 . . . . 0.0 111.06 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo . . . . . 0 C--O 1.232 0.22 0 CA-C-O 120.891 0.288 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 56' ' ' LEU . 2.1 pt? -135.65 160.01 39.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.939 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.758 HG21 HD11 ' A' ' 39' ' ' ILE . 5.6 mt -85.96 143.9 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.736 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.488 ' HA ' HG23 ' A' ' 74' ' ' ILE . 11.5 m -165.32 50.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.29 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -176.52 132.76 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.979 0.419 . . . . 0.0 111.42 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.402 HG21 ' HA ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -149.15 152.26 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.059 179.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.58 155.45 16.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.164 0.507 . . . . 0.0 111.275 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.67 38.85 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.846 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.0 t0 179.08 28.69 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.772 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.41 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 33.4 m -124.35 139.19 32.37 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.591 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 2.8 Cg_endo -45.51 -27.95 3.82 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.865 2.377 . . . . 0.0 112.77 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.64 96.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.846 0.355 . . . . 0.0 110.843 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' HA ' HG21 ' A' ' 60' ' ' ILE . 3.6 tp10 -78.56 -48.43 15.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.05 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -73.06 -7.23 50.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.893 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.72 -25.89 4.88 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.841 0.353 . . . . 0.0 111.175 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.87 25.27 73.12 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.559 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.644 ' O ' HG22 ' A' ' 71' ' ' VAL . 14.4 p -158.07 29.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.034 0.445 . . . . 0.0 110.874 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 mt -135.82 151.96 50.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.715 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -151.37 172.2 16.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.488 HG23 ' HA ' ' A' ' 58' ' ' SER . 22.3 mm -83.01 73.0 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.77 37.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.66 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.7 123.07 48.35 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.75 105.85 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 111.744 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.865 ' CG1' HG23 ' A' ' 111' ' ' ILE . 1.3 m -71.45 138.26 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -148.05 21.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.261 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -174.26 59.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.931 0.396 . . . . 0.0 111.319 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 78' ' ' VAL . 32.3 mt -88.65 124.61 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 44.24 31.21 0.53 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.324 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.31 -46.67 1.18 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mm -70.33 112.57 13.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.553 0.216 . . . . 0.0 111.166 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 C--N 1.347 0.477 0 C-N-CA 122.636 2.224 . . . . 0.0 112.819 -179.901 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.862 0.363 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HB3' HD13 ' A' ' 41' ' ' LEU . . . -57.68 -42.08 82.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.685 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -39.48 77.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.286 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -62.97 -41.49 99.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.341 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.419 HD12 HD12 ' A' ' 81' ' ' ILE . 13.3 mt -58.77 -41.9 87.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.591 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.3 mt -77.87 -30.67 50.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.82 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -38.98 92.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -75.33 -7.15 53.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.4 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.473 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 8.7 m -63.95 -22.19 66.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.972 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.89 -39.44 81.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.787 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.8 mm -49.3 -65.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.472 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 106' ' ' LYS . 7.6 t -84.32 -4.81 59.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.039 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.838 ' O ' HG23 ' A' ' 30' ' ' THR . 0.4 OUTLIER 63.0 21.0 12.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.236 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.764 ' HD2' HG22 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -156.41 150.14 24.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.247 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.572 HG12 ' CE2' ' A' ' 37' ' ' PHE . 9.4 p -155.33 145.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.617 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.976 HG23 HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -122.23 108.89 13.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.295 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -103.48 128.36 50.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.041 0.448 . . . . 0.0 111.836 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -92.41 107.46 19.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.634 178.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.865 HG23 ' CG1' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -109.36 159.9 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.22 0.533 . . . . 0.0 112.152 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.582 ' HG3' HG22 ' A' ' 24' ' ' THR . 6.5 tt0 -118.83 121.97 41.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.783 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.405 ' CD1' ' O ' ' A' ' 23' ' ' GLU . 52.0 p90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -178.44 177.97 0.9 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.989 0.423 . . . . 0.0 111.585 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.525 HG22 ' HB2' ' A' ' 112' ' ' GLU . 68.1 p -87.23 143.14 27.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.509 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 t -132.72 135.09 45.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.6 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.02 99.25 11.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.645 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -103.51 130.48 53.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' VAL . 9.6 p -82.97 122.06 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.092 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.508 HD11 ' HA ' ' A' ' 66' ' ' ALA . 1.7 mm? -116.09 147.97 40.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.635 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 105' ' ' SER . 74.5 m -130.43 144.13 51.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.872 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -82.84 147.53 28.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.098 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 2.4 m-20 -110.61 156.13 41.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 32' ' ' ASP . 3.1 Cg_exo -80.15 0.11 10.26 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.938 2.425 . . . . 0.0 112.424 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 t -91.25 -55.22 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.157 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 t -135.31 -46.69 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.27 -111.99 0.6 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.452 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.872 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 67.0 m-85 -109.17 -24.86 10.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.766 0.317 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 64.88 42.94 96.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.934 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -143.41 128.4 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.875 0.369 . . . . 0.0 110.689 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.439 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -116.22 150.37 37.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 111.458 -179.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.783 HD13 ' CB ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -119.83 160.89 21.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.474 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 111.111 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.664 ' C ' HD13 ' A' ' 56' ' ' LEU . 97.7 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.849 0.27 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.664 HD13 ' C ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -160.54 -178.67 7.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.871 HG21 HD11 ' A' ' 39' ' ' ILE . 26.5 mt -87.18 141.19 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.698 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 m -161.85 49.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.392 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.439 ' CG ' ' HB2' ' A' ' 40' ' ' GLN . 24.4 t80 -177.36 132.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 111.462 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.407 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -151.88 152.54 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.982 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.83 155.02 17.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 111.401 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.73 42.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.856 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.408 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER 170.4 31.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.821 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.411 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 3.9 m -122.84 145.29 45.08 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.002 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.54 -37.48 11.07 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.073 2.515 . . . . 0.0 112.6 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.508 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -58.51 -38.51 77.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 1.2 tm-20 -78.24 -51.97 9.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.856 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.408 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -67.03 -11.27 56.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.827 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -24.65 51.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 110.874 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.31 30.58 73.55 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.174 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.536 ' CB ' HG11 ' A' ' 27' ' ' VAL . 4.4 t -145.47 -54.46 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.093 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.9 mt -59.58 145.67 43.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -160.88 167.87 25.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.778 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.7 mm -70.24 67.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.74 38.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.474 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.478 ' HB3' HG21 ' A' ' 111' ' ' ILE . 56.2 m-20 -109.59 107.52 17.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.733 0.301 . . . . 0.0 110.554 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -82.21 93.89 7.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.306 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.901 ' HB ' HD11 ' A' ' 81' ' ' ILE . 30.5 m -58.63 123.57 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.703 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.0 ttp -118.37 -16.01 9.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.808 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -167.12 98.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 111.551 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.901 HD11 ' HB ' ' A' ' 78' ' ' VAL . 3.9 mp -103.12 113.27 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.5 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 45.87 29.94 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.224 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.31 -44.38 1.52 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.767 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mm -80.89 113.74 42.87 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.505 0.193 . . . . 0.0 111.166 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 C--N 1.348 0.504 0 C-N-CA 122.509 2.139 . . . . 0.0 112.866 -179.882 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.7 mt-10 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.816 0.341 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.783 ' CB ' HD13 ' A' ' 41' ' ' LEU . . . -57.8 -49.16 77.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -60.12 -34.82 74.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.525 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.61 -41.11 98.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.568 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 94' ' ' ALA . 3.6 mt -70.08 -30.56 67.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.462 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 94' ' ' ALA . 3.4 mm? -64.08 -46.44 84.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.927 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -73.64 -29.76 62.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.061 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -75.0 -5.61 44.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.503 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.445 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 58.1 m -66.44 -22.06 66.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 0.0 111.196 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -58.66 -27.31 64.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.007 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.5 mm -57.35 -48.98 81.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.477 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -100.79 -14.81 17.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.284 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER 77.57 -3.79 2.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.949 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -156.78 129.62 7.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.858 0.361 . . . . 0.0 111.029 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.441 HG21 ' OG ' ' A' ' 101' ' ' SER . 0.0 OUTLIER -120.38 166.82 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.86 106.75 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.794 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.93 138.28 35.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.001 0.429 . . . . 0.0 111.881 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -116.2 104.62 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.821 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.645 HD11 ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -120.28 149.02 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.525 ' HB2' HG22 ' A' ' 24' ' ' THR . 49.0 tt0 -103.62 118.79 37.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.871 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.301 -179.363 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.46 0.072 0 CA-C-O 120.725 0.298 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.402 ' O ' ' CD2' ' A' ' 113' ' ' PHE . 1.1 mt-10 -151.68 176.56 11.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 0.0 111.26 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 p -103.71 140.79 37.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.412 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.828 HG23 ' CD1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -116.89 142.07 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.064 0.459 . . . . 0.0 111.441 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.62 98.93 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.783 HG23 HD12 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -102.91 131.24 51.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.0 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.845 HG22 HG22 ' A' ' 108' ' ' THR . 12.3 t -107.62 113.4 43.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.179 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 65' ' ' PRO . 3.1 mm? -99.91 164.29 12.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.335 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 105' ' ' SER . 17.0 m -117.5 132.24 56.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 110.819 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.775 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -79.35 91.64 5.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.163 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.15 140.87 94.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.63 -4.96 16.28 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.476 2.117 . . . . 0.0 112.846 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.7 t -99.69 -54.18 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.066 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.446 HG23 ' N ' ' A' ' 36' ' ' GLY . 10.9 t -108.3 -47.15 3.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.446 ' N ' HG23 ' A' ' 35' ' ' THR . . . 97.45 -91.17 1.17 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.672 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.775 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 80.9 m-85 -141.61 77.92 1.61 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.938 0.399 . . . . 0.0 110.223 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.48 18.93 0.4 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.072 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.744 HD11 HG21 ' A' ' 57' ' ' ILE . 3.4 tt -96.35 130.02 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.91 0.355 . . . . 0.0 110.611 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.603 ' C ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -111.07 145.81 37.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.987 0.422 . . . . 0.0 111.463 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.696 HD22 HG12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -122.01 156.98 32.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.479 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.915 -179.914 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo . . . . . 0 C--O 1.231 0.142 0 CA-C-O 120.866 0.277 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.563 ' N ' HD23 ' A' ' 56' ' ' LEU . 2.3 pt? -167.91 152.94 6.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.97 0.414 . . . . 0.0 111.109 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.744 HG21 HD11 ' A' ' 39' ' ' ILE . 47.7 mt -72.9 152.48 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.835 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.18 44.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.537 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -176.58 129.38 0.19 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.209 0.528 . . . . 0.0 111.854 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.509 HD13 HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -142.21 152.14 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.374 179.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 63' ' ' ASP . 5.5 tp10 -109.88 154.93 22.36 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.078 0.466 . . . . 0.0 111.858 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.29 42.04 0.15 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.016 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER 175.11 31.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.192 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -122.21 135.05 25.09 Favored Pre-proline 0 CA--C 1.527 0.075 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.665 ' HB2' HD12 ' A' ' 29' ' ' LEU . 3.5 Cg_endo -46.37 -30.54 8.34 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.506 2.137 . . . . 0.0 112.424 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.734 ' HA ' HD21 ' A' ' 72' ' ' LEU . . . -70.08 -33.27 71.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.768 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.452 ' HA ' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -75.04 -49.93 18.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.844 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.419 ' NH2' ' C ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -79.31 -8.26 58.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.943 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.53 -34.78 37.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.772 0.32 . . . . 0.0 111.082 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.26 27.12 70.13 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.591 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 72' ' ' LEU . 11.2 p -136.08 -45.3 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.629 0.252 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.734 HD21 ' HA ' ' A' ' 66' ' ' ALA . 2.5 pp -77.99 163.04 26.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.013 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.59 165.29 29.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.865 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.51 75.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.085 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.8 40.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.776 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.524 ' HB2' HD12 ' A' ' 57' ' ' ILE . 45.8 m-20 -99.95 119.13 37.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 110.56 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -86.13 85.64 7.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.218 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 111' ' ' ILE . 3.5 t -65.54 138.64 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.118 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.2 ttp -171.14 34.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.128 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.807 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -179.88 49.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.13 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.638 HD11 HG11 ' A' ' 78' ' ' VAL . 8.7 mt -73.0 117.68 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.54 HD22 HG22 ' A' ' 81' ' ' ILE . 13.6 p30 45.55 30.48 0.77 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.56 -37.65 3.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.096 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.778 HG21 HD21 ' A' ' 97' ' ' LEU . 7.7 mm -74.28 112.04 15.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.552 0.215 . . . . 0.0 111.137 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 N--CA 1.458 -0.617 0 C-N-CA 122.676 2.251 . . . . 0.0 112.488 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.856 0.36 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.73 -48.33 79.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.503 ' HA ' HD21 ' A' ' 98' ' ' LEU . 9.8 m-80 -61.86 -34.73 76.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.496 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -35.98 82.02 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.51 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 94' ' ' ALA . 4.6 mt -69.74 -48.24 60.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.996 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HA ' HG21 ' A' ' 107' ' ' VAL . 3.2 pp -70.1 -37.02 75.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.157 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.548 ' N ' HD12 ' A' ' 98' ' ' LEU . 4.7 mtt85 -69.87 -30.41 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.81 0.338 . . . . 0.0 111.009 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -89.16 4.78 47.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.369 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.453 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 0.4 OUTLIER -83.12 -12.12 57.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.338 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.5 p -57.68 -24.77 58.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.714 0.292 . . . . 0.0 110.887 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.7 mm -56.36 -31.51 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.954 0.406 . . . . 0.0 110.896 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -114.34 -5.93 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.058 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.583 ' O ' HG23 ' A' ' 30' ' ' THR . 8.9 t 69.42 23.81 5.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.399 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.583 ' HD3' HG11 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -156.23 150.38 25.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.952 0.406 . . . . 0.0 111.282 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.606 HG21 ' HA ' ' A' ' 98' ' ' LEU . 13.9 p -144.14 136.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.28 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.845 HG22 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -111.32 113.39 25.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.225 179.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.783 HD12 HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -113.97 125.2 53.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.966 0.412 . . . . 0.0 111.369 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.807 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 12.9 tt0 -101.32 105.0 16.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.871 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.907 HG22 HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -110.2 164.3 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 121.08 0.467 . . . . 0.0 112.07 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -104.19 120.41 41.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.916 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 23' ' ' GLU . 45.0 p90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.29 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.421 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.586 0.232 . . . . 0.0 111.135 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 22.2 mt-10 -162.29 143.99 10.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.943 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 69.5 p -91.94 127.12 37.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.62 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.812 HG23 ' CD1' ' A' ' 111' ' ' ILE . 1.6 t -115.72 136.59 52.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 111.204 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.71 99.83 11.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.022 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.473 HG11 HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -106.61 129.01 60.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -179.266 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.681 HG22 ' CG2' ' A' ' 108' ' ' THR . 19.5 t -94.3 120.62 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.176 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB2' HD21 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -111.17 123.91 51.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.855 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 105' ' ' SER . 28.7 m -105.62 141.64 36.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.717 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.65 136.39 37.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.226 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.49 141.91 23.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.828 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.35 55.87 5.28 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.78 2.32 . . . . 0.0 112.56 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -155.41 -64.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.162 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -114.14 -44.48 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.93 -115.57 2.93 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.406 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.694 ' HB3' HG22 ' A' ' 39' ' ' ILE . 54.0 m-85 -113.96 -28.85 7.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.682 0.277 . . . . 0.0 110.971 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.99 24.64 43.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.691 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.748 HD11 HG21 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -130.44 140.55 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.967 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.702 ' C ' HD13 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -139.54 164.81 28.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.099 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.702 HD13 ' C ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -117.28 160.07 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.7 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.957 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.713 0.214 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.747 HD22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -131.9 153.34 50.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 0.0 110.952 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.748 HG21 HD11 ' A' ' 39' ' ' ILE . 12.1 mt -59.87 145.39 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.684 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.881 ' HA ' HG23 ' A' ' 74' ' ' ILE . 3.0 m -165.37 44.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.801 0.334 . . . . 0.0 111.557 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.593 ' O ' HD12 ' A' ' 39' ' ' ILE . 30.8 t80 -169.97 133.57 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.174 0.511 . . . . 0.0 111.534 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.423 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -151.88 152.52 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.879 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 1.4 mt-10 -103.55 155.39 18.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.065 0.46 . . . . 0.0 111.426 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.89 39.44 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.8 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.03 29.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.684 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.37 142.15 34.77 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.624 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.487 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 97.0 Cg_exo -43.07 -29.48 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.65 2.233 . . . . 0.0 112.87 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.407 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -62.89 -40.26 97.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.423 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 2.4 mm-40 -78.12 -52.92 8.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.728 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.84 -8.63 55.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.743 -179.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -38.37 56.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.811 0.339 . . . . 0.0 110.952 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.97 -18.66 55.55 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.819 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.473 HG23 HG11 ' A' ' 27' ' ' VAL . 7.7 m -128.09 39.24 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.836 0.35 . . . . 0.0 111.188 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -139.78 143.84 37.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -169.12 152.91 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.713 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 58' ' ' SER . 24.9 mt -58.36 107.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.048 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.22 -25.34 1.41 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.406 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.452 ' CB ' HD12 ' A' ' 57' ' ' ILE . 16.6 m-20 -60.14 122.98 15.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.832 0.348 . . . . 0.0 110.662 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.4 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -96.13 105.74 17.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.214 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.119 HG11 HD11 ' A' ' 81' ' ' ILE . 14.8 t -70.54 146.12 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -165.17 27.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.462 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.786 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . 174.07 78.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.969 0.414 . . . . 0.0 111.419 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.119 HD11 HG11 ' A' ' 78' ' ' VAL . 21.0 mt -103.83 118.09 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.846 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 45.1 30.57 0.62 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 108.9 -46.1 1.22 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.581 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.696 HG21 HD21 ' A' ' 97' ' ' LEU . 9.0 mm -70.62 109.96 6.08 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.548 0.214 . . . . 0.0 111.436 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 86.0 Cg_endo . . . . . 0 N--CA 1.456 -0.72 0 C-N-CA 122.861 2.374 . . . . 0.0 112.234 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.869 0.366 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.739 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.85 -46.27 85.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.884 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.686 ' N ' HD23 ' A' ' 41' ' ' LEU . 11.2 m-20 -60.25 -36.2 77.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.441 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -40.21 96.58 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.394 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.739 HD12 ' HA ' ' A' ' 94' ' ' ALA . 1.7 mt -72.74 -28.31 62.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.515 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.92 -47.0 79.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.801 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.4 mpp_? -76.12 -28.57 57.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.966 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.95 -9.03 57.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.431 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.435 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 51.9 m -72.62 -23.72 60.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.098 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 p -58.95 -34.85 72.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 25.7 mm -53.64 -60.66 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.523 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.4 t -75.27 -8.86 57.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.388 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 30' ' ' THR . 0.9 OUTLIER 84.19 -16.3 0.53 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.009 179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.595 ' O ' HG23 ' A' ' 104' ' ' THR . 1.5 ptpt -156.65 158.08 36.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.758 0.313 . . . . 0.0 111.051 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 108' ' ' THR . 12.1 p -146.47 160.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.673 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.681 ' CG2' HG22 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -119.02 109.43 15.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.263 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -103.06 133.18 48.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 111.619 -179.422 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 6.2 mt-10 -107.84 104.79 14.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.057 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.812 ' CD1' HG23 ' A' ' 25' ' ' THR . 0.2 OUTLIER -109.37 159.47 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.08 0.467 . . . . 0.0 112.25 -178.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.79 119.24 38.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.884 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 23.4 p90 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.964 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 120.633 0.254 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.456 ' HG2' ' CZ ' ' A' ' 113' ' ' PHE . 1.8 pt-20 -177.99 176.91 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.1 p -101.81 127.36 48.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.532 HG23 HG13 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -101.49 158.78 15.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.194 0.521 . . . . 0.0 111.28 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.13 99.17 8.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.622 HG21 HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.24 105.81 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.774 -178.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 28' ' ' VAL . 10.0 p -82.97 116.01 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.437 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.634 HD11 ' HA ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -106.52 141.59 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.916 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 105' ' ' SER . 87.4 m -115.46 142.17 47.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.84 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.784 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -85.93 141.61 29.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.147 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.61 138.26 22.53 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.865 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.06 58.68 5.64 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.547 2.165 . . . . 0.0 112.356 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 t -154.19 -68.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.055 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 p -110.63 -28.99 8.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -118.15 4.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.381 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.784 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 40.8 m-85 -113.0 -22.77 10.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.675 0.274 . . . . 0.0 111.153 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.01 32.1 66.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.872 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.618 HG22 ' HB3' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -140.52 141.05 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.732 0.301 . . . . 0.0 110.821 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.31 138.45 47.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.246 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.806 HD23 HG21 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -107.08 113.05 26.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.487 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 -179.775 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.663 ' C ' HD13 ' A' ' 56' ' ' LEU . 98.0 Cg_endo . . . . . 0 N--CA 1.461 -0.402 0 CA-C-O 120.791 0.246 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.663 HD13 ' C ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -162.99 170.69 17.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.577 HG21 HD11 ' A' ' 39' ' ' ILE . 7.6 mt -80.26 139.12 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.457 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.6 m -156.79 48.46 0.45 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 111.505 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -173.12 133.51 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.11 0.481 . . . . 0.0 111.545 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.595 HG22 ' HB2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.3 152.03 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.96 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.69 155.61 17.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.107 0.48 . . . . 0.0 111.432 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.55 38.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.723 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.86 29.68 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.643 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 p -122.11 137.46 27.5 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.478 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 82.9 Cg_exo -43.98 -29.2 2.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.511 2.141 . . . . 0.0 112.829 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.732 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -62.51 -43.21 99.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.793 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.595 ' HB2' HG22 ' A' ' 60' ' ' ILE . 27.2 tp10 -78.3 -49.53 13.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -73.6 -8.41 55.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.554 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.426 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -51.9 -28.16 15.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.769 0.318 . . . . 0.0 110.96 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.22 45.35 95.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.412 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.9 p -170.06 41.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.019 0.438 . . . . 0.0 111.074 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.732 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -176.6 145.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -142.3 -175.43 4.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.821 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 60' ' ' ILE . 31.5 mm -78.93 77.51 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.58 41.02 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.623 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -112.09 119.23 37.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.333 . . . . 0.0 110.701 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 93.65 9.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.207 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.806 HG21 HD23 ' A' ' 41' ' ' LEU . 1.8 t -71.19 134.34 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.54 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -157.21 29.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 111.298 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.826 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -179.22 68.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.131 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.711 ' HB ' HD22 ' A' ' 97' ' ' LEU . 3.9 mp -90.6 120.03 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.4 p30 45.41 29.64 0.61 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.286 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 107.55 -36.15 4.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.356 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.5 mm -77.12 110.82 13.28 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.503 0.192 . . . . 0.0 111.218 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 89.3 Cg_endo . . . . . 0 N--CA 1.456 -0.678 0 C-N-CA 122.789 2.326 . . . . 0.0 112.448 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.844 0.354 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.821 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.75 -50.89 71.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -59.55 -34.14 72.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.533 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -62.63 -40.19 96.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.641 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.821 HD12 ' HA ' ' A' ' 94' ' ' ALA . 1.8 mt -67.87 -37.53 81.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.512 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.44 HD11 ' CD1' ' A' ' 41' ' ' LEU . 49.8 mt -70.26 -39.94 74.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.626 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -65.38 -34.13 77.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.26 -10.27 59.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.276 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.472 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 5.1 m -79.22 -33.44 43.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 110.736 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -32.72 74.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.81 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.17 -58.01 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.51 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.8 t -96.17 1.54 52.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.234 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.736 ' O ' HG23 ' A' ' 30' ' ' THR . 8.3 t 69.98 9.75 7.2 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.577 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 104' ' ' THR . 1.5 ttmp? -156.56 155.86 32.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.895 0.379 . . . . 0.0 111.05 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.413 HG22 ' N ' ' A' ' 108' ' ' THR . 12.0 p -153.22 155.7 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.576 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 107' ' ' VAL . 0.6 OUTLIER -121.48 117.99 28.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.146 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.469 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -114.19 132.3 56.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.973 0.416 . . . . 0.0 111.989 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.826 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -95.41 109.48 21.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.43 178.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.738 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -116.59 143.13 27.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.052 -178.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -95.62 118.72 32.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.056 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.456 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 29.6 p90 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.001 0.429 . . . . 0.0 111.461 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 1.9 m . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.129 0.49 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -178.1 176.94 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.678 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.81 130.82 55.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.651 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 t -122.61 135.3 54.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.019 0.437 . . . . 0.0 111.487 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -99.22 99.07 9.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.449 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.648 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.49 115.33 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.303 -178.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 28' ' ' VAL . 10.2 p -83.3 122.01 36.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.118 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.92 160.82 15.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.424 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 105' ' ' SER . 19.8 m -123.06 153.36 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.859 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.742 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -93.86 141.11 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.47 144.65 29.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.49 -0.26 10.45 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.705 2.27 . . . . 0.0 112.819 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.15 -52.59 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.728 0.299 . . . . 0.0 111.168 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -119.71 -57.19 1.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.35 -110.33 0.62 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.56 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.742 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 55.2 m-85 -112.3 -32.4 6.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.739 0.304 . . . . 0.0 110.758 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 70.61 8.49 63.34 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.518 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.902 HD11 ' CG2' ' A' ' 57' ' ' ILE . 6.1 tp -97.12 130.43 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.997 0.398 . . . . 0.0 110.781 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.93 147.0 47.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.089 0.471 . . . . 0.0 111.406 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 4.8 mt -118.51 163.2 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.638 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.988 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 C--O 1.232 0.2 0 CA-C-O 120.721 0.217 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.52 163.45 32.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.0 111.177 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.902 ' CG2' HD11 ' A' ' 39' ' ' ILE . 5.0 mt -76.07 141.54 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.578 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.876 ' HA ' HG23 ' A' ' 74' ' ' ILE . 3.0 m -168.28 41.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.688 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -177.24 125.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.029 0.442 . . . . 0.0 111.529 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.581 HD12 ' OE1' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -137.33 152.6 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.095 179.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.43 155.36 21.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.067 0.461 . . . . 0.0 111.442 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -88.03 41.06 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.722 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 168.52 31.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.854 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.401 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 49.3 m -119.3 143.91 35.29 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-O 120.716 0.293 . . . . 0.0 110.911 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.56 -28.39 8.93 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.916 2.41 . . . . 0.0 112.738 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -66.0 -46.51 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 110.956 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.581 ' OE1' HD12 ' A' ' 60' ' ' ILE . 9.5 tp10 -78.15 -39.81 39.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.829 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.432 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.06 -19.36 64.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.364 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -41.08 68.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 110.879 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.24 -12.35 64.83 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.827 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 m -98.79 -32.41 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 111.184 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.83 HD13 HD13 ' A' ' 39' ' ' ILE . 11.0 mt -74.91 128.46 35.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.866 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -141.06 148.5 40.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 58' ' ' SER . 34.9 mt -64.05 114.51 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.07 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.21 -27.07 2.29 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.495 ' HB2' HD12 ' A' ' 57' ' ' ILE . 10.2 m-20 -63.39 138.01 58.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.709 0.29 . . . . 0.0 110.837 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.434 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 51.9 mtt180 -109.24 100.95 10.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.406 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.633 ' CA ' HG22 ' A' ' 111' ' ' ILE . 29.5 m -64.55 122.69 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.4 ptm -151.37 30.35 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.1 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -178.35 52.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.025 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.429 HD11 ' HB ' ' A' ' 78' ' ' VAL . 29.4 mt -82.36 128.76 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.058 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 43.67 31.52 0.46 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.235 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.77 -43.85 1.67 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.463 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.6 mm -71.28 113.27 17.95 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.471 0.176 . . . . 0.0 111.316 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo . . . . . 0 N--CA 1.461 -0.427 0 C-N-CA 122.74 2.293 . . . . 0.0 112.796 -179.699 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.929 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.72 -33.22 72.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.985 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -64.27 -48.33 76.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.826 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -33.89 75.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.647 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.929 HD12 ' HA ' ' A' ' 94' ' ' ALA . 17.2 mt -64.02 -41.41 97.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.461 HD13 ' CG2' ' A' ' 39' ' ' ILE . 62.6 mt -67.71 -40.19 84.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.757 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -65.26 -30.12 70.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.49 -7.34 51.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.37 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 m -71.87 -16.01 62.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.175 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -58.56 -27.01 64.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.045 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.9 mm -52.9 -41.11 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 111.309 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.8 t -120.01 -2.07 10.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.293 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.702 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 1.3 m 62.6 26.32 15.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.05 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HE2' HG21 ' A' ' 28' ' ' VAL . 2.1 mmtp -156.19 144.83 20.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.844 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.502 HG13 HD21 ' A' ' 109' ' ' LEU . 10.2 p -153.97 156.9 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.02 0.438 . . . . 0.0 111.888 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -122.07 125.44 46.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.934 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.502 HD21 HG13 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -119.21 136.64 54.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.098 0.475 . . . . 0.0 111.928 -178.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.743 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -111.89 106.71 15.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.334 178.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -107.49 157.84 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.139 0.495 . . . . 0.0 112.322 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.91 119.56 35.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.482 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 22' ' ' THR . 4.8 p90 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 3.0 m . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.875 0.369 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.9 mm-40 -151.62 177.36 10.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.114 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.0 p -107.39 129.51 54.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.134 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.536 HG23 ' CD1' ' A' ' 111' ' ' ILE . 1.9 t -114.59 137.32 52.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.122 0.487 . . . . 0.0 111.83 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.15 99.32 10.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.152 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -102.7 107.71 22.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.281 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 28' ' ' VAL . 13.7 p -88.67 113.84 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.036 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.403 ' HB2' ' CG1' ' A' ' 107' ' ' VAL . 54.5 mt -102.91 164.97 11.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.955 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 105' ' ' SER . 76.2 m -128.68 141.15 51.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.822 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.715 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -83.09 119.71 24.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.231 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.66 140.41 31.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.98 59.74 3.63 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.615 2.21 . . . . 0.0 112.502 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.6 t -154.88 -59.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -122.31 -42.73 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.823 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.57 -119.4 3.03 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.559 ' CE1' HG12 ' A' ' 107' ' ' VAL . 38.0 m-85 -103.64 -26.93 12.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.86 39.72 92.01 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.649 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.865 HD11 HG21 ' A' ' 57' ' ' ILE . 3.2 tt -136.5 127.1 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.953 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 127.83 56.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.91 HD22 HG12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -105.75 103.15 12.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.711 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.878 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.755 ' O ' HD12 ' A' ' 56' ' ' LEU . 64.5 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.579 0.158 . . . . 0.0 112.133 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 55' ' ' PRO . 5.8 mp -150.71 142.77 24.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.115 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.91 HG12 HD22 ' A' ' 41' ' ' LEU . 40.6 mt -80.91 122.5 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.744 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.62 51.63 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -178.16 126.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.002 0.43 . . . . 0.0 111.365 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.464 HG21 ' HA ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -142.77 152.09 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.1 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -102.05 155.53 18.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.019 0.438 . . . . 0.0 111.507 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.73 43.09 0.95 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.781 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 p30 178.32 28.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.861 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.402 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -128.81 137.02 30.07 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.277 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.46 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -43.76 -33.84 5.26 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.876 2.384 . . . . 0.0 112.649 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.466 ' HB1' HD12 ' A' ' 39' ' ' ILE . . . -57.86 -42.78 85.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.843 0.354 . . . . 0.0 111.15 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' HA ' HG21 ' A' ' 60' ' ' ILE . 17.1 tp10 -78.35 -50.23 12.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.216 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.32 -8.44 53.71 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.1 t -53.0 -33.63 52.5 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.824 0.345 . . . . 0.0 110.775 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.64 31.47 76.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.07 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.14 -65.78 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.098 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -71.73 150.28 44.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.147 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.4 -177.92 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 74' ' ' ILE . 19.8 tt -84.51 56.59 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 111.269 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.29 39.83 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.474 ' HB3' HG21 ' A' ' 111' ' ' ILE . 67.3 m-20 -82.7 147.27 28.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.618 0.247 . . . . 0.0 110.74 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -94.86 76.24 3.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.709 0.29 . . . . 0.0 111.503 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.591 ' HA ' HG22 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -58.28 128.36 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.709 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.416 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -158.35 29.38 0.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.097 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.863 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 178.34 66.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 0.0 111.065 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.409 HG22 ' OD1' ' A' ' 82' ' ' ASN . 9.1 mt -96.91 119.82 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.98 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.409 ' OD1' HG22 ' A' ' 81' ' ' ILE . 1.4 p-10 44.05 30.61 0.44 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.407 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.88 -48.62 0.92 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.543 ' HB ' HD13 ' A' ' 97' ' ' LEU . 8.8 mm -69.78 111.76 10.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.602 0.239 . . . . 0.0 111.113 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 C--N 1.347 0.485 0 C-N-CA 122.536 2.157 . . . . 0.0 112.844 -179.836 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.447 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.792 0.329 . . . . 0.0 110.88 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.818 ' HB1' HD12 ' A' ' 41' ' ' LEU . . . -57.51 -53.87 53.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.179 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.494 ' HA ' HD23 ' A' ' 98' ' ' LEU . 7.4 m-80 -56.93 -34.8 68.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.88 -46.92 85.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.171 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.543 HD13 ' HB ' ' A' ' 84' ' ' ILE . 7.1 mt -60.38 -43.45 96.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.141 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -76.87 -32.59 57.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.459 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -78.99 -29.13 43.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.751 0.31 . . . . 0.0 111.178 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -66.34 -15.56 63.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.503 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 3.8 m -83.39 -15.39 49.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.321 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.2 t -58.36 -29.51 66.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.9 mm -54.07 -38.24 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.346 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.3 t -118.02 -3.91 11.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.199 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.784 ' O ' HG23 ' A' ' 30' ' ' THR . 1.1 m 65.81 42.16 3.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.109 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 3.1 tppt? -156.04 128.93 7.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 111.342 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.559 HG12 ' CE1' ' A' ' 37' ' ' PHE . 14.7 p -137.48 145.42 29.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.135 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.523 HG23 HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -120.82 105.6 10.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.314 179.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -104.21 124.81 49.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.018 0.437 . . . . 0.0 111.685 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 18.1 tt0 -107.11 105.65 15.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.584 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -110.26 165.13 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.301 0.572 . . . . 0.0 112.27 -178.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -113.23 121.65 45.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.694 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 22' ' ' THR . 18.4 p90 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.881 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.464 0.243 0 CA-C-O 121.117 0.484 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -177.99 168.09 2.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.2 p -87.75 143.43 27.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.446 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.654 HG23 HG13 ' A' ' 111' ' ' ILE . 2.9 t -129.47 156.4 44.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.141 0.496 . . . . 0.0 111.355 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.57 98.71 7.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.457 ' CG1' HG11 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -100.82 103.14 14.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.477 -178.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 108' ' ' THR . 4.2 t -82.78 115.04 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.592 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.654 HD11 ' CD1' ' A' ' 72' ' ' LEU . 14.4 mt -111.59 127.3 55.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.032 0.444 . . . . 0.0 110.918 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 105' ' ' SER . 3.0 m -99.05 144.45 28.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HB2' ' HE1' ' A' ' 37' ' ' PHE . . . -74.23 124.94 27.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.949 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.42 136.81 52.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.67 -3.65 14.2 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.584 2.189 . . . . 0.0 112.609 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.42 -49.47 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.227 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.5 p -118.99 -57.07 2.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.9 -108.38 0.63 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.519 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.646 ' HB3' HG22 ' A' ' 39' ' ' ILE . 26.0 m-85 -114.66 -32.46 5.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.704 0.288 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.72 40.32 70.71 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.785 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.652 HD11 ' CG2' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -142.42 140.85 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.343 . . . . 0.0 110.92 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.427 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -123.29 145.14 48.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.222 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.714 HD23 HD11 ' A' ' 98' ' ' LEU . 1.1 mm? -104.41 105.37 15.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.738 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.867 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 C--O 1.23 0.111 0 CA-C-O 120.821 0.259 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.58 146.66 44.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.156 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.72 HD12 HG21 ' A' ' 111' ' ' ILE . 47.1 mt -60.64 133.61 26.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.28 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' HG13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -159.72 40.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 111.464 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CG ' ' HB2' ' A' ' 40' ' ' GLN . 34.2 t80 -167.08 131.12 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 111.198 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.79 152.33 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.03 155.33 17.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.989 0.423 . . . . 0.0 111.16 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.83 44.4 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.961 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER 168.39 32.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.666 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.78 146.45 55.2 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.926 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -43.82 -35.93 7.36 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.801 2.334 . . . . 0.0 112.867 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB1' HD13 ' A' ' 39' ' ' ILE . . . -59.17 -39.47 82.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 111.023 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.69 -50.34 13.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.722 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -72.31 -8.36 54.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.557 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.445 ' SG ' HD21 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -51.72 -26.22 8.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.719 0.295 . . . . 0.0 111.254 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.05 45.21 96.03 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.438 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 72' ' ' LEU . 8.1 p -173.1 -44.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.974 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.654 ' CD1' HD11 ' A' ' 29' ' ' LEU . 11.7 mt -60.91 164.69 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -154.8 171.8 19.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 0.0 111.203 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 74' ' ' ILE . 2.7 tt -84.85 56.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.136 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.24 59.1 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.765 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -101.24 125.06 47.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.759 0.314 . . . . 0.0 110.755 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -69.34 71.98 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.249 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.924 HG22 HG22 ' A' ' 111' ' ' ILE . 3.0 t -63.37 146.64 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -161.18 27.4 0.14 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.392 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 173.34 79.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.786 0.327 . . . . 0.0 111.203 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.814 HD11 HG11 ' A' ' 78' ' ' VAL . 38.1 mt -100.52 126.73 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.045 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.2 30.1 0.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 102.14 -41.8 2.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.678 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 mm -75.53 109.86 8.98 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.569 0.223 . . . . 0.0 111.352 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 96.8 Cg_endo . . . . . 0 N--CA 1.455 -0.779 0 C-N-CA 123.051 2.501 . . . . 0.0 112.264 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.489 0.185 . . . . 0.0 111.258 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.69 -52.41 65.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.029 0.442 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -55.85 -35.93 66.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.235 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -62.67 -39.59 94.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.29 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.477 HD12 HD12 ' A' ' 81' ' ' ILE . 12.6 mt -60.22 -43.09 96.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.096 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.714 HD11 HD23 ' A' ' 41' ' ' LEU . 41.6 mt -76.57 -30.58 57.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.865 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -35.8 81.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.323 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -72.33 -9.41 58.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.556 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 4.9 m -69.6 -24.65 63.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 0.0 110.802 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.9 p -63.2 -55.33 25.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.662 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.7 mm -55.19 -40.65 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.32 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.3 m -80.41 -21.96 41.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 30' ' ' THR . 1.9 t 77.58 -6.74 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.838 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -156.74 149.85 24.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.602 0.239 . . . . 0.0 110.82 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 29' ' ' LEU . 14.4 p -150.08 141.87 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 1.019 HG22 HG22 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -112.96 113.35 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.988 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.547 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -106.2 142.97 35.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 112.065 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.864 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 14.5 tt0 -104.73 105.92 16.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.537 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.924 HG22 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -116.92 150.51 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.401 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -112.1 120.84 43.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.138 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.6 p90 . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 120.959 0.409 . . . . 0.0 111.365 -179.424 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.513 -0.452 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -170.45 171.85 6.32 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.524 -177.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 74.2 p -99.2 132.52 44.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -109.53 135.39 50.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.224 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 99.07 9.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.631 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.549 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -105.97 122.84 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.034 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.027 HG22 HG22 ' A' ' 108' ' ' THR . 3.7 t -90.46 120.8 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.252 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.7 HD21 ' HA ' ' A' ' 66' ' ' ALA . 10.9 mp -112.47 143.82 42.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.612 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.773 HG23 ' O ' ' A' ' 105' ' ' SER . 82.3 m -105.25 144.06 32.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -87.19 89.54 8.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.92 138.74 97.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.12 56.5 5.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.581 2.187 . . . . 0.0 112.447 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.9 t -155.33 -66.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 t -111.36 -29.8 7.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.63 -130.03 10.11 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.481 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.675 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 74.5 m-85 -99.53 -23.55 15.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.712 0.291 . . . . 0.0 111.023 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.58 34.88 56.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.903 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.779 HD11 ' CG2' ' A' ' 57' ' ' ILE . 2.1 tt -132.65 143.83 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.79 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.42 148.93 48.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.571 HD13 ' HA ' ' A' ' 57' ' ' ILE . 3.2 mm? -104.07 157.68 16.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.837 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.808 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.939 0.308 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 56' ' ' LEU . 2.6 mp -133.49 136.99 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.965 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.779 ' CG2' HD11 ' A' ' 39' ' ' ILE . 33.2 mt -61.7 118.77 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.166 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.877 ' HA ' HG23 ' A' ' 74' ' ' ILE . 94.2 p -139.68 46.65 1.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 111.745 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -174.23 129.13 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.132 0.491 . . . . 0.0 111.493 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -147.53 151.96 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.002 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.58 155.55 17.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.123 0.487 . . . . 0.0 111.483 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.4 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -88.5 42.03 1.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.86 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 168.15 33.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.757 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.55 150.08 60.27 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.037 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.01 -31.87 29.09 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.912 2.408 . . . . 0.0 112.51 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.7 ' HA ' HD21 ' A' ' 29' ' ' LEU . . . -59.63 -48.59 81.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.028 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -78.11 -39.64 40.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.4 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -72.54 -8.76 56.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.56 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.526 ' SG ' HD11 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -52.91 -24.85 10.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.704 0.288 . . . . 0.0 110.996 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.84 73.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.305 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.646 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.6 p -170.57 33.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.953 0.406 . . . . 0.0 110.972 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.68 153.01 50.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -168.97 161.9 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.877 HG23 ' HA ' ' A' ' 58' ' ' SER . 62.5 mt -71.13 117.25 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.081 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.01 -21.96 4.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.666 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.553 ' HB2' HD12 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -52.79 136.57 33.53 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.688 0.28 . . . . 0.0 110.768 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -96.86 82.2 3.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.055 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.075 HG21 HD11 ' A' ' 81' ' ' ILE . 7.2 p -68.78 159.02 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.052 0.453 . . . . 0.0 111.323 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.663 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -152.0 -81.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.134 179.485 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.409 ' HB3' ' CD ' ' A' ' 110' ' ' GLU . . . -75.82 100.16 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 0.0 111.809 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.075 HD11 HG21 ' A' ' 78' ' ' VAL . 17.0 mt -119.38 125.88 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.357 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.576 ' HB3' HG23 ' A' ' 107' ' ' VAL . 6.9 p30 51.9 24.31 2.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.308 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.442 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 104.32 -39.0 2.98 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.753 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mm -84.18 108.86 15.7 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.42 0.156 . . . . 0.0 111.42 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 79' ' ' MET . 98.4 Cg_endo . . . . . 0 N--CA 1.451 -1.028 0 C-N-CA 122.779 2.319 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 7.0 mm-40 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.536 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -57.67 -44.67 85.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.807 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -56.77 -40.72 76.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.102 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -62.95 -35.95 81.83 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.267 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' A' ' 81' ' ' ILE . 24.3 mt -60.86 -48.1 83.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.782 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 81' ' ' ILE . 12.9 mt -74.64 -24.95 58.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -35.7 66.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.185 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -77.57 -4.48 46.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.5 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.463 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 14.8 m -62.72 -26.75 68.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.758 0.313 . . . . 0.0 111.022 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 t -58.75 -30.35 67.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.997 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.1 mm -53.09 -56.45 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.943 0.402 . . . . 0.0 111.44 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.8 t -94.99 -1.42 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.144 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.773 ' O ' HG23 ' A' ' 30' ' ' THR . 0.5 OUTLIER 68.36 10.76 8.05 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.442 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.624 ' HD3' HG11 ' A' ' 28' ' ' VAL . 21.5 ttmt -156.64 154.95 30.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.861 0.363 . . . . 0.0 111.008 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 82' ' ' ASN . 9.8 p -152.89 145.95 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.598 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 1.027 HG22 HG22 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -107.65 112.92 25.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.3 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.655 HD11 HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -99.31 131.54 45.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.5 -179.373 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.409 ' CD ' ' HB3' ' A' ' 80' ' ' ALA . 25.6 mt-10 -114.93 104.53 12.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.888 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.637 HG22 ' CA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -114.67 154.79 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 120.951 0.405 . . . . 0.0 112.007 -178.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -108.21 129.24 55.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.864 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 23' ' ' GLU . 5.5 p90 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.878 0.371 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -175.65 167.55 3.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.062 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.17 140.77 29.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.554 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.495 HG23 HG12 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -119.96 147.5 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.048 0.451 . . . . 0.0 111.403 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -110.35 98.03 7.36 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.457 HG23 HD11 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -101.63 107.09 20.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.141 -178.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.93 HG22 HG22 ' A' ' 108' ' ' THR . 7.9 t -82.63 120.61 34.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.195 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.0 mt -112.47 164.19 13.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 105' ' ' SER . 28.0 m -124.66 133.26 53.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.795 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -80.1 92.09 5.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -73.02 146.69 87.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.12 49.04 2.9 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.934 2.422 . . . . 0.0 112.569 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -153.35 -59.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.814 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 p -114.49 -16.71 11.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.085 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.6 -121.73 5.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.324 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.795 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 95.0 m-85 -109.08 -26.82 9.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.659 0.266 . . . . 0.0 110.788 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.94 48.26 30.98 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.944 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.695 HD11 HG21 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -132.59 125.17 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.806 0.336 . . . . 0.0 111.069 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.41 122.84 47.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.721 HD11 ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -111.06 100.88 9.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.811 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.819 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.945 ' HB2' HG23 ' A' ' 78' ' ' VAL . 71.0 Cg_exo . . . . . 0 CA--C 1.526 0.107 0 CA-C-O 120.752 0.23 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.591 HD11 ' NE ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -164.86 130.59 2.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.096 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.695 HG21 HD11 ' A' ' 39' ' ' ILE . 40.6 mt -81.59 139.74 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.676 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 m -160.28 37.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.819 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -173.95 140.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.953 0.406 . . . . 0.0 111.682 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -149.49 152.76 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.229 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.03 155.78 23.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.082 0.467 . . . . 0.0 111.428 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -87.98 40.37 0.94 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.789 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.55 31.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.26 144.18 37.43 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.824 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -46.29 -29.36 6.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.937 2.424 . . . . 0.0 112.573 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -61.8 -48.24 81.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.03 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.442 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 8.6 tp10 -78.63 -33.44 47.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.077 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -80.04 -8.84 59.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.002 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.0 p -55.97 -29.86 60.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.06 46.2 93.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.44 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 t -144.58 -67.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 111.286 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -75.71 165.0 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.13 -170.27 2.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.695 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.5 mm -82.47 79.28 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.83 61.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.677 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.455 ' HB2' HD12 ' A' ' 57' ' ' ILE . 67.0 m-20 -112.24 152.22 28.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.714 0.292 . . . . 0.0 110.71 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.591 ' NE ' HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -103.52 83.62 2.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.893 0.378 . . . . 0.0 111.664 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.945 HG23 ' HB2' ' A' ' 55' ' ' PRO . 1.6 m -62.45 126.91 21.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.68 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -160.33 30.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.205 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 178.29 52.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 111.079 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.477 ' HB ' HD12 ' A' ' 97' ' ' LEU . 3.1 mt -79.01 126.5 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.025 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.41 ' OD1' HG22 ' A' ' 81' ' ' ILE . 1.1 p-10 43.41 31.73 0.44 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.481 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.5 -45.5 1.32 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.541 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.775 ' HB ' HD13 ' A' ' 97' ' ' LEU . 8.4 mm -71.25 112.89 15.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.605 0.241 . . . . 0.0 111.267 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo . . . . . 0 N--CA 1.46 -0.462 0 C-N-CA 122.752 2.302 . . . . 0.0 112.837 -179.905 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.9 tp10 . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.842 0.353 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.66 -51.31 70.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.967 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.421 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 25.3 m-20 -58.36 -35.24 71.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.492 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -37.98 88.8 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.666 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.775 HD13 ' HB ' ' A' ' 84' ' ' ILE . 1.3 mt -65.81 -48.02 73.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.493 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.721 ' CD2' HD11 ' A' ' 41' ' ' LEU . 1.5 pp -75.84 -24.15 55.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.27 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -71.14 -36.32 72.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -7.55 54.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.393 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.462 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.0 m -67.38 -18.69 65.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.723 0.297 . . . . 0.0 111.112 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.5 m -58.69 -33.11 69.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.13 -61.43 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.184 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 106' ' ' LYS . 5.1 t -85.63 -6.75 59.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.093 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.69 ' O ' HG23 ' A' ' 30' ' ' THR . 33.2 t 62.93 25.19 14.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.301 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HE2' HG11 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -156.47 150.51 25.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.945 0.402 . . . . 0.0 111.449 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.605 HG12 ' CE1' ' A' ' 37' ' ' PHE . 13.0 p -153.38 157.43 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.47 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.93 HG22 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -120.57 107.33 12.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.558 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.416 HD13 HG12 ' A' ' 81' ' ' ILE . 4.0 mm? -83.2 127.38 33.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.714 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 21.9 tt0 -118.01 104.68 11.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.756 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.757 HG22 ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -125.89 165.29 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.112 0.482 . . . . 0.0 112.119 -178.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -121.63 128.19 51.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.745 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 10.6 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 120.917 0.389 . . . . 0.0 111.09 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.633 0.254 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' CG ' ' CZ ' ' A' ' 113' ' ' PHE . 17.5 pt-20 -177.97 171.66 1.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.066 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 p -87.84 148.22 24.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.636 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.816 HG23 HG13 ' A' ' 111' ' ' ILE . 0.8 OUTLIER -129.7 159.69 35.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 111.101 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -113.33 99.37 7.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.13 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.499 HG21 HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -105.07 102.61 14.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.494 -178.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 108' ' ' THR . 16.2 t -83.68 115.61 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.937 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.584 HD12 ' CD1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -107.56 128.97 55.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 111.005 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 105' ' ' SER . 67.8 m -110.63 134.01 52.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.99 153.63 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.059 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -130.65 137.46 30.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.83 60.14 5.23 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.584 2.189 . . . . 0.0 112.302 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.75 -65.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -131.4 17.9 4.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.3 -116.41 5.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.563 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.733 ' HB3' HG22 ' A' ' 39' ' ' ILE . 49.6 m-85 -113.36 -30.48 6.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.861 0.362 . . . . 0.0 111.257 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.71 23.9 63.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.687 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 37' ' ' PHE . 3.6 tt -124.69 139.75 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.725 0.298 . . . . 0.0 110.877 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -135.18 149.5 49.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.049 0.452 . . . . 0.0 111.297 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.637 HD23 HG13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -114.89 168.94 9.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.376 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.082 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.465 -0.165 0 CA-C-O 120.825 0.26 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -176.42 156.68 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.673 HD12 ' HB2' ' A' ' 76' ' ' ASP . 10.0 mt -68.75 147.71 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.888 ' HA ' HG23 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -171.8 47.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 111.573 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -176.76 134.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 111.583 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -151.94 152.0 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.934 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.03 155.0 17.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 111.289 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -86.8 39.6 0.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.869 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 28.1 t0 174.06 31.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.607 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.9 m -122.54 144.26 41.82 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.055 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -42.34 -36.53 4.41 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.958 2.439 . . . . 0.0 112.947 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.62 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -57.88 -40.1 79.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.841 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -78.13 -51.88 9.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.766 179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -12.75 61.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.482 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.577 ' HB3' HG22 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -56.28 -30.28 62.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 0.0 110.838 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.69 24.94 57.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.571 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.577 HG22 ' HB3' ' A' ' 69' ' ' CYS . 29.2 m -136.58 10.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.585 0.231 . . . . 0.0 111.603 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.62 HD11 ' O ' ' A' ' 66' ' ' ALA . 4.2 pp -147.56 158.67 44.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.874 0.369 . . . . 0.0 111.023 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -154.45 150.45 27.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.619 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.888 HG23 ' HA ' ' A' ' 58' ' ' SER . 21.2 mt -57.17 107.46 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.72 40.14 0.19 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.595 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.673 ' HB2' HD12 ' A' ' 57' ' ' ILE . 59.2 m-20 -114.83 127.72 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 110.575 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -88.18 89.97 8.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.064 HG11 HD11 ' A' ' 81' ' ' ILE . 13.3 t -69.02 139.64 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.627 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 1.8 ttp -164.42 31.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.61 0.243 . . . . 0.0 111.452 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.882 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 178.21 69.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.005 0.431 . . . . 0.0 111.319 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.064 HD11 HG11 ' A' ' 78' ' ' VAL . 37.8 mt -98.78 118.19 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.957 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.426 ' OD1' HG22 ' A' ' 81' ' ' ILE . 4.7 p-10 44.55 31.64 0.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.303 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.54 -47.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.453 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.433 ' CB ' HD21 ' A' ' 97' ' ' LEU . 7.8 mm -72.39 121.12 83.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.59 0.233 . . . . 0.0 111.13 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 C--N 1.348 0.508 0 C-N-CA 122.688 2.259 . . . . 0.0 112.952 -179.898 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.738 0.304 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.858 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -58.03 -45.49 86.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.008 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.69 ' HA ' HD23 ' A' ' 98' ' ' LEU . 70.8 m-80 -60.81 -42.89 98.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.561 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -62.95 -32.87 74.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.516 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.858 HD12 ' HA ' ' A' ' 94' ' ' ALA . 21.1 mt -65.71 -48.07 73.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.69 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -68.67 -28.56 66.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.53 -36.81 76.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.56 -5.69 48.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.38 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 m -60.14 -20.15 57.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.207 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.7 m -63.13 -31.51 72.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.61 -59.2 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.133 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.4 t -83.24 -7.88 59.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.294 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.731 ' O ' HG23 ' A' ' 30' ' ' THR . 1.9 p 80.82 -8.65 1.43 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.628 ' O ' HG23 ' A' ' 104' ' ' THR . 5.5 ptpt -156.5 163.37 39.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 111.166 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.4 147.97 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.709 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.833 HG22 HG22 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -112.74 112.05 23.27 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.245 179.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -108.85 125.62 52.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.934 0.397 . . . . 0.0 111.946 -179.157 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.882 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 6.8 tt0 -93.11 104.87 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.881 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -110.09 158.53 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.179 -178.555 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -116.82 119.0 34.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.247 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CZ ' ' CG ' ' A' ' 23' ' ' GLU . 23.0 p90 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.142 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.701 0.286 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -155.69 169.6 23.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 111.052 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.0 p -94.66 130.66 41.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.457 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.639 HG23 HD11 ' A' ' 111' ' ' ILE . 4.6 t -111.79 135.29 52.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.828 0.346 . . . . 0.0 111.409 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.1 pt-20 -99.82 98.82 9.58 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.737 HG11 ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -105.19 111.54 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.94 -179.203 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.872 HG22 HG22 ' A' ' 108' ' ' THR . 10.6 t -82.7 121.85 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.092 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' A' ' 65' ' ' PRO . 4.1 mm? -111.9 140.58 46.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 105' ' ' SER . 26.8 m -105.34 147.85 27.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.808 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.618 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -90.37 104.25 16.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.243 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.24 135.18 76.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.677 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.12 55.79 5.48 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.558 2.172 . . . . 0.0 112.489 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.9 t -155.21 -49.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.942 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -125.4 -44.11 1.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.968 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.76 -121.09 4.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.425 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.618 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 40.4 m-85 -110.97 -26.2 9.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.705 0.288 . . . . 0.0 111.082 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.96 33.66 79.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.794 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.537 HG22 ' HB3' ' A' ' 37' ' ' PHE . 1.1 tt -136.95 140.76 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.448 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 68.2 mm-40 -131.7 136.69 47.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.127 0.489 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.975 HD13 ' HB1' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -112.25 130.36 55.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.717 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--O 1.23 0.122 0 CA-C-O 120.819 0.258 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 mp -157.16 136.67 12.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.353 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.541 ' CD1' HG21 ' A' ' 111' ' ' ILE . 68.1 mt -71.51 144.84 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.436 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.2 p -163.4 55.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.986 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.448 ' CD1' ' HG2' ' A' ' 40' ' ' GLN . 11.2 t80 -177.95 132.68 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 111.618 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.431 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -152.89 152.03 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.751 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -96.87 155.13 16.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.38 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.97 41.91 0.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.918 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.428 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 1.2 p30 168.88 32.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.705 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.78 145.86 44.35 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.697 0.284 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.678 ' HB2' HD12 ' A' ' 29' ' ' LEU . 82.0 Cg_exo -44.96 -37.21 12.07 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.769 2.313 . . . . 0.0 112.578 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.505 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -59.07 -38.95 80.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.977 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -76.16 -50.18 15.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.687 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.428 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.9 -8.74 56.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.667 -179.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.511 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -58.25 -24.89 60.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.664 0.268 . . . . 0.0 110.79 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.14 30.24 77.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.148 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.737 ' HB ' HG11 ' A' ' 27' ' ' VAL . 9.3 t -142.3 -49.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.348 . . . . 0.0 111.068 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 39' ' ' ILE . 9.5 mt -69.22 159.62 32.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.032 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 -171.14 3.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' O ' HG22 ' A' ' 74' ' ' ILE . 24.7 mm -93.58 49.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.76 39.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.65 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -89.95 146.15 24.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.762 0.315 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.6 85.31 2.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.052 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.918 HG11 HD11 ' A' ' 81' ' ' ILE . 2.6 t -55.54 159.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -50.49 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.45 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.27 86.29 1.76 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.808 0.337 . . . . 0.0 111.641 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.918 HD11 HG11 ' A' ' 78' ' ' VAL . 4.3 mt -77.51 111.81 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.771 HD22 HG22 ' A' ' 81' ' ' ILE . 8.4 p30 46.53 28.42 0.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.228 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 112.94 -49.57 0.84 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.418 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.9 mm -69.33 109.12 3.89 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.548 0.213 . . . . 0.0 111.182 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 87.0 Cg_endo . . . . . 0 N--CA 1.452 -0.944 0 C-N-CA 122.907 2.405 . . . . 0.0 112.458 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.848 0.356 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.975 ' HB1' HD13 ' A' ' 41' ' ' LEU . . . -67.46 -42.51 82.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.442 ' HA ' HD23 ' A' ' 98' ' ' LEU . 2.0 m-80 -67.36 -41.7 84.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.441 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -64.33 -53.05 54.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.222 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 98' ' ' LEU . 4.2 pp -57.89 -35.19 70.66 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.159 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.888 ' N ' HD12 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -78.47 -35.5 46.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.727 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -27.84 67.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -15.3 63.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.175 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.455 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -73.33 -21.57 60.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.885 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.0 t -70.03 -32.38 70.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.815 0.341 . . . . 0.0 110.408 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -82.03 -41.73 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.681 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.0 m -79.74 -20.28 46.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.856 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.669 ' O ' HG23 ' A' ' 30' ' ' THR . 2.6 m 76.78 -1.76 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.789 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' CE ' HG11 ' A' ' 28' ' ' VAL . 10.1 tttt -156.56 152.24 27.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.825 0.345 . . . . 0.0 111.501 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.415 HG12 ' CE2' ' A' ' 37' ' ' PHE . 13.8 p -150.65 151.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.239 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.872 HG22 HG22 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -107.95 109.45 20.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.988 0.423 . . . . 0.0 110.531 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.76 HD22 HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -87.5 127.94 35.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.512 -179.35 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -119.25 104.6 10.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.097 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -124.92 162.7 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.091 0.472 . . . . 0.0 112.088 -178.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.52 118.61 37.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.779 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 29.3 p90 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.309 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.929 0.395 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.776 HG12 ' HA ' ' A' ' 118' ' ' SER . 9.3 p -76.26 146.18 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.067 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.69 126.73 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.098 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.637 ' O ' HG23 ' A' ' 22' ' ' THR . 0.2 OUTLIER -127.83 -173.55 2.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.927 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 21' ' ' HIS . 0.1 OUTLIER 174.77 102.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.381 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 2.6 mm-40 -144.34 176.87 9.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.967 0.413 . . . . 0.0 111.169 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -110.9 134.95 52.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.498 HG23 HG13 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -115.66 146.9 41.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.257 0.551 . . . . 0.0 111.415 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.3 99.26 8.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.087 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.759 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -102.15 102.37 13.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.768 -178.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.4 p -85.97 119.32 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.466 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.8 mt -110.63 164.14 13.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.945 0.403 . . . . 0.0 111.221 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 105' ' ' SER . 90.4 m -130.31 127.71 40.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.581 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -55.24 112.27 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.416 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.04 146.02 99.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.24 -7.3 20.87 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.659 2.239 . . . . 0.0 112.902 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -98.81 -67.05 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.061 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.8 p -105.6 -51.33 3.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.46 -75.3 0.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.744 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 95.9 m-85 -138.72 76.25 1.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.955 0.407 . . . . 0.0 110.423 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.28 0.64 1.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.911 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.852 HD11 HG21 ' A' ' 57' ' ' ILE . 17.8 tt -95.86 132.89 38.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 116.861 0.331 . . . . 0.0 110.599 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -116.95 145.61 43.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.133 0.492 . . . . 0.0 111.731 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -125.76 122.71 37.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.01 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -104.59 137.45 42.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.036 0.446 . . . . 0.0 111.296 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.736 ' HA2' ' HA ' ' A' ' 55' ' ' PRO . . . -93.55 45.81 2.36 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.49 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.439 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 3.2 m 53.97 61.46 3.06 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.219 0.533 . . . . 0.0 109.958 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.665 HG23 HD21 ' A' ' 51' ' ' LEU . 2.4 p -155.3 -39.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.702 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 19.9 t80 -94.17 28.11 2.62 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.895 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.45 134.03 17.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.965 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.13 -16.61 53.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.736 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.61 101.94 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.9 m 58.14 164.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.163 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.665 HD21 HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -158.83 178.59 9.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.998 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.612 ' H ' HD23 ' A' ' 51' ' ' LEU . 0.3 OUTLIER 59.44 26.5 15.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.134 0.493 . . . . 0.0 111.113 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.445 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -112.43 170.08 5.66 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.134 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 53' ' ' SER . 38.4 Cg_endo -67.27 174.36 7.24 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.709 2.273 . . . . 0.0 112.746 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.736 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 85.4 Cg_endo -84.19 144.14 10.45 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.005 2.47 . . . . 0.0 113.112 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -158.48 161.03 37.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.75 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.852 HG21 HD11 ' A' ' 39' ' ' ILE . 5.2 mt -80.22 138.57 19.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.897 ' HA ' HG23 ' A' ' 74' ' ' ILE . 8.7 t -164.34 41.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.241 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -176.32 123.19 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 0.0 111.48 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.539 HD11 ' HA ' ' A' ' 73' ' ' GLN . 3.6 mt -133.73 152.51 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.084 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -100.57 155.62 17.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.07 0.462 . . . . 0.0 111.36 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.15 43.25 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.902 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER 168.18 31.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.676 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -112.97 144.38 30.97 Favored Pre-proline 0 CA--C 1.527 0.088 0 CA-C-O 120.707 0.289 . . . . 0.0 110.782 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -45.1 -32.89 7.3 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.638 2.225 . . . . 0.0 112.661 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.422 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -66.39 -46.03 78.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.788 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -65.34 -39.13 91.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.632 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' NE ' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -87.37 -8.49 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.652 -179.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' A' ' 71' ' ' VAL . 35.0 t -53.43 -25.03 14.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 111.033 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.64 27.24 73.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.201 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.651 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.3 p -170.97 34.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.406 . . . . 0.0 111.007 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.416 HD21 HG21 ' A' ' 27' ' ' VAL . 14.4 mt -141.42 147.67 38.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.009 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.539 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.1 mm-40 -168.95 171.69 8.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.725 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.897 HG23 ' HA ' ' A' ' 58' ' ' SER . 36.9 mt -70.46 123.63 24.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.088 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.42 -24.6 3.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.607 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.676 ' HB3' HG21 ' A' ' 111' ' ' ILE . 69.7 m-20 -57.73 123.62 16.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.762 0.315 . . . . 0.0 110.732 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.635 ' C ' HG22 ' A' ' 111' ' ' ILE . 4.4 mtm-85 -94.34 98.42 10.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.433 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.654 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.6 m -75.89 118.31 21.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.972 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.3 ttp -141.14 27.48 1.94 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.873 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -178.86 61.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.643 HD11 ' HB ' ' A' ' 78' ' ' VAL . 25.6 mt -92.45 130.82 40.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.216 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.433 ' OD1' HD22 ' A' ' 97' ' ' LEU . 1.9 p-10 43.93 31.14 0.47 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.316 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.84 -44.44 1.64 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.602 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.461 ' HB ' HD21 ' A' ' 97' ' ' LEU . 7.6 mm -71.77 110.78 8.41 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.501 0.191 . . . . 0.0 111.289 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -90.95 15.87 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.814 2.343 . . . . 0.0 112.686 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.665 HG21 ' HG3' ' A' ' 55' ' ' PRO . 2.8 p 61.68 150.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.836 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -114.06 111.62 21.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.164 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 61.94 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.129 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.8 p -161.02 114.82 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 p -146.73 92.8 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.97 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -58.67 -44.22 90.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.604 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -60.26 -32.32 71.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.733 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -45.07 84.87 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.604 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.865 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -58.02 -49.9 75.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.679 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -58.01 -36.77 73.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.545 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -43.95 97.52 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.653 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 94' ' ' ALA . 5.3 mt -59.71 -42.49 93.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.613 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.829 HD11 HD11 ' A' ' 41' ' ' LEU . 61.3 mt -62.86 -37.13 85.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -77.74 -28.42 50.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.126 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.41 -6.72 49.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.463 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 3.5 m -72.68 -26.24 61.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.74 0.305 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.92 -26.85 64.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.218 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.8 mm -53.9 -49.32 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.494 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.1 t -104.73 -1.06 26.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.599 ' O ' HG23 ' A' ' 30' ' ' THR . 1.5 m 78.97 -4.54 2.1 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.791 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.646 ' O ' HG23 ' A' ' 104' ' ' THR . 0.0 OUTLIER -156.58 152.64 27.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.868 0.366 . . . . 0.0 111.111 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 108' ' ' THR . 10.7 p -131.13 157.54 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.778 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.447 ' N ' HG22 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -120.56 106.87 12.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.86 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.421 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -100.64 120.15 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 111.871 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.873 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -87.96 112.12 22.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.454 178.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.759 HD11 ' CG2' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -118.43 164.97 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.361 0.6 . . . . 0.0 112.443 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -123.12 124.87 44.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.833 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.422 ' CE1' ' HB2' ' A' ' 23' ' ' GLU . 49.9 p90 -114.65 152.66 31.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.955 0.407 . . . . 0.0 111.263 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.84 97.73 5.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.451 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.7 t -68.38 126.99 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.238 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -140.65 46.19 1.79 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.014 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -179.82 53.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.815 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.776 ' HA ' HG12 ' A' ' 19' ' ' VAL . 5.4 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.865 0.364 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.42 HG12 ' OG ' ' A' ' 118' ' ' SER . 22.0 t -100.74 77.84 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.173 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.6 106.65 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.975 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.4 ' CG ' HG21 ' A' ' 115' ' ' VAL . 0.9 OUTLIER -92.93 176.74 6.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.245 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m 167.55 132.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.22 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 22.1 pt-20 -175.15 177.08 1.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.969 0.414 . . . . 0.0 111.212 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 15.8 p -89.53 128.19 35.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.109 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.587 HG23 ' CD1' ' A' ' 111' ' ' ILE . 2.7 t -107.28 136.0 47.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.277 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.79 99.38 11.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.639 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -101.02 103.18 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.718 -178.435 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 108' ' ' THR . 10.9 t -83.59 113.95 23.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.406 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.431 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 8.7 mt -110.08 137.64 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.009 0.433 . . . . 0.0 111.251 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 105' ' ' SER . 96.7 m -109.91 137.89 47.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.577 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.67 146.62 51.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.214 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.02 139.46 28.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.794 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.0 57.23 5.1 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.61 2.207 . . . . 0.0 112.432 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.4 t -155.42 -68.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 -29.76 6.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.011 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.75 -110.93 3.15 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.406 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.562 ' HB3' HG22 ' A' ' 39' ' ' ILE . 52.3 m-85 -114.61 -33.01 5.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.51 31.87 82.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.77 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.912 HD13 HD13 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -140.96 140.96 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 110.959 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.24 159.18 42.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.039 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.538 HD13 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -127.49 121.64 31.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.733 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.34 171.3 13.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' O ' HD22 ' A' ' 51' ' ' LEU . . . -131.9 75.9 0.41 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.52 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.419 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . 13.4 p -172.46 171.6 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 111.213 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.724 HG21 ' OG ' ' A' ' 53' ' ' SER . 72.6 t -123.71 -41.46 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.277 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 173.38 44.46 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -175.57 114.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.239 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.6 p -58.07 -21.28 45.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.261 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 50' ' ' THR . 10.1 mm-40 -92.67 136.06 33.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.728 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 49' ' ' GLU . 14.5 t 46.29 -170.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.424 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.552 HD11 HG23 ' A' ' 45' ' ' VAL . 18.1 tp -177.52 133.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.574 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.98 14.26 15.02 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.724 ' OG ' HG21 ' A' ' 45' ' ' VAL . 1.4 m -136.44 139.79 30.61 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.996 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.98 173.07 2.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.354 2.036 . . . . 0.0 111.933 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.704 ' C ' HD13 ' A' ' 56' ' ' LEU . 35.1 Cg_endo -65.08 166.38 18.92 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.484 2.123 . . . . 0.0 112.105 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.704 HD13 ' C ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -152.52 150.29 29.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.069 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.447 HD12 HG21 ' A' ' 111' ' ' ILE . 80.7 mt -74.52 147.93 8.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.861 ' HA ' HG23 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -175.4 50.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.153 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -173.79 134.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 0.0 111.437 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -150.69 151.88 12.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.219 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.75 155.36 18.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 0.0 111.582 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.87 41.0 1.02 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.863 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER 171.82 33.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.521 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 m -127.11 143.67 47.82 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.07 -32.81 7.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.729 2.286 . . . . 0.0 112.809 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.99 -51.66 68.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.986 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.558 ' HB2' HG22 ' A' ' 60' ' ' ILE . 10.6 tp10 -69.67 -43.14 73.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.69 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -67.15 -14.11 62.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.402 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.694 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -55.91 -27.44 52.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.941 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.18 31.58 65.93 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.239 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 69' ' ' CYS . 10.4 t -137.29 -58.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 111.206 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.912 HD13 HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -75.38 166.09 24.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.053 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.432 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.1 pp0? -164.86 169.23 16.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.707 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.861 HG23 ' HA ' ' A' ' 58' ' ' SER . 18.0 mt -67.54 114.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.068 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.67 22.17 4.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.648 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.431 ' HB3' HG21 ' A' ' 111' ' ' ILE . 1.3 m-20 -83.45 141.52 31.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.679 0.276 . . . . 0.0 110.673 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.409 ' HB3' ' HB3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -98.84 89.66 4.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.345 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.896 HG22 ' CG2' ' A' ' 111' ' ' ILE . 5.4 t -74.82 145.85 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.602 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -170.29 29.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.771 ' HB3' ' CB ' ' A' ' 110' ' ' GLU . . . -176.18 46.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 111.661 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.598 HG22 ' OD1' ' A' ' 82' ' ' ASN . 16.5 mt -67.8 112.99 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.029 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.598 ' OD1' HG22 ' A' ' 81' ' ' ILE . 5.2 p-10 44.06 35.69 1.25 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.436 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.59 -49.7 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.386 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.55 HG22 ' H ' ' A' ' 86' ' ' THR . 13.0 mm -70.11 120.29 77.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.534 0.207 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -86.07 19.29 1.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.719 2.28 . . . . 0.0 112.915 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.575 HG22 HD12 ' A' ' 81' ' ' ILE . 4.6 p 58.55 107.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.88 126.72 28.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.952 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -65.91 78.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.832 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.94 -49.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.51 136.48 14.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.05 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -61.56 -22.63 65.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.967 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -53.56 -30.59 42.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.012 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 4.2 mt-10 -63.76 -47.78 79.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.962 0.411 . . . . 0.0 110.21 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.882 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.32 -38.54 84.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.764 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -61.93 -43.67 98.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -62.56 -38.06 88.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.446 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.882 HD12 ' HA ' ' A' ' 94' ' ' ALA . 12.2 mt -61.71 -40.7 95.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.248 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.4 mt -78.02 -32.17 50.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.363 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -65.89 -25.86 67.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.916 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.54 15.02 10.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.522 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 m -79.32 -23.22 43.62 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.81 0.338 . . . . 0.0 110.853 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 p -58.59 -35.25 72.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.807 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.9 mm -53.95 -54.37 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.4 p -86.93 -8.69 57.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.984 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.789 ' O ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER 79.35 -5.02 1.99 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.025 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -156.62 166.8 32.37 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.853 0.358 . . . . 0.0 111.187 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 11.4 p -151.13 148.32 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.902 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.891 HG22 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -112.33 107.19 15.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.087 179.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -101.83 126.16 48.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.776 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.771 ' CB ' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -92.5 120.53 33.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.62 178.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.896 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -133.79 165.48 31.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.383 -178.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 77' ' ' ARG . 21.1 tt0 -116.86 126.75 53.49 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.102 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.445 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 34.5 p90 -118.09 148.48 42.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.15 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -123.1 97.8 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.503 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.4 HG21 ' CG ' ' A' ' 21' ' ' HIS . 33.3 m -59.17 168.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.266 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -174.51 48.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.964 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -174.04 48.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.929 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.42 ' OG ' HG12 ' A' ' 19' ' ' VAL . 29.8 p . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.859 0.361 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.18 75.09 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.3 p -147.82 139.49 18.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.024 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.654 ' O ' HG23 ' A' ' 22' ' ' THR . 0.5 OUTLIER 64.17 46.45 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.749 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 21' ' ' HIS . 0.2 OUTLIER 167.13 105.79 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.226 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.6 OUTLIER -168.26 154.18 7.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.393 . . . . 0.0 111.572 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 72.5 p -89.85 127.06 35.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.265 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.553 HG23 ' CD1' ' A' ' 111' ' ' ILE . 7.3 t -114.61 131.07 56.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.925 0.393 . . . . 0.0 111.366 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.18 99.42 11.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.724 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.633 HG11 ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -107.69 133.64 51.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.081 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.703 HG22 HG22 ' A' ' 108' ' ' THR . 21.6 t -94.28 117.42 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.405 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.652 HD11 ' N ' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -109.17 126.1 52.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.331 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.0 t -103.11 165.88 10.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.215 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.8 115.99 30.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.081 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.25 140.22 79.57 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.769 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.02 -0.69 10.83 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.659 2.239 . . . . 0.0 112.874 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.4 t -108.04 -35.69 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.002 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.9 p -133.91 -66.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.72 -109.1 0.57 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.434 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 35.6 m-85 -118.41 -35.43 3.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.7 26.0 38.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.776 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.544 HG23 HD13 ' A' ' 98' ' ' LEU . 3.0 tt -111.16 127.18 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.994 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 125.14 51.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.922 HD11 HD11 ' A' ' 98' ' ' LEU . 2.1 mt -108.84 116.3 31.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.756 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.417 ' HA ' ' CD2' ' A' ' 91' ' ' PHE . 1.0 OUTLIER -84.59 145.43 28.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.546 ' O ' HD21 ' A' ' 51' ' ' LEU . . . -91.56 -7.05 65.37 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.618 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -119.4 165.36 14.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.785 0.326 . . . . 0.0 111.009 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 45' ' ' VAL . 33.1 t -123.28 -3.22 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.695 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -171.6 132.66 0.75 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.342 . . . . 0.0 111.041 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 59.24 110.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.399 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -65.8 -14.51 61.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.62 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -94.4 22.83 5.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.236 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -167.65 177.57 5.79 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.838 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 43' ' ' GLY . 0.6 OUTLIER -164.03 137.75 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.844 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.78 22.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.506 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.84 157.91 32.07 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.78 171.7 10.6 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.542 2.161 . . . . 0.0 112.066 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.51 ' HG3' HG21 ' A' ' 86' ' ' THR . 32.4 Cg_endo -64.07 174.35 4.09 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.441 2.094 . . . . 0.0 111.979 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 56' ' ' LEU . 1.7 pt? -178.08 169.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.622 HD13 ' HB2' ' A' ' 76' ' ' ASP . 3.4 mp -75.62 141.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.429 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.9 t -117.34 -31.29 5.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.849 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -165.56 167.43 17.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.194 0.521 . . . . 0.0 111.886 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.523 HG13 HD13 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -144.94 153.18 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.922 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -86.37 155.46 20.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.086 0.469 . . . . 0.0 111.516 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.87 38.34 0.8 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.82 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -179.72 26.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.992 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.5 p -120.62 134.58 24.25 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.626 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.466 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 89.2 Cg_exo -43.52 -29.21 2.03 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.492 2.128 . . . . 0.0 112.752 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.652 ' N ' HD11 ' A' ' 29' ' ' LEU . . . -62.24 -42.85 99.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.983 0.42 . . . . 0.0 110.815 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' CA ' HG21 ' A' ' 60' ' ' ILE . 8.8 tp10 -78.48 -50.22 12.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.152 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.466 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.88 -8.36 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.916 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -24.95 11.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.771 0.32 . . . . 0.0 111.0 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.84 30.71 63.22 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.237 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.633 ' HB ' HG11 ' A' ' 27' ' ' VAL . 5.4 t -145.03 -52.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.926 0.393 . . . . 0.0 111.116 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.414 HD21 HD12 ' A' ' 111' ' ' ILE . 12.1 mt -75.69 130.68 39.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.047 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 -170.99 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.798 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.523 HD13 HG13 ' A' ' 60' ' ' ILE . 12.9 mm -92.16 75.61 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.187 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.88 42.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.891 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.622 ' HB2' HD13 ' A' ' 57' ' ' ILE . 32.9 m-20 -85.18 -176.03 5.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.583 0.23 . . . . 0.0 110.534 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.91 79.27 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 111.203 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.032 HG11 HD11 ' A' ' 81' ' ' ILE . 12.2 t -58.45 147.82 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.054 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 11.9 tpt -134.98 -65.36 0.62 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.07 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -125.37 96.95 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.032 HD11 HG11 ' A' ' 78' ' ' VAL . 9.7 mt -88.48 122.96 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.943 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.724 HD22 HG22 ' A' ' 81' ' ' ILE . 9.6 p30 46.53 31.63 1.4 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.01 -34.23 5.2 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.219 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.558 ' HB ' HD22 ' A' ' 97' ' ' LEU . 4.1 mm -87.72 110.85 37.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.511 0.196 . . . . 0.0 111.155 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -90.57 24.8 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.669 2.246 . . . . 0.0 112.56 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.51 HG21 ' HG3' ' A' ' 55' ' ' PRO . 2.0 p 63.45 142.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.795 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -80.78 106.85 13.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.3 t70 62.95 -79.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.027 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 p -179.8 106.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.14 128.38 12.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.806 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 42' ' ' GLN . 27.2 t80 -59.28 -43.76 92.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -62.45 -30.9 71.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -52.4 62.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.878 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.86 -50.45 73.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -58.16 -36.36 72.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.582 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.92 -43.95 97.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.724 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' A' ' 94' ' ' ALA . 3.8 mt -60.5 -43.75 96.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.721 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.922 HD11 HD11 ' A' ' 41' ' ' LEU . 57.3 mt -70.96 -31.24 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -67.55 -32.68 73.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.98 -5.82 50.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.233 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -75.55 -23.18 56.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.751 0.31 . . . . 0.0 111.017 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.6 p -63.7 -30.98 72.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.714 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -65.14 -56.14 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.995 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 105' ' ' SER . 42.7 p -77.61 -11.7 59.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.126 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 104' ' ' THR . 1.8 p 84.19 -18.3 0.42 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.925 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 8.6 ptpt -156.43 160.53 39.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 111.284 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 9.8 p -144.67 155.27 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.713 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.703 HG22 HG22 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -110.99 121.85 46.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.206 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.512 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -115.07 143.84 44.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.446 -179.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -115.18 104.71 12.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.983 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.667 HG22 HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -116.55 161.31 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -93.59 133.57 36.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.689 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 30.6 p90 -131.78 164.99 24.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.979 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.453 ' HB3' ' CE1' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -119.31 97.77 5.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.72 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 116' ' ' ALA . 13.5 p -93.88 158.99 2.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.34 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.494 ' N ' HG22 ' A' ' 115' ' ' VAL . . . -128.17 48.82 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -171.9 73.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.883 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.416 ' O ' HG22 ' A' ' 20' ' ' VAL . 25.5 mt-30 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.803 0.335 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.4 t -70.7 66.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.945 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.69 HG23 ' H ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -68.37 -177.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.27 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.524 ' O ' ' CZ ' ' A' ' 113' ' ' PHE . 0.7 OUTLIER -154.03 119.94 5.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.631 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.752 ' N ' ' HB ' ' A' ' 115' ' ' VAL . 5.6 t -62.81 112.55 2.59 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER 179.26 177.28 0.55 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.739 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 19.7 p -86.61 127.58 34.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.29 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.598 HG22 HD12 ' A' ' 111' ' ' ILE . 9.9 t -113.98 140.77 48.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.37 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 99.01 9.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.5 HG21 HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -101.64 103.17 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.305 -178.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.4 p -82.74 115.25 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.929 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.401 HD22 ' C ' ' A' ' 28' ' ' VAL . 4.4 mm? -113.78 147.99 37.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.117 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 105' ' ' SER . 82.2 m -108.11 144.7 35.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.873 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.722 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -84.1 108.82 17.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.3 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -68.3 140.6 92.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.99 41.38 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.771 2.314 . . . . 0.0 112.814 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.88 -47.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.799 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -127.39 -43.42 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.977 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.17 -118.57 2.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.52 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 29.9 m-85 -108.07 -25.49 11.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.761 0.315 . . . . 0.0 110.943 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.53 41.88 99.65 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.532 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.645 HG23 HD13 ' A' ' 98' ' ' LEU . 18.8 tt -150.66 126.63 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.775 0.321 . . . . 0.0 111.098 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' A' ' 59' ' ' TYR . 2.8 pm0 -124.28 156.54 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.037 0.446 . . . . 0.0 111.268 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.733 HD13 ' CB ' ' A' ' 94' ' ' ALA . 2.6 mp -103.67 162.3 13.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.01 169.76 6.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.465 ' HA2' HD21 ' A' ' 51' ' ' LEU . . . 74.98 34.41 52.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.419 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.423 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 3.2 t -101.4 67.05 1.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.883 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.614 ' H ' HD11 ' A' ' 51' ' ' LEU . 74.3 t 65.69 -0.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.077 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -138.69 101.87 4.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.773 0.321 . . . . 0.0 110.905 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.422 ' HB3' HD23 ' A' ' 51' ' ' LEU . . . -175.77 134.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.049 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.504 HG22 ' N ' ' A' ' 49' ' ' GLU . 93.0 m 61.97 -100.92 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' N ' HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -102.01 -75.56 0.59 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.654 0.264 . . . . 0.0 110.914 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.0 m -165.69 115.12 1.01 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.023 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.614 HD11 ' H ' ' A' ' 45' ' ' VAL . 3.1 pp -124.1 173.61 8.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.902 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.587 ' N ' HD12 ' A' ' 51' ' ' LEU . 3.8 m -136.41 105.09 5.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.941 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.08 141.94 0.22 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.763 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.84 170.13 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.42 2.08 . . . . 0.0 112.053 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.37 133.24 27.69 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.376 2.051 . . . . 0.0 112.029 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -140.39 145.12 36.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.198 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 6.3 mt -59.64 145.27 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.516 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 m -147.45 16.84 1.16 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 4.0 t80 -162.26 149.84 14.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.222 0.534 . . . . 0.0 111.799 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.712 HD11 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -151.41 152.36 11.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.788 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -94.45 155.63 16.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 111.825 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -87.86 41.48 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.716 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 169.6 31.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.71 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.9 m -120.83 144.15 38.31 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.795 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.45 -27.25 7.03 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.885 2.39 . . . . 0.0 112.547 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -66.29 -46.84 75.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.976 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 2.9 tp10 -78.06 -39.73 40.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.6 -19.16 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.476 ' HB3' HG22 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -52.78 -30.12 31.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.075 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.1 23.56 52.53 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.816 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 69' ' ' CYS . 2.9 m -122.39 -38.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.763 0.316 . . . . 0.0 111.232 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 pp -93.59 148.63 21.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.955 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -125.86 169.09 12.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.686 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.712 HD13 HD11 ' A' ' 60' ' ' ILE . 32.9 mm -67.44 107.07 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.047 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.87 4.39 6.7 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.073 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.91 133.18 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.86 0.33 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -98.28 95.71 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.219 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.963 HG11 HD11 ' A' ' 81' ' ' ILE . 2.7 t -76.19 129.82 36.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.546 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -150.77 31.87 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.274 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.931 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 179.36 81.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.963 HD11 HG11 ' A' ' 78' ' ' VAL . 41.7 mt -111.91 126.7 69.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.234 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.745 HD22 HG22 ' A' ' 81' ' ' ILE . 11.8 p30 45.19 31.35 0.76 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.234 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.41 -34.75 5.05 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.312 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.465 HG22 ' H ' ' A' ' 86' ' ' THR . 5.0 mm -82.15 111.68 29.55 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.455 0.169 . . . . 0.0 111.083 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.512 ' C ' HG23 ' A' ' 86' ' ' THR . 83.6 Cg_endo -86.06 11.0 3.45 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.682 2.254 . . . . 0.0 112.713 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.512 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.2 p 71.33 6.59 5.83 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.545 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 52.61 22.45 2.21 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.5 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 43.53 33.65 0.68 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.697 0.284 . . . . 0.0 111.462 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.57 -79.01 0.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.1 p -129.34 160.26 33.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.98 0.419 . . . . 0.0 111.027 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -70.23 -25.72 63.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.993 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -54.97 -40.31 69.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.975 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.454 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 35.0 mt-10 -59.84 -49.27 78.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.701 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.733 ' CB ' HD13 ' A' ' 41' ' ' LEU . . . -57.36 -43.02 83.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -56.59 -40.94 76.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.058 0.456 . . . . 0.0 110.054 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -63.03 -38.03 89.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.32 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.514 HD12 HD12 ' A' ' 81' ' ' ILE . 41.3 mt -61.02 -39.0 88.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.645 HD13 HG23 ' A' ' 39' ' ' ILE . 60.6 mt -78.09 -28.59 48.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.053 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -74.91 -35.8 62.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.412 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -78.39 -3.2 42.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.652 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.486 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 67.0 m -69.77 -25.02 63.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.858 0.361 . . . . 0.0 110.733 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.03 -27.22 65.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 21.9 mm -49.92 -47.2 23.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.824 0.345 . . . . 0.0 111.241 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.1 t -108.75 0.94 20.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.057 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.752 ' O ' HG23 ' A' ' 30' ' ' THR . 1.4 t 62.81 18.06 10.41 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.256 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 0.5 OUTLIER -156.94 144.14 18.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.865 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.518 HG12 ' CE2' ' A' ' 37' ' ' PHE . 10.4 p -152.36 151.94 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.705 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 p -122.15 104.32 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.007 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -102.41 149.17 24.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.181 0.515 . . . . 0.0 112.183 -178.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.931 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 1.3 tt0 -107.27 124.87 50.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.252 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.958 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -138.18 133.31 43.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.177 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 35.2 tt0 -92.7 118.64 31.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.524 ' CZ ' ' O ' ' A' ' 21' ' ' HIS . 18.8 p90 -109.89 152.8 25.34 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.783 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 113' ' ' PHE . 5.9 t0 -66.8 163.11 20.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.348 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.752 ' HB ' ' N ' ' A' ' 22' ' ' THR . 8.4 p -117.38 161.05 16.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.052 0.453 . . . . 0.0 112.135 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.69 ' H ' HG23 ' A' ' 20' ' ' VAL . . . -104.98 -169.11 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.117 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -135.02 85.46 2.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.893 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.289 -0.863 . . . . 0.0 110.872 -179.912 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.63 109.75 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.737 HG22 HG21 ' A' ' 115' ' ' VAL . 3.9 p -58.59 140.02 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.836 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.4 ' O ' ' HB ' ' A' ' 22' ' ' THR . 16.2 m-70 -154.02 36.89 0.44 Allowed 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 113' ' ' PHE . 96.5 m 62.13 146.85 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.991 0.424 . . . . 0.0 111.307 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -178.31 168.31 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.726 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 12.5 p -87.78 151.68 22.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.71 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.858 HG23 ' CD1' ' A' ' 111' ' ' ILE . 0.6 OUTLIER -132.15 143.49 50.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.032 0.444 . . . . 0.0 111.53 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.28 99.61 9.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.55 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.638 HG12 ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -105.4 106.89 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.616 -178.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.794 HG22 ' HD3' ' A' ' 106' ' ' LYS . 13.6 p -90.01 114.98 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.703 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 66' ' ' ALA . 10.8 mt -104.27 164.42 11.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 0.0 110.961 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 105' ' ' SER . 11.5 m -121.19 142.54 49.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.608 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.642 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -86.85 114.54 23.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 111.121 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.64 147.83 71.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.96 18.64 1.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.968 2.445 . . . . 0.0 112.853 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.84 -41.28 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.801 0.334 . . . . 0.0 111.078 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 t -136.04 -45.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.074 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.4 -109.98 0.93 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.512 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.642 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 87.1 m-85 -118.7 -31.7 4.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.631 0.253 . . . . 0.0 111.191 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.48 35.78 90.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.648 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 57' ' ' ILE . 1.7 tt -135.39 131.33 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.965 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.9 155.78 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.041 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.656 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -136.65 135.9 38.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -90.8 171.17 9.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.6 ' O ' HD12 ' A' ' 51' ' ' LEU . . . -123.59 155.41 17.63 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.279 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p -48.75 173.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 111.169 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.614 HG11 HG21 ' A' ' 50' ' ' THR . 88.3 t -146.76 -80.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 111.243 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.19 116.43 3.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.845 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.424 ' O ' ' HB ' ' A' ' 48' ' ' THR . . . -65.14 100.45 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.147 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 47' ' ' ALA . 3.1 t 175.67 -33.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.148 0.499 . . . . 0.0 110.958 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -164.4 -65.69 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.785 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.614 HG21 HG11 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -52.02 174.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.129 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.679 ' O ' HD13 ' A' ' 51' ' ' LEU . 2.3 tm? -54.41 106.15 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.37 . . . . 0.0 110.831 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.92 89.19 2.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.8 134.74 0.4 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.844 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.76 178.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.488 2.125 . . . . 0.0 111.972 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -43.02 94.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.601 2.201 . . . . 0.0 112.368 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 56' ' ' LEU . 2.6 pt? -115.95 151.2 35.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.124 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 39' ' ' ILE . 29.2 mt -84.37 154.1 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.92 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 57' ' ' ILE . 44.3 t -177.81 51.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -175.53 133.86 0.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.971 0.415 . . . . 0.0 111.288 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.433 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -150.58 152.18 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.357 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.99 155.46 17.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.652 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.0 41.63 1.01 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.811 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER 172.19 32.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.589 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -126.73 145.61 54.08 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.73 -31.73 15.28 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.991 2.461 . . . . 0.0 112.591 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.494 ' HA ' HD21 ' A' ' 29' ' ' LEU . . . -58.8 -45.25 90.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.953 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 11.8 tp10 -77.96 -41.9 34.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.775 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.424 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -69.38 -11.77 61.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.402 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.425 ' O ' HG22 ' A' ' 71' ' ' VAL . 1.1 t -52.98 -30.67 36.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.821 0.343 . . . . 0.0 111.112 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.09 27.89 68.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.44 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.638 ' CG2' HG12 ' A' ' 27' ' ' VAL . 2.8 m -152.54 30.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.347 . . . . 0.0 111.179 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.469 HD23 ' OD2' ' A' ' 76' ' ' ASP . 3.3 mt -136.92 162.23 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.75 159.07 43.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.3 mm -75.66 98.05 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.244 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.67 38.52 0.61 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.618 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' OD2' HD23 ' A' ' 72' ' ' LEU . 28.8 m-20 -82.1 126.84 32.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 110.73 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -84.68 90.04 7.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.073 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.029 HG11 HD11 ' A' ' 81' ' ' ILE . 2.1 t -70.66 144.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.522 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -163.42 28.47 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.212 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . 172.16 89.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 111.278 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.029 HD11 HG11 ' A' ' 78' ' ' VAL . 20.4 mt -116.54 115.09 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.785 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.531 HD22 HG22 ' A' ' 81' ' ' ILE . 7.9 p30 49.6 26.75 1.87 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.248 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.12 -44.25 1.55 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.698 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.506 HG21 HD21 ' A' ' 97' ' ' LEU . 6.9 mm -74.35 111.65 13.7 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.531 0.205 . . . . 0.0 111.191 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -91.11 16.65 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.858 2.372 . . . . 0.0 112.777 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.463 ' H ' HG22 ' A' ' 84' ' ' ILE . 11.4 p 55.42 98.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 0.0 110.88 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -87.13 146.04 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 58.79 167.61 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.077 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.9 m -74.77 92.37 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.813 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.98 86.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.954 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -57.92 -23.34 53.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.949 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -54.21 -37.26 64.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.742 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.67 -47.45 85.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.272 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 41' ' ' LEU . . . -57.89 -35.37 70.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.076 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.51 ' HA ' HD23 ' A' ' 98' ' ' LEU . 7.2 m-20 -62.78 -39.4 94.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.178 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -62.34 -40.3 95.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.09 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.506 HD21 HG21 ' A' ' 84' ' ' ILE . 11.7 mt -59.34 -47.04 86.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.617 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -78.01 -26.71 48.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.873 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -73.93 -30.44 62.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.32 7.24 29.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.441 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.448 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -74.22 -17.53 60.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.726 0.298 . . . . 0.0 111.259 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.1 m -59.14 -30.77 68.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.913 0.387 . . . . 0.0 110.615 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.4 mt -57.04 -66.3 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 t -84.98 -2.75 58.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.159 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.661 ' O ' HG23 ' A' ' 30' ' ' THR . 0.9 OUTLIER 64.85 19.6 11.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.244 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.794 ' HD3' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -156.37 153.91 29.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 111.423 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.445 HG12 ' CE2' ' A' ' 37' ' ' PHE . 13.8 p -145.73 143.67 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.19 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -118.16 120.89 39.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.488 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -121.54 132.86 54.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.552 -179.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 26.9 mt-10 -107.26 104.68 14.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.821 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.858 ' CD1' HG23 ' A' ' 25' ' ' THR . 0.2 OUTLIER -110.99 163.89 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -114.52 121.3 43.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.784 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.786 ' O ' HG23 ' A' ' 22' ' ' THR . 39.2 p90 -112.33 140.53 46.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 111.733 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.99 162.95 15.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.144 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.737 HG21 HG22 ' A' ' 20' ' ' VAL . 3.6 m -144.75 -166.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.058 0.456 . . . . 0.0 111.962 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.98 101.55 11.11 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.972 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -60.86 92.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.956 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.824 ' O ' HG23 ' A' ' 20' ' ' VAL . 6.3 mt-30 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.686 0.279 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.7 p 32.89 47.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.478 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.006 HG22 ' HB3' ' A' ' 116' ' ' ALA . 47.5 t -129.61 156.32 41.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.154 0.502 . . . . 0.0 111.571 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.531 ' O ' ' CB ' ' A' ' 22' ' ' THR . 6.6 m-70 64.81 44.59 3.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.899 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 1.1 m 154.05 102.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.85 0.357 . . . . 0.0 111.361 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -147.85 149.77 32.91 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.317 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -88.76 127.12 35.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.814 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.658 HG23 HG13 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -114.79 152.4 32.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.244 0.545 . . . . 0.0 111.401 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.32 99.14 6.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.261 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.702 HG21 HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.03 129.53 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.554 -178.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.716 HG22 ' CG2' ' A' ' 108' ' ' THR . 21.3 t -105.17 113.58 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.464 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.539 HD12 ' HD1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -102.12 124.66 48.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.374 . . . . 0.0 110.935 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 67.8 m -105.85 115.31 30.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.08 140.29 44.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.355 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.03 157.36 34.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.41 -1.33 11.5 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.935 2.423 . . . . 0.0 112.753 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 t -104.03 -67.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.33 . . . . 0.0 111.285 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.5 p -105.05 -71.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.62 -72.37 0.28 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.578 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.539 ' HD1' HD12 ' A' ' 29' ' ' LEU . 45.7 m-85 -145.41 -43.88 0.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 111.018 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.4 26.86 70.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.733 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.947 HD13 HD13 ' A' ' 72' ' ' LEU . 1.7 tt -124.55 130.71 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.89 0.376 . . . . 0.0 110.922 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.79 148.08 41.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.876 HD13 ' HB1' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -122.13 120.83 35.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.651 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -82.65 140.76 32.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.422 ' O ' HD11 ' A' ' 51' ' ' LEU . . . -84.31 4.56 83.47 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.827 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.535 ' O ' HD21 ' A' ' 56' ' ' LEU . 10.5 t -126.5 172.35 10.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.804 0.335 . . . . 0.0 111.063 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 46' ' ' PHE . 3.7 p -125.79 -45.29 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.29 0.567 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.456 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -156.25 38.04 0.34 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.002 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.37 98.73 7.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.0 p -58.67 -19.82 42.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.498 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -136.77 144.06 43.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.777 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 51' ' ' LEU . 9.6 m 59.71 165.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.83 HD21 HG21 ' A' ' 90' ' ' THR . 15.0 tp -67.86 151.68 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.902 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.465 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -114.02 -158.64 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.662 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.424 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -50.4 177.56 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.099 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.424 ' HD2' ' CB ' ' A' ' 53' ' ' SER . 99.2 Cg_exo -44.12 154.16 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.616 2.211 . . . . 0.0 112.654 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.586 ' HD3' HG22 ' A' ' 90' ' ' THR . 31.7 Cg_exo -58.2 178.28 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.681 2.254 . . . . 0.0 112.512 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -177.89 141.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.768 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.857 HG21 HD11 ' A' ' 39' ' ' ILE . 23.6 mt -64.02 134.83 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.83 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 t -159.97 42.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -172.44 135.9 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.081 0.467 . . . . 0.0 111.222 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.411 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -151.37 152.52 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.234 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.52 155.24 17.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 111.272 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.67 42.37 0.96 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.138 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.421 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER 168.97 33.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.727 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.57 144.57 44.63 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -43.5 -37.75 8.09 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.798 2.332 . . . . 0.0 112.766 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.44 77.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.991 0.424 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -75.73 -50.52 15.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.683 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.421 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.36 -8.95 57.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.697 -179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.517 ' O ' HG23 ' A' ' 71' ' ' VAL . 42.1 t -56.38 -25.24 49.03 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.806 0.336 . . . . 0.0 110.835 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.08 31.76 81.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.293 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.635 HG11 HG13 ' A' ' 27' ' ' VAL . 5.4 t -143.69 -52.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 0.0 111.067 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.947 HD13 HD13 ' A' ' 39' ' ' ILE . 76.5 mt -58.96 150.44 24.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.018 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -144.09 160.59 40.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.5 mm -71.67 89.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.26 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.19 35.17 0.83 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.784 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.652 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -74.93 130.94 40.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.785 0.326 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -85.32 79.33 9.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.733 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.913 HG11 HD11 ' A' ' 81' ' ' ILE . 5.8 t -56.88 158.53 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.425 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -137.75 -65.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.342 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.21 96.0 4.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.377 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.913 HD11 HG11 ' A' ' 78' ' ' VAL . 21.4 mt -86.63 121.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.775 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.794 ' OD1' HD22 ' A' ' 97' ' ' LEU . 4.2 p-10 44.83 30.51 0.56 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.242 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.96 -37.49 3.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.646 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.682 ' HB ' HD21 ' A' ' 97' ' ' LEU . 4.2 mm -84.77 111.07 32.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.499 0.19 . . . . 0.0 111.208 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -90.54 23.36 0.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.742 2.295 . . . . 0.0 112.72 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 p 54.22 71.77 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.955 0.407 . . . . 0.0 111.059 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.98 -43.5 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -77.11 -68.89 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.68 165.38 11.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.992 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.83 HG21 HD21 ' A' ' 51' ' ' LEU . 2.9 p -107.57 -77.93 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -69.98 -41.07 74.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.34 -38.13 86.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.06 -48.61 75.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.883 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -58.29 -44.74 88.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.176 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -60.26 -39.63 87.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.781 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -62.45 -41.55 98.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.883 HD12 ' HA ' ' A' ' 94' ' ' ALA . 5.2 mt -62.21 -48.17 81.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.55 HD11 HD11 ' A' ' 41' ' ' LEU . 73.9 mt -59.89 -33.85 72.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -29.61 39.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -6.01 49.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.478 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.2 t -79.25 -27.22 42.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.691 0.282 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.2 m -59.43 -34.96 73.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.1 mm -52.48 -46.78 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.496 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.3 t -101.48 -4.32 27.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.098 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER 78.41 -3.31 2.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.77 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.639 ' O ' HG23 ' A' ' 104' ' ' THR . 5.0 ptpt -156.8 165.01 37.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.94 0.4 . . . . 0.0 111.131 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.3 146.54 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.525 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.716 ' CG2' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -109.96 109.56 20.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.299 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.897 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -110.25 143.94 39.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 0.0 111.653 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -106.6 121.43 44.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.93 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.702 HD11 HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -119.4 164.48 15.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.15 0.5 . . . . 0.0 111.984 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -122.57 118.65 28.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.301 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.895 ' CE1' HG12 ' A' ' 115' ' ' VAL . 5.4 p90 -117.84 164.86 14.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.26 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.424 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -114.57 96.78 5.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.764 0.316 . . . . 0.0 110.721 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.895 HG12 ' CE1' ' A' ' 113' ' ' PHE . 0.9 OUTLIER 178.28 -169.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.647 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.006 ' HB3' HG22 ' A' ' 20' ' ' VAL . . . 178.76 142.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.972 0.415 . . . . 0.0 111.507 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -127.03 40.94 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.223 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.831 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.504 ' HB3' HG12 ' A' ' 20' ' ' VAL . 12.3 mt-30 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.916 0.389 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 19' ' ' VAL . 10.6 p -73.21 64.26 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 21' ' ' HIS . 14.4 p -148.66 162.41 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.615 ' O ' ' HB ' ' A' ' 22' ' ' THR . 78.1 m-70 65.36 52.98 1.34 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.246 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' A' ' 21' ' ' HIS . 6.7 t 171.76 111.05 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.959 0.409 . . . . 0.0 110.551 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -168.94 156.09 7.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.408 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 7.9 p -87.68 129.27 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.813 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.431 HG22 ' HD2' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -117.37 148.09 42.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.033 0.444 . . . . 0.0 110.995 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.56 98.98 9.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.627 ' CG1' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -100.96 100.36 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.104 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.6 p -85.38 117.94 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.045 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.962 HD23 HD21 ' A' ' 109' ' ' LEU . 3.5 mm? -111.22 152.9 26.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.8 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 105' ' ' SER . 27.5 m -116.53 150.45 37.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.714 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.79 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -92.58 103.84 16.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.162 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 86.1 m-20 -74.89 154.66 86.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.791 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 32' ' ' ASP . 2.9 Cg_exo -75.21 0.02 9.49 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.762 2.308 . . . . 0.0 112.729 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -66.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.821 0.343 . . . . 0.0 110.981 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -108.96 -43.21 4.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.62 -85.72 0.86 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.79 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 96.4 m-85 -133.27 73.66 1.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.975 0.417 . . . . 0.0 110.098 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.89 10.43 0.56 Allowed Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.135 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 66' ' ' ALA . 13.1 tt -96.16 130.25 45.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.891 0.377 . . . . 0.0 110.788 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.72 136.8 50.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -127.64 114.79 17.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.029 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.09 151.77 34.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.34 21.62 45.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.576 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 t -177.01 -172.73 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.965 0.412 . . . . 0.0 111.097 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.848 HG23 ' HB3' ' A' ' 53' ' ' SER . 58.7 t -110.93 -3.82 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.541 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.4 87.33 1.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.369 . . . . 0.0 110.853 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.37 80.04 9.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.128 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 m -165.91 -40.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 111.19 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.82 140.6 0.97 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.57 77.8 0.31 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 51' ' ' LEU . 6.7 tt -97.49 124.24 41.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.17 23.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.419 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.848 ' HB3' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -109.76 149.03 39.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.942 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.0 171.12 2.32 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.636 2.224 . . . . 0.0 112.148 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.84 ' O ' HD12 ' A' ' 56' ' ' LEU . 53.9 Cg_endo -69.48 154.1 69.31 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.478 2.119 . . . . 0.0 112.245 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 55' ' ' PRO . 4.8 mp -149.2 127.45 12.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.014 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 76' ' ' ASP . 69.7 mt -75.63 141.15 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.616 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.935 ' HA ' HG23 ' A' ' 74' ' ' ILE . 46.7 t -164.04 49.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.723 0.297 . . . . 0.0 111.683 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' O ' HG13 ' A' ' 39' ' ' ILE . 70.4 t80 -176.15 133.81 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.031 0.443 . . . . 0.0 111.504 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.411 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.33 152.05 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.035 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.92 155.5 18.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 111.357 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.27 43.49 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.842 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.84 32.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.609 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -121.47 144.62 40.63 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.04 -35.2 4.47 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.812 2.341 . . . . 0.0 112.86 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 39' ' ' ILE . . . -60.67 -44.36 96.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.9 OUTLIER -71.15 -46.73 60.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.842 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -8.68 57.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.633 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.48 ' SG ' HG22 ' A' ' 71' ' ' VAL . 53.5 t -52.0 -40.9 61.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.894 0.378 . . . . 0.0 111.006 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.57 -27.4 15.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.466 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.627 HG23 ' CG1' ' A' ' 27' ' ' VAL . 30.2 m -117.51 26.12 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.757 0.313 . . . . 0.0 111.303 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 66' ' ' ALA . 5.9 mt -124.82 143.48 50.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -169.12 153.39 5.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.785 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.935 HG23 ' HA ' ' A' ' 58' ' ' SER . 40.9 mt -59.34 110.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.53 -15.56 3.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.767 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.559 ' HB2' HD12 ' A' ' 57' ' ' ILE . 65.0 m-20 -59.04 139.32 56.97 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.814 0.34 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.28 96.16 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.08 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.665 HG22 ' CG2' ' A' ' 111' ' ' ILE . 2.8 t -65.33 152.04 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.2 tpt -137.05 -63.28 0.61 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.232 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -125.2 93.9 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.338 . . . . 0.0 111.356 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.885 HG23 ' HB3' ' A' ' 109' ' ' LEU . 10.6 mt -82.66 124.08 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.433 ' OD1' HG22 ' A' ' 81' ' ' ILE . 4.1 p-10 44.35 31.77 0.62 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.154 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.09 -37.57 3.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.3 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 86' ' ' THR . 4.2 mm -85.75 112.66 46.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.57 0.224 . . . . 0.0 111.179 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -89.17 19.87 1.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.632 2.222 . . . . 0.0 112.716 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.431 ' H ' HG22 ' A' ' 84' ' ' ILE . 1.9 p 63.13 129.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.998 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -155.49 149.3 25.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.719 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.32 25.65 15.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.0 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 m 179.96 -48.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.674 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.55 -71.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.298 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.22 -48.23 57.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.246 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -69.04 -43.59 74.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -63.41 -45.33 91.48 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.82 0.343 . . . . 0.0 110.7 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.67 -45.99 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.678 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.08 -38.04 78.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.241 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -62.68 -46.38 88.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.472 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.63 -31.72 71.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.182 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -78.06 -31.49 50.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.612 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.24 -30.62 38.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.87 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -10.58 59.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.243 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.532 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 16.6 m -72.43 -19.33 61.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.041 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.5 p -65.91 -37.09 85.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.882 0.373 . . . . 0.0 110.746 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -58.55 -55.77 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.893 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.3 p -83.19 -9.48 59.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.992 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.79 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER 62.28 17.21 9.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.347 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' HG22 ' A' ' 28' ' ' VAL . 2.9 tppt? -156.81 146.18 20.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 0.0 111.021 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.414 ' HB ' ' OG ' ' A' ' 101' ' ' SER . 11.7 p -154.8 149.89 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 28' ' ' VAL . 1.2 p -122.65 124.84 44.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.059 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.962 HD21 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -125.15 148.22 48.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.088 0.47 . . . . 0.0 111.993 -179.048 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -102.1 129.65 48.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.693 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.665 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -138.39 156.62 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.923 0.392 . . . . 0.0 111.815 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -93.9 126.11 38.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.248 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 24.5 p90 -118.95 164.58 15.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.672 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -120.61 97.73 5.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.493 HG22 ' N ' ' A' ' 116' ' ' ALA . 15.0 p -95.0 158.72 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.227 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 115' ' ' VAL . . . -109.1 55.49 0.63 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.009 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -149.67 98.25 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.871 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.835 0.35 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.8 p -82.52 105.2 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.878 HG21 HG22 ' A' ' 115' ' ' VAL . 31.5 m -62.99 -166.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.554 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 22' ' ' THR . 0.1 OUTLIER 171.12 34.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.813 HG23 ' O ' ' A' ' 113' ' ' PHE . 57.0 m 58.99 146.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.997 0.427 . . . . 0.0 111.352 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HG2' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -178.6 166.9 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.174 179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.2 p -90.31 131.83 35.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.108 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.469 HG23 HD11 ' A' ' 111' ' ' ILE . 5.2 t -116.26 133.62 55.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.031 0.443 . . . . 0.0 111.936 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.34 98.98 10.43 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.552 ' CG1' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -100.88 119.17 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.723 -178.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 28' ' ' VAL . 13.6 p -88.73 113.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.965 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 66' ' ' ALA . 3.5 mm? -104.84 164.77 11.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.567 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 105' ' ' SER . 37.6 m -127.2 146.0 50.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.871 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -82.87 97.49 8.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.148 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.34 142.47 90.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.64 -3.86 14.45 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.61 2.207 . . . . 0.0 112.785 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.73 -61.0 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 t -125.57 -41.22 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.01 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.1 -105.06 0.49 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.462 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.695 ' CE1' HG12 ' A' ' 107' ' ' VAL . 96.6 m-85 -113.85 -28.97 7.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.767 0.318 . . . . 0.0 111.005 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.26 47.28 83.09 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.836 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.838 HD13 HD13 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -146.87 127.63 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 0.0 111.075 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.58 147.87 46.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.909 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.83 ' O ' HD12 ' A' ' 41' ' ' LEU . 2.8 pp -131.68 127.0 36.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.408 ' NE2' ' CB ' ' A' ' 58' ' ' SER . 3.7 mt-30 -67.33 171.36 6.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.77 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.402 ' N ' ' HB3' ' A' ' 91' ' ' PHE . . . -90.6 -134.98 6.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.617 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 53' ' ' SER . 0.8 OUTLIER -104.37 -169.3 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.04 0.447 . . . . 0.0 111.172 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.681 HG13 ' N ' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -84.31 -161.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.456 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.681 ' N ' HG13 ' A' ' 45' ' ' VAL . 46.9 m-85 54.48 26.95 7.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 111.009 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.47 133.91 26.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m 61.32 -120.97 0.79 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.403 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.43 -77.87 0.5 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.84 0.352 . . . . 0.0 110.741 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -63.15 -166.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.705 HD11 HD21 ' A' ' 56' ' ' LEU . 12.5 tp 66.71 140.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.245 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.552 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -149.07 163.96 36.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.857 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 68.45 162.13 0.14 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.818 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 78.3 Cg_exo -50.45 -175.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.707 2.271 . . . . 0.0 112.457 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 54' ' ' PRO . 72.2 Cg_exo -48.76 136.03 27.91 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.099 . . . . 0.0 112.274 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.705 HD21 HD11 ' A' ' 51' ' ' LEU . 1.3 pt? -152.09 145.53 24.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.205 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.631 HD11 HG22 ' A' ' 78' ' ' VAL . 8.5 mt -77.59 143.49 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.612 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.408 ' CB ' ' NE2' ' A' ' 42' ' ' GLN . 3.7 t -162.79 48.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.281 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -172.9 131.54 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.099 0.476 . . . . 0.0 111.389 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.685 HG13 HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -149.61 152.31 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.031 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.83 155.45 17.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 111.261 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.63 39.88 0.9 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.752 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 175.55 29.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.773 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.62 136.14 26.94 Favored Pre-proline 0 C--O 1.231 0.127 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 92.2 Cg_exo -43.52 -29.24 2.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.622 2.214 . . . . 0.0 112.807 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.521 ' HB1' HD13 ' A' ' 39' ' ' ILE . . . -62.72 -42.08 99.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.932 0.396 . . . . 0.0 111.01 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.462 ' HB2' HG22 ' A' ' 60' ' ' ILE . 5.8 tp10 -78.31 -49.61 13.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -72.14 -8.19 53.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.655 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.76 -28.03 14.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 111.001 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.0 26.36 69.05 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.66 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' CG1' ' A' ' 27' ' ' VAL . 1.1 m -145.5 -47.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 111.117 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.838 HD13 HD13 ' A' ' 39' ' ' ILE . 27.1 mt -58.76 156.56 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.18 156.07 18.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.685 HD11 HG13 ' A' ' 60' ' ' ILE . 30.3 mm -70.21 97.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.44 40.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.712 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB3' HD12 ' A' ' 57' ' ' ILE . 2.3 m-20 -101.42 153.22 19.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.641 0.258 . . . . 0.0 110.508 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -111.91 82.93 1.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.167 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.745 HG21 HD22 ' A' ' 41' ' ' LEU . 3.6 t -61.8 143.48 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -168.67 34.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.642 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.917 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 174.26 54.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.849 0.357 . . . . 0.0 111.271 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.742 HD11 HG11 ' A' ' 78' ' ' VAL . 25.5 mt -76.12 118.16 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.619 HD22 HG22 ' A' ' 81' ' ' ILE . 15.1 p30 44.89 30.79 0.59 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.271 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.72 -35.43 5.07 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.38 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 mm -78.68 110.83 15.51 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 121.999 0.119 . . . . 0.0 111.198 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -86.17 99.67 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.563 2.175 . . . . 0.0 112.411 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 94' ' ' ALA . 71.2 p -69.96 119.47 14.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.026 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.07 74.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.0 -76.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.8 p -178.16 -39.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 t -85.5 101.11 12.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.402 ' HB3' ' N ' ' A' ' 43' ' ' GLY . 45.0 p90 -66.55 -22.28 66.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -53.37 -30.6 40.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.079 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 20.4 pt-20 -62.91 -47.15 84.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.168 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.917 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -59.21 -41.09 87.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -61.18 -42.3 98.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.791 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -62.73 -34.8 77.92 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.764 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 94' ' ' ALA . 8.8 mt -68.13 -37.75 81.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.631 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.9 -41.65 59.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -68.16 -31.89 71.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.993 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -5.13 49.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.35 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.417 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 69.7 m -69.62 -13.9 62.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.261 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -58.56 -28.38 65.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.0 mm -54.83 -30.9 23.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.172 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -117.45 -4.5 11.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.223 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.682 ' O ' HG23 ' A' ' 30' ' ' THR . 1.4 m 62.91 21.46 12.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.211 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 5.6 mttt -156.12 151.21 26.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.0 110.956 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.695 HG12 ' CE1' ' A' ' 37' ' ' PHE . 13.2 p -150.08 111.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.88 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.435 HG23 HG23 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -90.87 107.29 19.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.36 150.5 23.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 111.41 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.917 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 3.6 tt0 -123.57 105.17 9.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.195 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.688 HG22 HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -111.04 159.71 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.097 0.475 . . . . 0.0 111.925 -178.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -110.18 118.49 36.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.517 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.813 ' O ' HG23 ' A' ' 22' ' ' THR . 14.6 p90 -121.61 154.02 37.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.343 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.04 97.8 5.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.878 HG22 HG21 ' A' ' 20' ' ' VAL . 1.3 p -80.75 145.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.743 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.97 126.63 30.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.283 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.666 ' HA ' HG22 ' A' ' 20' ' ' VAL . 1.4 mp0 -68.55 135.01 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.834 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.894 0.378 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.71 149.21 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.235 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 p -58.05 141.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.401 ' CB ' ' HB ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -87.26 157.79 19.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.027 0.441 . . . . 0.0 111.079 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.9 108.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.034 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 mt-10 -148.34 173.79 12.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.084 0.468 . . . . 0.0 111.423 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 112' ' ' GLU . 44.8 p -108.42 134.15 51.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.288 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.666 HG23 HG13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -111.96 144.52 41.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.083 0.468 . . . . 0.0 111.691 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.9 pt-20 -104.07 100.17 9.93 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.676 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -99.87 102.85 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.826 -178.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.976 HG23 HG23 ' A' ' 108' ' ' THR . 9.2 p -86.2 115.55 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.41 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.438 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 7.6 mt -115.58 152.44 33.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.018 0.437 . . . . 0.0 111.339 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 105' ' ' SER . 97.9 m -113.78 137.54 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.616 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -68.7 107.01 2.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.02 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.35 142.53 86.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.06 55.3 5.59 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.796 2.331 . . . . 0.0 112.482 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 t -153.2 -69.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.013 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -116.8 -24.55 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.18 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.67 -112.63 2.29 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.323 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.572 ' CE2' HG12 ' A' ' 107' ' ' VAL . 21.5 m-85 -113.03 -23.28 10.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 0.0 111.139 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 58.85 54.23 39.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.863 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 57' ' ' ILE . 2.0 tt -147.88 127.2 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.731 0.3 . . . . 0.0 110.747 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.51 147.06 38.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.066 0.46 . . . . 0.0 111.53 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.657 HD23 HG13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -121.25 169.09 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.372 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -147.11 149.04 32.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.879 0.371 . . . . 0.0 111.06 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.74 36.62 3.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.35 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.443 ' O ' HD21 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -143.01 128.52 19.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.944 0.402 . . . . 0.0 111.072 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.69 HG22 HD22 ' A' ' 56' ' ' LEU . 85.4 t -115.11 -32.86 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.027 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 178.69 115.14 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.801 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -169.5 54.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.121 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.4 m 67.6 -71.06 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.09 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -143.75 -62.48 0.39 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.746 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.7 t -55.88 -170.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.137 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.567 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.2 pt? -112.96 149.84 32.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -175.43 24.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.66 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -129.09 159.31 69.52 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.724 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.25 152.04 8.7 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.52 2.146 . . . . 0.0 112.319 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.21 128.22 16.21 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.488 2.126 . . . . 0.0 112.345 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.69 HD22 HG22 ' A' ' 45' ' ' VAL . 2.1 pt? -135.65 160.01 39.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.939 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.758 HG21 HD11 ' A' ' 39' ' ' ILE . 5.6 mt -85.96 143.9 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.736 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.488 ' HA ' HG23 ' A' ' 74' ' ' ILE . 11.5 m -165.32 50.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.29 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -176.52 132.76 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.979 0.419 . . . . 0.0 111.42 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.402 HG21 ' HA ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -149.15 152.26 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.059 179.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.58 155.45 16.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.164 0.507 . . . . 0.0 111.275 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.67 38.85 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.846 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.0 t0 179.08 28.69 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.772 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.41 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 33.4 m -124.35 139.19 32.37 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.591 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 2.8 Cg_endo -45.51 -27.95 3.82 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.865 2.377 . . . . 0.0 112.77 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.64 96.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.846 0.355 . . . . 0.0 110.843 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' HA ' HG21 ' A' ' 60' ' ' ILE . 3.6 tp10 -78.56 -48.43 15.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.05 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -73.06 -7.23 50.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.893 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.72 -25.89 4.88 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.841 0.353 . . . . 0.0 111.175 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.87 25.27 73.12 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.559 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.644 ' O ' HG22 ' A' ' 71' ' ' VAL . 14.4 p -158.07 29.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.034 0.445 . . . . 0.0 110.874 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 mt -135.82 151.96 50.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.715 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -151.37 172.2 16.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.488 HG23 ' HA ' ' A' ' 58' ' ' SER . 22.3 mm -83.01 73.0 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.77 37.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.66 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.7 123.07 48.35 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.75 105.85 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 111.744 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.865 ' CG1' HG23 ' A' ' 111' ' ' ILE . 1.3 m -71.45 138.26 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -148.05 21.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.261 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -174.26 59.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.931 0.396 . . . . 0.0 111.319 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 78' ' ' VAL . 32.3 mt -88.65 124.61 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 44.24 31.21 0.53 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.324 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.31 -46.67 1.18 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 86' ' ' THR . 8.4 mm -70.33 112.57 13.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.553 0.216 . . . . 0.0 111.166 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.12 13.61 2.69 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.636 2.224 . . . . 0.0 112.819 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.536 ' H ' HG22 ' A' ' 84' ' ' ILE . 21.0 p 54.04 79.51 0.13 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.802 0.334 . . . . 0.0 111.055 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -84.52 63.69 8.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.82 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.632 ' HB3' HG22 ' A' ' 90' ' ' THR . 0.3 OUTLIER -174.55 166.07 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.3 t -99.07 31.37 3.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.632 HG22 ' HB3' ' A' ' 88' ' ' ASP . 4.2 t -118.16 114.04 22.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -58.3 -23.92 57.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -54.74 -31.46 58.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.7 -53.48 50.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.521 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HB3' HD13 ' A' ' 41' ' ' LEU . . . -57.68 -42.08 82.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.685 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -39.48 77.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.286 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -62.97 -41.49 99.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.341 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.419 HD12 HD12 ' A' ' 81' ' ' ILE . 13.3 mt -58.77 -41.9 87.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.591 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.3 mt -77.87 -30.67 50.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.82 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -38.98 92.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -75.33 -7.15 53.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.4 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.473 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 8.7 m -63.95 -22.19 66.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.972 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.89 -39.44 81.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.787 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.8 mm -49.3 -65.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.472 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 106' ' ' LYS . 7.6 t -84.32 -4.81 59.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.039 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.838 ' O ' HG23 ' A' ' 30' ' ' THR . 0.4 OUTLIER 63.0 21.0 12.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.236 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.764 ' HD2' HG22 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -156.41 150.14 24.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.247 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.572 HG12 ' CE2' ' A' ' 37' ' ' PHE . 9.4 p -155.33 145.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.617 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.976 HG23 HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -122.23 108.89 13.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.295 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -103.48 128.36 50.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.041 0.448 . . . . 0.0 111.836 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -92.41 107.46 19.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.634 178.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.865 HG23 ' CG1' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -109.36 159.9 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.22 0.533 . . . . 0.0 112.152 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.582 ' HG3' HG22 ' A' ' 24' ' ' THR . 6.5 tt0 -118.83 121.97 41.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.783 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.405 ' CD1' ' O ' ' A' ' 23' ' ' GLU . 52.0 p90 -112.31 135.49 52.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -112.8 97.56 6.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.42 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.401 ' HB ' ' CB ' ' A' ' 21' ' ' HIS . 3.0 t -75.79 152.0 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.247 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.16 53.08 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -128.65 47.9 2.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.842 179.938 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.712 0.291 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.492 ' O ' HG22 ' A' ' 19' ' ' VAL . 13.0 p 34.54 47.67 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.253 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.807 HG22 HG23 ' A' ' 115' ' ' VAL . 14.9 p -148.91 153.23 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.781 ' CB ' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -58.89 -161.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.91 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.622 HG23 ' HA ' ' A' ' 114' ' ' ASP . 93.3 m 115.36 120.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.962 0.905 . . . . 0.0 109.503 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -178.44 177.97 0.9 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.989 0.423 . . . . 0.0 111.585 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.525 HG22 ' HB2' ' A' ' 112' ' ' GLU . 68.1 p -87.23 143.14 27.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.509 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 t -132.72 135.09 45.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.6 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.02 99.25 11.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.645 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -103.51 130.48 53.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' VAL . 9.6 p -82.97 122.06 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.092 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.508 HD11 ' HA ' ' A' ' 66' ' ' ALA . 1.7 mm? -116.09 147.97 40.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.635 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 105' ' ' SER . 74.5 m -130.43 144.13 51.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.872 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -82.84 147.53 28.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.098 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 2.4 m-20 -110.61 156.13 41.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 32' ' ' ASP . 3.1 Cg_exo -80.15 0.11 10.26 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.938 2.425 . . . . 0.0 112.424 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 t -91.25 -55.22 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.157 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 t -135.31 -46.69 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.27 -111.99 0.6 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.452 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.872 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 67.0 m-85 -109.17 -24.86 10.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.766 0.317 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 64.88 42.94 96.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.934 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -143.41 128.4 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.875 0.369 . . . . 0.0 110.689 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.439 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -116.22 150.37 37.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 111.458 -179.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.783 HD13 ' CB ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -119.83 160.89 21.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.474 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.93 158.67 25.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 111.111 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.88 88.31 1.2 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.381 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.0 t -162.38 112.25 1.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 0.0 110.748 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 53' ' ' SER . 44.8 t -107.73 -18.19 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.48 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.54 -26.42 6.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.219 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 46.71 42.19 11.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.607 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.8 m -92.52 -65.43 1.0 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.836 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -151.78 -81.3 0.1 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.719 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.2 t -69.17 166.05 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 52' ' ' SER . 1.1 tt -119.58 121.11 38.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.957 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.55 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -163.6 23.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.578 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.659 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -113.35 151.82 44.7 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.897 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -51.22 153.92 8.77 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.726 2.284 . . . . 0.0 112.425 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.664 ' C ' HD13 ' A' ' 56' ' ' LEU . 97.7 Cg_endo -79.26 154.59 24.98 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.727 2.285 . . . . 0.0 112.592 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.664 HD13 ' C ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -160.54 -178.67 7.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.871 HG21 HD11 ' A' ' 39' ' ' ILE . 26.5 mt -87.18 141.19 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.698 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 m -161.85 49.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.392 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.439 ' CG ' ' HB2' ' A' ' 40' ' ' GLN . 24.4 t80 -177.36 132.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 111.462 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.407 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -151.88 152.54 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.982 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.83 155.02 17.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 111.401 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.73 42.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.856 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.408 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER 170.4 31.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.821 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.411 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 3.9 m -122.84 145.29 45.08 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.002 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.54 -37.48 11.07 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.073 2.515 . . . . 0.0 112.6 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.508 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -58.51 -38.51 77.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 1.2 tm-20 -78.24 -51.97 9.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.856 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.408 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -67.03 -11.27 56.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.827 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -24.65 51.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 110.874 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.31 30.58 73.55 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.174 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.536 ' CB ' HG11 ' A' ' 27' ' ' VAL . 4.4 t -145.47 -54.46 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.093 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.9 mt -59.58 145.67 43.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -160.88 167.87 25.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.778 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.7 mm -70.24 67.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.74 38.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.474 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.478 ' HB3' HG21 ' A' ' 111' ' ' ILE . 56.2 m-20 -109.59 107.52 17.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.733 0.301 . . . . 0.0 110.554 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -82.21 93.89 7.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.306 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.901 ' HB ' HD11 ' A' ' 81' ' ' ILE . 30.5 m -58.63 123.57 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.703 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.0 ttp -118.37 -16.01 9.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.808 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -167.12 98.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 111.551 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.901 HD11 ' HB ' ' A' ' 78' ' ' VAL . 3.9 mp -103.12 113.27 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.5 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 45.87 29.94 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.224 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.31 -44.38 1.52 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.767 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 86' ' ' THR . 5.2 mm -80.89 113.74 42.87 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.505 0.193 . . . . 0.0 111.166 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.81 0.84 9.71 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.509 2.139 . . . . 0.0 112.866 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.705 ' CG2' HD13 ' A' ' 81' ' ' ILE . 2.5 p 59.9 22.28 11.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.045 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 55.7 -178.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 0.0 110.963 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -110.53 29.61 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 p -177.59 38.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.4 m -154.31 75.82 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -60.64 -26.05 66.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.057 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.78 -35.44 68.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.053 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.7 mt-10 -64.38 -45.66 86.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.71 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.783 ' CB ' HD13 ' A' ' 41' ' ' LEU . . . -57.8 -49.16 77.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -60.12 -34.82 74.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.525 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.61 -41.11 98.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.568 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 94' ' ' ALA . 3.6 mt -70.08 -30.56 67.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.462 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 94' ' ' ALA . 3.4 mm? -64.08 -46.44 84.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.927 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -73.64 -29.76 62.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.061 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -75.0 -5.61 44.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.503 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.445 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 58.1 m -66.44 -22.06 66.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 0.0 111.196 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -58.66 -27.31 64.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.007 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.5 mm -57.35 -48.98 81.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.477 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -100.79 -14.81 17.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.284 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER 77.57 -3.79 2.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.949 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -156.78 129.62 7.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.858 0.361 . . . . 0.0 111.029 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.441 HG21 ' OG ' ' A' ' 101' ' ' SER . 0.0 OUTLIER -120.38 166.82 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.86 106.75 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.794 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.93 138.28 35.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.001 0.429 . . . . 0.0 111.881 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -116.2 104.62 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.821 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.645 HD11 ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -120.28 149.02 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.525 ' HB2' HG22 ' A' ' 24' ' ' THR . 49.0 tt0 -103.62 118.79 37.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.871 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -115.76 144.13 44.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.301 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.622 ' HA ' HG23 ' A' ' 22' ' ' THR . 13.0 m-20 -100.01 162.19 13.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.494 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.807 HG23 HG22 ' A' ' 20' ' ' VAL . 3.2 m -134.0 171.61 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.306 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.466 ' O ' HG21 ' A' ' 20' ' ' VAL . . . -57.08 105.6 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.322 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.604 ' HG2' HG11 ' A' ' 20' ' ' VAL . 27.4 mt-10 -73.62 83.61 1.56 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.974 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.029 179.831 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.801 0.334 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.558 ' O ' HG13 ' A' ' 19' ' ' VAL . 11.3 p -74.39 113.98 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.154 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 20' ' ' VAL . 11.3 p -122.95 124.92 71.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.64 ' O ' HG23 ' A' ' 22' ' ' THR . 11.2 m170 -87.85 173.23 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.908 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 21' ' ' HIS . 0.1 OUTLIER 173.08 108.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.202 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.402 ' O ' ' CD2' ' A' ' 113' ' ' PHE . 1.1 mt-10 -151.68 176.56 11.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.972 0.415 . . . . 0.0 111.26 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 p -103.71 140.79 37.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.412 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.828 HG23 ' CD1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -116.89 142.07 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.064 0.459 . . . . 0.0 111.441 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.62 98.93 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.783 HG23 HD12 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -102.91 131.24 51.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.0 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.845 HG22 HG22 ' A' ' 108' ' ' THR . 12.3 t -107.62 113.4 43.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.179 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 65' ' ' PRO . 3.1 mm? -99.91 164.29 12.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.335 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 105' ' ' SER . 17.0 m -117.5 132.24 56.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 110.819 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.775 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -79.35 91.64 5.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.163 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.15 140.87 94.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.63 -4.96 16.28 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.476 2.117 . . . . 0.0 112.846 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.7 t -99.69 -54.18 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.066 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.446 HG23 ' N ' ' A' ' 36' ' ' GLY . 10.9 t -108.3 -47.15 3.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' N ' HG23 ' A' ' 35' ' ' THR . . . 97.45 -91.17 1.17 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.672 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.775 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 80.9 m-85 -141.61 77.92 1.61 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.938 0.399 . . . . 0.0 110.223 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.48 18.93 0.4 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.072 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.744 HD11 HG21 ' A' ' 57' ' ' ILE . 3.4 tt -96.35 130.02 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.91 0.355 . . . . 0.0 110.611 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.603 ' C ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -111.07 145.81 37.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.987 0.422 . . . . 0.0 111.463 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.696 HD22 HG12 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -122.01 156.98 32.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.479 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -124.82 147.6 48.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.915 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.749 ' O ' HD11 ' A' ' 51' ' ' LEU . . . -95.59 25.34 25.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.556 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.9 p -143.7 129.18 19.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 110.752 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.433 HG22 HD22 ' A' ' 56' ' ' LEU . 58.9 t -94.88 -74.98 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.64 88.22 0.7 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.948 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.44 114.86 8.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.06 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -58.44 -20.41 44.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.468 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -154.64 145.54 22.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.924 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.92 162.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.749 HD11 ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -113.41 100.56 8.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.43 20.97 12.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.3 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.405 ' HB2' HG23 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -127.77 120.04 21.56 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.15 167.89 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.405 2.07 . . . . 0.0 112.274 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.71 168.12 12.33 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.55 2.167 . . . . 0.0 112.149 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.563 ' N ' HD23 ' A' ' 56' ' ' LEU . 2.3 pt? -167.91 152.94 6.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.97 0.414 . . . . 0.0 111.109 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.744 HG21 HD11 ' A' ' 39' ' ' ILE . 47.7 mt -72.9 152.48 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.835 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.18 44.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.537 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -176.58 129.38 0.19 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.209 0.528 . . . . 0.0 111.854 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.509 HD13 HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -142.21 152.14 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.374 179.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 63' ' ' ASP . 5.5 tp10 -109.88 154.93 22.36 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.078 0.466 . . . . 0.0 111.858 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.29 42.04 0.15 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.016 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER 175.11 31.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.192 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -122.21 135.05 25.09 Favored Pre-proline 0 CA--C 1.527 0.075 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.665 ' HB2' HD12 ' A' ' 29' ' ' LEU . 3.5 Cg_endo -46.37 -30.54 8.34 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.506 2.137 . . . . 0.0 112.424 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.734 ' HA ' HD21 ' A' ' 72' ' ' LEU . . . -70.08 -33.27 71.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.768 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.452 ' HA ' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -75.04 -49.93 18.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.844 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.419 ' NH2' ' C ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -79.31 -8.26 58.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.943 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.53 -34.78 37.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.772 0.32 . . . . 0.0 111.082 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.26 27.12 70.13 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.591 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 72' ' ' LEU . 11.2 p -136.08 -45.3 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.629 0.252 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.734 HD21 ' HA ' ' A' ' 66' ' ' ALA . 2.5 pp -77.99 163.04 26.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.013 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.59 165.29 29.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.865 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.51 75.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.085 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.8 40.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.776 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.524 ' HB2' HD12 ' A' ' 57' ' ' ILE . 45.8 m-20 -99.95 119.13 37.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 110.56 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -86.13 85.64 7.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.218 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 111' ' ' ILE . 3.5 t -65.54 138.64 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.118 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.2 ttp -171.14 34.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.128 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.807 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -179.88 49.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.13 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.638 HD11 HG11 ' A' ' 78' ' ' VAL . 8.7 mt -73.0 117.68 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.54 HD22 HG22 ' A' ' 81' ' ' ILE . 13.6 p30 45.55 30.48 0.77 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.56 -37.65 3.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.096 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.778 HG21 HD21 ' A' ' 97' ' ' LEU . 7.7 mm -74.28 112.04 15.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.552 0.215 . . . . 0.0 111.137 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -89.98 32.61 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.676 2.251 . . . . 0.0 112.488 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 p 58.29 22.28 9.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 47.95 94.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.487 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 t70 63.71 -77.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.276 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -164.13 120.25 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.89 0.376 . . . . 0.0 111.071 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -179.67 98.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.636 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -55.35 -33.05 63.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.171 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -43.02 83.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.839 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -41.31 97.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.799 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.73 -48.33 79.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.503 ' HA ' HD21 ' A' ' 98' ' ' LEU . 9.8 m-80 -61.86 -34.73 76.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.496 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -35.98 82.02 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.51 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 94' ' ' ALA . 4.6 mt -69.74 -48.24 60.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.996 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HA ' HG21 ' A' ' 107' ' ' VAL . 3.2 pp -70.1 -37.02 75.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.157 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.548 ' N ' HD12 ' A' ' 98' ' ' LEU . 4.7 mtt85 -69.87 -30.41 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.81 0.338 . . . . 0.0 111.009 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -89.16 4.78 47.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.369 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.453 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 0.4 OUTLIER -83.12 -12.12 57.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.338 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.5 p -57.68 -24.77 58.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.714 0.292 . . . . 0.0 110.887 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.7 mm -56.36 -31.51 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.954 0.406 . . . . 0.0 110.896 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -114.34 -5.93 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.058 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.583 ' O ' HG23 ' A' ' 30' ' ' THR . 8.9 t 69.42 23.81 5.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.399 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.583 ' HD3' HG11 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -156.23 150.38 25.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.952 0.406 . . . . 0.0 111.282 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.606 HG21 ' HA ' ' A' ' 98' ' ' LEU . 13.9 p -144.14 136.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.28 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.845 HG22 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -111.32 113.39 25.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.225 179.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.783 HD12 HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -113.97 125.2 53.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.966 0.412 . . . . 0.0 111.369 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.807 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 12.9 tt0 -101.32 105.0 16.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.871 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.907 HG22 HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -110.2 164.3 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 121.08 0.467 . . . . 0.0 112.07 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -104.19 120.41 41.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.916 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 23' ' ' GLU . 45.0 p90 -108.69 139.97 42.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.29 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.01 97.71 6.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.301 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 21' ' ' HIS . 2.4 t -71.76 144.14 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.158 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.87 48.03 1.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.965 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -142.47 60.72 1.44 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.8 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.767 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.903 0.383 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 19' ' ' VAL . 24.0 t -89.1 54.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.085 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.436 ' O ' ' CG ' ' A' ' 21' ' ' HIS . 20.8 t -144.39 155.76 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.057 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.67 ' O ' HG23 ' A' ' 22' ' ' THR . 13.8 p-80 43.68 63.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.863 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 21' ' ' HIS . 0.2 OUTLIER 166.52 102.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.135 179.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 22.2 mt-10 -162.29 143.99 10.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.943 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 69.5 p -91.94 127.12 37.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.62 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.812 HG23 ' CD1' ' A' ' 111' ' ' ILE . 1.6 t -115.72 136.59 52.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 111.204 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.71 99.83 11.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.022 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.473 HG11 HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -106.61 129.01 60.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -179.266 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.681 HG22 ' CG2' ' A' ' 108' ' ' THR . 19.5 t -94.3 120.62 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.176 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB2' HD21 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -111.17 123.91 51.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.855 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 105' ' ' SER . 28.7 m -105.62 141.64 36.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.717 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.65 136.39 37.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.226 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.49 141.91 23.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.828 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.35 55.87 5.28 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.78 2.32 . . . . 0.0 112.56 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -155.41 -64.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.162 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -114.14 -44.48 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.93 -115.57 2.93 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.406 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.694 ' HB3' HG22 ' A' ' 39' ' ' ILE . 54.0 m-85 -113.96 -28.85 7.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.682 0.277 . . . . 0.0 110.971 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.99 24.64 43.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.691 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.748 HD11 HG21 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -130.44 140.55 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.967 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.702 ' C ' HD13 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -139.54 164.81 28.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.099 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.702 HD13 ' C ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -117.28 160.07 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.7 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.19 171.67 3.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.957 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.12 75.52 1.0 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.571 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.417 ' O ' HD22 ' A' ' 51' ' ' LEU . 15.6 p -100.84 -167.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.5 t -60.48 -17.78 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.563 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.12 84.39 2.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.633 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 51' ' ' LEU . . . -122.54 131.67 53.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.253 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -73.35 63.5 0.76 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.5 34.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.081 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.1 m 53.45 82.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.206 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 52' ' ' SER . 6.8 tt -151.98 135.28 15.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.745 ' N ' HD23 ' A' ' 51' ' ' LEU . 1.7 m -135.32 97.59 3.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.003 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 170.52 156.67 0.2 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.43 168.62 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.319 2.013 . . . . 0.0 112.005 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.42 137.07 38.63 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.465 2.11 . . . . 0.0 112.253 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.747 HD22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -131.9 153.34 50.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.379 . . . . 0.0 110.952 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.748 HG21 HD11 ' A' ' 39' ' ' ILE . 12.1 mt -59.87 145.39 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.684 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.881 ' HA ' HG23 ' A' ' 74' ' ' ILE . 3.0 m -165.37 44.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.801 0.334 . . . . 0.0 111.557 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.593 ' O ' HD12 ' A' ' 39' ' ' ILE . 30.8 t80 -169.97 133.57 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.174 0.511 . . . . 0.0 111.534 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.423 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -151.88 152.52 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.879 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 1.4 mt-10 -103.55 155.39 18.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.065 0.46 . . . . 0.0 111.426 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.89 39.44 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.8 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.03 29.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.684 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.37 142.15 34.77 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.624 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.487 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 97.0 Cg_exo -43.07 -29.48 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.65 2.233 . . . . 0.0 112.87 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.407 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . . . -62.89 -40.26 97.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 2.4 mm-40 -78.12 -52.92 8.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.728 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.84 -8.63 55.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.743 -179.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -38.37 56.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.811 0.339 . . . . 0.0 110.952 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.97 -18.66 55.55 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.819 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.473 HG23 HG11 ' A' ' 27' ' ' VAL . 7.7 m -128.09 39.24 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.836 0.35 . . . . 0.0 111.188 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -139.78 143.84 37.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -169.12 152.91 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.713 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 58' ' ' SER . 24.9 mt -58.36 107.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.048 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.22 -25.34 1.41 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.406 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.452 ' CB ' HD12 ' A' ' 57' ' ' ILE . 16.6 m-20 -60.14 122.98 15.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.832 0.348 . . . . 0.0 110.662 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.4 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -96.13 105.74 17.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.214 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.119 HG11 HD11 ' A' ' 81' ' ' ILE . 14.8 t -70.54 146.12 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -165.17 27.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.462 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.786 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . 174.07 78.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.969 0.414 . . . . 0.0 111.419 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.119 HD11 HG11 ' A' ' 78' ' ' VAL . 21.0 mt -103.83 118.09 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.846 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 45.1 30.57 0.62 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 108.9 -46.1 1.22 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.581 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.696 HG21 HD21 ' A' ' 97' ' ' LEU . 9.0 mm -70.62 109.96 6.08 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.548 0.214 . . . . 0.0 111.436 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 86.0 Cg_endo -92.25 103.09 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.861 2.374 . . . . 0.0 112.234 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.746 HG21 ' HB2' ' A' ' 94' ' ' ALA . 55.1 p -57.59 101.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.381 . . . . 0.0 111.109 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -123.69 -176.89 3.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 59.66 169.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.862 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.79 89.65 3.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.773 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 t -176.31 76.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.003 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -59.41 -23.93 63.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -54.77 -30.93 57.97 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.757 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.25 -51.81 67.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.431 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.746 ' HB2' HG21 ' A' ' 86' ' ' THR . . . -57.85 -46.27 85.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.884 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.686 ' N ' HD23 ' A' ' 41' ' ' LEU . 11.2 m-20 -60.25 -36.2 77.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.441 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -40.21 96.58 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.394 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.739 HD12 ' HA ' ' A' ' 94' ' ' ALA . 1.7 mt -72.74 -28.31 62.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.515 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.92 -47.0 79.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.801 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.4 mpp_? -76.12 -28.57 57.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.966 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.95 -9.03 57.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.431 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.435 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 51.9 m -72.62 -23.72 60.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.098 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 p -58.95 -34.85 72.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 25.7 mm -53.64 -60.66 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.523 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.4 t -75.27 -8.86 57.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.388 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 30' ' ' THR . 0.9 OUTLIER 84.19 -16.3 0.53 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.009 179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.595 ' O ' HG23 ' A' ' 104' ' ' THR . 1.5 ptpt -156.65 158.08 36.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.758 0.313 . . . . 0.0 111.051 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 108' ' ' THR . 12.1 p -146.47 160.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.673 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.681 ' CG2' HG22 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -119.02 109.43 15.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.263 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -103.06 133.18 48.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 111.619 -179.422 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 6.2 mt-10 -107.84 104.79 14.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.057 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.812 ' CD1' HG23 ' A' ' 25' ' ' THR . 0.2 OUTLIER -109.37 159.47 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.08 0.467 . . . . 0.0 112.25 -178.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.79 119.24 38.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.884 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 115' ' ' VAL . 23.4 p90 -112.59 165.09 12.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.964 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 21' ' ' HIS . 0.6 OUTLIER -132.31 97.01 4.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.211 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 113' ' ' PHE . 35.9 m -96.44 167.28 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.057 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.71 45.61 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.29 79.21 0.38 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.762 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.402 ' HB2' HG22 ' A' ' 20' ' ' VAL . 18.8 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.826 0.346 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.33 82.76 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 20' ' ' VAL . 11.2 p -122.82 118.57 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.075 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.413 ' CB ' ' CG2' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -74.27 168.52 19.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.34 137.69 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.451 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' HG2' ' CZ ' ' A' ' 113' ' ' PHE . 1.8 pt-20 -177.99 176.91 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.1 p -101.81 127.36 48.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.532 HG23 HG13 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -101.49 158.78 15.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.194 0.521 . . . . 0.0 111.28 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.13 99.17 8.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.622 HG21 HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.24 105.81 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.774 -178.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 28' ' ' VAL . 10.0 p -82.97 116.01 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.437 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.634 HD11 ' HA ' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -106.52 141.59 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.916 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 105' ' ' SER . 87.4 m -115.46 142.17 47.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.84 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.784 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -85.93 141.61 29.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.147 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.61 138.26 22.53 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.865 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.06 58.68 5.64 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.547 2.165 . . . . 0.0 112.356 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 t -154.19 -68.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.055 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 p -110.63 -28.99 8.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -118.15 4.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.381 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.784 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 40.8 m-85 -113.0 -22.77 10.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.675 0.274 . . . . 0.0 111.153 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.01 32.1 66.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.872 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.618 HG22 ' HB3' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -140.52 141.05 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.732 0.301 . . . . 0.0 110.821 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.31 138.45 47.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.246 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.806 HD23 HG21 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -107.08 113.05 26.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.487 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -88.0 137.42 32.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.18 25.34 22.68 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.529 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.812 ' HB3' HD11 ' A' ' 51' ' ' LEU . 13.1 p -136.8 159.29 42.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.925 HG22 HD11 ' A' ' 56' ' ' LEU . 33.9 t -126.94 -3.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.631 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -152.96 166.12 33.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.06 100.7 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.979 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -165.67 -38.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.239 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.03 109.55 2.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.184 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 57.59 -171.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.328 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' A' ' 44' ' ' SER . 0.8 OUTLIER -141.29 122.64 14.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.463 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -157.32 23.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.98 0.419 . . . . 0.0 111.559 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.509 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -96.07 154.88 38.76 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.939 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' O ' HG23 ' A' ' 45' ' ' VAL . 45.2 Cg_exo -56.48 148.94 59.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.575 2.183 . . . . 0.0 112.256 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.663 ' C ' HD13 ' A' ' 56' ' ' LEU . 98.0 Cg_endo -85.82 146.04 9.1 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.818 2.345 . . . . 0.0 112.504 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.925 HD11 HG22 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -162.99 170.69 17.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.577 HG21 HD11 ' A' ' 39' ' ' ILE . 7.6 mt -80.26 139.12 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.457 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.6 m -156.79 48.46 0.45 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 111.505 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -173.12 133.51 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.11 0.481 . . . . 0.0 111.545 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.595 HG22 ' HB2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -151.3 152.03 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.96 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.69 155.61 17.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.107 0.48 . . . . 0.0 111.432 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.55 38.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.723 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.86 29.68 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.643 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 p -122.11 137.46 27.5 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.478 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 82.9 Cg_exo -43.98 -29.2 2.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.511 2.141 . . . . 0.0 112.829 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.732 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -62.51 -43.21 99.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.793 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.595 ' HB2' HG22 ' A' ' 60' ' ' ILE . 27.2 tp10 -78.3 -49.53 13.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -73.6 -8.41 55.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.554 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.426 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -51.9 -28.16 15.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.769 0.318 . . . . 0.0 110.96 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.22 45.35 95.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.412 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.9 p -170.06 41.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.019 0.438 . . . . 0.0 111.074 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.732 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -176.6 145.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -142.3 -175.43 4.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.821 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 60' ' ' ILE . 31.5 mm -78.93 77.51 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.58 41.02 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.623 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -112.09 119.23 37.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.333 . . . . 0.0 110.701 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 93.65 9.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.207 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.806 HG21 HD23 ' A' ' 41' ' ' LEU . 1.8 t -71.19 134.34 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.54 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -157.21 29.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 111.298 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.826 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -179.22 68.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.131 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.711 ' HB ' HD22 ' A' ' 97' ' ' LEU . 3.9 mp -90.6 120.03 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.4 p30 45.41 29.64 0.61 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.286 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 107.55 -36.15 4.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.356 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.5 mm -77.12 110.82 13.28 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.503 0.192 . . . . 0.0 111.218 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 89.3 Cg_endo -91.47 72.33 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.789 2.326 . . . . 0.0 112.448 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.673 HG22 HD13 ' A' ' 81' ' ' ILE . 1.2 t -57.47 103.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.34 123.88 27.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.914 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.0 30.65 19.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.9 p -102.26 -169.71 1.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.94 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.2 m -86.56 162.11 18.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -59.6 -28.05 66.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.71 -33.1 69.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.113 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.83 -52.64 64.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.714 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.821 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -57.75 -50.89 71.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -59.55 -34.14 72.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.533 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -62.63 -40.19 96.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.641 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.821 HD12 ' HA ' ' A' ' 94' ' ' ALA . 1.8 mt -67.87 -37.53 81.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.512 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.44 HD11 ' CD1' ' A' ' 41' ' ' LEU . 49.8 mt -70.26 -39.94 74.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.626 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -65.38 -34.13 77.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.26 -10.27 59.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.276 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.472 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 5.1 m -79.22 -33.44 43.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 110.736 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -32.72 74.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.81 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.17 -58.01 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.51 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.8 t -96.17 1.54 52.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.234 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.736 ' O ' HG23 ' A' ' 30' ' ' THR . 8.3 t 69.98 9.75 7.2 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.577 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 104' ' ' THR . 1.5 ttmp? -156.56 155.86 32.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.895 0.379 . . . . 0.0 111.05 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.413 HG22 ' N ' ' A' ' 108' ' ' THR . 12.0 p -153.22 155.7 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.576 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 107' ' ' VAL . 0.6 OUTLIER -121.48 117.99 28.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.146 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.469 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -114.19 132.3 56.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.973 0.416 . . . . 0.0 111.989 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.826 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -95.41 109.48 21.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.43 178.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.738 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -116.59 143.13 27.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.052 -178.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -95.62 118.72 32.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.056 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.456 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 29.6 p90 -111.37 156.07 22.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.001 0.429 . . . . 0.0 111.461 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -133.35 97.47 3.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.316 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.417 HG13 ' CD1' ' A' ' 113' ' ' PHE . 11.7 m -74.88 139.1 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.332 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -137.67 47.6 2.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.959 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -135.61 47.54 2.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.0 p . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.868 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.2 t -82.7 103.92 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.982 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.953 HG22 HG13 ' A' ' 115' ' ' VAL . 0.3 OUTLIER 46.76 -170.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.358 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.695 ' N ' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER 72.65 42.42 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.047 0.451 . . . . 0.0 110.865 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 1.9 m 79.08 139.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.388 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -178.1 176.94 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.678 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.81 130.82 55.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.651 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 t -122.61 135.3 54.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.019 0.437 . . . . 0.0 111.487 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -99.22 99.07 9.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.449 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.648 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -103.49 115.33 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.303 -178.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 28' ' ' VAL . 10.2 p -83.3 122.01 36.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.118 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.92 160.82 15.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.424 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 105' ' ' SER . 19.8 m -123.06 153.36 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.859 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.742 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -93.86 141.11 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.47 144.65 29.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.49 -0.26 10.45 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.705 2.27 . . . . 0.0 112.819 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.15 -52.59 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.728 0.299 . . . . 0.0 111.168 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -119.71 -57.19 1.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.35 -110.33 0.62 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.56 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.742 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 55.2 m-85 -112.3 -32.4 6.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.739 0.304 . . . . 0.0 110.758 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 70.61 8.49 63.34 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.518 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.902 HD11 ' CG2' ' A' ' 57' ' ' ILE . 6.1 tp -97.12 130.43 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.997 0.398 . . . . 0.0 110.781 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.93 147.0 47.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.089 0.471 . . . . 0.0 111.406 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 4.8 mt -118.51 163.2 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.638 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.16 172.06 3.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.988 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.713 ' C ' HD13 ' A' ' 51' ' ' LEU . . . 77.2 82.07 0.58 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.743 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.609 ' H ' ' HB3' ' A' ' 47' ' ' ALA . 2.6 p -132.06 -175.06 3.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.672 0.273 . . . . 0.0 110.659 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 46' ' ' PHE . 3.7 p -53.38 -43.79 52.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.358 0.599 . . . . 0.0 111.078 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.454 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 10.8 t80 -114.15 71.69 0.76 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.872 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.609 ' HB3' ' H ' ' A' ' 44' ' ' SER . . . -163.42 168.65 20.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.165 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 p 51.39 -138.33 1.08 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.64 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.85 -34.5 10.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.823 0.344 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.59 150.36 5.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.713 HD13 ' C ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -176.5 146.96 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.5 22.45 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.213 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.5 m -135.37 153.11 77.72 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.12 169.48 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.537 2.158 . . . . 0.0 112.131 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 40.3 Cg_endo -66.94 150.32 82.95 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.552 2.168 . . . . 0.0 112.098 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.52 163.45 32.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.0 111.177 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.902 ' CG2' HD11 ' A' ' 39' ' ' ILE . 5.0 mt -76.07 141.54 15.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.578 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.876 ' HA ' HG23 ' A' ' 74' ' ' ILE . 3.0 m -168.28 41.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.688 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -177.24 125.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.029 0.442 . . . . 0.0 111.529 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.581 HD12 ' OE1' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -137.33 152.6 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.095 179.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.43 155.36 21.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.067 0.461 . . . . 0.0 111.442 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -88.03 41.06 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.722 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 168.52 31.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.854 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.401 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 49.3 m -119.3 143.91 35.29 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-O 120.716 0.293 . . . . 0.0 110.911 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.56 -28.39 8.93 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.916 2.41 . . . . 0.0 112.738 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -66.0 -46.51 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 110.956 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' OE1' HD12 ' A' ' 60' ' ' ILE . 9.5 tp10 -78.15 -39.81 39.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.829 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.06 -19.36 64.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.364 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -41.08 68.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 110.879 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.24 -12.35 64.83 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.827 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 m -98.79 -32.41 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 111.184 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.83 HD13 HD13 ' A' ' 39' ' ' ILE . 11.0 mt -74.91 128.46 35.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.866 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -141.06 148.5 40.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 58' ' ' SER . 34.9 mt -64.05 114.51 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.07 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.21 -27.07 2.29 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.47 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.495 ' HB2' HD12 ' A' ' 57' ' ' ILE . 10.2 m-20 -63.39 138.01 58.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.709 0.29 . . . . 0.0 110.837 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.434 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 51.9 mtt180 -109.24 100.95 10.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.406 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.633 ' CA ' HG22 ' A' ' 111' ' ' ILE . 29.5 m -64.55 122.69 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.4 ptm -151.37 30.35 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.1 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . -178.35 52.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.025 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.429 HD11 ' HB ' ' A' ' 78' ' ' VAL . 29.4 mt -82.36 128.76 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.058 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 43.67 31.52 0.46 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.235 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.77 -43.85 1.67 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.463 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.456 HG22 ' H ' ' A' ' 86' ' ' THR . 10.6 mm -71.28 113.27 17.95 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.471 0.176 . . . . 0.0 111.316 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -88.36 25.26 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.74 2.293 . . . . 0.0 112.796 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.456 ' H ' HG22 ' A' ' 84' ' ' ILE . 18.0 p 54.49 78.93 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.92 0.391 . . . . 0.0 111.043 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.88 -26.51 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.534 ' HB3' HG22 ' A' ' 90' ' ' THR . 4.4 t0 -56.62 -22.61 35.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.27 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.17 42.6 1.72 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 88' ' ' ASP . 13.1 t -151.23 137.83 18.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.722 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.426 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 32.0 p90 -58.48 -28.21 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.136 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.89 -31.08 68.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -65.79 -52.32 51.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.644 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.929 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.72 -33.22 72.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.985 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -64.27 -48.33 76.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.826 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -33.89 75.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.647 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.929 HD12 ' HA ' ' A' ' 94' ' ' ALA . 17.2 mt -64.02 -41.41 97.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.461 HD13 ' CG2' ' A' ' 39' ' ' ILE . 62.6 mt -67.71 -40.19 84.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.757 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -65.26 -30.12 70.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.49 -7.34 51.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.37 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 m -71.87 -16.01 62.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.175 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -58.56 -27.01 64.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.045 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.9 mm -52.9 -41.11 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 111.309 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.8 t -120.01 -2.07 10.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.293 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.702 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 1.3 m 62.6 26.32 15.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.05 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HE2' HG21 ' A' ' 28' ' ' VAL . 2.1 mmtp -156.19 144.83 20.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.844 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.502 HG13 HD21 ' A' ' 109' ' ' LEU . 10.2 p -153.97 156.9 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.02 0.438 . . . . 0.0 111.888 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -122.07 125.44 46.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.934 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.502 HD21 HG13 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -119.21 136.64 54.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.098 0.475 . . . . 0.0 111.928 -178.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.743 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -111.89 106.71 15.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.334 178.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -107.49 157.84 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.139 0.495 . . . . 0.0 112.322 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.91 119.56 35.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.482 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 22' ' ' THR . 4.8 p90 -133.98 165.15 25.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -124.56 135.16 52.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.377 178.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.953 HG13 HG22 ' A' ' 20' ' ' VAL . 3.1 p -147.26 147.37 17.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.019 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.77 78.58 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.067 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -122.72 58.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.975 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.914 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.81 0.338 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.78 120.82 44.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.787 HG22 ' HB ' ' A' ' 115' ' ' VAL . 12.5 p 37.66 96.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.13 0.49 . . . . 0.0 112.14 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.405 ' O ' ' CB ' ' A' ' 22' ' ' THR . 1.8 t-160 -126.0 56.73 1.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 113' ' ' PHE . 3.0 m 80.61 116.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.799 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 1.9 mm-40 -151.62 177.36 10.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.114 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.0 p -107.39 129.51 54.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.134 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.536 HG23 ' CD1' ' A' ' 111' ' ' ILE . 1.9 t -114.59 137.32 52.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.122 0.487 . . . . 0.0 111.83 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.15 99.32 10.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.152 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -102.7 107.71 22.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.281 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 28' ' ' VAL . 13.7 p -88.67 113.84 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.036 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.403 ' HB2' ' CG1' ' A' ' 107' ' ' VAL . 54.5 mt -102.91 164.97 11.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.955 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 105' ' ' SER . 76.2 m -128.68 141.15 51.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.822 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.715 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -83.09 119.71 24.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.231 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.66 140.41 31.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.98 59.74 3.63 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.615 2.21 . . . . 0.0 112.502 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.6 t -154.88 -59.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -122.31 -42.73 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.823 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.57 -119.4 3.03 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.559 ' CE1' HG12 ' A' ' 107' ' ' VAL . 38.0 m-85 -103.64 -26.93 12.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.86 39.72 92.01 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.649 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.865 HD11 HG21 ' A' ' 57' ' ' ILE . 3.2 tt -136.5 127.1 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.953 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 127.83 56.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.91 HD22 HG12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -105.75 103.15 12.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.711 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.446 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 13.5 pt20 -61.83 156.84 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.878 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.58 ' O ' HD11 ' A' ' 51' ' ' LEU . . . -94.66 30.53 7.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.544 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 t -141.11 165.47 27.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.657 HG23 ' CB ' ' A' ' 52' ' ' SER . 66.6 t -96.68 -2.99 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.386 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.41 ' CG ' ' O ' ' A' ' 45' ' ' VAL . 42.2 m-85 -159.47 -40.22 0.06 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.173 0.511 . . . . 0.0 111.038 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.77 44.25 8.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.269 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 46' ' ' PHE . 41.0 p -94.66 -13.84 25.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.19 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.69 -81.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.379 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 t -73.37 -170.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.516 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.58 HD11 ' O ' ' A' ' 43' ' ' GLY . 19.3 tp -115.74 149.07 39.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.998 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.657 ' CB ' HG23 ' A' ' 45' ' ' VAL . 15.5 m -94.92 -165.65 1.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.637 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.475 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -102.5 -65.74 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.368 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.475 ' HD3' ' CB ' ' A' ' 53' ' ' SER . 84.6 Cg_endo -80.79 150.26 18.52 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.332 2.021 . . . . 0.0 112.593 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.755 ' O ' HD12 ' A' ' 56' ' ' LEU . 64.5 Cg_endo -73.36 164.53 34.93 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.443 2.095 . . . . 0.0 112.133 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 55' ' ' PRO . 5.8 mp -150.71 142.77 24.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.115 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.91 HG12 HD22 ' A' ' 41' ' ' LEU . 40.6 mt -80.91 122.5 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.744 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.62 51.63 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -178.16 126.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.002 0.43 . . . . 0.0 111.365 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.464 HG21 ' HA ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -142.77 152.09 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.1 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -102.05 155.53 18.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.019 0.438 . . . . 0.0 111.507 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.73 43.09 0.95 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.781 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 p30 178.32 28.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.861 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.402 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -128.81 137.02 30.07 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.277 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.46 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -43.76 -33.84 5.26 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.876 2.384 . . . . 0.0 112.649 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.466 ' HB1' HD12 ' A' ' 39' ' ' ILE . . . -57.86 -42.78 85.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.843 0.354 . . . . 0.0 111.15 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' HA ' HG21 ' A' ' 60' ' ' ILE . 17.1 tp10 -78.35 -50.23 12.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.216 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.32 -8.44 53.71 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.1 t -53.0 -33.63 52.5 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.824 0.345 . . . . 0.0 110.775 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.64 31.47 76.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.07 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.14 -65.78 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.098 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -71.73 150.28 44.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.147 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.4 -177.92 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 74' ' ' ILE . 19.8 tt -84.51 56.59 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 111.269 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.29 39.83 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.474 ' HB3' HG21 ' A' ' 111' ' ' ILE . 67.3 m-20 -82.7 147.27 28.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.618 0.247 . . . . 0.0 110.74 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -94.86 76.24 3.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.709 0.29 . . . . 0.0 111.503 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.591 ' HA ' HG22 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -58.28 128.36 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.709 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.416 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -158.35 29.38 0.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.097 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.863 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 178.34 66.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 0.0 111.065 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.409 HG22 ' OD1' ' A' ' 82' ' ' ASN . 9.1 mt -96.91 119.82 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.98 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.409 ' OD1' HG22 ' A' ' 81' ' ' ILE . 1.4 p-10 44.05 30.61 0.44 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.407 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.88 -48.62 0.92 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.543 ' HB ' HD13 ' A' ' 97' ' ' LEU . 8.8 mm -69.78 111.76 10.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.602 0.239 . . . . 0.0 111.113 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.21 -9.61 11.53 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.536 2.157 . . . . 0.0 112.844 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.0 p 56.35 95.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.891 0.377 . . . . 0.0 110.917 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.17 32.32 5.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.438 ' HB3' HG22 ' A' ' 90' ' ' THR . 4.9 t0 -145.33 176.24 9.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.96 63.89 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.003 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.636 HG23 ' HB2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -121.36 113.59 20.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.703 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -60.69 -45.67 93.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.341 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -54.95 -34.27 63.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.277 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.636 ' HB2' HG23 ' A' ' 90' ' ' THR . 0.6 OUTLIER -60.04 -52.76 63.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.88 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.818 ' HB1' HD12 ' A' ' 41' ' ' LEU . . . -57.51 -53.87 53.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.179 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.494 ' HA ' HD23 ' A' ' 98' ' ' LEU . 7.4 m-80 -56.93 -34.8 68.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.88 -46.92 85.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.171 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.543 HD13 ' HB ' ' A' ' 84' ' ' ILE . 7.1 mt -60.38 -43.45 96.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.141 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -76.87 -32.59 57.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.459 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -78.99 -29.13 43.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.751 0.31 . . . . 0.0 111.178 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -66.34 -15.56 63.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.503 ' CB ' ' HB ' ' A' ' 107' ' ' VAL . 3.8 m -83.39 -15.39 49.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.321 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.2 t -58.36 -29.51 66.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.9 mm -54.07 -38.24 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.346 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.3 t -118.02 -3.91 11.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.199 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.784 ' O ' HG23 ' A' ' 30' ' ' THR . 1.1 m 65.81 42.16 3.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.109 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HD2' ' CG2' ' A' ' 28' ' ' VAL . 3.1 tppt? -156.04 128.93 7.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 111.342 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.559 HG12 ' CE1' ' A' ' 37' ' ' PHE . 14.7 p -137.48 145.42 29.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.135 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.523 HG23 HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -120.82 105.6 10.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.314 179.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -104.21 124.81 49.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.018 0.437 . . . . 0.0 111.685 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 18.1 tt0 -107.11 105.65 15.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.584 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -110.26 165.13 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.301 0.572 . . . . 0.0 112.27 -178.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -113.23 121.65 45.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.694 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 22' ' ' THR . 18.4 p90 -118.5 163.59 16.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.881 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.21 139.75 53.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.641 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.787 ' HB ' HG22 ' A' ' 20' ' ' VAL . 7.5 t -148.48 159.72 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.257 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.448 ' N ' HG12 ' A' ' 115' ' ' VAL . . . 179.99 48.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.005 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -160.65 47.65 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.933 179.904 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.757 0.313 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -95.37 125.26 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG13 HG23 ' A' ' 115' ' ' VAL . 5.7 t 56.34 105.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.283 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.67 ' O ' HG22 ' A' ' 22' ' ' THR . 0.5 OUTLIER -176.24 34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.233 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 21' ' ' HIS . 6.6 t 52.17 138.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.62 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -177.99 168.09 2.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.2 p -87.75 143.43 27.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.446 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.654 HG23 HG13 ' A' ' 111' ' ' ILE . 2.9 t -129.47 156.4 44.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.141 0.496 . . . . 0.0 111.355 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.57 98.71 7.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.457 ' CG1' HG11 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -100.82 103.14 14.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.477 -178.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 108' ' ' THR . 4.2 t -82.78 115.04 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.592 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.654 HD11 ' CD1' ' A' ' 72' ' ' LEU . 14.4 mt -111.59 127.3 55.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.032 0.444 . . . . 0.0 110.918 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 105' ' ' SER . 3.0 m -99.05 144.45 28.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.775 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HB2' ' HE1' ' A' ' 37' ' ' PHE . . . -74.23 124.94 27.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.949 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.42 136.81 52.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.67 -3.65 14.2 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.584 2.189 . . . . 0.0 112.609 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.42 -49.47 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.227 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.5 p -118.99 -57.07 2.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.9 -108.38 0.63 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.519 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.646 ' HB3' HG22 ' A' ' 39' ' ' ILE . 26.0 m-85 -114.66 -32.46 5.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.704 0.288 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.72 40.32 70.71 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.785 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.652 HD11 ' CG2' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -142.42 140.85 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.343 . . . . 0.0 110.92 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.427 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -123.29 145.14 48.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.222 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.714 HD23 HD11 ' A' ' 98' ' ' LEU . 1.1 mm? -104.41 105.37 15.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.738 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -69.08 132.16 46.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.21 28.07 15.67 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.319 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.686 ' OG ' HD13 ' A' ' 51' ' ' LEU . 11.9 t -171.32 142.99 1.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.376 . . . . 0.0 110.93 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 53' ' ' SER . 0.0 OUTLIER -81.43 118.47 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 0.3 OUTLIER 69.9 -168.04 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.666 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' O ' HG22 ' A' ' 48' ' ' THR . . . -135.82 128.24 30.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.28 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 47' ' ' ALA . 13.3 t 44.57 43.88 6.82 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.518 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.426 ' HG3' ' CD2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -128.58 -65.3 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.58 97.53 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.686 HD13 ' OG ' ' A' ' 44' ' ' SER . 4.3 tp -88.86 116.46 27.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.915 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.563 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -157.64 21.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.4 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.484 ' HB3' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -127.33 144.88 52.31 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.911 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.33 172.41 11.24 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.508 2.138 . . . . 0.0 112.179 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.14 124.2 14.29 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.482 2.121 . . . . 0.0 112.038 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.58 146.66 44.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.156 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.72 HD12 HG21 ' A' ' 111' ' ' ILE . 47.1 mt -60.64 133.61 26.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.28 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' HG13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -159.72 40.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 111.464 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CG ' ' HB2' ' A' ' 40' ' ' GLN . 34.2 t80 -167.08 131.12 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 111.198 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.79 152.33 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.03 155.33 17.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.989 0.423 . . . . 0.0 111.16 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.83 44.4 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.961 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER 168.39 32.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.666 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.78 146.45 55.2 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.926 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -43.82 -35.93 7.36 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.801 2.334 . . . . 0.0 112.867 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB1' HD13 ' A' ' 39' ' ' ILE . . . -59.17 -39.47 82.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 111.023 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.69 -50.34 13.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.722 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -72.31 -8.36 54.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.557 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.445 ' SG ' HD21 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -51.72 -26.22 8.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.719 0.295 . . . . 0.0 111.254 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.05 45.21 96.03 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.438 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 72' ' ' LEU . 8.1 p -173.1 -44.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.974 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.654 ' CD1' HD11 ' A' ' 29' ' ' LEU . 11.7 mt -60.91 164.69 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -154.8 171.8 19.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 0.0 111.203 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 74' ' ' ILE . 2.7 tt -84.85 56.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.136 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.24 59.1 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.765 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -101.24 125.06 47.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.759 0.314 . . . . 0.0 110.755 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -69.34 71.98 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.249 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.924 HG22 HG22 ' A' ' 111' ' ' ILE . 3.0 t -63.37 146.64 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -161.18 27.4 0.14 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.392 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 173.34 79.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.786 0.327 . . . . 0.0 111.203 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.814 HD11 HG11 ' A' ' 78' ' ' VAL . 38.1 mt -100.52 126.73 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.045 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.2 30.1 0.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 102.14 -41.8 2.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.678 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 mm -75.53 109.86 8.98 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.569 0.223 . . . . 0.0 111.352 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 96.8 Cg_endo -94.22 70.91 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.051 2.501 . . . . 0.0 112.264 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.7 t -53.19 93.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.015 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -123.25 66.9 0.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.894 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -161.0 29.18 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.998 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.0 t 56.44 88.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.035 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -154.44 106.98 2.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.063 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -70.46 -48.12 57.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.311 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -61.41 -41.35 97.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.763 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -59.8 -48.89 79.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.258 -179.452 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.69 -52.41 65.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.029 0.442 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -55.85 -35.93 66.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.235 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -62.67 -39.59 94.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.29 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.477 HD12 HD12 ' A' ' 81' ' ' ILE . 12.6 mt -60.22 -43.09 96.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.096 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.714 HD11 HD23 ' A' ' 41' ' ' LEU . 41.6 mt -76.57 -30.58 57.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.865 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -35.8 81.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.323 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -72.33 -9.41 58.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.556 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 4.9 m -69.6 -24.65 63.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 0.0 110.802 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.9 p -63.2 -55.33 25.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.662 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.7 mm -55.19 -40.65 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.32 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.3 m -80.41 -21.96 41.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 30' ' ' THR . 1.9 t 77.58 -6.74 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.838 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -156.74 149.85 24.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.602 0.239 . . . . 0.0 110.82 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 29' ' ' LEU . 14.4 p -150.08 141.87 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 1.019 HG22 HG22 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -112.96 113.35 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.988 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.547 ' HB3' HG23 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -106.2 142.97 35.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 112.065 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.864 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 14.5 tt0 -104.73 105.92 16.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.537 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.924 HG22 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -116.92 150.51 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.401 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -112.1 120.84 43.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.138 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -116.6 164.03 15.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.959 0.409 . . . . 0.0 111.365 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -134.96 107.63 7.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.367 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.433 HG23 HG13 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -101.7 152.41 5.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.241 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.02 45.29 1.46 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.016 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.19 47.11 2.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.875 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.19 141.74 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.093 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.988 HG13 HG23 ' A' ' 115' ' ' VAL . 5.1 p -71.29 157.63 6.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.497 ' CA ' ' HB ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER -154.61 52.05 0.64 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.768 0.318 . . . . 0.0 111.18 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER 67.93 108.43 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.185 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -170.45 171.85 6.32 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.524 -177.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 74.2 p -99.2 132.52 44.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -109.53 135.39 50.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.224 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 99.07 9.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.631 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.549 ' CG2' HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -105.97 122.84 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.034 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.027 HG22 HG22 ' A' ' 108' ' ' THR . 3.7 t -90.46 120.8 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.252 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.7 HD21 ' HA ' ' A' ' 66' ' ' ALA . 10.9 mp -112.47 143.82 42.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.612 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.773 HG23 ' O ' ' A' ' 105' ' ' SER . 82.3 m -105.25 144.06 32.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -87.19 89.54 8.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.92 138.74 97.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.12 56.5 5.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.581 2.187 . . . . 0.0 112.447 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.9 t -155.33 -66.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 t -111.36 -29.8 7.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.63 -130.03 10.11 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.481 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.675 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 74.5 m-85 -99.53 -23.55 15.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.712 0.291 . . . . 0.0 111.023 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.58 34.88 56.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.903 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.779 HD11 ' CG2' ' A' ' 57' ' ' ILE . 2.1 tt -132.65 143.83 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.79 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.42 148.93 48.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.571 HD13 ' HA ' ' A' ' 57' ' ' ILE . 3.2 mm? -104.07 157.68 16.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.837 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.2 159.89 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.808 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.06 37.54 6.28 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.488 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.5 p -79.59 -177.12 5.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.802 0.334 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 45' ' ' VAL . 30.0 t -72.85 -8.43 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.784 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.429 ' CB ' HG22 ' A' ' 90' ' ' THR . 0.1 OUTLIER -135.52 52.41 2.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.06 0.457 . . . . 0.0 110.88 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.36 156.64 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -59.96 -18.67 47.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.465 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.53 24.53 12.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.095 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.7 m 62.15 146.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.178 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -171.0 -178.67 2.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.954 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.71 24.05 0.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 0.0 111.314 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.453 ' C ' HG22 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -141.75 160.7 55.17 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.117 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 36.3 Cg_exo -57.23 174.92 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.73 2.286 . . . . 0.0 112.038 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 54' ' ' PRO . 55.8 Cg_endo -70.38 151.4 65.5 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.474 2.116 . . . . 0.0 112.34 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 56' ' ' LEU . 2.6 mp -133.49 136.99 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.965 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.779 ' CG2' HD11 ' A' ' 39' ' ' ILE . 33.2 mt -61.7 118.77 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.166 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.877 ' HA ' HG23 ' A' ' 74' ' ' ILE . 94.2 p -139.68 46.65 1.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 111.745 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -174.23 129.13 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.132 0.491 . . . . 0.0 111.493 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -147.53 151.96 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.002 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.58 155.55 17.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.123 0.487 . . . . 0.0 111.483 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.4 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -88.5 42.03 1.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.86 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 168.15 33.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.757 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.55 150.08 60.27 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.037 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.01 -31.87 29.09 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.912 2.408 . . . . 0.0 112.51 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.7 ' HA ' HD21 ' A' ' 29' ' ' LEU . . . -59.63 -48.59 81.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.028 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -78.11 -39.64 40.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.4 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -72.54 -8.76 56.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.56 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.526 ' SG ' HD11 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -52.91 -24.85 10.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.704 0.288 . . . . 0.0 110.996 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.84 73.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.305 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.646 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.6 p -170.57 33.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.953 0.406 . . . . 0.0 110.972 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.68 153.01 50.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -168.97 161.9 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.877 HG23 ' HA ' ' A' ' 58' ' ' SER . 62.5 mt -71.13 117.25 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.081 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.01 -21.96 4.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.666 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.553 ' HB2' HD12 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -52.79 136.57 33.53 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.688 0.28 . . . . 0.0 110.768 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -96.86 82.2 3.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.055 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.075 HG21 HD11 ' A' ' 81' ' ' ILE . 7.2 p -68.78 159.02 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.052 0.453 . . . . 0.0 111.323 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.663 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -152.0 -81.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.134 179.485 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.409 ' HB3' ' CD ' ' A' ' 110' ' ' GLU . . . -75.82 100.16 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 0.0 111.809 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.075 HD11 HG21 ' A' ' 78' ' ' VAL . 17.0 mt -119.38 125.88 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.357 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.576 ' HB3' HG23 ' A' ' 107' ' ' VAL . 6.9 p30 51.9 24.31 2.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.308 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.442 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 104.32 -39.0 2.98 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.753 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mm -84.18 108.86 15.7 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.42 0.156 . . . . 0.0 111.42 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 79' ' ' MET . 98.4 Cg_endo -94.03 123.77 0.44 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.779 2.319 . . . . 0.0 112.508 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 p -89.35 106.01 18.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.763 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -134.4 37.97 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -177.11 -40.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.74 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -67.18 -177.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.429 HG22 ' CB ' ' A' ' 46' ' ' PHE . 32.9 p -92.25 174.66 7.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -60.41 -25.43 65.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -55.97 -39.46 71.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 7.0 mm-40 -59.94 -46.02 90.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.604 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.536 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -57.67 -44.67 85.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.807 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -56.77 -40.72 76.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.102 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -62.95 -35.95 81.83 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.267 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' A' ' 81' ' ' ILE . 24.3 mt -60.86 -48.1 83.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.782 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 81' ' ' ILE . 12.9 mt -74.64 -24.95 58.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -35.7 66.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.185 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -77.57 -4.48 46.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.5 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.463 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 14.8 m -62.72 -26.75 68.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.758 0.313 . . . . 0.0 111.022 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 t -58.75 -30.35 67.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.997 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.1 mm -53.09 -56.45 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.943 0.402 . . . . 0.0 111.44 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.8 t -94.99 -1.42 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.144 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.773 ' O ' HG23 ' A' ' 30' ' ' THR . 0.5 OUTLIER 68.36 10.76 8.05 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.442 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.624 ' HD3' HG11 ' A' ' 28' ' ' VAL . 21.5 ttmt -156.64 154.95 30.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.861 0.363 . . . . 0.0 111.008 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 82' ' ' ASN . 9.8 p -152.89 145.95 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.598 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 1.027 HG22 HG22 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -107.65 112.92 25.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.3 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.655 HD11 HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -99.31 131.54 45.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.5 -179.373 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.409 ' CD ' ' HB3' ' A' ' 80' ' ' ALA . 25.6 mt-10 -114.93 104.53 12.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.888 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.637 HG22 ' CA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -114.67 154.79 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 120.951 0.405 . . . . 0.0 112.007 -178.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -108.21 129.24 55.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.864 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 20' ' ' VAL . 5.5 p90 -137.21 164.11 29.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.576 ' HA ' HG23 ' A' ' 22' ' ' THR . 1.7 t70 -96.16 132.61 41.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.806 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.988 HG23 HG13 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -44.49 134.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.68 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.42 132.67 33.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.924 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -55.42 112.15 1.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.064 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.935 179.984 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.615 0.245 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.1 p 31.75 46.59 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.36 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 21' ' ' HIS . 12.6 p -125.87 159.91 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.481 ' N ' HG22 ' A' ' 20' ' ' VAL . 2.3 t60 -157.6 46.5 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.07 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.808 HG23 ' HA ' ' A' ' 114' ' ' ASP . 2.0 m 77.29 124.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.518 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -175.65 167.55 3.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.062 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.17 140.77 29.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.554 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.495 HG23 HG12 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -119.96 147.5 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.048 0.451 . . . . 0.0 111.403 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -110.35 98.03 7.36 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.457 HG23 HD11 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -101.63 107.09 20.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.141 -178.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.93 HG22 HG22 ' A' ' 108' ' ' THR . 7.9 t -82.63 120.61 34.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.195 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.0 mt -112.47 164.19 13.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 105' ' ' SER . 28.0 m -124.66 133.26 53.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.795 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -80.1 92.09 5.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -73.02 146.69 87.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.12 49.04 2.9 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.934 2.422 . . . . 0.0 112.569 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -153.35 -59.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.814 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 p -114.49 -16.71 11.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.085 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.6 -121.73 5.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.324 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.795 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 95.0 m-85 -109.08 -26.82 9.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.659 0.266 . . . . 0.0 110.788 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.94 48.26 30.98 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.944 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.695 HD11 HG21 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -132.59 125.17 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.806 0.336 . . . . 0.0 111.069 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.41 122.84 47.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.721 HD11 ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -111.06 100.88 9.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.811 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -62.41 152.76 33.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.819 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.76 40.06 2.65 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.501 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -178.11 179.06 0.86 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.975 0.417 . . . . 0.0 111.203 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.552 HG13 ' N ' ' A' ' 46' ' ' PHE . 11.9 p -69.08 -48.97 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.42 0.628 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.552 ' N ' HG13 ' A' ' 45' ' ' VAL . 2.1 p90 -161.31 154.22 20.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.813 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.685 ' O ' HG23 ' A' ' 48' ' ' THR . . . -103.59 109.28 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.213 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER 175.66 81.07 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.729 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 50' ' ' THR . 5.8 mt-10 60.35 39.37 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.98 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER 179.7 146.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.433 ' C ' HD23 ' A' ' 51' ' ' LEU . 3.0 tt -177.0 107.7 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.06 24.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.435 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.1 m -110.97 154.75 43.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.79 172.54 3.67 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.635 2.223 . . . . 0.0 112.294 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.945 ' HB2' HG23 ' A' ' 78' ' ' VAL . 71.0 Cg_exo -49.01 154.91 2.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.637 2.225 . . . . 0.0 112.462 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.591 HD11 ' NE ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -164.86 130.59 2.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.096 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.695 HG21 HD11 ' A' ' 39' ' ' ILE . 40.6 mt -81.59 139.74 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.676 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 m -160.28 37.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.819 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -173.95 140.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.953 0.406 . . . . 0.0 111.682 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -149.49 152.76 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.229 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.03 155.78 23.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.082 0.467 . . . . 0.0 111.428 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -87.98 40.37 0.94 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.789 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.55 31.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.26 144.18 37.43 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.824 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -46.29 -29.36 6.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.937 2.424 . . . . 0.0 112.573 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -61.8 -48.24 81.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.03 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 8.6 tp10 -78.63 -33.44 47.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.077 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -80.04 -8.84 59.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.002 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.0 p -55.97 -29.86 60.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.06 46.2 93.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.44 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 t -144.58 -67.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 111.286 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -75.71 165.0 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.13 -170.27 2.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.695 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.5 mm -82.47 79.28 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.065 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.83 61.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.677 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.455 ' HB2' HD12 ' A' ' 57' ' ' ILE . 67.0 m-20 -112.24 152.22 28.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.714 0.292 . . . . 0.0 110.71 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.591 ' NE ' HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -103.52 83.62 2.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.893 0.378 . . . . 0.0 111.664 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.945 HG23 ' HB2' ' A' ' 55' ' ' PRO . 1.6 m -62.45 126.91 21.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.68 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -160.33 30.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.205 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 178.29 52.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 111.079 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.477 ' HB ' HD12 ' A' ' 97' ' ' LEU . 3.1 mt -79.01 126.5 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.025 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.41 ' OD1' HG22 ' A' ' 81' ' ' ILE . 1.1 p-10 43.41 31.73 0.44 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.481 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.5 -45.5 1.32 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.541 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.775 ' HB ' HD13 ' A' ' 97' ' ' LEU . 8.4 mm -71.25 112.89 15.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.605 0.241 . . . . 0.0 111.267 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -89.12 22.48 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.752 2.302 . . . . 0.0 112.837 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.509 ' H ' HG22 ' A' ' 84' ' ' ILE . 8.3 p 56.23 100.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.895 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -117.66 -49.66 2.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.97 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -67.19 -76.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.402 ' CB ' ' CG ' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -101.31 -170.41 1.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.81 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.485 HG22 ' HG3' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -126.82 -71.37 0.68 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.087 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -70.32 -48.3 57.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.996 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.402 ' CG ' ' CB ' ' A' ' 89' ' ' SER . 13.8 pt-20 -72.14 -35.17 69.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.9 tp10 -67.96 -50.64 54.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.66 -51.31 70.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.967 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.421 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 25.3 m-20 -58.36 -35.24 71.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.492 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -37.98 88.8 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.666 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.775 HD13 ' HB ' ' A' ' 84' ' ' ILE . 1.3 mt -65.81 -48.02 73.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.493 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.721 ' CD2' HD11 ' A' ' 41' ' ' LEU . 1.5 pp -75.84 -24.15 55.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.27 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -71.14 -36.32 72.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -7.55 54.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.393 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.462 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.0 m -67.38 -18.69 65.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.723 0.297 . . . . 0.0 111.112 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.5 m -58.69 -33.11 69.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.13 -61.43 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.184 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 106' ' ' LYS . 5.1 t -85.63 -6.75 59.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.093 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.69 ' O ' HG23 ' A' ' 30' ' ' THR . 33.2 t 62.93 25.19 14.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.301 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HE2' HG11 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -156.47 150.51 25.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.945 0.402 . . . . 0.0 111.449 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.605 HG12 ' CE1' ' A' ' 37' ' ' PHE . 13.0 p -153.38 157.43 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.47 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.93 HG22 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -120.57 107.33 12.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.558 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.416 HD13 HG12 ' A' ' 81' ' ' ILE . 4.0 mm? -83.2 127.38 33.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.714 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 21.9 tt0 -118.01 104.68 11.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.756 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.757 HG22 ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -125.89 165.29 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.112 0.482 . . . . 0.0 112.119 -178.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -121.63 128.19 51.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.745 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 10.6 p90 -127.42 150.06 49.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.917 0.389 . . . . 0.0 111.09 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.808 ' HA ' HG23 ' A' ' 22' ' ' THR . 0.7 OUTLIER -105.47 141.36 37.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.699 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -163.71 179.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.109 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -173.93 44.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.88 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -107.1 41.59 1.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.728 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.94 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.816 0.341 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.816 HG23 ' OG ' ' A' ' 118' ' ' SER . 12.1 p -66.57 127.5 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 21' ' ' HIS . 38.1 t 58.81 156.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.132 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.473 ' O ' ' HB ' ' A' ' 22' ' ' THR . 6.1 m-70 -150.08 157.4 43.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 21' ' ' HIS . 14.4 t 177.56 144.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.355 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' CG ' ' CZ ' ' A' ' 113' ' ' PHE . 17.5 pt-20 -177.97 171.66 1.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.066 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.5 p -87.84 148.22 24.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.636 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.816 HG23 HG13 ' A' ' 111' ' ' ILE . 0.8 OUTLIER -129.7 159.69 35.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 111.101 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -113.33 99.37 7.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.13 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.499 HG21 HD11 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -105.07 102.61 14.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.494 -178.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 108' ' ' THR . 16.2 t -83.68 115.61 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.937 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.584 HD12 ' CD1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -107.56 128.97 55.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 111.005 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 105' ' ' SER . 67.8 m -110.63 134.01 52.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.99 153.63 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.059 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -130.65 137.46 30.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.83 60.14 5.23 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.584 2.189 . . . . 0.0 112.302 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.75 -65.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -131.4 17.9 4.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.3 -116.41 5.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.563 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.733 ' HB3' HG22 ' A' ' 39' ' ' ILE . 49.6 m-85 -113.36 -30.48 6.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.861 0.362 . . . . 0.0 111.257 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.71 23.9 63.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.687 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 37' ' ' PHE . 3.6 tt -124.69 139.75 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.725 0.298 . . . . 0.0 110.877 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -135.18 149.5 49.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.049 0.452 . . . . 0.0 111.297 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.637 HD23 HG13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -114.89 168.94 9.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.376 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.27 155.5 9.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.082 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 55' ' ' PRO . . . -98.93 97.58 1.87 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.326 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.4 ' HA ' HD13 ' A' ' 51' ' ' LEU . 1.7 m -164.76 93.18 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 111.09 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 45' ' ' VAL . 19.2 t -105.85 -5.02 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.375 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.35 34.34 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.597 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 48' ' ' THR . . . -53.2 121.11 6.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.447 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER 173.35 -32.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.966 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -40.52 0.47 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 t -167.25 164.18 15.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.91 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 43' ' ' GLY . 54.6 tp -101.36 140.92 35.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.144 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.85 25.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.307 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.1 m -127.61 156.51 75.31 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.084 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.32 176.1 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.645 2.23 . . . . 0.0 112.259 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.44 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 71.8 Cg_endo -77.28 171.23 18.11 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.619 2.212 . . . . 0.0 112.421 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -176.42 156.68 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.673 HD12 ' HB2' ' A' ' 76' ' ' ASP . 10.0 mt -68.75 147.71 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.888 ' HA ' HG23 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -171.8 47.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 111.573 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -176.76 134.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 111.583 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -151.94 152.0 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.934 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.03 155.0 17.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 111.289 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -86.8 39.6 0.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.869 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 28.1 t0 174.06 31.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.607 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.9 m -122.54 144.26 41.82 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.055 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -42.34 -36.53 4.41 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.958 2.439 . . . . 0.0 112.947 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.62 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -57.88 -40.1 79.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.841 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -78.13 -51.88 9.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.766 179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -12.75 61.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.482 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.577 ' HB3' HG22 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -56.28 -30.28 62.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 0.0 110.838 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.69 24.94 57.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.571 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.577 HG22 ' HB3' ' A' ' 69' ' ' CYS . 29.2 m -136.58 10.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.585 0.231 . . . . 0.0 111.603 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.62 HD11 ' O ' ' A' ' 66' ' ' ALA . 4.2 pp -147.56 158.67 44.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.874 0.369 . . . . 0.0 111.023 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -154.45 150.45 27.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.619 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.888 HG23 ' HA ' ' A' ' 58' ' ' SER . 21.2 mt -57.17 107.46 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.72 40.14 0.19 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.595 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.673 ' HB2' HD12 ' A' ' 57' ' ' ILE . 59.2 m-20 -114.83 127.72 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 110.575 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -88.18 89.97 8.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.064 HG11 HD11 ' A' ' 81' ' ' ILE . 13.3 t -69.02 139.64 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.627 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 1.8 ttp -164.42 31.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.61 0.243 . . . . 0.0 111.452 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.882 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . . . 178.21 69.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.005 0.431 . . . . 0.0 111.319 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.064 HD11 HG11 ' A' ' 78' ' ' VAL . 37.8 mt -98.78 118.19 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.957 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.426 ' OD1' HG22 ' A' ' 81' ' ' ILE . 4.7 p-10 44.55 31.64 0.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.303 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.54 -47.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.453 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.589 HG22 ' H ' ' A' ' 86' ' ' THR . 7.8 mm -72.39 121.12 83.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.59 0.233 . . . . 0.0 111.13 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -85.14 19.8 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.688 2.259 . . . . 0.0 112.952 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.589 ' H ' HG22 ' A' ' 84' ' ' ILE . 4.9 p 57.61 23.62 9.52 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.22 -167.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.048 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.3 124.16 51.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.37 36.15 17.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 62.3 m -139.44 78.0 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.411 ' CA ' ' HB3' ' A' ' 55' ' ' PRO . 51.1 p90 -61.96 -24.64 67.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.047 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -55.28 -34.83 64.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.55 -45.68 74.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.858 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -58.03 -45.49 86.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.008 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.69 ' HA ' HD23 ' A' ' 98' ' ' LEU . 70.8 m-80 -60.81 -42.89 98.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.561 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -62.95 -32.87 74.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.516 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.858 HD12 ' HA ' ' A' ' 94' ' ' ALA . 21.1 mt -65.71 -48.07 73.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.69 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -68.67 -28.56 66.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.53 -36.81 76.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.56 -5.69 48.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.38 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 m -60.14 -20.15 57.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.207 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.7 m -63.13 -31.51 72.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.61 -59.2 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.133 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 106' ' ' LYS . 1.4 t -83.24 -7.88 59.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.294 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.731 ' O ' HG23 ' A' ' 30' ' ' THR . 1.9 p 80.82 -8.65 1.43 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.628 ' O ' HG23 ' A' ' 104' ' ' THR . 5.5 ptpt -156.5 163.37 39.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 111.166 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.4 147.97 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.709 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.833 HG22 HG22 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -112.74 112.05 23.27 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.245 179.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -108.85 125.62 52.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.934 0.397 . . . . 0.0 111.946 -179.157 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.882 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 6.8 tt0 -93.11 104.87 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.881 ' CG2' HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -110.09 158.53 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.179 -178.555 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -116.82 119.0 34.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.247 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CZ ' ' CG ' ' A' ' 23' ' ' GLU . 23.0 p90 -109.28 140.67 42.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.142 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -119.69 97.5 5.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.288 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.414 ' CG2' ' CB ' ' A' ' 21' ' ' HIS . 30.5 m -86.92 151.96 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.376 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.28 45.44 2.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -95.61 44.54 1.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.765 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.816 ' OG ' HG23 ' A' ' 19' ' ' VAL . 47.4 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.727 0.299 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.1 t -74.3 79.12 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 t -73.23 116.21 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.665 ' O ' HG23 ' A' ' 22' ' ' THR . 0.5 OUTLIER -90.38 176.62 6.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 21' ' ' HIS . 0.2 OUTLIER 170.39 110.42 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.398 -179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -155.69 169.6 23.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 111.052 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.0 p -94.66 130.66 41.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.457 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.639 HG23 HD11 ' A' ' 111' ' ' ILE . 4.6 t -111.79 135.29 52.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.828 0.346 . . . . 0.0 111.409 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.1 pt-20 -99.82 98.82 9.58 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.737 HG11 ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -105.19 111.54 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.94 -179.203 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.872 HG22 HG22 ' A' ' 108' ' ' THR . 10.6 t -82.7 121.85 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.092 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' A' ' 65' ' ' PRO . 4.1 mm? -111.9 140.58 46.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 105' ' ' SER . 26.8 m -105.34 147.85 27.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.808 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.618 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -90.37 104.25 16.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.243 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.24 135.18 76.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.677 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.12 55.79 5.48 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.558 2.172 . . . . 0.0 112.489 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.9 t -155.21 -49.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.942 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -125.4 -44.11 1.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.968 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.76 -121.09 4.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.425 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.618 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 40.4 m-85 -110.97 -26.2 9.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.705 0.288 . . . . 0.0 111.082 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.96 33.66 79.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.794 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.537 HG22 ' HB3' ' A' ' 37' ' ' PHE . 1.1 tt -136.95 140.76 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.448 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 68.2 mm-40 -131.7 136.69 47.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.127 0.489 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.975 HD13 ' HB1' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -112.25 130.36 55.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.717 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -82.24 137.1 34.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.65 -20.44 46.64 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.54 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.417 ' CB ' ' HG ' ' A' ' 51' ' ' LEU . 12.2 p -155.49 -177.42 6.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.964 0.411 . . . . 0.0 111.055 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.803 HG22 HD13 ' A' ' 56' ' ' LEU . 69.2 t -63.48 -81.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.061 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.53 132.48 10.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.29 105.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.081 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 p -58.04 -20.56 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.343 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -144.76 122.73 12.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.894 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 62.21 172.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.007 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' H ' HG22 ' A' ' 50' ' ' THR . 9.5 tt -107.22 140.34 40.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.13 21.57 0.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.818 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.494 ' HB3' HG23 ' A' ' 45' ' ' VAL . 3.2 m -141.77 160.53 55.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.054 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.711 ' O ' HD12 ' A' ' 56' ' ' LEU . 53.7 Cg_endo -69.25 151.97 71.98 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.586 2.19 . . . . 0.0 112.251 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.38 146.78 95.99 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.641 2.227 . . . . 0.0 112.284 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.803 HD13 HG22 ' A' ' 45' ' ' VAL . 1.8 mp -157.16 136.67 12.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.353 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.541 ' CD1' HG21 ' A' ' 111' ' ' ILE . 68.1 mt -71.51 144.84 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.436 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.2 p -163.4 55.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.986 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.448 ' CD1' ' HG2' ' A' ' 40' ' ' GLN . 11.2 t80 -177.95 132.68 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 111.618 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.431 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -152.89 152.03 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.751 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -96.87 155.13 16.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.38 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.97 41.91 0.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.918 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.428 ' N ' ' NH2' ' A' ' 68' ' ' ARG . 1.2 p30 168.88 32.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.705 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.78 145.86 44.35 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.697 0.284 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.678 ' HB2' HD12 ' A' ' 29' ' ' LEU . 82.0 Cg_exo -44.96 -37.21 12.07 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.769 2.313 . . . . 0.0 112.578 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.505 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -59.07 -38.95 80.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.977 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -76.16 -50.18 15.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.687 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.428 ' NH2' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.9 -8.74 56.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.667 -179.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.511 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -58.25 -24.89 60.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.664 0.268 . . . . 0.0 110.79 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.14 30.24 77.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.148 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.737 ' HB ' HG11 ' A' ' 27' ' ' VAL . 9.3 t -142.3 -49.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.348 . . . . 0.0 111.068 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 39' ' ' ILE . 9.5 mt -69.22 159.62 32.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.032 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 -171.14 3.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' O ' HG22 ' A' ' 74' ' ' ILE . 24.7 mm -93.58 49.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.76 39.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.65 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -89.95 146.15 24.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.762 0.315 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.6 85.31 2.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.052 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.918 HG11 HD11 ' A' ' 81' ' ' ILE . 2.6 t -55.54 159.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -50.49 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.45 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.27 86.29 1.76 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.808 0.337 . . . . 0.0 111.641 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.918 HD11 HG11 ' A' ' 78' ' ' VAL . 4.3 mt -77.51 111.81 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.771 HD22 HG22 ' A' ' 81' ' ' ILE . 8.4 p30 46.53 28.42 0.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.228 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 85' ' ' PRO . . . 112.94 -49.57 0.84 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.418 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.9 mm -69.33 109.12 3.89 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.548 0.213 . . . . 0.0 111.182 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 87.0 Cg_endo -94.63 155.98 1.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.907 2.405 . . . . 0.0 112.458 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p -130.95 114.15 14.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.407 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -116.63 -70.66 0.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.424 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -110.61 112.73 24.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 111.286 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.2 m 47.14 83.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.242 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.16 30.96 1.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.799 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -58.28 -47.87 82.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.721 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -45.66 91.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.572 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -62.31 -30.55 71.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.975 ' HB1' HD13 ' A' ' 41' ' ' LEU . . . -67.46 -42.51 82.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.442 ' HA ' HD23 ' A' ' 98' ' ' LEU . 2.0 m-80 -67.36 -41.7 84.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.441 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -64.33 -53.05 54.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.222 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 98' ' ' LEU . 4.2 pp -57.89 -35.19 70.66 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.159 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.888 ' N ' HD12 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -78.47 -35.5 46.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.727 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -27.84 67.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -15.3 63.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.175 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.455 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -73.33 -21.57 60.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.885 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.0 t -70.03 -32.38 70.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.815 0.341 . . . . 0.0 110.408 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.3 mt -82.03 -41.73 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.681 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.0 m -79.74 -20.28 46.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.856 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.669 ' O ' HG23 ' A' ' 30' ' ' THR . 2.6 m 76.78 -1.76 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.789 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.459 ' CE ' HG11 ' A' ' 28' ' ' VAL . 10.1 tttt -156.56 152.24 27.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.825 0.345 . . . . 0.0 111.501 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.415 HG12 ' CE2' ' A' ' 37' ' ' PHE . 13.8 p -150.65 151.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.239 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.872 HG22 HG22 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -107.95 109.45 20.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.988 0.423 . . . . 0.0 110.531 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.76 HD22 HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -87.5 127.94 35.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.512 -179.35 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -119.25 104.6 10.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.097 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -124.92 162.7 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.091 0.472 . . . . 0.0 112.088 -178.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.52 118.61 37.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.779 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.45 ' CD1' HG23 ' A' ' 115' ' ' VAL . 29.3 p90 -107.36 161.39 14.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.309 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -133.74 97.42 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.394 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.45 HG23 ' CD1' ' A' ' 113' ' ' PHE . 3.4 t -86.53 141.01 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -147.27 47.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.52 56.4 1.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.861 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.96 179.94 . . . . . . . . 1 1 . 1 stop_ save_